{"title": "PDF", "author": "PDF", "url": "www.incliva.es/wp-content/uploads/2023/07/Memoria-2021_.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "SCIENTIFIC REPORT 2021 Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico of Valencia INCLIVA Health Research Institute2021 SCIENTIFIC REPORT Avda. Men\u00e9ndez Pelayo, 4 accesorio \u00b7 46010 Valencia (Espa\u00f1a) Tel. 34 96 197 35 17 Fax 34 96 197 35 40 www.incliva. es incliva@incliva.es Published by: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia INCLIVA Health Research Institute Avd. Men\u00e9ndez Pelayo, 4 Accesorio - 46010 Valencia Direction: Andr\u00e9s Cervantes Ruip\u00e9rez MD PhD, General Director Coordination and writing: Scientific Management Department Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia INCLIVA Health Research Institute Design: Marta Ballester Collado Layout: Antonio G. Valledor1. Introduction 5 2. INCLIVA origin and structure 9 2.1 History 11 2.2 Organizational structure 12 2.3 Core facilities 17 3. INCLIVA global analysis 19 3.1 Scientific production global analysis 21 3.2 Financial resources 24 3.3 Cooperative research networks 28 3.4 Knowledge transfer activities 29 3.5 Gender perspective 36 4. Scientific activity 43 4.1 Scientific structure 45 4.2 Scientific translational programs 46 4.2.1 Overweight and cardiovascular and renal risk 46 4.2.2 Detection and control of ventricular dysfunction associated diseases 59 4.3 Research areas 63 4.3.1 Cardiovascular Area 65 4.3.2 Oncology Area 96 4.3.3 Metabolism 126 4.3.4 Reproductive Medicine Area 177 4.3.5 Associated Clinical Groups 187 4.4 Hospital division research area 190 4.5 Other scientific contributions from scientific platforms Unit 5. Clinical trials and other studies 247 5.1 Activity of the Ethical Committee for investigation with medicinal products (CEIm) 249 5.2 Clinical research activity performed by Valencia Cl\u00ednico-Malvarrosa Health Department 251 6. Initiatives for research promotion 257 6.1 Grants for external fellowships 259 6.2 Training and teaching activities 263 7.1 Highlights 2021 267 8. INCLIVA social 269 projects 274 8.2 Private philanthropic donations and acknowledgments 276 9. Publication list. present this year's INCLIVA Annual Scientific Report, an appraisal of the scientific activity carried out in 2021 by research groups at the Hospital Cl\u00ednico Universitario de Valencia and its Department of Health, as well as the groups of scientific excellence at the Faculty of Medicine and Dentistry of the University of Valencia and the INCLIVA-affiliated IGENOMIX Foundation. The following pages show the result of the joint effort of our professionals, which have consolidated INCLIVA as among the foremost health research institutes in Spain in 2021, with great international prestige and exceptional scientific output. The main milestones reached this obtained a accreditation from the Carlos III Health Institute (ISCIII) as a health research institute after meeting the biomedical health research institute accreditation requirements and evaluation criteria set out in articles 4 and 11, respectively, of Royal Decree 279/2016, June that INCLIVA \"is a clinical and translational research centre with a solid track record, on good course to adapt to the requirements of the new accreditation guide, especially in the areas of impact, transfer and citizen participation\" highlight via of young researchers\". As a second notable milestone, INCLIVA Board of Trustees has approved the renewal of the Conselleria de Sanidad Universal y Salud P\u00fablica (Universal Healthcare and Public Health) agreement for research management at the Clinical Hospital and Department of Health. The first collaboration framework agreement between INCLIVA and the Ministry of Health establishing the rules of collaboration between the entities to manage and facilitate research activity at the Clinical Hospital Department of Health was formalized in November 2000. New agreements have subsequently been signed, the latest in 2013 which was extended in 2017 until 2021. In light of the success of this both entities have signed a new framework agreement. Throughout its history, INCLIVA has been committed to quality of life in people with rare diseases; indeed, we are the first Health Research Institute in Spain to create a rare diseases research area, and have promoted the creation of the Alliance for Translational Research in Rare Diseases, an initiative awarded by the Spanish Federation of Rare Diseases (FEDER). This firm commitment to rare diseases research has led to the incorporation of FEDER to the INCLIVA Board of Trustees to intensify its line of transversal also strengthens INCLIVA's competitive civil society and patients, due to the translational nature of our research. Regarding scientific output, our research staff published 834 articles in 2021, with a cumulative impact factor of over 6,000 points. The quality of our scientific output should also be highlighted: around 80% of published articles are in the first and second quartiles, 20% in the first decile and 21% with an impact factor higher than 7. In addition, 46% of scientific output has involved international collaboration. A total of 65 doctoral theses were defended in 2021, 12 of them obtaining nearly five million euros in funding for 20 new national and regional projects. Our researchers have also achieved million euros in funds for projects in the areas of oncology, women's health, microbiology, big data and artificial intelligence, personalized medicine, aging and fragility. In other standout activity, we have participated in international networks such as the Big Data Value Association (BDVA/DAIRO), infrastructure for translational medicine cancer medicine. Turning to calls for staff funded by the Carlos III Health Institute, in total, Incliva staff were awarded two Joan Rod\u00e9s grants, two R\u00edo Hortega grants, a new Miguel Servet grant, the confirmation of a Miguel Servet type II grants, and two predoctoral grants in health research. In addition, two national predoctoral grants were obtained (Ministry of Science, and Ministry of Universities). Likewise, ten grants were awarded from the Department of Innovation, Universities, Science and Digital Society of the Autonomous Public Health Department, and two grants from the Valencian Innovation Agency. Another key achievement in 2021 has been formal recognition of a new emerging group working within the priority research lines of cardiovascular, metabolism and organ damage and medicine. Regarding clinical trials, our Drug Research Ethics Committee (CEIm) at the Hospital Cl\u00ednico Universitario de Valencia, the first to receive this certification in the Valencian Community and among the first at a national level, has been a reference committee in 70 of 84 studies since the new legislation was approved in 2016, and throughout 2021 it has started 206 of 269 new clinical studies, and is involved in 579 of a total of 596 active studies this year. In December 2021, the obtained UNE166002 standard. Another of the year has patients\" (number EP16382509) in September. addition, has two has resulted in an important milestone for the Quality and Data Protection Unit, which obtained the certificate of compliance with the ISO:9001:2015 quality standard for technical Scientific SCIENTIFIC REPORT 2021INCLIVA origin and structure 22.1. History The Hospital Cl\u00ednico Universitario of Valencia Research Foundation was constituted in the year 2000 as the first Valencian research foundation affiliated to a public hospital. Ten years later, various centers of excellence in biomedical research from the University of Valencia and IGENOMIX joined the Foundation through the establishment of specific agreements, and thus INCLIVA Health Research Institute aims are to manage the biomedical research carried out by the Hospital Cl\u00ednico Universitario de Valencia and its Health Department, and to encourage teaching and scientific activities, thus improving sharing. In 2011 INCLIVA was accredited as a Health Research Institute by the Ministry of Science and Innovation thus obtaining preferential treatment from the Carlos III Health Institute, in recognition of its excellence in renewal of its accreditation as Health Research Institute for the next five years. 12 INCLIVA SCIENTIFIC REPORT 2021INCLIVA Foundation, the Board of Trustees is headed by the Regional Minister for Health of the Valencian Government. This body appoints a Board of Governors - headed by the Chief Executive Officer of the Health Department - the General Di- rector, the Scientific Director and the Financial Director. These are guided by two Research Committees: the External Scientific Committee and the Internal Scientific Committee. 2.2.1.1 Board of Trustees President, Ms. Ana Barcel\u00f3 Chico, Regional Minister for Health of the Valencian Government Vice-president, Mr. \u00c1lvaro Bonet, Chief Executive Officer of the Hospital Cl\u00ednico Universitario of Valencia and of the Valencia Cl\u00edni- co - Malvarrosa Health Department Board members Mrs. Mar\u00eda Vicenta Mestre, Distinguished Dean of the University of Valencia Mrs. Concha Andr\u00e9s Sanchis, Autonomous Secretary of Efficien- cy and Health Technology of the Conselleria de Sanidad Universal y Salud P\u00fablica (Autonomous Public Health Department) of the Valencian Government Mr. Javier Burgos Mu\u00f1oz, General Director of Research and High Sanitary Inspection of the Conselleria de Sanidad Universal y Salud P\u00fablica (Autonomous Public Health Department) of the Valencian Government Mrs. Emilia Ad\u00e1n Garc\u00eda. President of the Social Council of the University of Valencia Mr. Carlos Sim\u00f3n, Scientific Director of the IGENOMIX Founda- tion Mr. Francisco Javier Chorro, Distinguished Dean of the Faculty of Medicine of the University of Valencia Mr. Jos\u00e9 Bernardo Noblejas P\u00e9rez, Valencia Chamber of Com - merce Mrs. Mar\u00eda \u00c1ngela Nieto Toledano, Instituto de Neurociencias de Alicante CSIC Mr. Rafael Alc\u00f3n Traver, President of Bancaja Foundation Mr. Joaqu\u00edn Santo, Valencian Council of Culture Mr. Juan L\u00f3pez-Trigo Pich\u00f3, Ca\u00f1ada Blanch Foundation Mr. Andr\u00e9s Cervantes Ruip\u00e9rez, INCLIVA General Director Mr. Rub\u00e9n Ventura, Fero Foundation Mrs. B\u00e1rbara Congost Mir\u00f3n, FEDER representative, Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras Board members under own name Mr. Carlos Pascual Mr. Joaqu\u00edn Ortega Serrano Mrs. Ana Lluch Hern\u00e1ndez Mr. Tom\u00e1s Tr\u00e9nor Puig Mr. Manuel Delgado Rodr\u00edguez, Board of Trustees Secretary 2.2.1.2 Board of Governors Mr. \u00c1lvaro Bonet Pla, Chief Executive Officer of the Hospital Cl\u00edni- co Universitario of Valencia and of the Valencia Cl\u00ednico - Malvar - rosa Health Department Mr. Francisco Javier Chorro, Distinguished Dean of the Faculty of Medicine of University of Valencia Mr. Andr\u00e9s Cervantes Ruip\u00e9rez, INCLIVA General Director Mr. Vicente de Juan Mart\u00edn, Financial-Administrative Director Mrs. Ana Sanmart\u00edn Almenar, Primary Care Director of the Hos - pital Cl\u00ednico Universitario of Valencia and of the Valencia Cl\u00ednico - Malvarrosa Health Department 13 INCLIVA SCIENTIFIC REPORT 2021INCLIVA origin and structure 2 Mr. Jorge Navarro P\u00e9rez, Medical Director of the Hospital Cl\u00edni- co Universitario of Valencia and of the Valencia Cl\u00ednico - Malvar - rosa Health Department Mr. Javier Burgos Mu\u00f1oz, General Director of Research and High Sanitary Inspection of the Conselleria de Sanidad Universal y Salud P\u00fablica (Autonomous Public Health Department) of the Valencian Government Mr. Pascual Medina Bes\u00f3, Coordinator of Central Medical Re- search Unit of the Faculty of Medicine of University of Valencia 2.2.1.3 General and Scientific Director Professor Andr\u00e9s Cervantes Ruip\u00e9rez is Full Professor of Medicine at the University of Valencia, Head of the Oncology Service of the Hospital Cl\u00ednico Universitario of Valencia and Director of the Cancer Area at the INCLIVA Health Research Institute. His training as a resident medical intern took place at the Hospital Cl\u00ednico Universitario of Valencia. After completing this residency, he ob- tained a predoctoral fellowship at the Free University Hospital in Amsterdam, where he obtained his Doctorate in the laboratory of cellular pharmacology, with work on multidrug resistance. His areas of interest and research are gastrointestinal and gynecological cancer, as well as phase I trials As clinical researcher in rectal cancer, he has published several papers on the quality of multidisciplinary work as well as on treat cancer of the upper third of the rectum. He is the President of the European Society of Medical Oncology (ESMO) since July 2019. Mr. Manuel Al\u00f3s, Head of the Pharmacy Service of Hospital Cl\u00ednico Universitario of Valencia and of the Valencia Cl\u00ednico - Malvarrosa Health Department Mrs. Marina Soro, President of Ethic Committee for Investigation with medicinal products Mr. Federico Pallard\u00f3, Professor of the Department of Physiology of the University of Valencia Mr. Carlos Sim\u00f3n, IGENOMIX Foundation Mrs. Maite S\u00e1enz, Secretary General 2.2.1.4 External Scientific Committee Mr. Javier D\u00edez. Professor of Medicine, University of Navarra. Director of the Cardiovascular Sciences Area, Center for Applied Medical Research (CIMA). University of Navarra Mr. Antonio Vidal-Puig. Professor of Molecular Nutrition and Metabolism, University of consultant in metabolic medicine. Metabolic research laboratories. Addenbrooke\u00b4s Hospital, Cambridge, United Kingdom Mr. Josep Tabernero. Head of the Medical Oncology Service. Vall d'Hebr\u00f3n Hospital. Mr. Juan Carlos Lacal Sanju\u00e1n. Research Professor at the CSIC. Institute of Biomedical Research, Madrid Mr. Manuel Tena Sempere. Professor of University. Department of Cell Biology, Physiology and University of Cordoba Mr. M Roser Torra Balcells. Nephrologist, Fundaci\u00f3 Puigvert. Research line in the Diseases Mrs. Laura Saucek. Group leader at VHIO (Oncology Institute of the Vall d'Hebron Hospital). Head of Modeling of Anti- tumor Therapies in mice. Founder executive director (CEO) at Peptomycs SL 14 INCLIVA SCIENTIFIC REPORT 2021INCLIVA origin and structure22.2.1.5 Internal Scientific Committee Mr. Andr\u00e9s Cervantes Ruip\u00e9rez, INCLIVA General Director Mrs. Ana Sanmart\u00edn Almenar, Primary Care Director of the Hospital Cl\u00ednico Universitario of Valencia and of the Valencia Cl\u00ednico - Malvarrosa Health Department Mr. Jorge Navarro P\u00e9rez, Medical Director of Hospital Cl\u00ednico Universitario of Valencia and of the Valencia Cl\u00ednico - Malvarrosa Health Department Mr. Julio N\u00fa\u00f1ez, Associate Professor of the Department of Medicine of the University of Valencia, attached to the Scientific Direction Mr. Vicente Bod\u00ed, Full Professor of the Department of Medicine of the University of Valencia Mr. Josep Red\u00f3n, INCLIVA Emeritus Researcher Mr. Federico Pallard\u00f3, Full Professor of the Department of Physiology of the University of Valencia Mrs. Mar\u00eda Jes\u00fas Sanz Ferrando, Full Professor of the Department of Pharmacology at the University of Valencia Mrs. Ana Lluch Hern\u00e1ndez, Emeritus Professor of the Department of Medicine of the University of Valencia Mrs. Mar\u00eda del Mar Tormo Garc\u00eda, Oncologist at the Hospital Cl\u00ednico Universitario of Valencia and of the Valencia Cl\u00ednico - Malvarrosa Health Department Hematology Service RESEARCH COMMISSION President: Mr. Luis Sabater Ort\u00ed, Section Head of Cardiology Associate at INCLIVA Mr. Jaime Signes-Costa, Neumology Service Head Mrs. Rosa Zaragoz\u00e1 researcher at INCLIVA Mr. Vicente Jos\u00e9 Bod\u00ed Peris, Professor of the Department of Medicine of the University of Valencia Mrs. M\u00aa Jos\u00e9 Terol Castera, Isabel Gabald\u00f3n S\u00e1nchez, Valencia Cl\u00ednico - Malvarrosa Health Department Mr. David Moro Valdezate, General Sugery Associate Physician Mrs. Mar\u00eda del Mar Tormo D\u00edaz, Hematology and Hemotherapy Associated Physician Mrs. Laura Piqueras Ruiz, researcher at INCLIVA Mrs. Patricia Rosell\u00f3, Pediatrics Associated Physician Mr. Mart\u00ednez Herv\u00e1s, Endocrinology and Associated Physician Mrs. Herminia Gonz\u00e1lez Navarro, Pilar researcher Jos\u00e9 Real Collado, Head of the Endocrinology and Nutrition Service Mr. Ra\u00fal G\u00f3mez Gallego, researcher at INCLIVA Mr. F. Javier Chaves Mart\u00ednez, researcher at INCLIVA Mr. Daniel Monle\u00f3n Salvad\u00f3, Carlos Rentero Medicine Unit Mrs. Ana Bel\u00e9n Paes, researcher at INCLIVA Mr. Jos\u00e9 Luis G\u00f3rriz Teruel, Head of the Nephrology Service Mr. Antonio Mart\u00ednez Sabater, general supervisor at the Hospital Cl\u00ednico Universitario de Valencia Mr. C\u00e9sar R\u00edos Navarro, researcher at INCLIVA Mrs. Lorena Peir\u00f3 Chova, researcher at Biobank Commission Management Unit : Mrs. Sof\u00eda Galant15 INCLIVA SCIENTIFIC REPORT 2021INCLIVA origin and structure 2INNOVATION Andr\u00e9s Cervantes Ruip\u00e9rez, INCLIVA General Director Commission Management: Mrs. Marta del Olmo Zurriaga, Head of UAI Mr. Vicente de Juan Mart\u00edn, Financial-Administrative Director Mr. Jorge Navarro P\u00e9rez, Medical Director of Hospital Cl\u00ednico Universitario de Valencia and of the Valencia Cl\u00ednico - Malvarrosa Health Department Mrs. Marta Peir\u00f3 Signes, Scientific Subdirector at INCLIVA Mrs. Maite S\u00e1enz Gonz\u00e1lez, Secretary General at INCLIVA Mr. Josep Red\u00f3n, INCLIVA Emeritus Researcher Mr. Enrique Rodr\u00edguez Borja, Clinical researcher with experience in the field of innovation Mr. Miguel Puche Torres, Clinical researcher with experience in the field of innovation Mr. Federico Pallard\u00f3 Calatayud, Basic researcher with experience in the field of innovation Mr. Rub\u00e9n Artero Allepuz, Basic researcher with experience in the field of innovation Mrs. Consuelo Borr\u00e1s Blasco, Basic researcher with experience in the field of innovation Mr. Felip Vilella Mitjana, Basic researcher with experience in the field of innovation Mrs. Carolina Mir S\u00e1nchez, Clinical researcher with experience in the field of innovation Mrs. Maite S\u00e1nchez, Clinical researcher with experience in the field of innovation 2.2.1.6. Ethics Committee for Investigation with Medicinal Products President : Mrs. Marina Soro Domingo, Head of Section of the Anesthesiology and Reanimation S\u00e1nchez, Clinical pharma- cologist Technical Secretary: Mr. Julio Palmero Da Radio- diagnosis Service Members: Mr. Manuel Al\u00f3s Almi\u00f1ana, Head of the Pharmacy Department Mr. Diego V. Cano Blanquer, Hospital Pharmacist Mr. Jos\u00e9 Luis Trillo Mata, Primary Care Pharmacist Mrs. M\u00aa Jos\u00e9 Tar\u00edn Blasco, Law Degree Mr. David Juan L\u00f3pez Ortega, Law Degree Mrs. Carmen Celda Ortega, Nurse Mr. Luis Gonz\u00e1lez Luj\u00e1n, Primary Attention doctor Mr. Joaqu\u00edn Ortega Serrano, Head of the General Surgery Ser- vice Mrs. Patricia Rosell\u00f3 Millet, Specialist of the Pediatrics Depart - ment Mr. Ruiz Granell, Head of of Cardiostimulation of Cardiology Department Mrs. M\u00aa Jes\u00fas Puchades Montesa, Specialist of the Nephrology Department Mr. Jos\u00e9 Alejandro P\u00e9rez Fidalgo, Specialist of the Oncology De - partment Mrs. Tania Fleitas Specialist Mu\u00f1oz, - Mr. Pel\u00e1ez Hern\u00e1ndez, Allergy Specialist Mr. Francisco Das\u00ed Fern\u00e1ndez, Stabilized Miguel Servet Re- searcher Mr. Luis Miguel Bayo Calaforra, \"Amics de la Gent Major\" Foun- dation Mr. Protection INCLIVA Administrative Llopis 16 INCLIVA SCIENTIFIC REPORT 2021INCLIVA structure22.2.2. Projects Management Training Event Trial CEIM Technical SecretaryHuman g General Service sRecruitmentAdmission, Archives andCommission Areas and Research Groups for Research Suppor t Research Areas Research Groups Emerging researcher sBiobank General Secretar y Support Unit s Management Are a Research Are aGeneral Directo rBOARD OF GOVERNORSBOARD OF TRUSTEES sCentral Medical is comprised of two sub-directorates, economical and scientific. The first sub-directorate is in charge of the administrative area, which deals with the financial and administrative matters as well as with human resource management. The second is in the charge of scientific activity management and innovation. It is responsible for integral scientific management that includes controlling and monitoring trials administrative support to the different affiliated scientific committees and to the Medical Research Central Unit. It comprises the innovation area in charge of quality and Housing Operating Theaters Unit Proteomics Unit Small Animals Camera de Juan Budget Control and Economic Management: Consuelo L\u00f3pez Human Resources and Equality Unit: Ruth Cano, Anabel Gil, Luc\u00eda Toledo Invoicing and Project Justify: Vera Mar\u00edn, Karen Iglesias, M\u00aa Rosal\u00e9n Records Unit: Garc\u00eda Receptionists: Inmaculada Montalt, Alicia Gumiel SCIENTIFIC MANAGEMENT AREA: Scientific Subdirector and Project Management: Marta Peir\u00f3 Scientific Culture Unit: Mercedes Navarro International projects Unit: Ana Ferrer, Ana Duarte, Eugenia Flores Innovation Management Unit: Marta de Olmo, Carlos Guerre- ro Clinical Management Unit: Dolores Iglesias, Portol\u00e9s, Merce- Ferrandis, Carlos Peris Training and Events Unit: Cristina Garc\u00eda, Mercedes Navarro, Clara Soriano CEIm Administrative Management: Sof\u00eda Galant, Maialen Llo- pis, Carlos Ballesteros Data Quality and Protection: Rafael Barajas, Mar\u00eda Dom\u00ednguez Scientific Production Unit: Patricia Ma\u00f1as Communication: Alexandra Mu\u00f1oz COMPUTING UNIT: Head of Information Systems and High Performance Compu- ting: Miguel Herreros IT system administrator and programmer: Enrique Herreras Computer technician: Joan Josep Lorena Munueraglobal analy- sis INCLIVA SCIENTIFIC REPORT 20213. Global analysis 3.1 Scientific production global analysis 3.2 Financial resources 3.3 Cooperative research networks 3.4 Knowledge transfer activities 3.4.1 Knowledge transfer to the National Health System analysis 33.1 Scientific production global analysis As in previous years, INCLIVA continued in 2021 with the upward trend in the quality of scientific production. The number of publications this year is 834, with a cumulative impact factor of 6.028,392 which translates into an 7,228. The following figures depict the number and of the published ma - nuscripts expressed in terms of total and Cumulative impact factor858834 shown below. In 2021, about 80% of papers that were published in in- dexed journals belong to the first quartile publications 2021 are: 21% 23% 20% 24% INCLIVA SCIENTIFIC analysis 3Another key performance indicator is the leadership role in scientific publications. The chart below shows the number of published articles in which sign as the main success factors for a biomedical research institution has to do with its potential to establish high level scientific collaborations. The percentage of national and international collaborations which led scientific output in 2021 is Collaborations Leadership in Correspondig of recent Funding source period among others. 2021.14.930.802 7.101.402 7.685.5928.268.804 9.832.90810.006.078 10.447.574 2014 analysis of the income obtained by the Foundation in its last fiscal year (2021) is shown the Annual Accounts of 2021 approved by the Board of Trustees of the Foundation and audited by the General Intervention of the Generalitat Valenciana (through the audit firm Fides Auditores) the information of the expenses executed is provided, with the explanation of the 2021global analysis3Finally, is the balance sheet of the foundation in official format, extracted from the Annual Accounts of 2021: receivables 5.341.276,58 5.267.161,86 Current Investments in group 6. 2021global analysis 3EQUITY YEAR 2021 2020 67.086,01 43.710,99 TOTAL NET LIABILITIES (A + C) 42.977.974,69 38.362.424,2028 INCLIVA SCIENTIFIC REPORT 2021global analysis33.3 Cooperative research networks The Carlos III Health Institute develops - through the General Subdirection of Networks and Centers for the Cooperative Research - the creation of stable research network structures such as CIBER (Network of Centres for Biomedical Research). INCLIVA participates in this research structure through its associated groups. The following table shows the participation in scientific networks according to the prioritized research area, the center and its principal investigator. CIBER Research Area INCLIVA PI Scientific Network Reference Tom\u00e1s Real CB07/08/0018 Mrs. Empar CIBERrer analysis 33.4 activities INCLIVA Health Research Institute is fully committed to transfer the knowledge created both to the National Health System and to the industrial sector in order to fulfil its organizational mission. 3.4.1 Knowledge transfer to the National Health System Clinical guidelines and consensus documents are one of the best indicators of knowledge transfer from research to clinical practice. The following table shows the guidelines have these clinical practice guidelines, 4 have been implemented in the IIS health centers. Clinical guidelines IF Oki E, Martinelli E, Taniguchi H, Arnold D, Mishima S, Li Y, Smruti B, Ahn J, Faud I, Chee C, Yeh K, Lin P, Chua C, Hasbullah H, Lee M, Sharma A, Sun Y, Curigliano G, Bando H, Lordick F, Yamanaka T, Tabernero J, Baba E, Cervantes A, Ohtsu A, G, European of Hyperten- sion practice guidelines for office and out-of-office blood pressure M, G, Persu A, Polonia J, Rajzer M, de Timary P, Weber T, Weisser F, Erkkola R, Goulis DG, L, P, Manso L, Martin-Lorente C, Martinez-Garcia J, Perez-Fidalgo J, Varela M, F, Paz J, Garcia March G, Santos-Lasaosa S, Latorre G, Gonzalez-Oria C, Rodriguez R, Pozo-Rosich Neuromodulation in headache and craniofacial neuralgia: guidelines from the Spanish Society of 1. Martin. Garcia A, Mitroi C, Mazon Ramos P, Garcia Sanz R, Virizuela J, Arenas M, Egocheaga Cabello I, Albert D, Anguita Sanchez M, Arrarte Esteban V, Ayala de la Pena F, Bonanand Lozano C, Castro A, Castro Fernandez A, Cordoba R, Cosin-Sales J, Chaparro-Munoz M, Dalmau R, Drak Hernandez Y, Deiros Bronte L, Diez-Villanueva P, Escobar Cervantes C, Fernandez Redondo C, Garcia Rodriguez E, Lozano T, Marco Vera P, Martinez Monzonis A, Mesa D, Oristrell G, Palma Gamiz J, Pedreira M, Reinoso-Barbero L, Rodriguez I, Serrano Antolin J, Toral B, Torres Royo L, Velasco Del Castillo S, Vicente-Herrero T, Zatarain-Nicolas E, Tamargo J, Lopez Fernandez T. Stratification and management of cardiovascular risk in cancer patients. A S, Lopez Castro R, Martinez Hernandez N, Mezquita Perez L, Moreno Casado P, Zabaleta Jimenez J. Spanish Society M, Julia Benito J, Ortega Casanueva C, Paniagua Calzon N, Perez Garcia M, Rodriguez Fernandez-Oliva C, Sanz Ortega J, Valdesoiro Navarrete L, Valverde-Molina Jimenez-Labaig P, Pacheco-Barcia V, Cebria A, Galvez F, Obispo B, Paez D, Quilez A, Quintanar T, Ramchandani A, Remon J, Sanchez D, Sanchez-Canovas A, Tarazona N, Cotes A, Gonzalez E, Bosch-Barrera J, Fernandez A, Felip E, Vera R, Rodriguez-Lescure A, Elez E. Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era: a study of the Spanish Society of Medical Bitzer J, Cano Ceausu I, Chedraui P, R, Geukes DG, Griffiths A, Hardy C, Hickey M, Hirschberg AL, Hunter M, Kiesel L, Jack G, Lopes P, Mishra G, Oosterhof H, Pines A, Riach K, Shufelt C, van Trotsenburg M, Weiss R, Lambrinoudaki I. Global recommendations V, Siepmann Martin-Moreno JM, Middleton J. ASPHER Statement: vu?. Planning for the Covid-19 third wave and planning for the winter 2021-22. International Journal of Knowledge transfer One of the main objectives of INCLIVA is the development of translational research, that is, research that transports scientific knowledge into clinical practice. To achieve this objective, multidisciplinary collaboration between treatment and, in conclu- sion, the quality of life of the patient. The Innovation Unit of gives support process, detecting ideas, evaluating them and facilitating their access to the market. This process that goes from the identification of a wide range of ideas to the market launch of those selected products or services through different phases is known as innovation funnel. The breakdown Pharma Bio Imaging Organizational Total Detection 3 4 0 6 0 3 16 Assessment 1 3 3 12 1 1 21 Development 1 2 2 3 0 0 8 Transfer 1 1 2 4 0 0 8 Market 2 2 1 3 1 2 11 Innovation Funnel 25 20 15 10 5 0 Detection Assets The protection knowledge is the first step to move scientific findings and ideas from researchers to the industry and the most common way to protect technologies that are new, inventive and have industrial application are patents. Research institutions can exploit the patents they hold by licensing them to companies. A large part of the results derived from the research activity, generated by the research staff in the field of their teaching and research functions, are capable of being protected by means of some of the forms of protection of industrial or intellectual property. During this year INCLIVA has obtained the license of two patents. The next plot summarizes the current status of these protected inventions. Patents Licensed Seeking partnering2013 2016 2 017 2018 2019 2020 202114 12 10 8 6 4 2 0 During 2021, 4 patents have been applied. The following the status of patent applications by territory Patent applications by territory ES EP US OTHERS4 39 533 INCLIVA SCIENTIFIC REPORT 2021global analysis 3The 2021. Use of Musashi 2 (msi2) as therapeutic target for the treatment of the characteristic myopathy of 1 66,67% EP 2019. Moxifloxacin for use in the treatment of spinal muscular atrophyES201930436 23% PCT 2019. Oropharyngeal obturation device ES20190003 100% PCT 2018. Injectable material for the regeneration of the articular cartilage ES201830730 29% PCT 2018. In vitro method for the circulating or shock (ss) patientsEP16382509.4 6%EU, USA, JP, CN, CA (Licensed) 2016. Intramedullary fixation device P201631220 2,5%EU, EEUU, Brasil (Licensed) 2016. Device the granted e internacionalizaci\u00f3n de HistShock, un test IVD para el diagn\u00f3stico y pron\u00f3stico de la sepsis y el shock s\u00e9ptico (FIPSE)\u20ac 30.000 Uso de moduladores de microRNAs como terapias experimentales en distrofia miot\u00f3nica de tipo 1 (GVA-APOTIP) \u20ac 36.000 \u20ac 8.600 Desarrollo precl\u00ednico Distrofia Miot\u00f3nica tipo 1 (DM1) (DTS-ISCIII)\u20ac 127.600 en p\u00e9ptidos marcados isot\u00f3picamente y espectrometr\u00eda de masas para la cuantificaci\u00f3n de histonas circulantes y prote\u00edna APC (DTS-ISCIII)\u20ac 122.100 Preservaci\u00f3n de \u00f3rganos de trasplante (ri\u00f1\u00f3n y coraz\u00f3n). Proyecto de CPI (CDTI-AINIA) \u20ac 169.491,70 2 Agentes de innovaci\u00f3n (AVI-Promoci\u00f3n Talento) \u20ac 250.677,62 Sistema de visi\u00f3n Artificial aumentada para la caracterizaci\u00f3n molecular y morfol\u00f3gica del C\u00e1ncer de piel (SAMUEL) (AVI-Estrat\u00e9gico)\u20ac 176.999,4 Sistema inteligente de apoyo a la toma de decisiones cl\u00ednicas en medicina de precisi\u00f3n (OGMIOS) generated in INCLIVA is disruptive and the researches willing to exploit it by themselves, the knowledge transfer is direct, thanks to the creation of a new venture (also known as a spin-off or start-up) based on such knowledge with the support S.L. Company created in 2014 as a result of a project led by researchers from INCLIVA and the Center for Research in Biomedicine Network (CIBER) in the area of Rare Diseases to transfer knowledge in the field of epigenetics and biomedical sciences at the service of society. Founding year: 2014 INCLIVA entrepreneurial team: Mr. Jos\u00e9 Mr. Federico Pallard\u00f3 http://www.epidisease.com/ Sequencing Multiplex S.L. Company created in 2013, which was born from the idea of generating solutions for research and clinical applications, using as a basis the S.L. The company arises from the results a Final Master Thesis in Biomedical Engineering, which lead to the obtaining of two patents on a novel intramedullary fixation system for joint endoprostheses, nails for fractures and exoprostheses; and a percutaneous ostomy Company created in 2020 at the University of Valencia that develops advanced RNA treatments against ge - medical needs. The first objective of the company will be to investigate anti-microRNAs for the treatment of ITEMAS Platform of the IDIBELL Node. INCLIVA is part of the Alliance for Health Inno - vation and Industrialization of the Mediterranean Axis (AIISEM) coordinated and created month, both the Technical Commission and the Strategic Commission. The Alliance has a 3-year Action or Work Plan divided into 5 key INCLIVA SCIENTIFIC REPORT guaranteeing real equality between women and the corresponding to activity in 2021 is as follows: Total cost INCLIVA staff 2021 Men \u20ac1,732,501.38 Women TOTAL 2021, whom percentage of women hired has increased every year for the last three years. following graphs differentiate between 69.89% of those carry Within the administrative area, 84.62% of Managerial/Technician positions are women and 100% of Auxiliary and Nursing staff con - tracts are for women In research, 96.30% of those hired as Nursing staff, 75% of Administrative staff and 64.03% of Research staff are women.Total cost of INCLIVA Staff 27% 4 10 5022 26893 1526 27Women 73% Administrarive Staff 30 20 10 0 150 100 50 0Auxiliary Research staffManagerial/Technician Nursing Men Women TotalSubordinate staff INCLIVA SCIENTIFIC REPORT 2021global 3Distribution by contract type The breakdown of contracts to for and 70.69% of tasks are for women. administration: 77.42% of contracts for women are temporary tasks for Auxiliary and Subordinate staff jobs. Fixed contracts for women within the administration are 100% for as Managerial/Technician. and 80% for research administration tasks are for women. 7 615 0 022 6 Shared parental leave Maternity/paternity leave was requested by only 9 employees throughout 2021: 3 by men, 6 by women. Organizational Unlike within our staff structure, governing bodies The each is summarized below: Men Women Total 2021 Board of Trustees 14 7 21 Board of Governors 10 3 13 External Scientific Committee 5 2 7 Internal Scientific Committee 6 4 10 Research Committe 15 18 33 Innovation Committe 10 5 15 Ethical Committee in Clinical Research 15 9 24 Research areas 4 0 4 Scientific translational programs 11 3 14 Research Groups 34 16 50Administrative Staff - women 25 20 15 10 Research Group staff A total of 636 researchers belong to consolidated, emerging and associated research groups, and whose EURAXESS profile distribution is as follows. Distribution by group of research staff in 2021: Distribution by group of research staff hired with public in 2021 Research projects Throughout tendering began for 20 new public projects, making a total of 129 currently active public projects under competitive tender. The Principal Investigators are distributed as shown in the table. In total, 33.33% of regional projects are led by women, compared with 36.67% of national projects and 7.69% of international projects. Men Women Total 2021 Autonomous Regions 17 8 24 National 57 33 90 International/European 12 1 13 Clinical studies and trials A total of 396 new studies 207 new female evaluators. 179 Submitted Essays 106 101 207 Evaluators 14 8 2280 70 60 50 40 30 20 10 0 250 200 150 100 50 0R1 REPORT to the in 2021 16 Patents in portfolio (IPs that have co-ownership of a patent) 11 9 20 Vlc-Biocl\u00ednic Applications 2021 14 16 30 Vlc-Biocl\u00ednic Concessions 2021 6 7 13 30 Bibliometric analysis: Research Institute (IIS) corresponding author, first and last author Of the 834 INCLIVA publications in 2021, the distribution of men to women according to the relevant position of signature (first, last with a Gender Perspective03/08/2021 RegionalINCLIVA SeminarOnline 1 21 always win (1st session)03/10/2021 LocalTraining DayOnline 3 10 of Science09/24/2021 face-to-face/ online1 9 You Always Win (2nd session)10/20/2021 LocalTraining DayOnline 2 17 3 14 1. Colloquium on Vision of Science of European Researchers' Night. The objective is to show the public the importance of science and research developed in Mediterranean countries -emphasizing the role of address Greece, Cyprus, the Valencian Community and the Murcia Region and is funded by the European Commission as part of the Marie responses received, 75% were from women (6 responses) and 25% from men (2 responses). The profes - sional profile comprised staff, 12.5% postdoctoral research staff, 12.5% management, administration and service staff, 25% others. 2. With equality you always win (2 sessions) The goals of this information day were to: Include the gender concepts on equality adapted to the work area. Make resources available to disaggregate data and statistics by sex. Provide resources and practical strategies to apply inclusive language in writing. Set guidelines and recommendations to contribute to real equality in material was provided. profile in 1st session: of the 10 responses received, 80% were from women (8 responses) and 20% from men (2 responses). The professional profile comprised 40% PI from Emerging Groups, 20% management staff, 10% emerging research staff, 10% manage - ment, administrative and services staff, 10% nursing staff, 10% others. Participant profile in 2nd session: of the 17 responses received, 82.4% were from women (14 responses) and (3 responses). The professional 35.3% 5.9% 5.9% principal research staff, 11.8% on Pain with a Gender Seminar given by Dr. Ana Peir\u00f3, Professor of Pharmacology at the Miguel Hern\u00e1ndez University of Elche and researcher at the ISABIAL Institute. YouTube link: https://youtu.be/-MAaVHQ8j28 Participant Profile: of the 21 responses received, 81% were from women (17 responses) and 19% from men (4 responses). The profes - sional profile comprised 28.6% administrative and services staff, medical staff, 14.3% research staff, 33% others. External stays Of a total of 8 external stays, 3 were granted to women, while of the 17 external stays funded by INCLIVA, 9 were women. In total, 48% of stays were completed by women.41 INCLIVA SCIENTIFIC REPORT 2021global Stays a total of 5 internal stays, 3 were granted to women, entailing 60% of total internal stays. Training placements The classification and distribution by gender placements in 2021 is shown in the table: Total 2021 Secondary and vocational training placements 3 19 22 Bachelor's placements 10 40 INCLIVA Calls) Total 21 88 109 Doctoral theses Below is a breakdown by gender of the 65 doctoral theses defended or supervised their in of those supervising the theses defended in 2021 were women. Men Women Total 2021 INCLIVA Doctoral students 7 17 4.2 Scientific translational 4.2.1 Overweight and cardiovascular risk Oncology Area Metabolism Area 4.3.4 Reproductive Medicine Area 4.4. Hospital divisions research areas 4.5 contributions articulates its research in 4 areas of research, 7 scientific programs, 4 platforms and one associated clinical group. Areas of research constitute the basis on which to articulate the scientific work of the groups: Research area in cardiovascular Research area in oncology Research area in metabolism and organ damage Research area in reproductive medicine Associated clinical group Scientific programs are aimed diseases from a translational perspective: Program in Overweight and cardiovascular and renal risk Program in Detection and control of ventricular dysfunction Program in Rare Diseases Program in Neurological Decline Program in Translational Oncology Program Reproductive in Aging and associated diseases Platforms are based on the provision of research services to the whole institute: Central Unit for Medical Research (UCIM) Biobank Precission Medicine Unit Bioinformatics and cardiovascular and renal risk Obesity and overweight is a field in which new strategies are developed both for prevention and treatment with the use of tradi- tional resources and the new technologies. The present program is focused on the study of pathology on the first stages of obesity (overweight with or without metabolic syndrome) integrating different clinical and experimental research studies. Coordinators: Dr. Jos\u00e9 Tom\u00e1s Real and Dr. Josep Redon i Mas Objectives: To deepen in the early alterations, mechanisms and biomar- kers that contribute to the development of obesity, vascular and renal alterations as a complication, from its fetal, biologi - cal, genetic and environmental origins To pathways susceptible to be thera- peutic targets Early application of new technologies for the prevention and treatment of obesity and vascular and renal alterations in overweight subjects Research lines: To renal changes in overweight sub- jects and in animal models To study the state, mechanisms of vascular inflammation and endothelial injury in overweight (genomic, epi - obesity and vascular and renal alterations overweight animal Interaction and and vascular and renal complicationsClinical groups: Research Group on the Study of Cardiometabolic and Renal Risk (Dr. Josep Red\u00f3n i Mas) Cardiometabolic Research Group on Primary Care (Dr. Jorge Navarro P\u00e9rez) Research Group on the Study of Cardiovascular Risk in Chil- dren and Adolescents (Dr. Empar Lurbe i Ferrer) Research Group on Oxidative Pathology (Dr. Guillermo S\u00e1ez Tormo) Research Group on Cardiometabolic Risk (Dr. Jos\u00e9 Tom\u00e1s Real Collado) Experimental groups: Research Group on Endothelial Cells (LINCE) (Dr. Carlos Herme- negildo Caudevilla, Dr. Susana Novella del Campo) Research Group on Molecular Imaging and Metabolomics (Dr. Daniel Monle\u00f3n Salvad\u00f3) Research Group on Inflammation (Dr. Esteban Morcillo S\u00e1n- chez, Dr. M\u00aa Jes\u00fas Sanz Ferrando) Research Group on Genetics of Osteoporosis (Dr. Miguel \u00c1ngel Garc\u00eda P\u00e9rez) Genomics and Diabetes Unit (Dr. Felipe Javier Chaves Mart\u00ednez) Molecular biology of renal and vascular dysfunction (Dr. Raquel Cort\u00e9s Vergaz)47 INCLIVA SCIENTIFIC REPORT 2021scientific molecular markers that its associated diseases measurements between associated diseases and morbidities and early altera - tions of metabolism. Focus on the metabolic interaction between Identification between associated diseases and morbidities and early altera - tions of metabolism. Focus on the metabolic interaction between (obese and morbid obese)X Development of new early detection sys - tems for between associated diseases and morbidities and early altera - tions of metabolism. Focus on the metabolic interaction between of targets obesity and its and deve of new therapiesX48 INCLIVA SCIENTIFIC REPORT 2021scientific Dr. Francisco J. Chorro Gasc\u00f3, Dr. Vicente Bod\u00ed Peris and Dr. Juan Sanchis Electrical Research lines: of direct electrophysiological effects of the active metabolite of sacubitril Study of modifications of the electrophysiological the inducibility of arrhythmias Development of useful working instruments in the study of car- diac multicenter registry (Hospital Cl\u00ednico Univer - sitario de Valencia and Hospital Cl\u00ednic de Barcelona and Hospi- tal Vall d'Hebr\u00f3n de Barcelona) Sanchis For\u00e9s) Research Group on Cardiac Experimental Electrophysiology (Dr. Francisco Javier Chorro Gasc\u00f3) Research Group on Heart Failure (Dr. Julio N\u00fa\u00f1ez Villota) Group on Translational Research in Ischemic Heart Disease (Dr. Vicente Bod\u00ed Peris) Cardiometabolic Research Group on Primary Care (Dr. Jorge Navarro P\u00e9rez) Research Group in Care. INVESTENF-INCLIVA (Dr. M\u00aa Jos\u00e9 Gastaldo Zaragoza) Experimental groups: Research Group on Endothelial Cells (LINCE) (Dr. Carlos Her- menegildo Caudevilla, Dr. Susana Novella del Campo) Research Group on Molecular Imaging and Metabolomics (Dr. Daniel Monle\u00f3n Salvad\u00f3) Research Group on Inflammation (Dr. Esteban Morcillo S\u00e1n - chez, Dr. M\u00aa Jes\u00fas Sanz Ferrando) Research Group on Nuclear Receptors in Cardiometabolic Pathology (Dr. Laura Piqueras Ruiz)4.2.2 Detection and control of ventricular dysfunction The program focuses study of the involved evaluation of diagnostic tools and markers and prognoses and on the study of new therapeutic approaches that may help to prevent their adverse consequences. It is a truly and translational research program that capitalizes the synergies between clinical and experimental research groups includes specialists in existing and incorporates other groups into the activities of the program. Innovation through the development of X X Diagnosis through new RM tools RM micro-image for the development of com - binations of RM sequences without contrast Analysis of myocardial tension CMR for - in Stress syndromesX X X X Prediction new Definition of new serological indicators are the diagnosis and current treatments of rare diseases (RDs). To this end, we will proceed to identify and validate rare disease biomarkers have effective diagnostic prognostic indicators. On the will be developed to treat these diseases. Human and animal model samples will be used to understand the program seeks to fill the gap between basic research and commercial development of diagnostic systems and treatments, so it aims to transfer this knowledge to companies to transform biomedical knowledge into products and services that improve human health. With these objectives, contacts with biotechnology and pharmaceutical companies have been established. On the other hand, the program aims to disseminate its findings to society to get feedback about actual patients' needs. Coordinators: Dr. Francisco Das\u00ed Fern\u00e1ndez and Dr. Federico Pallard\u00f3 Calatayud Objectives: Development of cell models derived from cells nosed RDs studied obtained the genetic manipulation of healthy cells to mimic the mutations as- sociated with these diseases or from animal models in order to improve the knowledge of the pathophysiology of the treatment of these pathologies Promote collaboration with services of the Clinical Hospital in- volved in the treatment of these RDs, emphasizing primary care to improve its diagnostic potential diagnostic and prognostic methods Development of \"omics\" technologies to advance research in RRDD Research lines: Study of the physiopathology the treatment of rare respiratory diseases Design and testing of new biomarkers for rare diseases Characterization of the cellular and molecular of like and Friedreich's ataxia and identification molecular targets for the development of new therapiesClinical groups: Research Group on Respiratory Diseases (Dr. Jaime Signes- Costa Mi\u00f1ana) Experimental groups: Research Group on Translational Genomics (Dr. Rub\u00e9n D Ar - tero Allepuz) Research Group on Rare Respiratory Diseases (RRD) (Dr. Das\u00ed Fern\u00e1ndez) Organic Physiopathology of Oxidative Stress (Dr. Federico V. Pallard\u00f3 Calatayud) Research Group on Molecular Imaging and Metabolomics (Dr. Daniel Monle\u00f3n Salvad\u00f3) Clinical Services Associated to the Program: Department of of Pneumology Department or septic shock (ss) patients\" (PCT/EP2017/078362)X EP, US, CA, JP y CN Acquisition of budget and resources from different programs X VLC-Bioclinic (2 projects), Plan Nacional I+D+i Mineco (1 project, 2016-2019), AES 2016 (2 projects, 2017-2019), project, 2017-2019), AES in Biomedical Research Master \"Enfermedades raras\" 2nd edition of the on-line Introducction to rare diseases, Program of the University of Valencia La Nau Gran Alliance for translational research in rare diseasesX falls, and adverse consequences, which implies an increase in hospitalizations the use of public resources. Cognitive and functional impairment associated with aging and many chronic diseases is one of the most important challenges in order to improve the quality of life of the population and secure the sustainability of health systems. Early detection and treatment and cognitive and functional improve or with chronic diseases and reduce the demand for resources to the health system, improving its sustainability. Therefore, it is necessary to design to address these challen- ges, on advances in knowledge on developed to clinical practice Evaluate in prevent or impairment that has been effective in animal models Transfer to clinical practice the new validated therapeutic pro - ceduresClinical groups: Research Group on the Study of Cardiometabolic and Renal Risk (Dr. Josep Red\u00f3n i Mas) Research Group on Anesthesiology and Reanimation (Dr. Ma- rina Soro Domingo, Dr. Ernesto Pastor Mart\u00ednez, Dr. Rafael Badenes Quiles) Research Group on Cardiometabolic Risk (Dr. Jos\u00e9 Real Tom\u00e1s) Experimental groups: Research Group on Neurological Impairment (Dr. Carmina Montoliu F\u00e9lix) Research Group on Personal Autonomy, Dependence and Se- vere Mental Disorders (TMAP) (Dr. Rafael Tabar\u00e9s Seisdedos, Dr. Gabriel Selva Vera) Research Group on Aging and Physical Activity (Dr. Jos\u00e9 Vi\u00f1a Ribes, Dr. Ana Lloret Alca\u00f1iz) Research Group on Inflammation (Dr. Esteban Morcillo S\u00e1n - chez, Dr. M\u00aa Jes\u00fas Sanz Ferrando) Clinical Services Associated to the Program: Department of Digestive Medicine (Dr. Miguel M\u00ednguez P\u00e9rez, Dr. Amparo Escudero Garc\u00eda) Department of Neurophysiology (Dr. Paula Cases Berg\u00f3n) University Department Associated with the Program: Biology Unit. Department of Pathology (Dr. with the appearance of cognitive and functional impairmentX We analysed the presence of neuroinflammation in post-mortem samples of the cerebellum from in patients with schizophrenia, disorder, and post- surgery We are better characterizing patients by computerized tests. 3. biomarkers impairmentX We are studying the genes in peripheral blood cells and the involved pathways associated with the appearance of cognitive functional impairmentX We have identified alterations of the immune sys - tem associated with the appearance of neurologi - cal alterations in cirrhotic patients with MHE. We and cognitive and motor function. We have shown that there is a dysregulation in the urea cycle in non-alcoholic fatty liver in neurotransmission and cognitive and motor in therapeutic Impairment in patients tumors. Its main objective is to evaluate the dynamics of the disease through non-invasive biopsies in order to detect cancer in inefficiency of even when they are directed against specific molecular tar- specimens makes genomic would facilitate the serial collection of samples out molecular analysis and would guarantee the follow-up and allowing a dynamic understanding the evolution of the genomic parameters of the patient. This point of view benefits the National Health System as a whole since it allows the application of more specific treatments to trials which stratified by mutations. Research Group of Innovative Diagnostic and Therapeutical Developments in Solid Tumors - Cervantes Ruip\u00e9rez) Research Group on Hematopoietic Transplantation (Dr. Car- los Solano Vercet) Research Group on Myeloid Neoplasms (Dr. Mar Tormo D\u00edaz) Research Group on Lymphoproliferative Disorders (Dr. M\u00aa Jos\u00e9 Terol Caster\u00e1) Translational Research Group on Pediatric Solid Tumors (Dr. Samuel Navarro Fos, Dr. Rosa Noguera Salv\u00e1) Clinical Services Associated to the Program Department of Radiology Department of Pathological Anatomy Central Laboratory Department of Pharmacy Department of Urology platforms: Biobank Precission of biomarkers of relapses Development of functional models mimetic to the characteris- tics of the patient Development of decision support systems through data analysis Research lines: Liquid biopsy as a diagnostic tool Functional models of murine and 3D bioprinted for the study of resistance and drug screening Integration of molecular and image data for the development of decision support systems Promote the development and implementation advanced / mechanis - tic analysis Proof of concept on commercial cell lines Establishment of cell lines with patient tu- Molecular characterization at single-cell resolution of the human uterus as a uterus and and their impact on reproductive health. Coordinators: Carlos Sim\u00f3n Vall\u00e9s and Dr. Felipe Vilella Mitjana Objectives: To create comprehensive reference - tion of the human uterus To study the origin of fibroids at the single-cell level To study the origin of late gestational endometriosis endometrial cancer To study the molecular mediators in on in endometrium to the risk of disease women Research lines: Study of endometrial receptivity and cell map of the human uterus. Previous research in our laboratory using microarray and other complications of pregnancy Study at the single-cell level of the origin of uterine fibroids Early diagnosis and treatment of endometriosis improve health indicators in womenClinical groups: Research Group on Women Health (Dr. Antonio Cano S\u00e1n - chez) Research Group on Endometriosis and Endometrial Cancer Therapies (Dr. Ra\u00fal G\u00f3mez Gallego) Experimental groups: Research Group on Maternal Fetal Communication (Dr. Felip Vilella Mitjana) Research Group on Reproductive Medicine (Dr. Carlos Sim\u00f3n Vall\u00e9s) Emergent researcher (Dr. Aymara Mas Perucho) Clinical Services Associated to the Program Department of Gynaecology and Obstetrics Department of and diseaseX Project is ongoing. Results Single cell study of origin of fibroids XProject is ongoing Study of resistance to decidualization of late gestational diseaseX is the of chronic program has the priority of improving the quality of life of the elderly and promoting longevity as much as possible. The aging po- pulation is a challenge for current health systems since the population over 65 years old contributes, in a very significant percentage, to health expenditure. As expectancy increases, so diseases. In this context, the concept of \"healthspan\" (quality of life) has emerged. The program is formed by many researchers and health professionals who consider that efforts to extend life at a severe physical or psychic disability are and, on the contrary, they should focus on lengthening the part of life during which we are able to maintain autonomy, independence, productivity, and well-being. A central guiding idea in this program is that people who achieve exceptional longevity (i.e., centenarians) serve as a model of satisfac - tory aging. On the other hand, it is considered that the most problematic expression of the population the clinical condition of frailty since an important part of older fulfill several frailty criteria. Approximately one-fourth of people of 85 are estimated to be frail. Frailty an alteration in the physiological reserves of multiple systems, leading to difficulties in maintaining homeostasis. The program tries to to improve the quality of life elderly. For this, INCLIVA has an enormous advantage because great integration that exists, by proximity and interests, between the Hospital Cl\u00ednico Universitario de Valencia and the Faculty of Medicine of the University of Valencia. This framework allows intense co- llaboration between basic research provide biological human samples and, on the other hand, can transfer to the patient those studies that have been successfully developed at the bench. In addition to this, INCLIVA has registered the first and only Spanish Group for the Study of Centenarians, which includes research groups working in this field distributed in different Spanish communities. Coordinators: Dr. Jos\u00e9 Vi\u00f1a Ribes, Dr. Consuelo Borr\u00e1s Blasco, Dr. Mar\u00eda Carmen G\u00f3mez Cabrera Objectives: Determination life for Alzheimer's and national age-sex-specific mortality and life expectan- cy, 1950-2017: a research groups: Research Group on the Study of Cardiometabolic and Renal Risk (Dr. Josep Red\u00f3n i Mas) Cardiometabolic Research Group on Primary Care (Dr. Jorge Navarro P\u00e9rez) Research Group on Clinical Cardiology (Dr. Juan Sanchis For\u00e9s) Research Group on Oxidative Pathology (Dr. Guillermo S\u00e1ez Tormo) Research Group on Women Health (Dr. Antonio Cano S\u00e1n - chez) Group on Translational Research in Ischemic Heart Disease (Dr. Vicente Bod\u00ed Peris)Experimental groups Research Group on Neurological Impairment (Dr. Carmina Montoliu F\u00e9lix) Research Group on Endothelial Cells (LINCE) (Dr. Carlos Her- menegildo Caudevilla, Dr. Susana Novella del Campo) Research Group on Exercise, Nutrition and Healthy Lifestyle (Dr. M\u00aa Carmen G\u00f3mez Cabrera) Research Group on Healthy Aging (Dra. Consuelo Borr\u00e1s Blasco) Research Group on Aging and Physical Activity (Dr. Jos\u00e9 Vi\u00f1a Ribes) Research Group on Cellular and Organic Physiopathology of Oxidative Stress (Dr. Federico V. Pallard\u00f3 Calatayud) Research Group on Inflammation (Dr. Esteban Morcillo S\u00e1n - chez, Dr. M\u00aa Jes\u00fas Sanz Ferrando) Research Group on Genetics of Osteoporosis (Dr. Miguel Garc\u00eda P\u00e9rez)61 Search of approach from an animal model identifies CD80 as a can - didate gene for the study of bone phenotypes in postmenopausal Centenarians development envejecimiento biomarkers associated rats-role Elderly training SCIENTIFIC REPORT 2021scientific activity 44.3. Research areas 2500 2000 1500 1000 500 0350 300 250 200 150 100 50 factorINCLIVA Health Research Institute has four research areas in order to organize its scientific activity. Despite their independence, they have a common objective: meeting health needs and improving R&D&i system. Their main aim is to establish a framework to promote one or several advisers from the External Scientific Committee. These lines are led by the following coordinators: Cardiovascular Area Coordinator: Dr. Francisco Javier Chorro Gasc\u00f3 Mission: to contribute to the study of different aspects of cardiovascular disease (CVD) from its origins to its consequences Oncology Area Coordinator: Dr. Andr\u00e9s Cervantes Ruip\u00e9rez Mission: to to the study of different aspects of oncological diseases, at the stage of diagnosis Metabolism and Organic Coordinator: Dr. Jos\u00e9 Vi\u00f1a Ribes Mission: to contribute to the study of the etiology, diagnosis mechanisms or or those that generate organ damage as a fundamental link of its trigger action Reproductive Medicine Area Coordinator: Dr. Carlos Sim\u00f3n Vall\u00e9s Mission: to advance in knowledge of human reproduction for translational application, improving the and reducing adverse effects Scientific production analysis by research area The following charts and figures summarize the main scientific activity indicators of the four areas of research and the other divisions from Hospital Cl\u00ednico de Valencia.64 INCLIVA SCIENTIFIC REPORT 2021scientific activity4Since there are some scientific articles which are shared by two or more areas, it is worth mentioning that the sum of publications by area exceeds INCLIVA's total scientific output. Additionally, the next tables shows scientific publications distribution by area in terms of number of articles and impact factor. 21% 21% distribution area Groups Research Group on Cardiometabolic Risk Genomics and Diabetes Unit Research Group on Cardiac Experimental Electrophysiology Research Group on Endothelial Cells (LINCE) Research Group on Clinical Cardiology Research Group on the Study of Cardiovascular Risk in Children and Adolescents Cardiometabolic Research Group on Primary Care Research Group on the Study of Cardiometabolic and Renal Risk Research Group on Vascular Function Research Group on Pedriatric Nutrition Group on Translational Research in Ischemic Heart Disease Research Group on Risk Consolidated group Leading Researcher, R4 Jos\u00e9 Tom\u00e1s Real Collado Hospital. University Established Researchers, R3 Francisco Javier Ampudia Blasco. Hospital. University Juan Francisco Ascaso Gimilio. University Miguel Civera Andr\u00e9s. Hospital. University Emerging Researcher, R2 Sergio Mart\u00ednez Herv\u00e1s. University Recognised Researcher, Researchers Palanca Palanca. Hospital Esther Benito Casado. CIBERdem Nurse Pilar Aguilar Santaisabel. HospitalGroup competitive calls or networks R4 2 Strategic aims In terms of scientific activity of the research group during 2021, our group is participating in the development of three competitive and multidisciplinary that synthesis Project: Main Role of inflammatory axes in people with New diabetes technologies Pharmacogenetic-based personalized treatment in diabetes Applying Big Data and Artificial Intelligence technologies to analyse cardiovascular risk in dyslipidemia and diabetes R1 R2 R3 STAFF disease Body composition analysis - effect of body composition analysis, vascular risk and treatment in people with diabetes - impact of body composition analysis on prognosis, 1. A, Ortega A, Martinez- Arroyo O, Perez-Gil D, Olivares D, Solaz E, Martinez F, Martinez-Hervas S, Chaves F, Redon J, S, Frias J, Ampudia-Blasco F, Banks P, Jiang W, Davies M, Sawhney S. Efficacy and safety of adding sotagliflozin, a dual and SGLT2 inhibitor, to optimized in J. Patient- reported outcomes L, S, abdominal Martinez-Hervas S, Gonzalez-Navarro H. Therapies for the treatment of cardiovascular disease associated with Type 2 Diabetes and Dyslipidemia. International Journal of Molecular PI19/00169 Title: Papel de los procesos inflamatorios en las enfermedades metab\u00f3licas y en las complicaciones asociadas Principal Investigator: Herminia Gonz\u00e1lez and Sergio Mart\u00ednez Funding Body: Instituto de Salud Carlos III - Co-financed FEDER PUBLICATIONSEmerging Researcher Sergio Mart\u00ednez Herv\u00e1s The line lipid metabolism, inflammation, fatty INCLIVA SCIENTIFIC REPORT 2021scientific activity4Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Total budget: \u20ac159.720 Reference: PI18/00209 Title: Identificaci\u00f3n de nuevos mecanismos implicados en la angiog\u00e9nesis e inflamaci\u00f3n en pacientes obesos. Modulaci\u00f3n por ligandos de receptores nucleares constitutivos de androstano Principal Investigator: Laura Piqueras Ruiz and Jos\u00e9 Tomas Real Collado Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico budget: \u20ac173.332,50 Reference: Asociadas (CIBERdem) Principal Investigator: Juan F. Ascaso Gimilio and Jos\u00e9 Tomas Real Collado Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2008-Reference: SAF2017-89714-R Title: Modulaci\u00f3n farmacol\u00f3gica del sistema inmune como diana clave en la prevenci\u00f3n de la enfermedad cardiovascular asociada a desordenes metab\u00f3licos. S\u00edntesis de f\u00e1rmacos novedosos Principal Investigator: M\u00aa Jes\u00fas Sanz Ferrando and Juan F. Ascaso Gimilio Funding Body: Ministerio de Econom\u00eda y Competitividad Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario budget: \u20ac205.700 Reference: PROMETEO/2019/032 Title: desde la cl\u00ednica a la experimentaci\u00f3n animal: estudio del papel del eje CCL11/CCR3 y la inflamaci\u00f3n eosinof\u00edlica en la patolog\u00eda cardiovascular asociada a des\u00f3rdenes metab\u00f3licos Principal Investigator: M\u00aa Jes\u00fas Sanz Ferrrando (Jos\u00e9 Tom\u00e1s, Sergio Mart\u00ednez as collaborating researchers) Funding Body: Conselleria de Educaci\u00f3n Cultura y de Valencia Jes\u00fas Rodr\u00edguez D\u00edaz. University Recognised Researchers, R2 Ana B\u00e1rbara Garc\u00eda Garc\u00eda. CIBER Irene Andr\u00e9s Blasco. INCLIVA Jos\u00e9 Miguel Juanes T\u00e9bar. INCLIVA Gozalbo Rovira. Fuentes Lara Hern\u00e1ndez. INCLIVA M\u00aa Elena Quiroz Rodr\u00edguez. INCLIVA Nazaret Pe\u00f1a Gil. University Valverde. INCLIVA Soraya Garc\u00eda Sorribes. INCLIVA Staff. Collaborating Diabetes Unit group Researchers by competitive public calls genetic and environmental factors involved in diseases Identify alterations of methylation and hydroxymethylation in relation to the development of type 2 diabetes and its potential use as biomarkers Identify genes environmental factors involved in the development of diseases of high cardiovascular risk, especially type 2 diabetes and associated organic damage Development of fast and easy procedures for SARS-CoV2 (COVID19) detection and characterization human genetic variations involved in COVID19) Main lines frequent and rare functional variants involved in high FUT2 genes to viral genotypes and their with intestinal microbiota Analysis of methylated pertains R2 J, Rubio-del-Campo Vila-Vicent S, Munoz C, M, Microbiota depletion promotes rotavirus COV20/00279 Title: Detecci\u00f3n y caracterizaci\u00f3n r\u00e1pida de COVID19 y del paciente Principal Investigator: Felipe Javier Chaves Mart\u00ednez Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Total budget: \u20ac175.000 Reference: PI17/00544 Title: Identificaci\u00f3n de variantes gen\u00e9ticas protectoras frente al desarrollo de diabetes tipo 2 en octogenarios Principal Investigator: Felipe Javier Chaves Mart\u00ednez Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de different genes, essential metals and relation to type 2 traits PUBLICATIONS Rubio-Del-Campo Rodriguez-Diaz J, M. Martinez- Arroyo O, Perez-Gil D, Olivares D, Solaz E, Martinez F, Martinez-Hervas S, Chaves F, Redon J, C, Lago A, Ocon P, Calle A, Castano L, Delgado E, Menendez E, Franch-Nadal J, Gaztambide S, Girbes J, S, Escobar E, Fernandez-Garcia Colomo Garcia-Fuentes Gutierrez-Repiso C, Goday-Arno A, Calle-Pascual A, Castano L, Castell C, Delgado Alvarez E, Menendez Torre E, Franch-Nadal J, Gaztambide S, Girbes J, Chaves F, Soriguer Iodine virus ent\u00e9ricos/hospedador: bases para proteger frente a la diarrea viral Principal Investigator: Jes\u00fas Rodr\u00edguez D\u00edaz Funding Body: Ministerio de Econom\u00eda y Hacienda Beneficiary AEST/2020/041 Title: Desarrollo de un sistema r\u00e1pido y econ\u00f3mico para la detecci\u00f3n de pat\u00f3genos causantes de gastroenteritis infecciosas mediante EOSAL Principal Investigator: Jes\u00fas Rodr\u00edguez D\u00edaz Funding Body: Conselleria de Educaci\u00f3n Cultura y Deporte Beneficiary title: de m\u00e9todos de an\u00e1lisis y visualizaci\u00f3n de datos gen\u00f3micos en biomedicina Doctoral candidate: Jos\u00e9 Miguel Juanes Tebar Director(s): Felipe Javier Chaves Mart\u00ednez, Pablo Mar\u00edn Garc\u00eda, Vicente Arnau Llombart Date of the defense: group Leading Researcher, R4 Francisco Javier Chorro Gasc\u00f3 Hospital. University Antonio M. Alberola Aguilar. University Luis Such Belenguer. University Recognised Researchers, R2 Germ\u00e1n Parra Giraldo. University Irene del Canto Serrano. INCLIVA Isabel Trapero Gimeno. University Luis Such Miquel. University Manuel Zarzoso Mu\u00f1oz. University First Stage Researchers, of to the KN-93, carrier Continuation of the analysis of the effects of modifications of the basic electrophysiological properties on the processes involved in the induction and maintenance of ventricular fibrillation Analysis of the electrophysiological effects mitochondrial oxidative stress and the involvement of the IKATP current Development of instruments for recording, processing and analysing cardiac electrophysiological signals obtained with mapping systems Progressive development the experimental series aimed to study the mechanisms involved in the deterioration of the systolic function, fibrosis and the inducibility of arrhythmias in a chronic model of infarction Progressive development of an experimental model of metabolic syndrome the electrophysiological modifications and by and basic heart failure: role of calcium homeostasis in arrhythmogenesis. of drugs acting on intracellular Ca2+ dynamics in basic electrophysiological properties on the processes in J, Marcos- Garces V, Forteza Oltra R, Vila J, Chorro Bodi V. Overexpression of genes involved in Javier Chorro Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: Study of electrophysiological effects of chronic against arrhythmias or scientific activity facilitation of its reversion; b) study of the influence of heart's nervous system and mitochondrial oxidative stress; and c) analysis of the effects on electrical instability induced by myocardial ischemia and the implication of IKATP current Development and extension of tools for the registration, processing and analysing of cardiac electrophysiological signals voltage and calcium signals Study in deterioration systolic function, fibrosis and the inducibility of arrhythmias in a model of electrophysiological modifications and inducibility cardiac arrhythmias in an experimental collaborations4 International collaborations SELECTED PUBLICATIONS 1. Palau P, Seller J, Dominguez E, Sastre C, Ramon JM, Espriella R, Santas E, Minana G, Bodi V, Sanchis J, Valle A, Chorro FJ, Llacer P, Bayes-Genis A, heart failure and preserved fraction. Journal R, Minana G, Santas E, Llacer P, Nunez E, Palau P, Bodi V, Chorro F, Sanchis J, Lupon J, Bayes-Genis A. Antigen carbohydrate 125 as a biomarker in heart failure: a Perez N, de Dios E, Nunez E, Sanchis J, Chorro FJ, Bayes-Genis A, Bodi V. Sex differences on Santas E, Minana G, Palau P, De La Espriella R, Lorenzo M, Nunez G, Sanchis J, Chorro FJ, Bayes-Genis A, Nunez Modificaci\u00f3n de los efectos pro-arr\u00edtmicos inducidos por la sobrecarga mec\u00e1nica o el remodelado ventricular Principal Investigator: Francisco Javier Chorro Gasc\u00f3 Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Total budget: \u20ac129.470 Reference: PROMETEO/2018/078 Title: Mecanismos la muerte cardiaca s\u00fabita de causa arr\u00edtmica Principal Investigator: Francisco Javier Chorro Gasc\u00f3 Funding body: Conselleria de Educaci\u00f3n Cultura y Deporte Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n del Hospital Cl\u00ednico Universitario de Valencia Duration: 2018-2021 Total budget: \u20ac275.859,02 Title: Resonancia magn\u00e9tica card\u00edaca de estr\u00e9s con vasodilatadores para predecir la mortalidad a largo plazo en un amplio registro retrospectivo de pacientes con cardiopat\u00eda isqu\u00e9mica conocida o sospechada Principal Investigator: Vicent Bod\u00ed Chorro Gasc\u00f3 Sociedad Espa\u00f1ola de Cardiolog\u00eda Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n del Hospital Cl\u00ednico Universitario de Valencia Duration: 2021-2022 Total budget: \u20ac15.000THESIS Thesis title: Estudio de la funci\u00f3n mioc\u00e1rdica en la enfermedad renal cr\u00f3nica avanzada y en la terapia de sustituci\u00f3n renal Doctoral candidate: Joana Melero Lloret Director(s): Francisco Javier Chorro Gasc\u00f3, Carlos Joaqu\u00edn Soriano Navarro Date the defense: 26/03/2021 Grade: Sobresaliente \"cum laude\" Thesis title: Cambios en la activaci\u00f3n electromiogr\u00e1fica de la musculatura de codo en sujetos sanos comparada con la activaci\u00f3n muscular en sujetos con tendinopat\u00eda y la influencia de la aplicaci\u00f3n de punci\u00f3n seca en la misma Doctoral candidate: Fredy Hanna Director(s): Yasser Alakhdar \"cum Thesis title: inhibici\u00f3n de la desacetilaci\u00f3n de las histonas en el remodelado post-infarto del sustrato arritmog\u00e9nico Doctoral candidate: Patricia Genov\u00e9s Mart\u00ednez Director(s): Francisco Javier Chorro Gasc\u00f3, Luis Such Belenguer, Irene Del Canto Serrano Sobresaliente \"cum laude\" Thesis title: Efectos ejercicio f\u00edsico cr\u00f3nico sobre el miocardio ventricular norm\u00f3xico y tras isquemia regional aguda: implicaci\u00f3n del canal Katp. Estudio en coraz\u00f3n aislado de conejo Doctoral candidate: Nathalia Gallego Rojas Director(s): Juan Guerrero Mart\u00ednez, Germ\u00e1n Parra Luis Such University Susana Novella del Campo University Recognised Researchers, R2 Daniel Bernardo P\u00e9rez Cremades. University Elena Monsalve UniversityGroup members http://www.uv.es/lince/SP/index.htmlResearch Group To of in the SAMR1/SAMP8 murine senesence model, which will allow us to evaluate the vascular effect of aging and sex and to verify that the change in expression of some miRNA observed in humans with AMI is reproduced To incorporate new pre and postdoctoral researchers to our group Main lines of research Sex differences in cardiovascular research Vascular effects of sex hormones Li H, P\u00e9rez-Cremades D, Wu W, Bestepe F, Ozdemir D, Niosi X, Mompeon A, Hermenegildo C, Novella S. Regulatory network analysis in estradiol-treated human endothelial cells. International Journal Deng Y, Chen J, Simion V, Yang D, Sukhova G, Shvartz Q, S, Zhou H, P\u00e9rez-Cremades D, Sun X, Chen L, Li J, Haneo-Mejia H, Yang T, Hollan I, Feinberg Valencia Duration: 2018-2021 Reference: PI19/01714 Title: Regulaci\u00f3n dependiente de sexo y estr\u00f3genos en el s\u00edndrome coronario agudo e impacto funcional en c\u00e9lulas endoteliales humanas. Nuevos biomarcadores para prevenci\u00f3n primaria Principal Investigator: Carlos Hermenegildo y Susana Novella Funding body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Duration: 2020-2022 Total Budget: \u20ac159.720Reference: AICO/2020/030 Title: Repercusi\u00f3n en vascular de miRNA regulados por estr\u00f3genos Principal Investigator: Susana Novella del Campo Funding body: Conselleria de Innovaci\u00f3n, Universidades, Ciencia y Sociedad Digital Beneficiary institution: Universidad de Valencia Duration: Researcher, R3 Ruiz Ros. Hospital. University Recognised Researchers, R2 Anna Mollar Fern\u00e1ndez. INCLIVA Sergio Garc\u00eda Blas. Stage Researchers, R1 Ernesto Valero Picher. Hospital Hospital. INCLIVA IF journals CIBER Cardiovascular Development of FIS projects Main lines of research Research line in heart failure: - Beta blocker treatment withdrawal in patients with heart with patients with heart 2021scientific activity4SELECTED PUBLICATIONS 1. Palau P, Seller J, Dominguez E, Sastre C, Ramon JM, Espriella R, Santas E, Minana G, Bodi V, Sanchis J, Valle A, Chorro FJ, Llacer P, Bayes-Genis A, heart failure and preserved fraction. Journal R, Minana G, Santas E, Llacer P, Nunez E, Palau P, Bodi V, Chorro F, Sanchis J, Lupon J, Bayes-Genis A. Antigen carbohydrate 125 as a biomarker in heart failure: a L, Patel M, Clinical outcomes and to vericiguat according to index event: insights Perez N, de Dios E, Nunez E, Sanchis J, Chorro FJ, Bayes-Genis A, Bodi V. Sex differences on Impact of PI18/01138 Title: Efecto de la modificaci\u00f3n de los niveles de ant\u00edgeno carbohidrato 125 antes del implante de pr\u00f3tesis valvular a\u00f3rtica percut\u00e1nea sobre el pron\u00f3stico implante Principal Investigator: Juan Sanchis For\u00e9s Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Duration: 2017- Reference: AP-2021-016 Title: BREIC: microbiota-sistema inmune por RMN para la estratificaci\u00f3n de pacientes con insuficiencia cardiaca Principal Investigator: Vannina Gonz\u00e1lez Marrachelli and Anna Mollar de Valencia REPORT 2021scientific activity 4Research Group on the Study of Cardiovascular Risk in Children and Adolescents Consolidated group Leading Isabel Torr\u00f3 Dom\u00e9nech. R2 Julio \u00c1lvarez Pitti. University First Stage Researchers, R1 Ana de Blas Zapata. University Nuria Garc\u00eda Carbonell. University Rafael G\u00f3mez Zafra. University Staff. Collaborating Researcher Juan Jos\u00e9 Alc\u00f3n S\u00e1ez. University Staff. daily contact with engineers developing software for signal capture through mobile devices. Studying the parameters patients the Unit The PAIDO Program is focused on personalized medical care extended through initiatives involving family, educators, nutritionists, physical education teachers and other agents. Treatment goes beyond the hospital setting to include the child\u00b4s environment and personal sphere and is supported by state-of the art artificial intelligence technologies To improve the knowledge of fetal life and postnatal growth on the development of cardiometabolic risk factors early in life. The KITE cohort is a prospective study starting at birth and assessing the determinants of cardiometabolic risk factors in first of life. Omics data from umbilical cord are available and the analysis of the interaction between clinical data and omics may help to introduce actions in critical periods of life and the potential contribution to reduce cardiometabolic disease later in life. Mrs. Lurbe is the coordinator of the new document of the European Guidelines on Arterial Hypertension in Children and Adolescents Main lines of research New technologies applied to the detection of the cardiorespiratory capacity New technologies applied treatment exercise preventing and treating obesity Arterial hypertension in children and adolescents Cardiovascular and renal risk in diabetesResearchers by categories Team involved in3 1 2 PI20/00269 Title: Impacto del peso al nacer y el patr\u00f3n de crecimiento en los factores de riesgo cardiometab\u00f3lico en adolescentes postpuberales: aproximaci\u00f3n cl\u00ednica y molecular Principal Investigator: Empar Lurbe i Ferrer Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Total budget: \u20ac174.845 Reference: PI17/01517 Title: postnatal en hijos de madres obesas: modulaci\u00f3n por la alimentaci\u00f3n en el primer a\u00f1o de vida Principal Investigator: Empar Lurbe i Ferrer Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Total budget: \u20ac170.005 Reference: CB06/03/0039 Biom\u00e9dica en (CIBER) de Fisiopatolog\u00eda de la Obesidad y Empar Lurbe i Ferrer Funding Salud Carlos III - Co-financed FEDER Beneficiary Institution: Consorcio Hospital General Universitario de Ingelfinger J. Developmental and early life origins R, A, V, Lopez-Valcarcel beginning in childhood and risk The USPSTF call to inaction on blood pressure Reference: COST CA19115 Title: Network for blood pressure research in children and study starting at birth (Cohort KITE) HyperChildNET: European Network for Research on Blood Pressure in Children and Adolescents81 INCLIVA SCIENTIFIC REPORT 2021scientific activity 4Cardiometabolic Care Consolidated group Leading Researcher, R4 Jorge Navarro P\u00e9rez Departament Established Researchers, R3 Alvaro Bonet Pl\u00e0. Cl\u00ednico-Malvarrosa Health Department Carolina Mir S\u00e1nchez. University. Cl\u00ednico-Malvarrosa Health Department Ruth Us\u00f3 Talamantes. Cl\u00ednico-Malvarrosa Health Department Staff. Collaborating Researchers Department Cl\u00ednico-Malvarrosa Health Departament Enrique Guinot Mart\u00ednez. Cl\u00ednico-Malvarrosa Health Departament Irene Marco Moreno. Cl\u00ednico-Malvarrosa Health Departament Isabel Gabald\u00f3n S\u00e1nchez. Cl\u00ednico-Malvarrosa Health Departament Jos\u00e9 Luis Trillo Mata. Hospital M\u00aa Jos\u00e9 Puchades Company. Cl\u00ednico-Malvarrosa Health Department Marisa G\u00f3mez Arnedo. Cl\u00ednico-Malvarrosa Health Departament Nidia Ruiz Varea. Cl\u00ednico-Malvarrosa Health Department Arnaldos. Cl\u00ednico-Malvarrosa Health Departament Pilar Botija Yag\u00fce. Cl\u00ednico-Malvarrosa Health Departament Pilar Roca Navarro. University. Cl\u00ednico-Malvarrosa Health Department Ruth Uribes Fillol. Cl\u00ednico-Malvarrosa Health Departament Tom\u00e1s S\u00e1nchez Ruiz. University. Cl\u00ednico-Malvarrosa Health Departament Vibiana Blanco Alvarado. Cl\u00ednico-Malvarrosa Health Departament of cardiometabolic research Consolidation of a network of partners in the area of primary careResearchers by categories 3 1 PI16/02130 Title: Impacto de la auto-medici\u00f3n y el auto-ajuste de la medicaci\u00f3n antihipertensiva en el control de la hipertensi\u00f3n arterial. Un ensayo cl\u00ednico pragm\u00e1tico: estudio ADAMPA Principal Investigator: Jorge Navarro P\u00e9rez and Jos\u00e9 Sanf\u00e9lix- Genov\u00e9s Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Total Budget: \u20ac86.515 THESIS Thesis title: Efectividad de una intervenci\u00f3n de automanejo de la hipertensi\u00f3n arterial en la mejora de la inercia terap\u00e9utica y la adherencia a los medicamentos antihipertensivos. Ensayo cl\u00ednico pragm\u00e1tico ADAMPA Doctoral candidate: Irene Marco Moreno Director(s): Gabriel Sanf\u00e9lix, Salvador Peir\u00f3 Moreno, Jose San F\u00e9lix Genov\u00e9s defense: 28/04/2021 Grade: determinantes socioecon\u00f3micos y de la morbilidad del Departamento de Salud Valencia Cl\u00ednico- Malvarrosa. Desarrollo de un \u00edndice de privaci\u00f3n poblacional integrado Doctoral candidate: Pilar Botija Yag\u00fce Director(s): Ruth Us\u00f3 Talamantes, Jorge Navarro P\u00e9rez, M\u00aa de las Mercedes Botija Yag\u00fce Date of the defense: 30/11/2021 Grade: Sobresaliente \"cum laude\"SELECTED PUBLICATIONS 1. Martinez MT, Monton-Bueno J, Simon S, Ortega B, Moragon S, Rosello S, Insa A, Navarro J, Sanmartin A, Julve A, Buch E, Pena A, Franco J, Martinez-Jabaloyas J, Marco J, Forner MJ, Cano A, Silvestre A, Teruel A, Lluch A, Cervantes A, Chirivella Gonzalez I. Ten-year assessment of a 6,54 2. Domingo O, Alberto G, Ana Maria C, Jorge N, Vicente G, Quesada-Rico Jose A, Pomares-Gomez Francisco J, Adriana L, Concepcion C. Hospital admissions trends for severe hypoglycemia in diabetes patients in Spain, 2005 to 2015. Gorriz J, Vivas-Consuelo D, Redon in Spain. International Journal of Environmental Research International Journal J, V, in around the three prevalent cardiovascular risk studies: protocol for a population-based cohort study. International Journal of the Study of Cardiometabolic and Renal Risk Consolidated group Leading Jos\u00e9 Forner Giner. Hospital. University Jos\u00e9 Galindo Puerto. Hospital. University M\u00aa Jos\u00e9 Garc\u00eda-Fuster Gonz\u00e1lez-Alegre. Emerging Researcher, R2 Raquel INCLIVA Recognised Researcher, R2 Ana Ortega Guti\u00e9rrez. Aguado. Hospital First Stage Researchers, R1 Adri\u00e1n Ruiz Hern\u00e1ndez. Hospital. University Mar\u00eda Grau P\u00e9rez. INCLIVA Olga Mart\u00ednez Arroyo. INCLIVA Staff. Collaborating Researchers Elena Solaz Moreno. Hospital Javier D\u00edaz INCLIVA Jos\u00e9 Miguel Calder\u00f3n Terol. INCLIVAGroup members Emerging Researcher Raquel Cort\u00e9s Vergaz The main objective of this new field of research is to study the molecular mechanisms associated with the development of early kidney damage due to hypertension and diabetes, focusing on the characterization of extracellular their roles as intercellular media- tors. In addition, a new line of research has been opened in kidney damage associated with systemic competitive R2 STAFF R1 Strategic aims To start-up the laboratory for the analysis podocytes cultivation phenotyping) renal damage progression The integration of metabolomics and genomics in the study of factors related to the development of kidney damage Development of studies for noninvasive hemodynamic pathology Analysis and linked to the presence of hypertension and renal injury of in REPORT 2021scientific activity44. Corma Gomez A, J, Morano L, Rivero A, Tellez F, Rios MJ, Santos M, Serrano M, Palacios R, Merino D, Real LM, De Los Santos I, Vera Mendez A, P, Escudero- Garcia D, Monton C, Aguilera V, Alberich-Bayarri A, Serra Marti-Bonmati in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population- representative Martinez- Arroyo O, Perez-Gil D, Olivares D, Solaz E, Martinez F, Martinez-Hervas S, Chaves F, Redon J, JM, Navarro J, von Wichmann MA, Tellez MJ, Quereda C, I, Sanz Jimenez Sousa MA, Perez Latorre JM, Resino S, Esteban H, Martinez E, Gonzalez Garcia J. Effects of HCV -renal tubular exosomes) Impact morbidity and population Inflammation and oxidative stress in the development of cardiovascular disease Genomics, proteomics and metabolomics of to the control of BMI and waist circumference and the risk of obesity genes Venous thrombosis in young patients: factors associated with development relationship between risk of venous thromboembolic disease and arteriosclerosis Molecular mechanisms associated with renal damage lupus SCIENTIFIC REPORT European Commission Beneficiary Fundaci\u00f3n budget: \u20ac395.250 Mas Funding body: European Commission Beneficiary Fundaci\u00f3n budget: \u20ac1.062.136,25 Reference: 785815 i Mas Funding body: European Commission Beneficiary Fundaci\u00f3n cl\u00ednicas del complejo proteico rabphilin-rab en da\u00f1o renal en la diabetes mellitus tipo 2 Principal Investigator: Josep Red\u00f3n i Mas Funding body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico budget: \u20ac196.020Reference: PI18/01405 Title: Perfil de microRNAs exosomales y su valor pron\u00f3stico a largo plazo en el lupus eritematoso sist\u00e9mico. Asociaci\u00f3n con marcadores establecidos de da\u00f1o renal Principal Investigator: Raquel Cort\u00e9s Vergaz Funding body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario Duration: Total budget: \u20ac111.320 Title: Estudio multic\u00e9ntrico de precisi\u00f3n diagn\u00f3stica para cuantificar y caracterizar la fibrosis de la enfermedad hep\u00e1tica metab\u00f3lica mediante patolog\u00eda digital avanzada Principal Investigator: David Mart\u00edn Aguado Funding body: Sociedad Valenciana de Patolog\u00eda Digestiva Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2021-2022 Total budget: \u20ac5.000 Title: CoVIHd: incidencia y severidad de COVID-19 en personas VIH-positivas en TAR en Espa\u00f1a Principal Investigator: M\u00aa Jos\u00e9 Galindo Puerto Funding body: Janssen - Cilag S.A. Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n de los biomarcadores de imagen en las hepatopat\u00edas cr\u00f3nicas difusas Doctoral candidate: David Mart\u00ed Aguado Director(s): Luis Mart\u00ed Bonmat\u00ed, Miguel \u00c1ngel Serra Desfilis Dolores Mauricio Avi\u00f1\u00f3. University Mart\u00edn Aldasoro University V\u00edctor Manuel V\u00edctor Gonz\u00e1lez. UniversityGroup members Strategic aims Vascular changes associated with different pathologies Regulation of blood flow Main lines of research Characterization of alterations in the control of vascular tone and endothelial function induced by aging The effects of R. Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar PUBLICATIONS IF 9 Arias-Mutis O, San-Miguel T, Valles S, Aldasoro M, Vila J, Zarzoso M, Mauricio M. PPARgamma as an indicator of vascular function in an experimental model of J, Marcos- Garces V, Forteza Oltra R, Vila J, Chorro Bodi V. Overexpression of genes involved in Perez del inflamasoma NLRP3 y las interacciones leucocito- endotelio en la diabetes: efectos del papel de la empagliflozina Doctoral candidate: Francesca Iannantuoni Director(s): V\u00edctor Manuel V\u00edctor Gonz\u00e1lez, Milagros Rocha Barajas Date autophagy and their relationship with cardiovascular complications in Type 2 Doctoral candidate: Ar\u00e1nzazu Mart\u00ednez de Mara\u00f1\u00f3n Peris Director(s): V\u00edctor Manuel V\u00edctor Gonz\u00e1lez, Milagros Rocha Barajas, Miguel Mart\u00ed Cabrera Date of the group Leading Researcher, R4 Cecilia Mart\u00ednez Costa Hospital. University Javier Buesa G\u00f3mez Hospital. University Established Researchers, R3 Elena Crehu\u00e1 Gaudiza. Hospital. University Francisco N\u00fa\u00f1ez G\u00f3mez. Hospital. University Javier Esta\u00f1 Capell. Hospital. University Laura Mart\u00ednez Rodr\u00edguez. Hospital Recognised Paula Grattarola. INCLIVA Alba Peret\u00f3 Moll. Hospital Ana Barr\u00e9s Fern\u00e1ndez. Hospital Ana Delgado Vicente. Hospital \u00c1ngel Vicente Valls Ar\u00e9valo. Hospital Carlos S\u00e1enz de Juano Petit. Hospital Isidro Robredo Garc\u00eda. INCLIVA Laura N\u00fa\u00f1ez Mart\u00ednez. Hospital Staff. Collaborating Researchers Inmaculada Tarazona Casany. Hospital Jos\u00e9 Vicente Arcos Strategic malnutrition and artificial nutrition: Validation of the pediatric screening tools detecting chronic disease Cardiovascular area: Analysis of microbiota in obese children before and after of maternal diet and development. Impact on host response and intestinal function Area of hospital malnutrition and artificial nutrition: Validation of the pediatric screening tools for detecting the risk of malnutrition Multicenter study of acceptance and quality of life in children treated with home collaborations3 International collaborations SELECTED PUBLICATIONS 1. Costa R, Bueno F, Albert E, Torres I, Carbonell-Sahuquillo S, Barres-Fernandez A, Sanchez D, tract SARS-CoV-2 Bonifacio J, Bucardo F, Buesa J, Bruggink L, Chan M, Fumian T, Giri S, Gonzalez M, Hewitt J, Lin J, Mans J, Munoz C, Pan C, Pang X, Pietsch C, Rahman M, Sakon N, Selvarangan R, Browne H, Barclay L, Vinje J. trends in norovirus Jimenez Vitamin status in pediatric and young adult cystic fibrosis patients. I, Calatayud M, Parra- Llorca A, Martinez Costa C, Collado M. Maternal diet during pregnancy and intestinal markers are associated NEODIAG-VR: Realidad virtual para la formaci\u00f3n multidisciplinar en neonatolog\u00eda Principal Investigator: Jes\u00fas Gimeno Sancho, Javier Esta\u00f1 Capell Funding body: Universidad de Valencia THESIS Thesis title: Efecto de la intervenci\u00f3n nutricional en escolares y adolescentes con obesidad con y sin resistencia a la insulina Doctoral candidate: Ana Paula Grattarola Director(s): Francisco N\u00fa\u00f1ez G\u00f3mez, Cecilia Mart\u00ednez Costa Date of the defense: 11/01/2021 Grade: Sobresaliente de la vacunaci\u00f3n antigripal y antineumoc\u00f3cica para prevenir la hospitalizaci\u00f3n en personas menores de 65 a\u00f1os que presentan condiciones de riesgo Principal Investigator: \u00c1ngela Dom\u00ednguez Garc\u00eda (Francisco N\u00fa\u00f1ez as collaborating researcher) Funding body: Instituto de Salud Carlos III Title: cognitiva en la descendencia: papel causa-efecto de la microbiota intestinal y prevenci\u00f3n diet\u00e9tica temprana Principal Investigator: Consuelo Borr\u00e1s Blasco (Cecilia Mart\u00ednez Costa as collaborating researcher) Funding body: Ministerio de Econom\u00eda y Researchers, R1 C\u00e9sar R\u00edos Navarro. de Dios Lluch. University V\u00edctor Marcos Garc\u00e9s. HospitalGroup members Strategic aims From our research experience from the last years in the clinical and experimental field related to ischemic cardiopathy, our current goal is to focus into a translational approach In 2021 we also a ischemia, necrosis, fibrosis, angiogenesis, collaborations12 de la obstrucci\u00f3n microvascular tras un infartodemiocardio: evaluaci\u00f3n de las consecuencias estructurales y cl\u00ednicas y b\u00fasqueda de nuevas opciones terap\u00e9uticas Principal Investigator: Vicent Bod\u00ed Peris and Clara Bonanad Lozano Funding Body: de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Budget: \u20ac129.470 Reference: the basic Bod\u00ed Peris Funding Innovaci\u00f3n, Universidades, Ciencia y Sociedad Digital Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: Total Budget: \u20ac435.929 Title: Resonancia magn\u00e9tica card\u00edaca de estr\u00e9s con vasodilatadores para predecir la mortalidad a largo plazo en un amplio registro retrospectivo de pacientes con cardiopat\u00eda isqu\u00e9mica conocida o sospechada Principal Investigator: Vicente Bod\u00ed Peris Funding Body: Sociedad Espa\u00f1ola de Cardiolog\u00eda Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2021-2022 Total Budget: \u20ac15.000SELECTED PUBLICATIONS 1. Nunez Perez N, de Dios E, Nunez E, Sanchis J, Chorro FJ, Bayes-Genis A, Bodi V. Sex differences on J, Marcos- Garces V, Forteza Oltra R, Vila J, Chorro Bodi V. Overexpression of genes involved in Canoves subsequent events in a large multicenter STEMI Registry. G, Bayes-Genis A, Husser O, J, Perez Failure Emerging group Leading Researcher, R4 Julio N\u00fa\u00f1ez Villota Hospital. University Recognised Researchers, R2 Enrique Santas Olmeda. Hospital Gemma Mi\u00f1ana Escriv\u00e1. Hospital. University Patricia Palau Sampio. Hospital. University First Stage Researchers, R1 Ana Bel\u00e9n Paes INCLIVA Raquel Heredia Cambra. University. CIBER Staff. Collaborating Researcher Rafael de la Espriella Juan. Hospital Raquel Heredia Cambra. INCLIVA Staff. Nurses Alberto Ram\u00edrez S\u00e1iz. INCLIVA Ana Mart\u00ednez \u00c1lvarez. INCLIVA Jos\u00e9 Manuel Civera G\u00f3mez. INCLIVA Staff. Technician Adriana Conesa Bona. INCLIVAGroup in the different phenotypes of disease Development of tools to improve the diagnostic process of heart failure Risk stratification in patients with acute and chronic heart strategies that allow improving the prognosis of failure lines of research Effect on functional capacity of withdrawal of heart failure of the carbohydrate antigen 125 marker in the evaluation of congestion of dapagliflozin on failure and reduced ejection fraction Usefulness INCLIVA SCIENTIFIC REPORT 2021scientific activity4SELECTED PUBLICATIONS 1. Palau P, Seller J, Dominguez E, Sastre C, Ramon JM, Espriella R, Santas E, Minana G, Bodi V, Sanchis J, Valle A, Chorro FJ, Llacer P, Bayes-Genis A, heart failure and preserved fraction. Journal Ix J, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos M, Cannon C, Mueller G, Birkhahn R, Taub P, Vilke G, Duff S, McDonald K, Mahon N, Nunez J, Briguori C, Passino C, function in Perez N, de Dios E, Nunez E, Sanchis J, Chorro FJ, Bayes-Genis A, Bodi V. Sex differences on Bayes-Genis A, Revuelta E, Mi\u00f1ana Escriva G, Santas Olmeda E, Llacer P, Garcia Blas S, Fern\u00e1ndez Cisnal A, Bonanad Lozano C, Ventura S, Sanchez R, Bod\u00ed Peris V, Cordero A, Facila De La Esperanza R, Fernandez A, Sanchis Minana G, Palau P, De La Espriella R, Lorenzo M, Nunez G, Sanchis J, Chorro FJ, Bayes-Genis A, Nunez renal aguda y s\u00edndroma cardiorenal: valoraci\u00f3n no invasiva mediante doppler vascular renal Principal Investigator: Julio N\u00fa\u00f1ez Villota Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico budget: \u20ac94.834 Reference: PI17/01426 en pacientes con insuficiencia card\u00edaca con funci\u00f3n sist\u00f3lica preservada e incompetencia cronotr\u00f3pica. Efecto sobre la capacidad funcional Principal Investigator: Julio N\u00fa\u00f1ez Villota Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Total budget: \u20ac127.050 Reference: PI17/01736 Title: Comparaci\u00f3n aleatoria entre las estrategias invasivas y conservadoras en pacientes ancianos fr\u00e1giles con infarto de miocardio sin elevaci\u00f3n del segmento ST (MOSCA-FRAIL) Principal Investigator: Gemma Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Duration: Total budget: \u20ac70.180 Title: Resonancia magn\u00e9tica card\u00edaca de estr\u00e9s con vasodilatadores para predecir la mortalidad a largo plazo en un amplio registro retrospectivo de pacientes con cardiopat\u00eda isqu\u00e9mica conocida o sospechada Principal Investigator: Vicent Villota Espa\u00f1ola de Cardiolog\u00eda Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario budget: \u20ac15.000 la activaci\u00f3n de TLR por medio de sus ligandos sobre la polarizaci\u00f3n de macr\u00f3fagos hacia M1 y su funci\u00f3n citocida frente a las c\u00e9lulas madre de glioblastoma Principal Investigator: Carlos Rom\u00e1 Mateo and Enrique Santas Body: Universidad de Valencia - el contenido mioc\u00e1rdico de hierro tras la administraci\u00f3n de hierro intravenoso (MYOCARDIAL -IRON) Doctoral candidate: Ingrid Cardells Beltr\u00e1n Director(s): Groups Research Group on Histopathology and Tissue Engineering Research Group on Central Nervous System Tumors Research Group of Innovative Diagnostic and Therapeutical Developments Cancer Biology Research Group on Skin Cancer Translational Research on Pediatric Solid Tumors Research Group on Hematopoietic Transplantation Research Group on Lymphoproliferative Disorders Research Group on Myeloid Neoplasms Research Group Engineering Researcher, R4 Carmen Carda Batalla. University Amando Peydr\u00f3 Olaya. University Antonio Silvestre Mu\u00f1oz. Hospital. University Manuel Mata Roig. University Established Researchers, R3 Antonio Fons Font. University Carlos Tejerina Botella. Hospital. University Francisco Forriol Brocal. Hospital Genaro Gal\u00e1n Gil. Hospital. University Jos\u00e9 Javier Mart\u00edn de Llano. University Mari Fe M\u00ednguez Rey. Hospital. University Mar\u00eda Sancho-Tello Valls. University Miguel Puche Torres. Hospital. University Rosa Mar\u00eda Cibri\u00e1n Ortiz de Anda. University Recognised Researcher, R2 Lara Mili\u00e1n Medina. University Mar\u00eda Oliver Ferr\u00e1ndiz. University Rub\u00e9n Salvador Clavell. University First Stage Researchers, R1 \u00c1ngel Aguilar Hern\u00e1ndez. Hospital funding continue working on to the line of Tissue Engineering with projects: Bone regeneration Biomimetic microgels for the study the tumor microenvironment (TME) and the mesenchymal epithelial transition (EMT) in lung cancer Cartilage and bone regeneration techniques and their application in pathologies Main lines of research Regenerative Medicine: Study of articular cartilage regeneration Study of bone Effect of age and gender on the regeneration processResearchers categories 3 9 R4 STAFF Collaborating Researcher Ignacio Peregr\u00edn Alc\u00e1cer Fern\u00e1ndez-Coronado. Microgeles biomim\u00e9ticos para el estudio del microentorno del tumor (TME) y la transici\u00f3n epitelio mes\u00e9nquima (EMT) en c\u00e1ncer de pulm\u00f3n Principal Investigator: Manuel Mata Roig and Jos\u00e9 Javier Mart\u00edn de Llano Funding Body: Ministerio de Ciencia e Innovaci\u00f3n Beneficiary Jos\u00e9 Luis G\u00f3mez Ribelles (Carmen Carda Batalla, Mar\u00eda Sancho-Tello, Manuel Mata Roig, Jos\u00e9 Javier Mart\u00edn de Llano, Lara Mili\u00e1n Medina as researchers)PUBLICATIONS M, Milian L, Sancho-Tello M, de Llano J, Roca F, Martinez-Ramos C, Carda C, Mata M. Alginate- agarose hydrogels improve the in vitro differentiation of human stem cells in M\u00e1s-Estell\u00e9s Ruiz-Sauri A, Zurriaga J, Carda C, Mata of decellularization of porcine tracheas. Long-term effects Llano JJ, Mili\u00e1n L, Oliver M, Mata M, Carda C, Sancho-Tello M. Chondrogenic potential of human dental pulp stem cells cultured as dental pulp cells as precursors in regenerative therapies Study of regeneration of 4Funding Body: Econom\u00eda y Competitividad - CIBER- BBN Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia and Universidad de Valencia Duration: 2018-2021 Total Budget: \u20ac59.241,25 Reference: PROMETEO/2020/069 Title: Regeneraci\u00f3n \u00f3sea en implantopr\u00f3tesis. Procesos biol\u00f3gicos condicionados por la edad y el g\u00e9nero. Dise\u00f1o de nuevos biomateriales (ROMEN) Principal Investigator: Carmen Carda Batalla Funding Body: Conselleria de Innovaci\u00f3n, Universidades, Ciencia y Sociedad Digital Beneficiary Institution: Universidad title: Regeneraci\u00f3n de cart\u00edlago mediante el uso de c\u00e9lulas madre de pulpa dental humanas (HDPSCS) Doctoral candidate: Mar\u00eda Oliver Ferr\u00e1ndiz Director(s): Manuel Mata Roig, Jos\u00e9 Javier Mart\u00edn De Llano the defense: 04/03/2021 Grade: Sobresaliente \"cum laude\" Thesis title: Efectos de la estimulaci\u00f3n mec\u00e1nica sobre c\u00e9lulas madre aplicado a la regeneraci\u00f3n de cart\u00edlago Doctoral candidate: Rub\u00e9n Salvador Clavell Director(s): Jos\u00e9 Javier Mart\u00edn De Llano, Mar\u00eda del Carmen Carda Batalla, Mar\u00eda Sancho-Tello Valls Date of the restauraciones de recubrimiento completo sobre preparaciones dentarias sin l\u00ednea de terminaci\u00f3n: estudio cl\u00ednico prospectivo a 6 a\u00f1os Doctoral candidate: Blanca Serra Pastor Director(s): Antonio Fons Font, Rub\u00e9n Agust\u00edn Panadero, M\u00aa Fernanda Sol\u00e1 Ruiz Date of the defense: 23/04/2021 Grade: Sobresaliente \"cum laude\"Thesis title: An\u00e1lisis de la correlaci\u00f3n entre la exploraci\u00f3n f\u00edsica y los hallazgos en la resonancia magn\u00e9tica en pacientes con disfunci\u00f3n de la articulaci\u00f3n temporo-mandibular Doctoral candidate: \u00c1lvaro Sada Malumbres Director(s): Miguel Puche Torres, Mario F Mu\u00f1oz Guerra defense: 08/06/2021 Grade: Sobresaliente \"cum laude\" Thesis title: Estudio de las malformaciones vasculares evaluadas a lo largo de una d\u00e9cada en un hospital de referencia con un comit\u00e9 multidisciplinar Doctoral candidate: Andrea Est\u00e9banez Corrales Director(s): Jos\u00e9 Mar\u00eda Mart\u00edn Hern\u00e1ndez, Miguel Puche Torres of the defense: INCLIVA Tumors Consolidated group R4 Miguel Cerd\u00e1 Nicol\u00e1s Hospital. Researchers, R3 Concepci\u00f3n L\u00f3pez Gin\u00e9s. University Javier Meg\u00edas Vericat. University Pedro Rold\u00e1n Bad\u00eda. Hospital. University Teresa San Miguel D\u00edez. University Recognised Researchers, R2 Lisandra Mu\u00f1oz Hidalgo. University Pablo Cerd\u00e1 Staff. Technician Navarro Cerver\u00f3. UniversityGroup their analysis have been performed. Analysis by FISH of EGFR status and freezing of the different passes according to established methodology The study of the proteomic the (frozen samples) hypoxia and the different amplification status of the EGFR The pilot study of viability effectiveness of xenotransplantation in nude mice has been completed with the achievement of neoplasias under study Main lines of research Primary GBM. of cell lines Development of a model of population analysis and spatial distribution of these neoplasms Metabolomics and microvascular environment characterization of and Estudio de la angiog\u00e9nesis en el glioblastoma y su asociaci\u00f3n con inflamaci\u00f3n y agresividad en tumores humanos y en cultivo in vitro. Introducci\u00f3n a la patolog\u00eda digital e integraci\u00f3n con datos \u00f3micos Principal Investigator: Teresa San Miguel D\u00edez Funding body: Conselleria de Innovaci\u00f3n, Universidades, Ciencia y Sociedad Digital Beneficiary institution: Universidad la activaci\u00f3n de TLR por medio de sus ligandos sobre la polarizaci\u00f3n de macr\u00f3fagos hacia M1 y su funci\u00f3n citocida frente a las c\u00e9lulas madre de glioblastoma Principal Investigator: Javier Meg\u00edas Vericat and Andrea Cabrera Pastor Funding body: Conselleria de Innovaci\u00f3n, Universidades, Ciencia y Sociedad Digital Beneficiary institution: Universidad de regenerativa Doctoral candidate: Francisco Javier Rodr\u00edguez Lozano Director(s): Leopoldo Forner Lozano, Mar\u00eda del Carmen Llena Puy, Concepci\u00f3n L\u00f3pez Gines Date of the defense: 03/12/2021 Casanova-Ferrer F, Urios A, Benlloch S, Marti-Aguado D, San- Miguel T, Tosca J, Rios M, Monton C, Durban L, Escudero- Garcia D, Aparicio L, Felipo V, Montoliu C. A score N, Urios A, Gallego J, Gimenez- Garzo C, Casanova F, Fiorillo A, Cabrera-Pastor A, San-Miguel T, Ipiens C, Escudero-Garcia D, Tosca J, Monton C, Ballester M, Ballester J, Aparicio L, Rios M, Durban L, Mir A, Kosenko E, Cases P, Felipo V, Sanz J, Lozano A, Pecci-Lloret M, Melo M, Lopez-Gines C, Forner L. Cytocompatibility properties of the San-Miguel T, Valles S, Aldasoro M, Vila J, Zarzoso M, Mauricio M. PPARgamma as an indicator of vascular function in an experimental model of Lopez-Gines C, Monleon D, Llena C, Forner L. Hospital. University Established Researchers, R3 Desamparados Roda P\u00e9rez. Hospital Gerardo L\u00f3pez Rodas. University Emerging researchers, R2 Noelia Tarazona Llavero. Hospital Tania Fleitas Kanonnikoff. Hospital Recognised Researchers, R2 Amelia Insa Moll\u00e1. Hospital Francisco Gimeno Valiente. INCLIVA Jose A. P\u00e9rez Fidalgo. Hospital. University Josefa Castillo Aliaga. University Maider Ibarrola Villava. INCLIVA Mar\u00eda Carolina Mart\u00ednez Ciarpaglini. Hospital. University Keranen. ESMO Fernanda Guti\u00e9rrez Bravo. INCLIVA Gema Bruixola Campos. Hospital Jorge Mart\u00edn Aranda. INCLIVA Jos\u00e9 Francisco Gonz\u00e1lez Mu\u00f1oz. INCLIVA Lorena Alarc\u00f3n Molero. University Manuel Cabeza Segura. INCLIVA Marisol Huerta \u00c1lvaro. Hospital Paloma Mart\u00edn Martorell. Hospital Roberto Tebar Mart\u00ednez. AECC Staff. Collaborating Researcher Clara Alfaro Cervell\u00f3. Hospital. University Staff. Technicians Alba Viala Monle\u00f3n. Hospital Am\u00e9rica Bueno G\u00f3mez. INCLIVA Ana Ferrer Mart\u00ednez. INCLIVA Beatriz L\u00f3pez Montero. INCLIVAGroup members Garc\u00eda Peris Helen L\u00f3pez. M\u00aa Pilar Natividad Romero Alcaide. INCLIVA Garz\u00f3n Lloria. INCLIVA competitive INCLIVA INCLIVA Elena Jim\u00e9nez Mart\u00ed. University Enrique Castell\u00f3 Moreno. INCLIVA Gabriela P\u00e9rez Garrity. INCLIVA Mireia Tom\u00e0s Petruskevicius Researchers Noelia Tarazona Llavero are based on the use of liquid biopsy with the use of circulating tumor DNA in plasma to detect minimal residual di- and tumor cells to characterize minimal residual disease and the establishment of organoids from the tumor and circulating tumor cells of patients with localized colon cancer and the study of new biomarkers Tania Fleitas Kanonnikoff Our scientific interests are based on of Gastric Cancer. Moreover, we are also the study the clinical-epidemiological-molecular characteristics of patients with young gastric tumors under 50 years of age, the study of the clinical-pathological-molecular characteristics of patients diagnosed with Our group aims to improve the patient's life through the development of new diagnostic and therapeutic methods. In addition to this main goal, we intend to implement strategies to facilitate the development of precission in solid tumors with innovative therapeutic approaches and provide knowledge on approach precission medicine in colorectal and gastric cancer from different such as molecular classification, the use of predictive biomarkers and new therapeutic approaches. Main lines of malignancies To use the latest technologies to improve our knowledge of the molecular and genetic causes of cancer To implement the cell cultures) from patients functional to understand the underlaying causes of tumorigenesis and to test the appropriateness of PUBLICATIONS 56 activity4SELECTED PUBLICATIONS 1. Yoshino T, Argiles G, Oki E, Martinelli E, Taniguchi H, Arnold D, Mishima S, Li Y, Smruti B, Ahn J, Faud I, Chee C, Yeh K, Lin P, Chua C, Hasbullah H, Lee M, Sharma A, Sun Y, Curigliano G, Bando H, Lordick F, Yamanaka T, Tabernero J, Baba E, Cervantes A, Ohtsu A, Atkinson V, Carpentier AF, Lohr M, Redman R, Mason W, Cervantes A, Le Rhun E, Ochsenreither S, Warren L, Zhao Y, Callies S, Estrem ST, Man M, Gandhi L, Avsar E, Melisi D. First-in-human phase I study of growth M, Alberich-Bayarri A, I, Martin-Arana J, Tebar-Martinez R, Viala Hernando C, Blasco I, Papaccio F, Martinez-Ciarpaglini C, Alfaro-Cervello C, Seda-Garcia E, Blesa S, Chirivella I, Castillo J, Monton-Bueno JV, Rosello S, Huerta M, Perez-Fidalgo A, Martin- Martorell P, Insa-Molla A, Fleitas T, Rentero-Garrido P, Zuniga- Trejos S, Cervantes A, Roda D. Molecular profiling of advanced solid tumours. The impact L, Tarazona N, Gambardella V, Cervantes A, Lopez-Rodas G, Franco L, Castillo J. Epigenetic mechanisms are Investigator: Andr\u00e9s Cervantes Funding Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Cervantes Ruip\u00e9rez Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico tumor, angiog\u00e9nesis tumoral y resistencia a las terapias en C\u00e1ncer G\u00e1strico Difuso fenotipo Mesenquimal Principal Investigator: Tania Carolina Fleitas Kanonnikoff and Desamparados Roda P\u00e9rez Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Total Budget: \u20ac99.220 Reference: con c\u00e1ncer colorrectal localizado: abordaje multi\u00f3mico de la Enfermedad M\u00ednima Residual en biopsia l\u00edquida y modelos de organoides Principal Investigator: Andr\u00e9s Cervantes Ruip\u00e9rez Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico de SCIENTIFIC REPORT 2021scientific activity 4Beneficiary Funding Body: Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Total budget: \u20ac266.475 Reference: CB16/12/00473 Title: (CIBERonc) Principal Investigator: Andr\u00e9s Cervantes Ruip\u00e9rez Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2017- Reference: GV/2020/189 Title: Estudio de la carga tumoral ganglionar y el budding tumoral como factores pron\u00f3sticos el c\u00e1ncer colorrectal en estadios localizados Principal Investigator: M\u00aa Carolina Mart\u00ednez Ciarpaglini Funding Body: Conselleria de Educaci\u00f3n Cultura y Deporte Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: Total budget: \u20ac992.996 Title: Organoides derivados de pacientes (PDOs) para personalizar el tratamiento en reca\u00eddas de c\u00e1ncer de colon (CC) localizado mediante secuenciaci\u00f3n del exoma completo y de Valencia 2020-2022 Total budget: \u20ac40.000 Title: Utilidad de la biopsia l\u00edquida y organoides en el manejo y tratamiento de adenocarcinoma de p\u00e1ncreas: hacia una medicina de precisi\u00f3n Principal Investigator: Ibarrola Villava Funding Body: Fundaci\u00f3n Mutua Madrile\u00f1a Beneficiary Fundaci\u00f3n Investigaci\u00f3n Hospital Budget: \u20ac100.000 Title: Carcionog\u00e9nesis colorrectal: la interacci\u00f3n el microambiente tumoral y las c\u00e9lulas madre. Impacto en el tratamiento personalizado Principal Investigator: Noelia Tarazona Llavero Funding Body: Fundaci\u00f3n Mutua Madrile\u00f1a Beneficiary Fundaci\u00f3n Investigaci\u00f3n de Total budget: \u20ac130.000 Title: Secuenciaci\u00f3n del exoma completo del DNA tumoral circulante y DNA gen\u00f3mico para aumentar la sensibilidad en la detecci\u00f3n de la enfermedad m\u00ednima residual y abrir nuevas v\u00edas para la medicina personalizada en c\u00e1ncer de colon localizado Principal Investigator: Noelia Tarazona Llavero (SEOM) Beneficiary Fundaci\u00f3n Investigaci\u00f3n Hospital Valencia Duration: 2021-2022 Total budget: \u20ac20.000 Title: Mecanismos moleculares y heterogeneidad tumoral asociados a la resistencia primaria y adquirida al tratamiento cont rastuzumab en c\u00e1ncer g\u00e1strico (CG) o de la uni\u00f3n (CUGE) Principal Investigator: Tania Carolina de Oncolog\u00eda M\u00e9dica (SEOM) Beneficiary Fundaci\u00f3n Investigaci\u00f3n Hospital budget: \u20ac9.096 Reference: PI-2021-007 Title: SCIENTIFIC REPORT Federica Papaccio Director(s): Andr\u00e9s Cervantes Ruip\u00e9rez, Josefa Castillo potenciales agentes antitumorales Principal Investigator: Francisco Jos\u00e9 Mart\u00ednez Lillo and Tania Fleitas Kanonnikoff Funding Body: Universidad de Valencia - de a trav\u00e9s del an\u00e1lisis prote\u00f3mico de organoides Principal Investigator: Manuel Mart\u00edn S\u00e1nchez del Pino and Josefa Castillo Aliaga Funding Body: Universidad de Valencia - INCLIVA Beneficiary Eroles Asensio INCLIVA Established Researchers, R3 Antonio Millet Serrano. University Isabel Chirivella Gonz\u00e1lez. Hospital. University Octavio Burgues Gasi\u00f3n. Hospital. University Recognised Researchers, R2 Bego\u00f1a Bermejo De Las Heras. Hospital. University Bego\u00f1a Pineda Merlo. University Diego Soriano Mena. Hospital Eduardo Tormo Mart\u00edn. CIBERONC Elvira Buch Villa. Hospital Juan Miguel Cejalvo And\u00fajar. Hospital Mar\u00eda Teresa Mart\u00ednez Mart\u00ednez. Hospital First R1 Ana Caterina Lameirinhas. AECC Anna Hernando Meli\u00e1. Hospital Iris Garrido Cano. CIBER Juan Jos\u00e9 Mart\u00ednez Pretel. INCLIVA Sandra Torres Ruiz. Administrative assistant Cristina Parrilla Mu\u00f1oz. Hospital Yolanda De La Cruz Robles. INCLIVAResearchers by categories 3 7 6 2 9 Researchers financed to anti-HER2 mesenchymal transition in the tumors women of AXL in trastuzumab-resistant breast cancer 2. Tutt A, Garber J, Kaufman B, Viale G, Fumagalli D, Rastogi P, Gelber R, de Azambuja E, Fielding Balmana Domchek S, Gelmon K, Hollingsworth S, Korde Z, Pippas A, Nowecki Z, Huzarski T, Ganz P, Lucas P, Baker N, Loibl S, McConnell R, Piccart M, Schmutzler V, S, Meric-Bernstam F, Albain SKL, Dhesy-Thind S, Rastogi Martin M, Kelly CM, Ruiz-Borrego M, Gil-Gil M, Arce-Salinas CH, Brain EGC, Lee ES, G, Ruiz Borrego M, Stradella A, Bermejo B, Schmid P, Marme F, Escriva-de-Romani S, Calvo L, Ribelles N, Martinez N, Albacar C, Prat A, Dalenc F, Kerrou K, Colleoni M, Afonso N, Di Cosimo S, Sampayo- Cordero M, Malfettone A, Cortes Zielinski Ruiz-Borrego M, Carrasco E, Turner N, Ciruelos E, Munoz M, Bermejo B, Margeli M, Anton A, Kahan Z, Csoszi T, Casas M, Murillo L, Morales S, Alba E, Gal-Yam E, Guerrero-Zotano A, Calvo L, Haba-Rodriguez J, Ramos M, Alvarez I, Garcia-Palomo A, Bartlett C, Koehler M, Caballero R, Corsaro M, Huang X, Garcia-Saenz J, Chacon J, Swift C, C, S, Casadevall D, Galbardi B, Dugo M, Servitja S, Montero J, Soria-Jimenez L, Sabbaghi M, Pena R, Madoz-Gurpide J, Lloveras B, Lluch A, Eroles P, Arribas J, Pandiella A, Gianni L, Rojo F, Rovira A, Albanell J. and Duration: 2021-2025 Total budget: \u20ac466.125Reference: PI18/01219 Title: Caracterizaci\u00f3n y repercusi\u00f3n terap\u00e9utica de la ecolog\u00eda de c\u00e1ncer de mama HER2 positivo Principal Investigator: Pilar Eroles Asensio Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Total budget: \u20ac112.530 Reference: PI18/00817 Title: Caracterizaci\u00f3n molecular del c\u00e1ncer de mama gestacional Principal Investigator: Juan de la Haba Rodr\u00edguez (Bego\u00f1a Bermejo as collaborating researcher) Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n \u20ac146.159,53 Title: Disecci\u00f3n multidiciplinar de los mecanismos de resistencia a quimioterapia en c\u00e1ncer de mama triple negativo: un paso hacia una mejor atenci\u00f3n cl\u00ednica Principal Investigator: Juan Miguel Cejalvo And\u00fajar Funding Body: Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer Beneficiary CIBERONC/Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Total budget: \u20ac268.500 Title: Disecci\u00f3n multidisciplinar de los mecanismos de resistencia a quimioterapia en c\u00e1ncer de mama triple negativo: un paso hacia una mejor atenci\u00f3n cl\u00ednica Principal Investigator: \u00c1ngel R Nebreda (Juan Miguel Cejalvo 2021-2026 Total budget: \u20ac268.500 Title: An\u00e1lisis del papel de la v\u00eda aurora kinasa-p53 como potencial marcador predictivo y dianas terap\u00e9uticas en c\u00e1ncer de mama triple negativo Principal Investigator: Bego\u00f1a Pineda Merlo Funding Body: Fundaci\u00f3n Mutua Madrile\u00f1a110 INCLIVA SCIENTIFIC REPORT 2021scientific activity4Beneficiary Fundaci\u00f3n Investigaci\u00f3n de Valencia Duration: 2018-2021 Total budget: \u20ac120.000 Title: Diferencias entre el perfil gen\u00f3mico en mujeres j\u00f3venes menores de 35 a\u00f1os con respecto al c\u00e1ncer de mama de mujeres mayores Principal Investigator: M\u00aa Teresa Mart\u00ednez Mart\u00ednez Funding Body: Fundaci\u00f3n Sandra Ibarra Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital de Valencia Total budget: \u20ac10.500 Title: Hemopach versus seroma post linfadenectom\u00eda axilar. Estudio cl\u00ednico Funding Body: Asociaci\u00f3n Espa\u00f1ola de Cirujanos Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2020-2021 Total budget: \u20ac10.000 Title: Factores pron\u00f3sticos y predictivos en c\u00e1ncer de mama oligometast\u00e1sico que identifiquen pacientes en las que el tratamiento local sobre la met\u00e1stasis aumente su supervivencia: Beneficio del estadio NED (no evidencia de enfermedad) Principal Investigator: Juan Miguel Cejalvo And\u00fajar Funding Body: C\u00e1ncer de Mama Metast\u00e1tico Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia 2020- 2022 Total budget: \u20ac16.500Title: Dimerizacion de AXL -HER2 como mecanismo de resistencia adquirida a la terapia anti-HER2 en c\u00e1ncer de mama HER2+: un paso hacia la medicina de precisi\u00f3n Principal Miguel Cejalvo And\u00fajar Funding Body: ADAMED Total budget: \u20ac18.000 THESIS Thesis title: Estudio de las alteraciones gen\u00e9ticas asociadas con la resistencia al tratamiento neoadyuvante de deprivaci\u00f3n estrog\u00e9nica en c\u00e1ncer de mama Doctoral candidate: \u00c1ngel Luis Guerrero Zotano Director(s): Jos\u00e9 Antonio L\u00f3pez Guerrero, Vicente Guillem Porta, Ana Lluch Hern\u00e1ndez Date of the defense: candidate: Garrido Cano Director(s): Pilar Eroles Asensio, Ram\u00f3n Mart\u00ednez Consolidated group Leading R4 Jos\u00e9 Carlos Monteagudo Castro Hospital. University Recognised Researchers, R2 Andrea Est\u00e9banez Corrales. Hospital Jos\u00e9 M\u00aa Mart\u00edn Hern\u00e1ndez. Hospital. University Liria Terr\u00e1dez M\u00e1s. Hospital. University First Stage Researchers, R1 Ana\u00efs Moscard\u00f3 Navarro. University Andr\u00e9s HospitalGroup members Prognostic of schedule at the time of diagnosis Machine learning in the study of whole slide University somatic 112 INCLIVA SCIENTIFIC REPORT 2021scientific activity4Reference: PI20/00094 Title: An\u00e1lisis combinado por Inteligencia Artificial de marcadores epigen\u00e9ticos e im\u00e1genes microsc\u00f3picas digitalizadas de tumores melanoc\u00edticos ambiguos para optimizar su clasificaci\u00f3n diagn\u00f3stica y pron\u00f3stica Principal Investigator: Jos\u00e9 Carlos Monteagudo Castro Funding body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Total Budget: \u20ac220.220 Reference: PI17/02019 Title: Estudio del valor del patr\u00f3n de metilaci\u00f3n y variaciones del n\u00famero de copias del genoma para determinar el grado de malignidad en los tumores melanoc\u00edticos de potencial maligno incierto Principal Investigator: Jos\u00e9 Carlos Monteagudo Castro Funding body: Instituto de Salud Carlos III - Cofinanced FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2018-2021 Total Budget: \u20ac99.220 Title: Estudio de factores pron\u00f3sticos en pacientes con linfomas cut\u00e1neos de c\u00e9lulas T (LCCT) Principal Duration: 2021 Total Budget: \u20ac22.500 Title: Estudio de las malformaciones vasculares evaluadas a lo largo de una d\u00e9cada en un hospital de referencia con comit\u00e9 multidisciplinario Principal Investigator: D, Garcia-Muret P, Haya L, Penate Y, Acebo E, Fernandez de Misa R, Blanes M, Suh-Oh HJ, Izu R, Silva-Diaz E, Sarriugarte Mateu-Puchades A, Prieto-Torres L, Morillas V, Morillo M, Sanchez-Caminero P, Calzado L, Perez-Ferriols A, Perez A, Dominguez JD, Navedo M, Muniesa PL. with Primary Cutaneous Lymphoma are at risk severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry. Journal of J, Silva E, Velasco R, Cuesta A, Monteagudo C, Mart\u00edn JM. Kutane und systemische L, Colomer A, Moscardo A, Mosquera- Zamudio A, Monteagudo C, Naranjo V. weakly Garcia J, Cunat A, Canales M, Felix M, Campos S, Canada J, Hernandez J. Characteristics of mucocutaneous vascular malformations Artificial Intelligence Monteagudo Castro Funding body: European Commission Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Budget: \u20ac252.000113 Tumors Consolidated group Leading Researchers, R4 Samuel Navarro Fos Hospital. University Rosa Noguera Salv\u00e1 University Recognised Researchers, R2 Inmaculada Noguera Salv\u00e1. University M\u00aa Amparo L\u00f3pez Carrasco. CIBERONC Rebeca Burgos neuroblastic infantile tumors Main lines of research analysis in neuroblastoma. At the European level, we participate in the establishment of a lines in and in vitro (2D and 3D) from fresh neuroblastic and malignant infantile solid tumor material PUBLICATIONS Title: Neuroblastoma: estrategias mecanoterap\u00e9uticas basadas en modelos 3D y tumores derivados de pacientes con microambiente rico en vitronectina Principal Investigator: Rosa Noguera Salv\u00e1 Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Salud Carlos III - Co-financed Funding body: familiares y amigos de pacientes con Neuroblastoma Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2017-2021 Total budget: \u20ac203.000 Title: Identificaci\u00f3n de nuevas dianas terap\u00e9uticas relacionadas con la matriz extracelular de los sarcomas \"Ewing-like\": estudio morfo-molecular Principal Investigator: Rosa Noguera \u00c1lava Funding body: Fundaci\u00f3n CRIS Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Universitario de Valencia Duration: 2019-2022 Total budget: \u20ac60.000SELECTED PUBLICATIONS 1. Bellini A, Potschger U, Bernard V, Lapouble E, Baulande S, Ambros PF, Auger N, Beiske K, M, Betts DR, Bhalshankar J, Bown N, de Preter K, Clement N, Combaret V, Font de Mora J, George SL, Jimenez I, Jeison M, Marques B, Martinsson T, Mazzocco A, Noguera R, Pierron G, Rossing M, Taschner-Mandl S, Van Roy N, Vicha A, Chesler L, Balwierz W, Castel V, Elliott M, Kogner P, Laureys G, Luksch R, Malis J, Popovic-Beck and alk J, Diaz- Lagares A, Jacome MA, Salguero-Aranda C, Garcia Ros D, Davidson B, Lopez R, Melero I, Navarro S, Ramon y Cajal S, de Alava E, Matias-Guiu X, Noguera R. Characterizing the invasive tumor S, Blanquer- Maceiras M, Castel V, Navarro S, Noguera Henderson M, Di Giacomo S, Russell A, Pigini P, Murray J, Valli E, Milazzo G, Giorgi F, Cowley M, Ashton L, Bhalshankar J, Schleiermacher G, Rihani A, Van Maerken Speleman Versteeg Koster R, Tonini G, Fong K, Vaksman Z, Diskin S, Maris J, London W, Marshall G, Ziegler D, Hogarty M, Perini G, Norris M, Haber M. Nieto Morales MG, Cruz J, Lavernia J, Giner F, Navarro S, Ferrandez Fundaci\u00f3n Neuroblastoma Beneficiary Total budget: Leading Researcher, R4 Carlos Solano Vercet Hospital. University David Navarro Ortega Hospital. University Recognised Researchers, R2 Jos\u00e9 Luis Pi\u00f1ana S\u00e1nchez. Hospital Mar\u00eda Jos\u00e9 Remigia Pellicer. Hospital Paula Amat Mart\u00ednez. Hospital. University Rafael Hernani Morales. Hospital Emerging Researcher, R2 Eliseo Alejandro Albert Vicent. Hospital Estela Gim\u00e9nez Quiles. Hospital First Stage Researchers, R1 Ariadna P\u00e9rez Mart\u00ednez. Hospital Torres Fink. Collaborating Researchers Ana Benzanqu\u00e9n Vallejos. Hospital Viciedo. INCLIVAGroup members transplant Creation of a Multidisciplinary Unit of Advanced Therapies-CART in Hospital Cl\u00ednico Universitario de Valencia - INCLIVA Design and implementation of new modalities of allogeneic compatible and incompatible alternative transplant outpatient settingStaff. Technicians INCLIVA M\u00aa Pilar Ortiz INCLIVAResearchers REPORT 2021scientific activity 44. Hernani R, Sancho A, Amat P, Hernandez-Boluda J, Perez A, Pinana J, Carretero C, Goterris R, Gomez M, Saus A, Ferrer B, Teruel A, Terol M, Solano C. therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature Perez A, Lopez O, Heras I, Arbona C, Viguria MC, Hernandez-Boluda JC, Martinez- a randomised controlled body: European Commission Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de ValenciaSELECTED PUBLICATIONS 1. Lopez M, Chiner-Oms A, Garcia de Viedma D, et al. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of R, Mikulska M, Tridello G, Aguado B, Al Zahrani M, Apperley J, Berceanu A, Bofarull RM, Calbacho M, Ciceri F, Vallisa L, Gimenez Quiles E, De La Camara R, Albert Vicent E, Rovira M, Espigado I, Calvo C, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, Perez Martinez Bermudez A, Saldana R, Heras I, Gonzalez-Huerta A, Torrado T, Bautista G, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta M, Pinana J, Navarro Ortega D. Cytomegalovirus DNAemia and risk of mortality in allogeneic Quiles The main objective is the study of the dynamics of the composition and of the viral load of the main components of the human plasma virome as a predictor of allogeneic transplantation hematopoietic progenitors Eliseo Alejandro Albert Vicent The main objective is the study of infection in con depleci\u00f3n ex vivo de linfocitos T CD45RA+ en pacientes con alto riesgo de infecci\u00f3n viral tras TPH alog\u00e9nico Principal Investigator: Carlos Solano Vercet Funding body: Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico citomegalovirus (CMV) en el paciente con neoplasia hematol\u00f3gicas en la era de las nuevas bioterapias Principal Investigator: David Navarro Ortega Funding body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico inmunol\u00f3gicos y genot\u00edpicos de predicci\u00f3n del riesgo y evoluci\u00f3n de la infecci\u00f3n por CMV en pacientes con trasplante renal Principal Investigator: Mar\u00eda Jos\u00e9 Remigia Pellicer Funding body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Total budget: \u20ac32.670 Reference: ICI21/00016 Title: Terapia celular combinada para pacientes COVID-19 de alto riesgo de mortalidad (DECODE-19) Principal Investigator: Bernat Soria Escoms (Carlos Solano as collaborating researcher) Funding body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico posible marcador del estado neto de inmunosupresi\u00f3n: evaluaci\u00f3n en el trasplante alog\u00e9nico de progenitores hematopoy\u00e9ticos Principal Investigator: Estela Gim\u00e9nez Quiles Funding body: Conselleria de Educaci\u00f3n Cultura y Deporte Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia budget: \u20ac16.000 Title: con depleci\u00f3n ex vivo de linfocitos T CD45RA+ en pacientes con alto riesgo de infecci\u00f3n viral tras TPH alog\u00e9nico Principal Investigator: Carlos Cilag S.A. Beneficiary institution: Fundaci\u00f3n Total budget: \u20ac22.500 Title: Torquetenovirus en terapia CAR-T: predicci\u00f3n del riesgo de s\u00edndrome de liberaci\u00f3n de citocinas y diagn\u00f3stico diferencial con infecci\u00f3n Principal Investigator: Rafael Hernani Morales Funding body: Fundaci\u00f3n Espa\u00f1ola de Hematolog\u00eda y Hemoterapia- Gilead Beneficiary Fundaci\u00f3n Investigaci\u00f3n Total budget: \u20ac60.000 Reference: AP178182020 Title: Estudio de la inmunidad y Creaci\u00f3n de un Banco Nacional de Terapia Celular Adoptiva de donantes de linfocitos que han superado COVID-19. Ensayo cl\u00ednico Fase I multic\u00e9ntrico para evaluar la seguridad de la infusi\u00f3n de c\u00e9lulas natural killer como terapia adoptiva en casos pacientes con neumon\u00eda y/o linfopenia debido al coronavirus SARS-CoV-2 (RELEASE) Principal Eguizabal (Carlos Solano Funding body: Fundaci\u00f3n Mutua Madrile\u00f1a Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia, IIS Biocruces Bizkaia-CVTTH, Hospital La Paz-IDIPAZ, Centro de Transfusiones de Madrid, Hospital General de Alicante119 de la inmunidad y Creaci\u00f3n de un Banco Nacional de Terapia Celular Adoptiva de donantes de linfocitos que han superado COVID-19. Ensayo cl\u00ednico Fase I multic\u00e9ntrico para evaluar la seguridad de la infusi\u00f3n de c\u00e9lulas natural killer como terapia adoptiva en casos pacientes con neumon\u00eda y/o linfopenia debido al coronavirus SARS-CoV-2 (RELEASE) Principal Eguizabal (Carlos Solano as collaborating researcher) Funding body: Vasca de Innovaci\u00f3n e investigaci\u00f3n Sanitarias (BIOEFF) Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico la diagnosis simult\u00e1nea de COVID19 y otros pat\u00f3genos a\u00e9reos Principal Investigator: David Gim\u00e9nez Romero (Estela Gim\u00e9nez Quiles as collaborating body: Universidad de Thesis title: de la infecci\u00f3n activa precoz por Citomegalovirus en el trasplante alog\u00e9nico de precursores hematopoy\u00e9ticos Doctoral candidate: Alberto Talaya Pe\u00f1alver Director(s): David Navarro Grade: Sobresaliente \"cum laude\" Thesis title: Estudio de la enfermedad residual m\u00ednima en pacientes con mieloma m\u00faltiple en muy buena respuesta parcial o completa convencional mediante citometr\u00eda de flujo de alta sensibilidad y la medici\u00f3n de cadenas mediante la t\u00e9cnica Hevylite Doctoral candidate: Mar\u00eda Jos\u00e9 Remigia Pellicer Director(s): Javier De la Rubia Comos, Amparo Sempere Talens, Carlos Solano Vercet Date title: Factores desarrollo y evoluci\u00f3n de infecci\u00f3n activa por citomegalovirus en el trasplante alog\u00e9nico de precursores hematopoy\u00e9ticos Doctoral candidate: V\u00edctor Vinuesa Velasco Director(s): David Navarro Ortega of the defense: University Recognised Researchers, R2 Ana Isabel Teruel Casa\u00fas. Hospital. University Blanca Ferrer Lores. Hospital Staff. Collaborating Researchers Alicia Serrano Alcal\u00e1. INCLIVA Edelmira Mart\u00ed Vidal. INCLIVAGroup Strategic aims During the year 2021, we were able to deepen knowledge of the role of advanced lines and in the patient's primary cells, we observed a variation in the number of gene copies by both FISH and PCRq in the NOTCH1, FBXW7 and PTEN genes, with relationship between and FBXW7/PTEN second objective Sg than the rest Thirdly, during 2021, the study of the status of IgVH in CLL and its prognostic impact in a wide series of patients has molecular techniques. In addition, the CLL project, Finally, we in projects in CLL, refractory lymphomas and multiple myeloma, both with the incorporation of new drugs and in the design and development of new therapeutic options Main lines of research Analysis of the interactions of CLL cells with their cellular with CLL-B of primary cells obtained at diagnosis and at the time of the progression, analyzing for this, the presence of mutations and number of copies of DNA, gene expression, FISH and (RT-PCR)Researchers by categories 1 2 1 6R3 R2 R4 STAFF Staff. Nurses Esther Lozano Garc\u00eda. INCLIVA Juan Ram\u00f3n de Moya Romero. Hospital. University Mercedes Bou Moreno. INCLIVA121 INCLIVA SCIENTIFIC REPORT International collaborations A, Franco J, Martinez-Jabaloyas J, Marco J, Forner MJ, Cano A, Silvestre A, Teruel A, Lluch A, Cervantes A, Chirivella Gonzalez I. Ten-year assessment of a C, Iacoboni G, Terol MJ, JA, Villanueva L, Gonzalez E, de Arriba F, Oriol A, Gonzalez-Calle V, Escalante F, de la Rubia J, Gironella M, Rios R, Garcia-Sanchez R, Arguinano JM, Alegre A, Martin J, Gutierrez NC, Calasanz MJ, Martin ML, Couto MC, Casanova M, Arnao M, Perez-Persona E, Garzon S, Gonzalez MS, Martin- Sanchez G, Ocio EM, Coleman M, Encinas C, Vale AM, Teruel AI, Cortes-Rodriguez M, Paiva B, Cedena MT, San-Miguel JF, Lahuerta JJ, Blade J, Niesvizky R, Mateos MV. Lenalidomide and dexamethasone with or without in A, P, Escudero- Garcia D, Monton C, Aguilera V, Alberich-Bayarri A, Serra Marti-Bonmati S, Ortega B, Moragon S, Rosello S, Insa A, Navarro J, Sanmartin A, Julve A, Buch E, Study of the in clonal evolution associated with tumor progression New therapeutic options for CLL/MM patients group Leading Researcher, R4 Mar Tormo D\u00edaz Hospital. University Juan Carlos Hern\u00e1ndez Boluda Hospital. University Recognised Researchers, R2 Carlos Carretero M\u00e1rquez. Hospital Marisa Calabuig Mu\u00f1oz. Hospital Montserrat G\u00f3mez Calafaz. Hospital First Stage Researcher, R1 Irene Ribate. INCLIVA Iv\u00e1n INCLIVAGroup members Strategic of the EZH2 gene and of genetic mutations alterations and other genetic mutations Main lines of research Study of mechanisms involved in leukemic transformation in the the Spanish SMD Palomino A, Ferrer- Marin F, Isabel Mata-Vazquez M, Moreto A, Magro E, Murillo I, Alonso-Dominguez J, Maria Guerra J, Guerrero L, Maria Raya J, Perez-Encinas M, Carreno-Tarragona G, Fox L, Pastor Galan from the Spanish R, Calasanz M, Irigoyen A, Sanz G, Such E, Mora E, Gutierrez M, Collado R, Garcia-Serra R, Vara M, Blanco M, Oiartzabal I, Alvarez S, Bernal T, Granada I, Xicoy B, Jerez A, Calabuig M, Diez R, Gil A, Diez-Campelo M, Solano C, Tormo M, Spanish de la infusi\u00f3n de linfocitos del donante con depleci\u00f3n ex vivo de linfocitos T CD45RA+ en pacientes con alto riesgo de infecci\u00f3n viral tras TPH alog\u00e9nico Principal Investigator: Carlos Solano - Cilag S.A. Beneficiary Cl\u00ednico Universitario de Valencia Duration: 2021-2021 Total Budget: \u20ac22.500SELECTED PUBLICATIONS 1. Ribera J, Morgades M, Ciudad J, Montesinos P, Esteve J, Genesca E, Barba P, Ribera J, Garcia Cadenas I, Moreno M, Martinez-Carballeira D, Torrent A, Martinez-Sanchez P, Monsalvo S, Gil C, Tormo M, Artola M, Cervera M, Gonzalez- Campos J, Rodriguez-Medina C, Bermudez A, Novo A, Soria B, Coll R, Amigo M, Lopez A, Fernandez Martin R, Serrano J, Mercadal S, Cladera A, Gimenez-Conca A, Penarrubia M, F, Hernandez-Rivas J, Garcia A, Bergua Burgues J, de Rueda B, Sanchez-Sanchez M, Serrano A, Calbacho M, Alonso Vence N, Mendez-Sanchez J, Garcia-Boyero R, Olivares M, Barrena S, Zamora L, Granada I, Lhermitte L, Feliu E, Orfao A. Chemotherapy or D, Robin M, Bornhaeuser M, Angelucci E, Vitek A, Blau I, Niittyvuopio R, Finke J, Cornelissen J, Passweg J, Dreger P, Petersen E, Kanz L, Sanz J, Zuckerman T, Zinger N, Iacobelli de Witte Wilson Platzbecker U, Sengeloev H, Blaise D, Einsele H, Sockel K, Kruger W, Lenhoff S, Salaroli A, Martin H, V, Pavone V, Larran Raya Malignancies Working Party of EBMT and the Spanish Soledad Noya M, Teresa Gomez-Casares M, Cuevas B, Caballero G, 124 INCLIVA SCIENTIFIC REPORT 2021scientific activity4Research Group on Molecular Carcel\u00e9n. University Jos\u00e9 Manuel Morales Tatay. University Mercedes Pardo Tendero. University Vannina Gonz\u00e1lez Marrachelli. University First Stage Researchers, R1 Geraldine Rocha Correal. University Mar\u00eda Mart\u00edn Grau. University Pilar Casanova Terol. University Serena Pisoni. University Main metabolism through cognitiva en la descendencia: papel causa-efecto de la microbiota intestinal y prevenci\u00f3n diet\u00e9tica Principal Consuelo Borr\u00e1s Blasco (Daniel Monle\u00f3n Body: Ministerio de Econom\u00eda, Industria y Competitividad Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario Total Budget: con ves\u00edculas extracelulares de c\u00e9lulas madre de grasa de ratones j\u00f3venes sobre par\u00e1metros de envejecimiento y fragilidad en ratones de edad avanzada Principal Investigator: Consuelo Borr\u00e1s Blasco (Vannina Gonz\u00e1lez Marrachelli as microbiota intestinal en la enfermedad cardiometab\u00f3lica. Detecci\u00f3n temprana, prevenci\u00f3n y tratamiento Doctoral candidate: Mar\u00eda Mercedes Pardo Tendero Director(s): Daniel Monle\u00f3n Amigo- Grau N, Lopez-Pineda A, Fernandez X, Masana Monle\u00f3n Lopez-Gines C, Monleon D, Llena C, Forner L. D, Bodi V, J, D, Nunez J. Bacterial metabolites trimethylamine N-oxide and butyrate as surrogates of small intestinal bacterial overgrowth in patients with a recent Gambini J, Jove M, Lopez-Grueso R, Mas-Bargues C, Monleon D, Pamplona R, Vina J. Lifelong soya consumption in males does not health span under a metabolic as type BREIC: Identificaci\u00f3n de biomarcadores eje coraz\u00f3n- microbiota-sistema inmune por RMN para la estratificaci\u00f3n de pacientes con insuficiencia cardiaca Principal Investigator: Vannina Gonz\u00e1lez Marrachelli and Anna Mollar de Valencia INCLIVA Beneficiary - INCLIVA126 INCLIVA SCIENTIFIC 2021scientific activity44.3.3 Metabolism area Groups Research on Genetics of Osteoporosis Research Group on Neurological Impairment Research Group on Inflammation Research Group on Oxidative Pathology Research Group on Psychiatry and Neurodegenerative Diseases on Respiratory Diseases Research Group on Tissular Biochemistry Research Group on Aging and Physical Activity Research Group on Anesthesiology and Reanimation Research Group on Translational Genomics Research Group on General and Digestive Surgery Research Group on Personal Autonomy, Dependence and Research Group on Organic Damage line Research group on Metabolic Diseases Research Group on Rare Respiratory Diseases (RRD) Consolidated our of osteoporosis, carrying out conducting allelic association studies phenotypes also to cardiovascular risk phenotypes such as arterial hypertension. With respect to the candidate genes studied, our interest has focused on and mechanisms. lines of research Identification of genes and polymorphisms associated with bone and cardiovascular phenotypes, mainly related to epigenetic mechanisms, of genes and miRNAs differentially due to fragility Analysis of metabolome and cytokines in bone fracture Functional characterization by genetic of and cytomic Integrated Care in Europe (VIGOUR) Principal Investigator: Simon Robinson (Miguel \u00c1ngel Garc\u00eda P\u00e9rez as collaborating researcher) Funding Body: Consumers, Health, Agriculture and \u00f3sea: identificaci\u00f3n de genes asociados y evaluaci\u00f3n del papel del metabolismo de la arginina Principal Investigator: Miguel \u00c1ngel Garc\u00eda P\u00e9rez Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2018-2021 Total budget: \u20ac99.220SELECTED PUBLICATIONS of the tibial component in knee arthroplasty: a study of four techniques in the cadaver. J, A. J, Cano A. Bazedoxifene increases the proliferation of human arterial endothelial cells but does not affect the expression of cyclins expression of the estrogen with increased carotid intima media thickness: a cross-sectional Escudero Garc\u00eda. Hospital. University Jos\u00e9 Ballester Fayos. Hospital Jos\u00e9 Luis Le\u00f3n Guijarro. Hospital Roberto Aliaga M\u00e9ndez. Hospital Recognised Researchers, R2 Amparo Uri\u00f3s Lluch. INCLIVA Andrea Cabrera Pastor. INCLIVA. University Cristina Mont\u00f3n Rodr\u00edguez. Hospital Joan Tosca Cuquerella. Hospital Mar\u00eda Pilar Ballester Ferrer. Hospital. INCLIVA Nicol\u00e1s Pe\u00f1aranda Sarmiento. Hospital Paloma Lluch Garc\u00eda. Hospital. University Paula Cases Berg\u00f3n. Hospital Rut Victorio Mu\u00f1oz. Hospital bioinformatic model of the molecular and cellular events of the immune system associated to the onset MHE. the early diagnosis of MHE Assess the effects of treatment of research Main Line of research: Characterization of neurological Rega Mar\u00eda Jes\u00fas Campa Santiago. Hospital Nuria Casas\u00fas Moya. Hospital Pilar Aguilar Santaisabel. Hospital Staff. Technicians Alberto Sabio Palomares. INCLIVA Alejandra Hern\u00e1ndez Hern\u00e1ndez. University. INCLIVA Consuelo Miguel Moreno. Hospital Laura Puchades Lanza. INCLIVAResearchers by categories 4 9 1 9 Identification molecular and response patients To assess usefulness eye movement analysis for the early diagnosis of MHE Research on cognitive and 5. Ballester M, Lluch P, Gomez C, Capilla M, Tosca J, Marti- Aguado D, Guijarro J, Minguez M. Funding body: de Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Total budget: \u20ac40.000 Reference: PI18/00150 alteraciones neurol\u00f3gicas y cere - brales en pacientes con encefalopat\u00eda hep\u00e1tica m\u00ednima. Contribu- ci\u00f3n de la inflamaci\u00f3n. Implicaciones Principal Investigator: Carmina Montoliu F\u00e9lix Funding body: Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2019-2021 Total budget: \u20ac171.820SELECTED PUBLICATIONS 1. Tosca J, Villagrasa R, Sanahuja A, Sanchez A, Trejo G, Herreros B, Pascual I, Mas P, Pena A, Minguez M. Caustic ingestion: S, Pastorelli R, Escudero-Garcia D, Tosca J, Urios A, Conesa analysis N, Urios A, Gallego J, Gimenez- Garzo C, Casanova F, Fiorillo A, Cabrera-Pastor A, San-Miguel T, Ipiens C, Escudero-Garcia D, Tosca J, Monton C, Ballester M, Ballester J, Aparicio L, Rios M, Durban L, Mir A, Kosenko E, Cases P, Felipo V, F, Urios A, Benlloch S, Marti-Aguado D, San- Miguel T, Tosca J, Rios M, Monton C, Durban L, Escudero- Garcia D, Aparicio L, Felipo V, Montoliu C. A score moleculares y cerebrales de las alteraciones cognitivas y motoras en hiperamonemia y encefalopat\u00eda hep\u00e1tica. response Areces Beneficiary Fundaci\u00f3n Investigaci\u00f3n Hospital Universitario de Valencia Duration: 2019-2022 Total budget: \u20ac129.600 Title: Adhesi\u00f3n al programa de detecci\u00f3n de Displasia y C\u00e1ncer colorrectal en la Enfermedad Inflamatoria Intestinal Principal Investigator: M\u00aa Pilar Ballester Ferr\u00e9 Funding body: Sociedad Valenciana de Patolog\u00eda Digestiva Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2019-2021 Total budget: \u20ac5.000 Title: LIGAM1: Efecto de la activaci\u00f3n de TLR por medio de sus ligandos sobre la polarizaci\u00f3n de macr\u00f3fagos hacia M1 y su funci\u00f3n citocida frente a las c\u00e9lulas madre de glioblastoma Principal Investigator: Javier Meg\u00edas Vericat and Andrea Cabre - body: Universidad de Valencia - Beneficiary diagn\u00f3stica para cuantifi- car y caracterizar la fibrosis de la Enfermedad Hep\u00e1tica Metab\u00f3li- ca mediante patolog\u00eda digital avanzada Principal Investigator: David Mart\u00edn Aguado (Amparo Escudero Garc\u00eda as collaborating researcher)Funding body: Sociedad Valenciana de Patolog\u00eda Digestiva Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2021-2022 Total budget: \u20ac5.000 Title: Estudio nacional en enfermedad inflamatoria intestinal so- bre determinantes gen\u00e9ticos y ambientales (Estudio ENEIDA) Principal Investigator: Miguel M\u00ednguez P\u00e9rez Funding body: Janssen - Cilag S.A. Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Total budget: \u20ac22.500 THESIS Thesis title: Caracterizaci\u00f3n del deterioro neurol\u00f3gico y la respuesta al tratamiento con rifaximina en pacientes con encefalopat\u00eda hep\u00e1tica m\u00ednima Doctoral candidate: Mar\u00eda Pilar Ballester Ferr\u00e9 Director(s): Carmina Montoliu F\u00e9lix, Desamparados Escudero Garc\u00eda, Miguel \u00c1ngel the defense: 08/01/2021 Grade: Sobresaliente \"cum laude\" Thesis title: Estudio epidemiol\u00f3gico retrospectivo de 10 a\u00f1os de los enfermos con virus C diagnosticados en el servicio de Medicina Digestiva del Hospital Cl\u00ednico Universitario de Valencia Doctoral candidate: Laura Puchades Lanza Director(s): Miguel \u00c1ngel Serra Desfilis, Desamparados Escudero Garc\u00eda defense: 28/06/2021 \"cum laude\" Thesis title: Impacto de la inmunosuppresi\u00f3n y otros factores de riesgo en el desarrollo de infecciones en pacientes con enfermedad inflamatoria intestinal: estudio caso-control Doctoral candidate: Natalia Garc\u00eda Gimeno Director(s): Miguel M\u00ednguez P\u00e9rez, Francisco Mora Miguel, Joan Tosca Cuquerella of the defense: group Leading Researchers, R4 Esteban Morcillo S\u00e1nchez Hospital. University Mar\u00eda Jes\u00fas Sanz Ferrando University Established Researcher, R3 Diego Stage Researchers, R1 Carlos Villarroel Vicente. University Elena Domingo P\u00e9rez. University Mar\u00eda Le\u00f3n T\u00e9llez. INCLIVA Staff. Technician Laura Vila of fibrosis Study Hypercholesterolemia CCL11/CCR3 atherosclerosis Study of the systemic inflammation and and of new dual PPAR/ agonists to be used in the control of cardiometabolic Synthesis of new dual LXR/PPAR/ agonists to in the control of cardiometabolic disordersResearchers by categories 1 2 1 2 the field of medicinal chemistry, the research is focused on the development of new synthetic molecules, analogues of natural FOR RESEARCH Titulo: The William Harvey International Translational Research Academy (WHRI-ACADEMY) Investigadora M\u00e1rta FP7 Marie Curie Actions Instituci\u00f3n beneficiaria: Fundaci\u00f3n Investigaci\u00f3n Hospital 2015- Total Budget: \u20ac6.500.000 Reference: PI18/01450 Title: Desarrollo qu\u00edmico y farmacol\u00f3gico de nuevos f\u00e1rmacos \"multidiana\" en el tratamiento de la diabetes mellitus tipo 2 y la enfermedad cardiovascular asociada Principal Investigator: Nuria Cabedo Escrig Funding Body: - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2019-2022 Total Budget: \u20ac61.710 SELECTED PUBLICATIONS 1. Collado A, Domingo E, Marques P, Perello E, Mart\u00ednez-Herv\u00e1s S, Piqueras L, Ascaso JF, of Escriva J, E, Cortijo in idiopathic pulmonary Cabedo N. products La Calle G, Orun O, Chen W, Raman R, Simpson B, Wilson-Linville S, Hinojal Olmedillo B, Vallejo de la Cueva A, van der Jagt M, Navarro Casado R, Leal Sanz P, Orhun G, Ferrer Gomez C, Nunez Vazquez K, Pineiro Otero P, Taccone F, Gallego Curto E, Caricato A, Woien H, Lacave G, O'Neal H, Peterson S, Brummel N, Girard T, Ely E, Pandharipande P, COVID-19 Intensive Care International Study Group. 134 INCLIVA REPORT CB06/06/0027 Title: Morcillo S\u00e1nchez Funding Body: Instituto de Salud Carlos III - Co-financed de la inflamaci\u00f3n metab\u00f3lica en la prevenci\u00f3n de la patolog\u00eda cardiovascular: Identificaci\u00f3n de nuevas dianas terap\u00e9uticas y desarrollo de f\u00e1rmacos novedosos Principal Investigator: Mar\u00eda Jes\u00fas Sanz Ferrando Funding Body: Ministerio de Ciencia, Innovaci\u00f3n y Universidades Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario Total Budget: \u20ac290.400Reference: SAF2017-89714-R Title: Modulaci\u00f3n farmacol\u00f3gica del sistema inmune como diana clave en la prevencion de la enfermedad cardiovascular asociada a des\u00f3rdenes metab\u00f3licos. S\u00edntesis de f\u00e1rmacos novedosos Principal Investigator: Juan F. Ascaso and Mar\u00eda Jes\u00fas Sanz Ferrando Funding body: Ministerio de Econom\u00eda y Competitividad Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario budget: \u20ac205.700 Reference: PROMETEO/2019/032 Title: desde la cl\u00ednica a la experimentaci\u00f3n animal: Estudio del papel del eje CCL11/CCR3 y la inflamaci\u00f3n eosinof\u00edlica en la patolog\u00eda cardiovascular asociada a des\u00f3rdenes metab\u00f3licos Principal Investigator: Mar\u00eda Jes\u00fas Sanz Ferrando Funding body: Conselleria de Educaci\u00f3n Cultura y Deporte de Valencia Established Researchers, R3 Antonio Iradi Casal. University Eulalia Alonso Iglesias. University Recognised Researchers, R2 Leticia Bag\u00e1n Deb\u00f3n. University Pedro Gargallo Bayo. Strategic gene in patients at high cardiovascular risk has been studied To monitor morbidly To analyze in DNA damage and different markers of oxidative stress in order to validate 8-oxo- dG as a possible tumor marker at high cardiovascular risk Main lines of research Study of the role of OS as a physiopathological mechanism of cardiometabolic diseases of DNA damage signaling routes in patients with cardiovascular evolution pathologies, in order to identify grades of expression in different genes Study of OS role in the pathology of neoplastic diseases, as products as key exercise Doctoral candidate: Pedro Gargallo Bayo Director(s): Juan Carlos Colado S\u00e1nchez, Guillermo S\u00e1ez Tormo Date of sialometr\u00eda en un grupo de 103 pacientes con s\u00edndrome de Sj\u00f6gren y su relaci\u00f3n con los criterios diagn\u00f3sticos establecidos en esta enfermedad autoinmune Doctoral candidate: Carlos Alvari\u00f1o Mart\u00edn Director(s): Jose Vicente Thesis title: Determinaci\u00f3n de los polimorfismos del receptor de la vitamina D en ni\u00f1os asm\u00e1ticos al\u00e9rgicos a los \u00e1caros del polvo Doctoral candidate: Sara Ferrer Suay Director(s): Miguel Tortajada Girbes, Eulalia Alonso Pilar of Sanchez-Vera I, Clapes S, Dasi F, Saez G, Carrera E, Alvarez-Gallego F, Loeken M, Viana M. Prevention of teratogenesis Banuls C, Saez G. The Effectiveness of glutathione redox status as a possible tumor marker in colorectal cancer. International Bagan L, Moreno A, Calabuig-Farinas S, Jantus-Lewintre Soriano B, Zhang F, Gallach S, Bagan L, Murillo J, Jantus-Lewintre Corpas-Burgos F, Fernandez SF, Hernandez CS, Saez G, Perez-Zafra E, Mora-Herranz A, Pardo O, C, Lopez A, risk International Journal Established Researchers, Jes\u00fas Aguilar Garc\u00eda-Iturrospe. Hospital. University Juan Nacher Rosell\u00f3. University Mar\u00eda Dolores Molt\u00f3 Ruiz. University Recognised Researchers, R2 Carlos Ca\u00f1ete Nicol\u00e1s. Hospital. University Esther Lorente Rovira. Hospital Francisco Olucha Bordonau. University Graci\u00e1n Garc\u00eda Mart\u00ed. CIBERSAM Jos\u00e9 Carlos Gonz\u00e1lez Piqueras. Hospital. University Mar\u00eda Jos\u00e9 Escart\u00ed Fabra. Hospital Marien Gadea Domenech. University Marta P\u00e9rez Rando. University Miguel Hern\u00e1ndez Viadel. Hospital. University Olga Mar\u00eda Rivero Mart\u00edn. INCLIVA First Stage Researchers, R1 Luc\u00eda Bonet Mora. University Javier David Lluesma. University Jon I\u00f1aki Etxeandia Pradera. Hospital Julia Alcaide Pozo. UniversityGroup members Strategic aims Elaboration of a mobile application associated to the Clinical Records to improve adherence to the treatment of patients first episode Publication of Results of Gene-Environmental interaction First of new techniques to diagnosis psychosis by fMRI and machine learning approach Development of animal models in severe mental disorder and neurodegenerative diseases and Friedreich's Ataxia Main lines and mental illness Study on animal models in serious mental illnessResearchers by categories 3 10 1 6 4 Santiago J, Arrojo M, Del-Ben C, Menezes P, Selten J, Jones P, Jongsma H, Kirkbride J, Rutten B, van Os J, Murray R, Gayer-Anderson C, Morgan C. Perceived major experiences of discrimination, ethnic group, and risk of in L, Lopez-Ilundain J, Ribeiro M, Cabada T, Lorente-Omenaca R, de Erausquin G, Garcia Marti G, Sanjuan Arias J, Sanchez-Torres A, Gomez M, Peralta V. Motor abnormalities and PI20/00473 Title: Estudio longitudinal de una cohorte representativa: superando la heterogeneidad cl\u00ednica y biol\u00f3gica en primeros episodios psic\u00f3ticos Principal Investigator: Julio Sanju\u00e1n Arias Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2021-2023 Total budget: \u20ac68.970SELECTED PUBLICATIONS 1. Velthorst Cognitive K, Weber MS, Green K, Rizzoli S, Nacher J, Nave KA, Ehrenreich H. Brain erythropoietin fine-tunes a di Forti M, Vassos E, Arango C, Berardi D, Bernardo M, Bobes J, de Haan L, Del- Ben CM, Gayer-Anderson C, J, Selten Tarricone I, D'Andrea G, Richards A, Tortelli A, Velthorst E, Jones PB, Arrojo Romero M, La Cascia C, Kirkbride JB, van Os J, O'Donovan Duration of untreated psychosis in first-episode psychosis is K, Borba C, Quattrone D, Di Forti M, Tripoli G, La Cascia C, La Barbera D, Ferraro L, Tarricone I, Berardi D, Lasalvia A, Tosato S, Szoke A, Llorca P, Arango C, Tortelli A, de Haan L, Velthorst E, (Friedreich of systems on Juan Nacher Rosell\u00f3 Funding Body: Carlos - institution: Universidad de Valencia Duration: 2008- Reference: RTI2018-098269-B-I00 Title: La matriz extracelular cerebral en la depresi\u00f3n: de modelos animales a pacientes Principal Investigator: Juan Salvador Nacher Rosell\u00f3 Funding body: Ministerio de PROMETEO/2020/024 Title: Desarrollo de nuevos marcadores biol\u00f3gicos y nuevas estrategias terap\u00e9uticas para el diagn\u00f3stico y el tratamiento de la psicosis Principal Investigator: Julio Sanju\u00e1n Arias Funding Body: Conselleria de Educaci\u00f3n, Cultura y Deporte Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario Total budget: \u20ac174.588 THESIS Thesis title: Estudio de la plasticidad estructural en enfermedades psiqui\u00e1tricas con modelos animales Doctoral candidate: Clara Bueno Fern\u00e1ndez Director(s): Juan Salvador Nacher Rosello, Esther Castillo G\u00f3mez \"cum laude\" Thesis title: Papel de n\u00facleo incertus en el reconocimiento social a trav\u00e9s de sus conexiones en el cerebro de rata Doctoral candidate: Cristina Garc\u00eda D\u00edaz Director(s): Francisco Olucha Simona Coviello Director(s): Juan Salvador programa de rehabilitaci\u00f3n de las funciones atencionales mediante tareas competitivas multijugador. Estudio cl\u00ednico, neurofisiol\u00f3gico y neuroanat\u00f3mico en pacientes con ictus Doctoral candidate: M\u00aa Dolores Navarro P\u00e9rez Director(s): Roberto Llor\u00e9ns Rodr\u00edguez, Mar\u00eda Engracia Gadea Dom\u00e8nech, Enrique Noe Grade: \"cum laude\" Thesis title: eficacia y viabilidad Doctoral candidate: Elvira Ferrando Aparicio Director(s): Eduardo Jes\u00fas Aguilar Garc\u00eda Iturrospe, Francisca Silvestre Pascual Date the defense: para primeros episodios psic\u00f3ticos integrada en la pr\u00e1ctica cl\u00ednica diaria Doctoral candidate: Luc\u00eda Bonet Mora Director(s): Julio Sanjuan Arias R3 Chinesta. Hospital Jos\u00e9 Franco Serrano. Hospital. University M\u00aa Cruz Gonz\u00e1lez Villaescusa. Hospital M\u00aa Luisa Briones Urtiaga. Hospital Recognised Researchers, R2 Carmen Mu\u00f1oz Esteban. Hospital Francisco Carri\u00f3n Valero. Hospital. University Jos\u00e9 Lu\u00eds D\u00edaz Cordob\u00e9s. Hospital M\u00aa Bel\u00e9n Safont Mu\u00f1oz. Hospital Pilar First Stage Researchers, R1 Irene Bocigas Hu\u00e9scar. Hospital Nieves Navarro Soriano. Hospital Paola Lisseth Ord\u00f3\u00f1ez G\u00f3mez. Hospital Santos Ferrer Espinosa. Hospital Staff. Collaborating Researchers Alba Mulet Arabi. Hospital Alejandro Ochoa Alvarado. Hospital Ana Ferrer Pons. Hospital Andrea Ballester F\u00e9rriz. Hospital Antonio Herrera Cuadros. INCLIVA Antonio Quezada Reynosa. Hospital Cristina Rosario Mart\u00edn. Hospital Elena Gim\u00e9nez Civera. INCLIVA Elvira Bond\u00eda Real. Hospital Enric Bur\u00e9s Sales. Hospital Erick Monclou Garz\u00f3n. Hospital Heidi Mora Bastida. Hospital Julia Tarras\u00f3 Castillo. Hospital Luc\u00eda Fern\u00e1ndez Presa. Hospital Manuela Mar\u00edn Gonz\u00e1lez. Hospital Mariam Garc\u00eda Alfaro. Hospital Natividad Blasco Angulo. INCLIVA Pablo Royo Sim\u00f3. UniversityGroup members Lindenfeld Ponikowski P, Agostoni P, Butler J, Desai A, Filippatos G, Gniot J, Fu M, Gullestad L, Howlett J, Nicholls S, Redon J, Schenkenberger I, J, S, Brueckmann Jamal W, Nordaby M, Peil B, Ritter I, Ustyugova A, Zeller C, Salsali A, S. Underlying A, de Bono S, Kartman C, Krishnan V, Liao R, Piruzeli M, Goldman J, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams D, Ely E, COV-BARRIER Study Group. Efficacy and safety of baricitinib for the treatment of hospitalised early detection program. Program early detection of Alpha 1 Antitrypsin ventilation in weaning the clinical tools available to evaluate frontotemporal dementia in them Study in smokers of the early stages of COPD. GOLD classification TLR7 deficiency in ~1% of men under Eid C, Aguado M, Romero R, Huang J, Mulet Arabi A, Ugo F, Rametta F, Liebetrau C, Aparisi A, Fernandez-Rozas I, Viana-Llamas M, Feltes G, Pepe M, Moreno-Rondon L, Cerrato E, Raposeiras-Roubin S, Alfonso E, Carrero-Fernandez A, Buzon-Martin L, Abumayyaleh M, Gonzalez A, Ortiz A, C, V, et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account Reference: COV20/01209 Title: Cambios en los test de funci\u00f3n pulmonar en pacientes con neumon\u00eda por COVID19 Principal Investigator: Jaime Signes-Costa Mi\u00f1ana Funding Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2020-2021 Total Budget: \u20ac73.500 Title: Evaluaci\u00f3n de la atenci\u00f3n con compasi\u00f3n en el \u00e1mbito sanitario: traducci\u00f3n y validaci\u00f3n en la poblaci\u00f3n espa\u00f1ola de un instrumento centrado en el paciente. Estudio multic\u00e9ntrico Principal Investigator: Jos\u00e9 Luis D\u00edaz Cordob\u00e9s Funding body: Conselleria de Innovaci\u00f3n, Universidades, Ciencia y Sociedad Digital Beneficiary institution: Universidad de Valencia Duration: 2019-2021Title: Valoraci\u00f3n de la demencia frontotemporal y su repercusi\u00f3n en el proceso de toma de decisiones terap\u00e9uticas en pacientes con esclerosis lateral amiotr\u00f3fica. Estudio Longitudinal Principal Investigator: Jaime Signes-Costa Mi\u00f1ana Funding (SEPAR) Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n 2020-2021 Total Budget: \u20ac9.000 Title: GOLD 0-DLCO 1. Una m\u00e1s all\u00e1 de la obstrucci\u00f3n. \u00bfEs suficiente la espirometr\u00eda en el screening de EPOC? Principal Investigator: Cruz Gonz\u00e1lez Funding body: Sociedad Valenciana de Neumolog\u00eda (SVN) Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2020-2022 Total Budget: \u20ac12.000 Title: Impacto cl\u00ednico asistencial de la creaci\u00f3n de circuitos de derivaci\u00f3n precoz en fibrosis pulmonar idiop\u00e1tica Principal Investigator: Bel\u00e9n Safont Mu\u00f1oz Funding body: Sociedad Valenciana de Neumolog\u00eda (SVN) Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Budget: group Leading Researcher, R4 Juan R. Vi\u00f1a Ribes. University Teresa Barber Ballester. University Established Researchers, R3 Elena Ruiz Garc\u00eda-Trevijano. University Luis Torres Asensi. University Rosa Zaragoz\u00e1 Colom. University Staff. Technicians Carmen Picher Latorre. University Concha Garc\u00eda de Mier. University Sonia Company Hern\u00e1ndez. UniversityGroup members being studied in rats with chronic VAD To study the and differentiation in vitro. To study the role of calpains 1, 2 and 3 as key mediators PROMETEOII/2018/167 Title: Estudios tridimensionales de ductos mamarios para determinar el papel de las calpa\u00ednas en la remodelaci\u00f3n del tejido mamario. Implicaciones biom\u00e9dicas Principal Investigator: Juan Vi\u00f1a Ribes Funding Body: Conselleria de Educaci\u00f3n, Cultura y Deporte Beneficiary muscular dystrophies Principal Investigator: Juan Vi\u00f1a Ribes Funding Body: Ram\u00f3n Universidad Total Budget: \u20ac121.176SELECTED PUBLICATIONS 1. Gimeno-Valiente F, Riffo-Campos A, Torres L, Tarazona N, Gambardella V, Cervantes A, Lopez-Rodas G, Franco L, Castillo J. Epigenetic mechanisms are J, Garcia-Trevijano E. Cleavage and activation of LIM as a novel mechanism for calpain 2-mediated Activity R4 Jos\u00e9 Vi\u00f1a Ribes University Researchers, R3 Ana Lloret Alca\u00f1iz. University Consolaci\u00f3n Garc\u00eda Lucerga. University Eva Serna Garc\u00eda. University Recognised Researchers, R2 Jos\u00e9 Vi\u00f1a Almunia. University Paloma Monllor Taltavull. University Emerging Researcher, R2 Ana Lloret Alca\u00f1iz. University First Stage Researcher, R1 \u00c1ngela Garc\u00eda a Alzheimer's Main lines of research Aging: identification of genes associated with aging, particularly genes that are specific in centenary people. Implication the estrogens and the prevention of age-related damage Physical activity: identification of the molecular mechanisms by which physical activity is good for health. Identification of the mechanisms by which physical help preventing Identification of best exercise death 3 European Commission Beneficiary Institution: CIBER (Fundaci\u00f3n Investigaci\u00f3n Cl\u00ednico Universitario de Valencia Duration: to reduce the risK of protein energy malnutrition in pre- dementia AGEd people. ERA-HDHL Call Joint Research Jos\u00e9 Vi\u00f1a Ribes Funding Body: de Salud Carlos III - Co-financed FEDER Investigator: Jos\u00e9 Vi\u00f1a Ribes Funding Body: Instituto de Salud Carlos III - Co-financed Universidad intervenciones terap\u00e9uticas multidominio para retrasar la fragilidad y la discapacidad. Identificaci\u00f3n de mecanismos moleculares con relevancia traslacional Principal Investigator: Jos\u00e9 Vi\u00f1a Ribes and Consuelo G\u00f3mez Cabrera Funding Body: Ministerio de Econom\u00eda y Competitividad Beneficiary Institution: Universidad Valencia Duration: 2020-2023 Correas AG, Olaso-Gonzalez G, D, Merino E, Teruel-Sanchis A, Cervera-Ferri A, Martinez-Ricos J, Lloret A, Lanuza E, Teruel-Marti V. Integrating pheromonal and spatial information in Correas A, Serna E, Brioche T, Chopard A, Fernandez-Marcos P, Serrano M, Serrano A, Munoz-Canoves P, Diferencias de fragilidad entre g\u00e9neros: evaluaci\u00f3n de biomarcadores y estrategias de intervenci\u00f3n Principal Investigator: Jos\u00e9 Vi\u00f1a Ribes Funding Body: Conselleria de Innovaci\u00f3n, Universidades, Ciencia y Sociedad Digital Beneficiary Institution: Universidad Thesis title: Influencia del procesamiento de la leche humana donada sobre la microbiota intestinal, la expresi\u00f3n gen\u00f3mica y el equilibrio oxidativo en reci\u00e9n nacidos pret\u00e9rmino menores de 32 semanas de edad gestacional Doctoral candidate: Anna Parra Llorca Director(s): M\u00e1ximo Vento, Mar\u00eda Carmen Collado Amores, Eva Serna Garc\u00eda Date of de la cortical vestibular en dientes anteriores maxilares y en la planificaci\u00f3n virtual de implantes mediante tomograf\u00edas computarizadas de hazc\u00f3nico Doctoral candidate: Julio Rojo Sanchis Director(s): David Pe\u00f1arrocha Oltra, Jose Vi\u00f1a Researchers, R3 Maruenda Paulino. University Gerardo Aguilar Aguilar. Hospital Marina Soro Domingo. Hospital. University Rafael Badenes Quiles. Hospital. University Recognised Researchers, R2 Ana Mugarra Llopis. Hospital Andrea Guti\u00e9rrez Valc\u00e1rcel. Hospital Benigno Escamilla Ca\u00f1ete. Hospital Jorge Ordu\u00f1a Valls. Hospital Mar Garzando Civera. Hospital Mar\u00eda Luisa Garc\u00eda P\u00e9rez. Hospital. University Rosa Herrera Castro. Hospital First Stage Researchers, R1 Strategic effects of and development methods infections Development of new strategies and drugs for pain treatment Main lines of healthy and injured lungs Development of hemodynamic monitoring its in the field of patients undergoing surgery or admitted to critical care units methods of detection of fungal and R4 STAFF R1 Estefan\u00eda Gracia Ferr\u00e1ndiz. Hospital Jos\u00e9 Antonio Carbonell L\u00f3pez. Hospital Laura Reviriego Agudo. Hospital Liliana Patricia Henao Guerrero. Hospital Luis Robert S\u00e1nchez. Hospital Mar\u00eda Jos\u00e9 Parra Gonz\u00e1lez. Hospital Mar\u00eda Luisa Laredo Alc\u00e1zar. Hospital Mario de Fez Barber\u00e1. Hospital Paola Valls Montero. Hospital Staff . E, Fernandez-Perez C, Pont T, Ruiz A, Perez- Redondo M, Oliver E, Atutxa L, Mancino JM, Daga D, Minambres E, Moya J, Vidal B, Duenas-Jurado JM, Mosteiro F, Rodriguez- Salgado A, Fernandez-Garcia E, Lara Hernandez-Marrero D, Estebanez B, Rodriguez-Ferrero ML, Barber M, Garcia-Lopez F, Andres A, Santiago C, Zapatero A, Badenes R, Carrizosa F, Blanco JJ, Bernal JL, Elola FJ, Vidal C, of death with the use of normothermic new strategies and drugs for pain treatment Development of M, Meyfroidt G, Helbok R, Taccone F, Prisco L, La Calle G, Orun O, Chen W, Raman R, Simpson B, Wilson-Linville S, Hinojal Olmedillo B, Vallejo de la Cueva A, van der Jagt M, Navarro Casado R, Leal Sanz P, Orhun G, Ferrer Gomez C, Nunez Vazquez K, Pineiro Otero P, Taccone F, Gallego Curto E, Caricato A, Woien H, Lacave G, O'Neal H, Peterson S, Brummel N, Girard T, Ely E, Pandharipande P, COVID-19 Intensive Care International Study Group. Prevalence and risk factors for delirium in critically ill J, Abad-Motos A, Ramirez-Rodriguez J, Galan-Menendez P, Mena G, Grant M, Spanish Perioperative Audit Res Ne, Spanish Perioperative Audit Res Ne, Audit Res Ne. Institutional protocols secondary INCLIVA FOR RESEARCH Reference: COV20/00096 Title: Sedaci\u00f3n con sevoflurano en pacientes con S\u00edndrome de distr\u00e9s respiratorio causado por la infecci\u00f3n COVID19 Principal Investigator: Rafael Badenes Quiles Funding body: Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico budget: \u20ac21.500 Reference: PI19/00141 Title: Modelos de y predicci\u00f3n en pacientes con insuficiencia respiratoria aguda hipox\u00e9mica con t\u00e9cnicas de inteligencia artificial y aprendizaje autom\u00e1tico Principal Investigator: Jes\u00fas Villar Hern\u00e1ndez (Marina Soro as collaborating researcher) Funding body: Instituto de Salud Carlos III - Beneficiary institution: Fundaci\u00f3n pulmonares mediante una estrategia ventilatoria perioperatoria de apertura pulmonar individualizada en pacientes intervenidos de cirug\u00eda tor\u00e1cica Principal Investigator: Carlos Mar\u00eda Ferrando Ortol\u00e1 (Francisco Javier Belda, Marina Soro, Jos\u00e9 Garc\u00eda de la Asunci\u00f3n as collaborating researchers) Funding body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de budget: \u20ac134.007,50 Title: Ensayo cl\u00ednico randomizado: hemoabsorci\u00f3n con cytosorb vs pr\u00e1ctica cl\u00ednica habitual para analizar su efecto sobre biomarcadores de da\u00f1o renal en la donaci\u00f3n en asistolia controlada con ECMO Principal Investigator: Rafael Badenes Quiles Entidad financiadora: Fundaci\u00f3n Mutua Madrile\u00f1a Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico classification on COVID-19 real world data through machine learning and data quality assessment Quiles, infecci\u00f3n Doctoral candidate: Carolina Ferrer G\u00f3mez Director(s): Rafael Badenes Quiles, de R4 Rub\u00e9n D. University Manuel P\u00e9rez Alonso. Established Researcher, R3 L\u00f3pez Castel. University Recognised Researchers, R2 Bargiela Sch\u00f6nbrunn. University Estefan\u00eda Cerro Herreros. University Piotr Konieczny. University P\u00e9rez G\u00f3mez. University First Stage Researchers, R1 \u00c1gueda Bl\u00e1zquez Bernal. University Irene Gonz\u00e1lez Mart\u00ednez. University Jorge Patricio Espinosa Espinosa. University Mar\u00eda Sabater Arc\u00eds. University Natalia Mariel Riedel Bistoco. University Nerea Moreno Cervera. University Sarah Overby. University Staff. Technicians Andrea Garc\u00eda Rey. INCLIVA Iv\u00e1n Gimeno Mart\u00ednez. INCLIVAGroup members Strategic aims During 2021 group has accomplished the publishing of scientific studies based on the main research strategy of looking for new drug candidates for neuromuscular (DM and SMA) rare diseases, but more prevalent diseases as those related with kidney pathologies. At the same time, it has been established a solid relationship with the spin-off Arhtex Biotech S.L. on the basis of several research goal of developing promising molecules with therapeutic potential in DM. The group the recipients for the renowned Grants from Myotonic Foundation. Main as therapeutic targets in myotonic dystrophy (DM) Discovery, development, and repurposing of drugs for the treatment of DM Study of the molecular causes of muscle atrophy, heart dysfunction, and CNS degeneration in DM Study of the molecular mechanisms associated with spinal muscular atrophy and search calls or networks R4 cl\u00ednicas del complejo proteico Rabphilin-Rab en da\u00f1o renal en la diabetes mellitus tipo 2 Principal Investigator: Josep Red\u00f3n i Mas (Arturo L\u00f3pez Castel as collaborating researcher) Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario Valencia 2020-2022 Total budget: \u20ac196.020 Reference: Investigator: Rub\u00e9n Artero Allepuz Funding Salud Carlos III - Cofinanced FEDER Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2020-2022 Total budget: \u20ac111.100 Reference : RTI2018-094599-B-I00 Title: Comprensi\u00f3n causas moleculares de la atrofia muscular en distrofia miot\u00f3nica tipo 1 Principal Investigator : Rub\u00e9n Artero Allepuz Funding Body: Ministerio de Ciencia, Innovaci\u00f3n y Universidades Beneficiary Institution : Universidad de Valencia Abdel-Aziz A, Abdelfatah S, et al. Guidelines for use R, Fernandez-Costa in Llamusi R. Title: de la Innovaci\u00f3n-AVI Generalitat Valenciana Beneficiary Institution : Universidad Total Reference: PROMETEO/2020/081 Title: microRNAs como terapias experimentales en distrofia miot\u00f3nica de tipo 1 Principal Investigator: Rub\u00e9n Artero Allepuz Funding Body: Conselleria de Innovaci\u00f3n, Universidades, Ciencia y Sociedad Digital Beneficiary Institution : Universidad de Valencia Duration: 2020 - 2023 budget: \u20ac193.051 Body: Fundaci\u00f3 Banc\u00e0ria La Caixa Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Beneficiary 2020-2021 Body: Universidad de Valencia - budget: de MSI2 a la atrofia muscular de DM1 utilizando nuevos modelos y murinos Principal Investigator: Ariadna Bargiela Sch\u00f6nbrunn Funding Body: Conselleria de Innovaci\u00f3n, Universidades, Ciencia y Sociedad Digital Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Total budget: \u20ac10.000154 INCLIVA Surgery Consolidated group R4 Hospital. University Recognised Researchers, R2 David Casado Rodrigo. Hospital David Moro Valdezate. Hospital. University Dimitri Dorcaratto. Hospital. University Elena Mu\u00f1oz Forner. Hospital. University Estefan\u00eda Garc\u00eda Botello. Hospital. University Fernando L\u00f3pez Mozos. Hospital. University Jos\u00e9 Mart\u00edn Ar\u00e9valo. Hospital. University Julio Calvete Chornet. Hospital. University Marina Garc\u00e9s Albir. Hospital. University Norberto Cassinello Fern\u00e1ndez. Hospital. University Raquel Alfonso Ballester. Hospital Roberto Mart\u00ed Obiol. Hospital Vicente Pla Mart\u00edn. Hospital First Stage Researchers, R1 Carlos Le\u00f3n Espinoza. Hospital Gemma Bellver Lobato. Hospital Isabel Mora Oliver. Hospital Mar\u00eda Lape\u00f1a Rodr\u00edguez. HospitalGroup members Strategic aims Research about the of 3D tumours oncologic outcome of metastatic disease Development of a protocol for the outpatient treatment of hyperparathyroidism Research about the revisional techniques within the bariatric surgery Main lines R4 STAFF R1 Leticia P\u00e9rez Santiago. Hospital M\u00aa Carmen Fern\u00e1ndez Moreno. Hospital Staff. Collaborating Researchers Elena Mart\u00ed Cu\u00f1at. Hospital Marcos Adrianz\u00e9n Vargas. Hospital Mar\u00eda Eugenia Barrios Carvajal. Hospital Rosa Mart\u00ed Fern\u00e1ndez. Hospital Vicente L\u00f3pez Flor. Hospital155 INCLIVA SCIENTIFIC REPORT 2021scientific activity 45. Fernandez Moreno M, P\u00e9rez Santiago L, Mart\u00ed Fernandez R, Le\u00f3n Espinoza C, Ortega Serrano J. Is laparoscopic approach still a risk factor for post-appendectomy intra-abdominal abscess?. Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico TRANSPAIRE. Ensayo cl\u00ednico en fase III Principal Investigator: Patricia S\u00e1nchez Vel\u00e1zquez (Dimitri Dorcaratto, Marina Garc\u00e9s, Elena Mu\u00f1oz and Luis Sabater B, Vicente E, Jimenez-Galanes S, Mora-Oliver I, Sabater L, Huber T, Lang H, Brusadin R, Lopez Conesa A, Melendez R, Castro Santiago MJ, Arevalo J, Moro Valdezate D, Garcia Botello S, Mora Oliver I, Gadea Mateo R, C\u00f3zar Lozano C, Esp\u00ed Macias A. Impact of the novel powered circular stapler on risk of leakage Carlos III - Co-financed FEDER Beneficiary institution: Instituto Hospital del Mar IMIM 2021-2023 Total Budget: \u20ac75.020 Title: Utilidad de la biopsia l\u00edquida y organoides en el manejo y tratamiento de adenocarcinoma de p\u00e1ncreas: hacia una medicina de precisi\u00f3n Principal Investigator: Maider Ibarrola Body: Fundaci\u00f3n Mutua Madrile\u00f1a Beneficiary Fundaci\u00f3n Universitario de Valencia Budget: \u20ac100.000 Espa\u00f1ola de Universitario Miguel Servet de Zaragoza Duration: 2020-2022157 REPORT Researchers, R3 Ferr\u00e1n Catal\u00e1 L\u00f3pez. INCLIVA Gabriel Selva Vera. Hospital. University Inmaculada Fuentes Dur\u00e1. University Jos\u00e9 Salazar Fraile. INCLIVA Manuel Gir\u00f3n Gim\u00e9nez. Ghisays. University Recognised Mart\u00edn Valenzuela. Jaume and cognitive and functional impairment in populations at risk the identification of and endophenotypes associated with cognitive deficits and functional impairment people severe and other diseases that diseases such Continue studies of the increased burden and other clinical practices in modern psychiatry Main lines of research multimorbidity in patients frailty, su uso en Espa\u00f1a Principal Investigator: Rosa Ayesa Arriola (Patricia Correa as collaborating researcher) Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution : Fundaci\u00f3n Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla Rafael Tabar\u00e9s Seisdedos Funding Body: Instituto de Salud Carlos : CIBERSAM Duration: 2015- Reference : UV-INV-AE-1554362 Title: Estigma social hacia personas con diagn\u00f3stico de esquizofrenia en estudiantes universitarios: PREVAL Principal Investigator: Rafael Tabar\u00e9s Seisdedos Funding Body: Universidad Valencia Beneficiary 2021-2022 Total budget: \u20ac7.510 Reference : UV-INV-AE19-1199985 Title: Evaluaci\u00f3n de un programa de musicoterapia en pacientes con trastorno mental grave Principal Investigator: Inmaculada Fuentes Dur\u00e1 Funding Body: Universidad de Valencia Beneficiary 1. GBD 2019 Collaborators. Global, regional, and national progress towards Sustainable Development Goal 3.2 for and cause- specific mortality findings assistance for health COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on S, Local Burden Dis Anaemia Collab. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of : PI20/00066 Title: Adaptaci\u00f3n y validaci\u00f3n de la bater\u00eda cognitiva Brief Assessment of Cognition App (BAC App) y del Virtual Reality Assessment of 159 INCLIVA SCIENTIFIC REPORT 2021scientific activity Hutton B, Moher Wells G (Ferr\u00e1n Catal\u00e1 as collaborating researcher) Funding Body: Canadian Institutes of un programa de intervenci\u00f3n psicoeducativa en la calidad de vida de los/las pacientes durante sus tratamientos de Reproducci\u00f3n Asistida Doctoral candidate: Ruth Elizabeth Abad Villavicencio Director(s): Inmaculada Fuentes Dur\u00e1, Carmen Das\u00ed Vivo, M\u00f3nica For\u00e9s Established Researchers, R3 Carlos Rom\u00e1 Mateo. University Jos\u00e9 Manuel Torres Ib\u00e1\u00f1ez. University Pilar Gonz\u00e1lez Cabo. University. CIBER Emerging Researcher, R2 Juan Antonio Navarro Langa. Stage Robles. Lape\u00f1a Luz\u00f3n. Remarkable achievements shock (ss) patients\" (PCT/EP2017/078362) Development of new therapies for the treatment of neuromuscular diseases Development of new therapies for the treatment of neurodegenerative diseases Main lines of research Pathophysiology of Friedreich's Ataxia and other neuromuscular diseases Development of new therapeutic strategies for Friedreich's Ataxia Development of new biomarkers in both adult and neonatal sepsis Epigenetic regulation pathophysiology Juan Antonio Navarro Langa Our scientific interests are focused on deciphering the programmed Drosophila melanogaster models. With Filippo V. Pallard\u00f3 Calatayud Funding Body: Instituto de Salud Carlos III - FEDER Beneficiary institution: Universidad de Valencia Duration: 2007- Title: de diagn\u00f3stico precoz y modelo mediante iPSC Principal Investigator: Pilar Gonz\u00e1lez Cabo Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution : CIBER Investigator: Pilar Gonz\u00e1lez Cabo (CoIP) Funding Body: Instituto Salud Carlos III - el Sistema CRISPR/ Cas9 en linfocitos de pacientes con Ataxia de Friedreich Principal Investigator: Pilar Gonz\u00e1lez Cabo Funding Body: Instituto de Salud Carlos III - Co-financed una prote\u00edna de uni\u00f3n a actina, con la desregulaci\u00f3n del calcio: un enfoque de precisi\u00f3n para el tratamiento de la Ataxia de FriedreichSELECTED PUBLICATIONS 1. Garcia-Gimenez J, Garces Garc\u00eda Rodriguez Melguizo L, Gonz\u00e1lez Cabo P, Lyakhovich A, Trifuoggi M. Title: Nuevas terapias en Ataxia Friedreich Principal Investigator: Federico V. Pallard\u00f3 Calatayud Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2020-2022 Total budget: \u20ac93.170162 Ministerio de Beneficiary nucleares: mecanismos moleculares y potencial para el desarrollo de biomarcadores de sepsis y choque s\u00e9ptico Principal Investigator: Carlos Rom\u00e1 Mateo Funding Body: Ministerio de Ciencia e Innovaci\u00f3n Beneficiary Institution : Valencia Duration: 2021-2024 Reference: RTC2019-006825-1 Title: Potencial de la leriglitazona para el tratamiento de enfermedades asociadas a la acumulaci\u00f3n de hierro, distrofias y enfermedades neuromusculares Principal Investigator: Pilar Gonz\u00e1lez Cabo Funding Body: Ministerio de Ciencia e Beneficiary of ferroptosis in Friedreich\u00b4s Ataxia Principal Investigator: Juan Antonio Navarro Langa Funding Body: Conselleria de Sanidad Universal y Salud P\u00fablica Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2020-2023 Total budget: \u20ac246.500 Investigator: Federico V. Pallard\u00f3 Calatayud Funding Body: Conselleria de Educaci\u00f3n, Investigaci\u00f3n, Cultura y Deporte Beneficiary Institution : Universidad de Funding Body: Marat\u00f3 TV3 Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de tratamiento del estr\u00e9s oxidativo en la Ataxia de Friedreich Principal Investigator: Jos\u00e9 Vicente Ros Lis and Federico V. Pallard\u00f3 Calatayud Funding Body: Universidad de Valencia - INCLIVA Beneficiary Institution : Paraparesia Esp\u00e1stica Hereditaria 7 (HSP7) Principal Investigator: M\u00aa Jos\u00e9 Mart\u00ednez Sebasti\u00e1n and Juan Antonio Navarro Langa Funding Body: Universidad de Valencia - INCLIVA Beneficiary Institution la activaci\u00f3n de TLR por medio de sus ligandos sobre la polarizaci\u00f3n de macr\u00f3fagos hacia M1 y su funci\u00f3n citocida frente a las c\u00e9lulas madre de glioblastoma Principal Investigator: Carlos Rom\u00e1 Mateo and Enrique Santas Olmeda Funding Body: Universidad de Valencia - INCLIVA Beneficiary Institution Valencia - a partir de IPSC de la enfermedad Charcot-Marie-Tooth causada por la ausencia de GDAP1 Doctoral candidate: Mar\u00eda \u00c1ngeles Le\u00f3n Rodr\u00edguez Director(s): Jos\u00e9 Manuel Torres Ib\u00e1\u00f1ez title: Prote\u00ednas nucleares y otros mediadores de inflamaci\u00f3n en pacientes en shock s\u00e9ptico sometidos a terapias de reemplazo renal Doctoral candidate: M\u00f3nica Crespo G\u00f3mez Director(s): Manuel Cervera Montes, Federico V. Pallard\u00f3 Calatayud, Carlos Rom\u00e1 Mateo Date of the Organic Damage line Emerging group Leading Researcher, Laura Piqueras Ruiz University. INCLIVA First Stage Researchers, Luisa Mar\u00eda patients: and characterization of the of CCR4 receptor and CCL17/TARCE, CKLF1 in with obstruction - To study the effects of the neutralization of the VEGF-165b isoform in a mouse model with acute myocardial infarction Study of the role of the SGLT2 transporter in the development of abdominal aortic aneurysm: evaluate the effect of empagliflozin, an SGLT2 inhibitor, in an animal model of abdominal aortic aneurysm and to investigate the possible anti-inflammatory effect on in the development of abdominal aortic aneurysmResearchers by 2 1 1 Researchers activity 4SELECTED PUBLICATIONS 1. Ortega R, Hueso L, Benito E, Ortega J, Civera M, Sanz M, Real J, Piqueras L. The nuclear retinoid-related orphan receptor RORalpha controls adipose tissue inflammation in patients with morbid Sanz MJ, Ascaso JF, Piqueras L, Real diabetic polyneuropathy in subjects with type Rios C, Hueso Soler L, Diaz Cuevas A, Marcos Garc\u00e9s V, Bonanad Lozano C, Ruiz Sauri A, Vila Salinas J, Sanz Ferrando M, Chorro Gasc\u00f3 F, Piqueras Ruiz L, Bod\u00ed Hueso L, Montesinos MC, Gomez- Cabrera MC, Sanz MJ, Real JT, Piqueras L, S, abdominal Reference: PI18/00209 Title: Identificaci\u00f3n de nuevos mecanismos implicados en la angiog\u00e9nesis e inflamaci\u00f3n en pacientes obesos. Modulaci\u00f3n por ligandos de receptores nucleares constitutivos de androstano Principal Investigator: Laura Piqueras Ruiz and Jos\u00e9 Tomas Real Collado Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital \u20ac173.332,50 Reference: Funding body: Conselleria de Sanitat Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Universitario de Valencia Total Budget: in murine models of insulin resistance Main lines of research Study of the effect of inflammatory mediators of the lymphotoxin family and their receptors on the development of fatty liver associated with insulin resistance Study of the cytokine LIGHT in the stability of the plaque during the progression of atherosclerosis through the use of animal models with gain and loss of function collaborations0 Rosa A, Gomez-Cabrera M, Vinue A, Gonzalez-Navarro H, function late Castel V, Navarro S, Noguera Body: Conselleria de Sanitat Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Universitario de Valencia Duration: 2020-2023 Total Budget: \u20ac253.000 Title: Papel de la v\u00eda de se\u00f1alizaci\u00f3n mediada por LIGHT en el fenotipo y la reprogramaci\u00f3n celular en la placa de ateroma Principal Investigator: Herminia Gonz\u00e1lez Navarro Funding arteriosclerosis/Fundaci\u00f3n Espa\u00f1ola de arteriosclerosis Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Budget: \u20ac12.000 THESIS dapagliflozina en la aterosclerosis diab\u00e9tica y caracterizaci\u00f3n de un modelo murino de EHNA inducido por dieta Doctoral candidate: Aida Taberner Cort\u00e9s Director(s): Herminia Gonz\u00e1lez Navarro Date laude\"Taberner-Cortes abdominal Martinez-Hervas S, Gonzalez-Navarro H. Therapies for the treatment of cardiovascular disease associated with Type 2 Diabetes and Dyslipidemia. International Journal of Molecular Rodriguez- Nogales C, Martin-Vano S, Vicente-Munuera P, Canete A, Commission Instituci\u00f3n beneficiaria: de Valencia Duration: 2018-2021 Reference: PI19/00169 Title: Papel de los procesos inflamatorios en las enfermedades metab\u00f3licas y en las complicaciones asociadas Principal Investigator: Herminia Gonz\u00e1lez Navarro and Sergio Mart\u00ednez Herv\u00e1s Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Moreno. University Recognised Castillo Corull\u00f3n. Hospital. University aims We have shown that NK and B express and secrete alpha-1 antitrypsin We have discovered a group of miRNAs that could be used for the diagnosis Dyskinesia been set up We have set up the high-speed video method to identify lines of research The group is currently conducting active basic research action of group are: - To characterize the molecular mechanisms (especially those aspects to of models from cells of patients with RRD, which allow research in these diseases develop therapeutic based - RRD, through the scientific dissemination of advances social and health policies aimed improving the quality of life of patientsResearchers by categories 1 3 1 1 1 Researchers FOR RESEARCH Reference: PI17/01250 Title: Estudio del efecto de la hipoxia en la degranulaci\u00f3n, producci\u00f3n de citoquinas y perfil oxidativo de neutr\u00f3filos de pacientes con d\u00e9ficit alfa-1 antitripsina Principal Investigator: Francisco Das\u00ed Fern\u00e1ndez Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2018-2021 Total budget: \u20ac99.220 Title: Estudio de los microRNAs circulantes como biomarcadores pron\u00f3sticos en pacientes con d\u00e9ficit de alfa-1 antitripsina. Un enfoque funcional Principal Investigator: Francisco Das\u00ed Fern\u00e1ndez Funding body: Sociedad Valenciana de Neumolog\u00eda Beneficiary institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2020-2022 Total budget: \u20ac6.000 Title: Estudio de la utilidad cl\u00ednica de los exosomas plasm\u00e1ticos en la discinesia ciliar primaria Principal Investigator: Fern\u00e1ndez Funding body: Sociedad Valenciana de Neumolog\u00eda Beneficiary institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2020-2023 Total budget: \u20ac12.000 Sanchez-Vera Clapes S, Dasi F, Saez G, Carrera E, Alvarez-Gallego F, Loeken M, Viana M. Prevention of teratogenesis M, M, Arumi E, Torrent-Vernetta A, De Mir Messa I, Gartner S, Iglesias Serrano I, Caballero-Rabasco M, Asensio De La Cruz O, Vizmanos-Lamotte G, Martin De Vicente C, Martinez-Colls M, Reula Martin A, Escribano Montaner A, Das\u00ed Fern\u00e1ndez Armengot M, Fernandez-Cancio M, A. Castillo S, S, Magallon M, Armengot M, Herrera G, O'Connor J, Banuls L, Navarro-Garcia M, Escribano A, Dasi F. New laboratory protocol to determine the oxidative stress profile of human nasal epithelial cells University Researchers, R2 University Cristina Mas Bargues. University Mar Dromant Jarque. INCLIVA Marta Ingl\u00e9s de la Torre. UniversityGroup members aims To know the To determine an index of quality of life in experimental animals To develop human imaging biomarkers for the diagnosis Role of the antiapoptotic gene Bcl-xL Main lines of research Development of a quality of life index (healthy aging) in experimental animals (derived from intervention studies in Development of on stem and senescence) - Study of Bcl-xL as a longevity gene (based on previous studies INCLIVA SCIENTIFIC REPORT 2021scientific con ves\u00edculas extracelulares de c\u00e9lulas madre de grasa de ratones j\u00f3venes sobre par\u00e1metros de envejecimiento y fragilidad en ratones de edad avanzada Principal Investigator: Consuelo Borr\u00e1s Blasco Funding Body: Ministerio de Ciencia e Title: cognitiva en la descendencia: papel causa-efecto de la microbiota intestinal y prevenci\u00f3n diet\u00e9tica temprana Principal Investigator: Consuelo Borr\u00e1s Blasco Funding Body: Ministerio de Econom\u00eda, Industria y Competitividad Thesis title: Eficacia terapia manual en pacientes con migra\u00f1a Doctoral candidate: Elena Mu\u00f1oz G\u00f3mez Director(s): Marta Ingl\u00e9s De La Torre, Gemma Victoria Esp\u00ed L\u00f3pez Date of Doctoral candidate: Mar Dromant Jarque Director(s): Marta Ingl\u00e9s De La Torre, Consuelo Borr\u00e1s Blasco, Jos\u00e9 Vi\u00f1a Ribes Date of the defense: 21/12/2021 Grade: Sobresaliente \"cum laude\"SELECTED Lopez-Grueso R, replacement A, Gambini J, Jove M, Lopez- Grueso R, Mas-Bargues C, Monleon D, Pamplona R, Vina J. Lifelong soya consumption in males does not health span under a metabolic as type Combining vitamin E-functionalized CHOcolate with physical exercise to reduce the risK of protein energy malnutrition in pre- dementia AGEd people. ERA-HDHL Call Joint Research as collaborating researcher) Funding Body: Instituto de Carmen G\u00f3mez Cabrera University Recognised Researchers, R2 Aitor Carretero Mart\u00ednez. INCLIVA Gloria Olaso Gonz\u00e1lez. University First Stage Researchers, R1 Esther Garc\u00eda Dom\u00ednguez. University Fernando energy associated aging Role of -hydroxybutyrate the loss muscle with aging Effect of an intervention with protein and vitamin supplementation in synergy with a multicomponent program of physical the reversal of frailty Effect of and of frailty Study of the effect of the activation of glucose phosphate intervention strategies the prevention of frailty Main lines of research Using molecular approaches in animal and human models, this group aims to establish the basic mechanisms modulated by exercise and to transfer them through clinical trials to the improvement of the quality of life in humans. The research lines of the Exercise, Nutrition and of involved in muscle atrophy with the of the importance of oxidative stress in the loss of muscle mass, both in clinical and preclinical models ensure terap\u00e9uticas multidominio para retrasar la fragilidad y la discapacidad. Identificaci\u00f3n de mecanismos moleculares con relevancia traslacional Principal Investigator: Jos\u00e9 Vi\u00f1a Ribes and Consuelo G\u00f3mez Cabrera Funding Body: Ministerio de Econom\u00eda y Competitividad Beneficiary Institution : Valencia Duration: 2020-2023 Total budget: \u20ac270.000 Reference: en ciencias del deporte: EXERNET. Red de ejercicio f\u00edsico y salud Principal Investigator: Jos\u00e9 Antonio Casaj\u00fas (M\u00aa Carmen G\u00f3mez- Cabrera as Funding Body: Ministerio de Cultura y Deporte Beneficiary Valencia Duration: 2021-2022 Total Reference: PROMETEO/2019/097 Title: Diferencias de fragilidad entre g\u00e9neros: evaluaci\u00f3n de biomarcadores y estrategias de intervenci\u00f3n Principal Investigator: Jos\u00e9 Vi\u00f1a Ribes (M\u00aa Carmen G\u00f3mez Cabrera as collaborating researcher) Funding Body: Generalitat Valenciana Beneficiary Total Budget: \u20ac189.391 Reference: 0551_PSL_6_E Title: Ejercicio f\u00edsico personalizado como intervenci\u00f3n para revertir la discapacidad en adultos mayores que viven en residencias (RESIFIT) Principal Investigator: M\u00aa Carmen G\u00f3mez-Cabrera Funding Body: Fundaci\u00f3n Valencia Duration: 2020-2021 Total Budget: \u20ac24.000 SELECTED PUBLICATIONS 1. Roman W, Pinheiro H, Pimentel M, Segales J, Oliveira L, Garcia- Dominguez E, Gomez-Cabrera M, Serrano A, Gomes E, Munoz- Canoves P. Muscle Correas A, Serna E, Brioche T, Chopard A, Fernandez-Marcos P, Serrano M, Serrano A, Munoz-Canoves P, Correas AG, Olaso-Gonzalez G, Gonzalez-Navarro H, function late De la Rosa A, Martinez-Hervas S, Gomez- Cabrera MC, Real JT. Frailty is associated with oxidative in LatinAmerica Principal Investigator: Leocadio Rodr\u00edguez Beneficiary Institution: CIBER (Fundaci\u00f3n Cl\u00ednico Universitario de Valencia as Third Party) Duration: 2019-2024 Total Budget: \u20ac273.720 174 Asociated CIBER Established Researchers, R3 Carmela Aguado Velasco. INCLIVA Nieves Salvador Mena Moll\u00e1. University First give variability in human diseases, can give rise to diagnostic and sepsis by generating organoid models lines research of for prognosis Sendra E, microRNAs circulantes como biomarcadores de pron\u00f3stico y evoluci\u00f3n cl\u00ednica en Ataxia de Friedreich. Hacia la medicina de precisi\u00f3n en las Enfermedades Raras Principal Investigator: Jos\u00e9 Luis Garc\u00eda Gim\u00e9nez Funding Body: Asociaci\u00f3n Espa\u00f1ola de Ataxias Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2020-2021 Total budget: \u20ac6.000 Title: Valorizaci\u00f3n e internacionalizaci\u00f3n de HistShock, un test IVD para el diagn\u00f3stico y pron\u00f3stico de la sepsis y el shock s\u00e9ptico Principal Investigator: Jos\u00e9 Luis Garc\u00eda Gim\u00e9nez Funding Body: Fundaci\u00f3n para la Innovaci\u00f3n y Prospectiva en Salud en Espa\u00f1a (FIPSE) Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario TKI en c\u00e1ncer de pulm\u00f3n EGFR mutante Principal Investigator: Salvador Mena Moll\u00e1 Funding Body: Universidad de Valencia Beneficiary TKI en c\u00e1ncer de pulm\u00f3n EGFR mutante Principal Investigator: Salvador Mena Moll\u00e1 Funding Body: UV-La Fe 2020 Programa Acciones Preparatorias Beneficiary : Universidad de Valencia Biomarcadores epigen\u00e9ticos en sepsis y su implicaci\u00f3n en inmunosupresi\u00f3n y futuras comorbilidades en supervivientes Principal Investigator: Jos\u00e9 Luis Garc\u00eda Gim\u00e9nez Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Title: Valorizaci\u00f3n, estrategia de protecci\u00f3n y transferencia de un m\u00e9todo de diagn\u00f3stico y pron\u00f3stico de la sepsis y el shock s\u00e9ptico Principal Investigator: Jos\u00e9 Luis Garc\u00eda Gim\u00e9nez Funding Body: Agencia Valenciana de Innovaci\u00f3n Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2020-2021 Total budget: \u20ac110.670 Title: Identificaci\u00f3n de biomarcadores mediante el uso de las \u00f3micas y la Inteligencia Artificial para el diagn\u00f3stico y el pron\u00f3stico de la sepsis neonatal Principal Investigator: Jos\u00e9 Luis Garc\u00eda Gim\u00e9nez Entidad financiadora: Fundaci\u00f3n Mutua Madrile\u00f1a Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico 176 gingival: expresi\u00f3n diferencial en sujetos con periodontitis cr\u00f3nica avanzada Doctoral candidate: Pedro Jos\u00e9 Almi\u00f1ana Pastor Director(s): Jos\u00e9 Luis Garc\u00eda Gim\u00e9nez, Jos\u00e9 Vicente Bag\u00e1n Sebasti\u00e1n, Andr\u00e9s L\u00f3pez Rold\u00e1n Date of the defense: 04/03/2021 Sobresaliente \"cum laude\" Thesis title: Influencia epigen\u00e9ticos en el desarrollo de la escoliosis idiop\u00e1tica del adolescente Doctoral candidate: Pedro Antonio Rubio Belmar Director(s): Jos\u00e9 Luis Garc\u00eda Gim\u00e9nez, Teresa Bas Hermida Date of the defense: 27/05/2021 Reproductive medicine area Groups Research Group on Women Health Research Group on Reproductive Medicine Research Group on Therapies Against Endometriosis and Endometrial Cancer Research Group on Women Health Consolidated group Leading Researcher, R4 Antonio Cano S\u00e1nchez. Hospital. University Juan Jos\u00e9 Tar\u00edn Folgado. University Recognised Researchers, R2 Ana Mart\u00ednez Aspas. Hospital. University Celia Bauset Castell\u00f3. Hospital Ester Ortiz Murillo. Hospital Gemma Arribas Ferriol. Hospital Irene Zolfaroli. Hospital Juan Jos\u00e9 Hidalgo Mora. Hospital Staff. Collaborating Researchers Aitana Monllor Tormos. Hospital Laura Carbonell L\u00f3pez. Hospital Roc\u00edo Belda Montesinos. Hospital Staff. Nurses Alicia Garc\u00eda Vigara. HospitalGroup members Strategic aims The positioned field of healthy ageing, particularly in what relates women, with special interest to frailty, where it has collaborated in the support of INCLIVA in the project ADVANTAGE. We have collaborated to position the reference site of the Valencia Region within EIPAHA, the partnership of the European Commission. Moreover, we have participated in the application to different European projects with groups from different European countries, including an application to the Maire Curie grants Main lines of research In healthy ageing in the female we are continuing our but also added frailty functional decline The EIPAHA commitment tracker, https://ec.europa.eu/eip/ageing/ commitments-tracker/a3/integrated-care-and-ict-reduce-frailty-and-chronic-diseases-ageing-women_en) There is a new area of interest on the use of ICT to promote women's health with regard to endometriosis: - To Investigator: Antonio Cano S\u00e1nchez Funding body: Consumers, Health, Agriculture and Food Executive Agency Universidad de Valencia Duration: 2019-2021 Total budget: \u20ac3.046.025SELECTED PUBLICATIONS 1. Martinez MT, Monton-Bueno J, Simon S, Ortega B, Moragon S, Rosello S, Insa A, Navarro J, Sanmartin A, Julve A, Buch E, Pena A, Franco J, Martinez-Jabaloyas J, Marco J, Forner MJ, Cano A, Silvestre A, Teruel A, Lluch A, Cervantes A, Chirivella Gonzalez I. Ten-year assessment of a A, Fernandez-Ramirez M, Tarin J, Cano A, Gomez R. A reassessment of the therapeutic potential of a dopamine receptor J, A. Title: Patrones diet\u00e9ticos en poblaci\u00f3n europea senescente: acercamiento multidisciplinar para combatir las enfermedades metab\u00f3licas ligadas a sobrepreso. Proyecto Eurodiet Principal Investigator: Antonio Cano S\u00e1nchez Funding body: European Commission Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Total budget: \u20ac27.225180 group Leading Researcher, R4 Carlos Sim\u00f3n Vall\u00e9s University. IGENOMIX Foundation Emerging researcher, R2 Aymara Mas Perucho. INCLIVA Recognised Researchers, R2 Antonio D\u00edez Juan. IGENOMIX Foundation Beatriz Ros\u00f3n Burgo. INCLIVA Carlos Lozano Asencio. IGENOMIX Foundation Carmen Garc\u00eda Pascual. IGENOMIX Carmen Rubio IGENOMIX Foundation Inmaculada IGENOMIX Foundation Miguel Mil\u00e1n S\u00e1nchez. IGENOMIX Foundation Nandakumar Venkatesan. University Tamara Garrido G\u00f3mez. IGENOMIX Foundation First Stage R1 Alba Machado aims predominantly in the field of Reproductive Medicine and women's health, with a particular focus on factors that cause infertility, and other gynecological and obstetric pathologies One of our aims is the characterization at single cell resolution of also in the scope Main lines of research Adult stem cells in the human endometrium: we have identified the existence of human endometrial stem cells, and we demonstrated the therapeutic potential of autologous bone marrow IGENOMIX Foundation Marta IGENOMIX A, Shukla V, Kudo Hoffding M, Krausz C, Hoffmann E, Simon Valles C. Preconception genome medicine: current state and future reproductive Patassini M, Cimadomo D, Benini F, Farcomeni A, Cuzzi J, Rubio C, Albani E, Sacchi L, Vaiarelli A, Figliuzzi M, Findikli N, Coban O, Boynukalin I, Hoffmann E, Livi C, Levi-Setti PE, Ubaldi FM, Simon C. Mosaic human their developmental potential in a J, Moreno Gimeno I, Simon Valles C. Bacterial vaginosis and its association with infertility, endometritis, and A, Jimenez-Almazan J, R, I, Roson B, Quake S, Simon C. Single- cell the discovered the transcriptomic signature of human endometrial receptivity. Now, we are part of the International Human Cell Atlas initiative to create the first human cell atlas of the uterus The endometrial microbiome in human reproduction: our research group has described existence of the microbiome The maternal implication in the origin of pre-eclampsia: our research has provided evidence that endometrial decidualization resistance is implicated in the This finding offers a new perspective contribution aiming myomas leiomyosarcomas. We diagnostic and focus uterine leiomyomas and leiomyosarcomas through characterization Emerging Researcher Aymara Mas Perucho The main objective of this research is focused on understanding those factors that contribute to the pathophysiology of INCLIVA Title: Human Vall\u00e9s Funding Body: European Commission Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2020-2022 Total budget : \u20ac4.118.942,50 Reference : PI20/00942 Title: Desarrollo de un modelo predictivo para el diagn\u00f3stico diferencial temprano de leiomiomas y leiomiosarcomas uterinos Principal Investigator: Aymara Mas Perucho Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2021-2023 Total budget : \u20ac99.825 Reference : PI19/01659 Title: transcript\u00f3mico a nivel de c\u00e9lula \u00fanica y tejido endometrial completo del fallo en decidualizaci\u00f3n presente en pacientes con preeclampsia severa Principal Investigator: Tamara Garrido G\u00f3mez Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2020-2022 Total budget : \u20ac93.170 Reference : enfermedades gestacionales tard\u00edas como la preeclampsia Principal Investigator : Carlos Sim\u00f3n Vall\u00e9s Funding Body: Ministerio de Ciencia, Innovaci\u00f3n y Universidades Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2019-2022 Total budget del \u00fatero humano: desde la terapia celular a la creaci\u00f3n del \u00f3rgano mediante bioingenier\u00eda Principal Investigator: Carlos Sim\u00f3n Vall\u00e9s Funding Body: Conselleria de Educaci\u00f3n, Cultura y Deporte Beneficiary institution : Universidad de Valencia Duration: \u20ac297.066,67 Reference : PI-2021-010 Title: CellStats: Desarrollo de un modelo estad\u00edstico para la evaluaci\u00f3n de cambios poblacionales en datos transcript\u00f3micos de c\u00e9lula \u00fanica del endometrio humano Principal Investigator: Guillermo Ayala Gallego and Beatriz Ros\u00f3n Burgo Funding Body: Universidad de Valencia - INCLIVA Beneficiary institution : Universidad de Valencia y despu\u00e9s de un embarazo con preeclampsia revela la contribuci\u00f3n materna en la etiolog\u00eda de la enfermedad Doctoral candidate: Laura Rubert Torr\u00f3 Director(s): Alfredo Perales Mar\u00edn, Carlos Sim\u00f3n Vall\u00e9s, Tamara Garrido G\u00f3mez Date of the defense: 08/02/2021 Grade: human reproduction Doctoral candidate: Iolanda Garc\u00eda Grau Director(s): Carlos Sim\u00f3n Vall\u00e9s, Inmaculada Moreno Gimeno, Jose Remoh\u00ed Gim\u00e9nez Date of the defense: Leading Researcher, R4 Ra\u00fal G\u00f3mez Gallego University Recognised Researcher, Tejada Gir\u00e1ldez. INCLIVA First Stage Researchers, R1 Ana Isabel Rodr\u00edguez Garc\u00eda. UniversityGroup members Strategic aims To refine the development of homologous and heterologous animal models initiated in the laboratory so that they allow to reproduce endometriosis in a more physiological way, reflecting the pain and infertility associated with it in order to achieve greater transferability of the findings in these to the clinic On optimized endometriosis non-hormonal treatment of are effective in the remission of pain as well as in the improvement of To down the molecular mechanisms involved in improving parameters study endometriosis through the combined analysis of multiple biomarkers Main lines of research Dysregulation of the angiogenic component in the appearance and maintenance of endometriosis Development of animal models of pain and infertility associated with endometriosis and testing of the therapeutic role of immunomodulators in them Early non-invasive diagnosis of endometriosis through combined analysis of Gonzalez-Cano R, Tejada M, Santos-Caballero M, Perazzoli G, Nieto F, Cobos E. Sigma-1 receptor: a drug Hoffmann A, Zollner T, Saunders P, Simitsidellis I, Charrua A, Cruz F, Gomez R, Tejada M, McMahon S, Lo Re L, Barthas F, Vincent K, Birch J, Meijlink J, Hummelshoj L, Sweeney P, Armstrong J, Treede R, M, Tarin J, Cano A, Gomez R. A reassessment of the therapeutic potential of a dopamine receptor M, J, Cano A. Bazedoxifene increases the proliferation of human arterial endothelial cells but does not affect the expression of cyclins European Commission Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Duration: 2018-2023 Total budget: \u20ac257.066,25Reference: PI20/01835 Title: Evaluaci\u00f3n del potencial papel terap\u00e9utico de la inhibici\u00f3n de RANK en modelos optimizados de dolor e infertilidad asociados a endometriosis Principal Investigator: Ra\u00fal G\u00f3mez Gallego Funding body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico dopamin\u00e9rgicos en el dolor e infertilidad asociados a endometriosis en modelos animales de nueva generaci\u00f3n Principal Investigator: Ra\u00fal G\u00f3mez Gallego Funding body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico invasivo de endometriosis mediante an\u00e1lisis de nuevos biomarcadores a trav\u00e9s de machine learning Principal Investigator: Ra\u00fal G\u00f3mez Gallego Funding body: Fundaci\u00f3n para la Innovaci\u00f3n y Prospectiva en Salud en Espa\u00f1a FIPSE Beneficiary institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de budget: \u20ac30.000185 INCLIVA Recuero. University Stage 2 patients to genes of miRNA miR-30d in human embryos to have a list of regions potentially susceptible to methylation. These regions will by the human endometrium on the pre- embryo: it has been described that the endometrial fluid specifically focusing on the different types of RNAs and DNA, and that their composition in these chemical species varies throughout of vesicles that is analyzed Main lines of research Study of endometrial receptivity, collaborations2 1 financed 1. Vilella F, Wang W, Moreno I, Roson B, Quake S, Simon C. Single- cell W, Moreno I, Quake SR, Simon C. Understanding the human endometrium in the 21st century. HUTER Title: Human Total budget: \u20ac4.118.942,50 Reference : PI18/00957 contenido en ves\u00edculas extracelulares secretadas por el endometrio humano sobre Principal Investigator: Felip Vilella Mitjana Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2019-2021 Total budget Associated Groups activity4Research Group Recognised Mart\u00ednez Sabater. Hospital. University Iv\u00e1n Juli\u00e1n Rochina. Hospital. University Montserrat Ca\u00f1abate Ros. Hospital. University Pablo Garc\u00eda Molina. University First Stage Researcher, R1 Evelin Balaguer L\u00f3pez. Hospital. University Staff. Nurses Ad\u00e1n \u00c1lvarez Ordiales. Hospital. University Ana Bela Espinosa Briones. Hospital Ana Gancedo Herrero. Hospital Concepci\u00f3n Mateo Orrios. Hospital Eva Mar\u00eda P\u00e9rez Lafuente. Hospital Laura Pla Marzo. INCLIVA M\u00aa \u00c1ngeles Montal Navarro. University M\u00aa Carmen Barber\u00e1 Ventura. Hospital M\u00aa Carmen Rodr\u00edguez Dolz. Hospital. University M\u00aa Concepci\u00f3n Rodrigo Ruiz. Hospital M\u00aa Dolores Cantero L\u00f3pez. Hospital M\u00aa Gabriela Chova Mallent. Hospital M\u00aa Jes\u00fas Zafra Pir\u00e9s. Hospital M\u00aa Luisa Mu\u00f1oz Pilar HospitalGroup research in nursing to disseminate new knowledge Work for the Quality and Safety of pediatric nursing care Main lines of research Child and adolescent health care Skin care and skin integrity Mental Health Care Care in aging, fragility and chronicityResearchers categories R4 STAFF M\u00aa Victoria Orej\u00f3n Lagunas. Hospital Mireia S\u00e1nchez Morcillo. Hospital Nuria Garrido Zafra. Hospital Sonia Mora Navarro. Hospital Staff. Technician David Palanca Broseta. Hospital189 INCLIVA a home-based primary care service in an urban area of Barcelona (Spain): an observational study and cluster analysis. Journal validity the Frail-VIG index with the EQ-5D-3L in P, J. diagnosis therapy in patients with non-specific low back pain: a Health literacy of patients on oral anticoagulation treatment- individual and social determinants and effect on health E, M, Blasco JM. Evaluation of interface pressure and temperature management in five wheelchair seat cushions and their effects on user Title: VISUALSKIN: Dise\u00f1o de dispositivo cl\u00ednico para la evaluaci\u00f3n del riesgo de lesi\u00f3n en la piel en personas encamadas o usuarias de silla de ruedas Principal Investigator: Julio Martos Torres and Pablo Garc\u00eda Molina Funding Body: Universidad de Valencia - INCLIVA Beneficiary and Arrhythmia and Cardiac Pacing Unit Department of Cardiology Department of Cardiovascular Surgery Department of Dentistry Department of Dermatology Department of Digestive Medicine Department of Endocrinology Department of Family and Community Medicine Department of General Surgery Department of Gynecology and Obstetrics Department of Hematology and Hemotherapy Department of Home Hospitalization Department of Infectious Diseases Department of Intensive Medicine Department of Internal Medicine Department of Maxillofacial Surgery Department of Medical Emergency Department of Medical Oncology Department of Microbiology Department of Nephrology Department of Neurology Department of Neurosurgery Department of Nuclear Medicine Department of Ophthalmology Department of Otorhinolaryngology Department of Pathological Anatomy Department of Pediatric Surgery Department of Pediatrics Department of Pharmacy Department of Plastic Surgery Department of Psychiatry Department of Radiologic Diagnosis Department of Radiotherapy Department of and development methods infections Development of new strategies and drugs for pain treatment Main lines of healthy and injured lungs Development of hemodynamic monitoring its in the field of patients undergoing surgery or admitted to critical care units methods of detection of infections, especially fungal and virological, and new strategies and drugs for pain treatment Development of new strategies and monitoring for Traumatic enhanced recovery Navarro CD, Puig Bernabeu J. A J, Abad-Motos A, Ramirez-Rodriguez J, Galan-Menendez P, Mena G, Grant M, Spanish Perioperative Audit Res Ne, Spanish Perioperative Audit Res Ne, Audit Res Ne. Institutional protocols for colorectal surgery: Secondary Ramirez-Rodriguez L, S, Cabellos-Olivares M, Bordonaba-Bosque D, Aldecoa C, Grp, POWER Group, Clinical of strategies for laboratory test requesting appropriateness with electronic request system in online communication with the Medical Services of the Cl\u00ednico-Malvarrosa Health Department Main lines of research Group-specific: managing laboratory test requests and patient safety through electronic requests Laboratory Service staff research is carried out in colonoscopy using the SOH test in the Colorectal author4 Juan R, Nu\u00f1ez Benito E, Ll\u00e0cer P, Garcia Blas S, Ventura Haro S, N\u00fa\u00f1ez J, S\u00e1nchez R, Facila De La Esperanza R, Vaquer Santamaria J, Santas Olmeda E, Mi\u00f1ana G, Mollar Fernandez A, N\u00fa\u00f1ez Mar\u00edn G, Chorro Gasc\u00f3 F, G\u00f3rriz Teruel J, Sanchis Fores in failure and renal dysfunction. A, Corchon-Peyrallo A, Vinyals-Bellido I, Carratala- Calvo A. Decision support system through automatic algorithms and electronic request in diagnosis of anaemia B, Simo G, Farinos J, Navarro I, de Miquel V, Sanchez R, Marco V, Ros M, Suela S, Estrada R. MicroRNAs expression associated Pozo A, Carratala A, Gonzalez J, Noceda J, Minana G, Nunez 2021scientific activity4Arrhythmia and Cardiac Pacing Unit Strategic aims Our Unit the Excellence Credit in the Program \"Atrial Fibrillation Ablation\" concluded. First results have been published Main lines of research Collaboration in the national prospective observational study atrial fibrillation Collaboration registry on alterations in patiens with pacemakers Leading A, Zorio E, Arce-Leon A, Sanchez-Gomez V, Teijeira E, Canadas-Godoy M, Guerra-Ramos J, Oloriz T, Basterra N, Sousa P, Elices-Teja J, Garcia-Bolao I, Gonzalez-Juanatey J, Brugada R, Gimeno J, Brugada J, Arbelo E. of multiparametric approaches for Barrera A, Toquero J, Ormaetxe J, Sanchez J, Ruiz-Granell R, Amador P, Rubio J, Marti-Amor J, Pascual P, Molina I, Martinez-Alday J, Grima E, Garcia-Fernandez A, Canadas-Godoy M, Jimenez-Ramos V, Oloriz T, Basterra N, Calvo D, Perez-Alvarez L, Arias M, Exposito V, Aleman A, Diaz-Infante E, Guerra-Ramos J, Fernandez-Armenta J, Arce-Leon A, Sanchez-Gomez J, Sousa P, Garcia-Bolao I, Baluja A, Campuzano O, Sarquella-Brugada G, Martinez-Sande J, J, Gimeno J, Brugada prognosis of women Marrazzo N, Pecora C, A, Donzelli S, De Ruvo E, Lavalle C, Sanchez-Gomez J, Pastor J, Grandio P, Ferraris F, Castro A, Rebellato L, Marchese P, Adao L, Primo J, Barra S, Casu G. Safety, efficacy, and reproducibility of Ruiz Granell R, Sanchez Gomez J, Perez L, Martinez-Ferrer J, Alzueta J, Perez-Lorente F, Vinolas X, Fidalgo Andres M, Fernandez de la Concha J. Predictors of adoption and impact Reference : PI-2021-015 Title: RECONST_ECG: Evaluaci\u00f3n del proceso de reconstrucci\u00f3n de un electrocardiograma de 12 derivaciones a partir de 3 en condiciones ambulatorias Principal Investigator: Javier Calpe Maravillas and Ricardo Ruiz GranellFunding Body: Universidad de Valencia - INCLIVA Beneficiary Insitution Valencia Budget: \u20ac8.712 Corresponding author13 collaborations3 International collaborations 4. Lorenzo M, Palau P, Llacer P, Dominguez E, Ventura B, Nunez G, Minana G, Solsona J, Santas E, De La Espriella R, Bodi V, Nunez E, Sanchis J, Bayes-Genis A, stay G, Bayes-Genis A, Husser O, J, Perez N, de Dios E, Nunez E, Sanchis J, Chorro FJ, Bayes-Genis A, Bodi V. Sex differences on Santas E, Minana G, Palau P, De La Espriella R, Lorenzo M, Nunez G, Sanchis J, Chorro FJ, Bayes-Genis A, Nunez Canoves subsequent events in a large multicenter STEMI Registry. Vazquez A, Carnero M, Sarralde J, Cal-Purrinos N, Canovas S, Maroto L, Gutierrez F, F, Bautista-Hernandez V. factors Martin-Gonzalez I. V, Blas S, Fores J, Romano J, Baena J, Giner M, Suarez N, F, trends risks, types, and mortality from 1998 to Mateos- Moreno MV, Ausina-Marquez V, E, Puche- Torres M, Giner MJ, Campos Gonzalez A, Santolaya Abad S, Artacho A, tumors. Melanoma: study of cytokines involved in tumor Hemangiomas Contact dermatitis Alopecia Psoriasis: application of new molecules in treatment PUBLICATIONS IF 15 of author5 National collaborations0 I, Negrete E, Gullon G, Roldan F. Double nail of the second toe: D, Boixeda P. Ex vivo dermoscopy in demodicosis. Journal of the Garcia J, Cunat A, Canales M, Felix M, Campos S, Canada J, Hernandez J. Characteristics of mucocutaneous vascular malformations of protocols and clinical guidelines of the Department It has been possible to consolidate the relationship of the Unit of Inflammatory Bowel Disease of our Department with the network of National Units, through collaborative studies that have been published in international Q1 and Q3198 INCLIVA SCIENTIFIC REPORT On encephalopathy, Ricart E, Nos P, Iglesias-Flores E, Vera I, Lopez-SanRoman A, Guardiola J, Taxonera C, Minguez M, Martin-Arranz MD, de Castro L, de Francisco R, Rivero M, Garcia-Planella E, Calvet X, Garcia-Lopez S, Marquez L, Gomollon F, Barrio J, Esteve M, Munoz F, Gisbert JP, Gutierrez A, Hinojosa J, Arguelles-Arias F, Busquets D, Bujanda L, Perez- Calle JL, Sicilia B, Merino O, Martinez P, Bermejo F, Lorente R, Barreiro-de Acosta M, Rodriguez C, Garcia-Sepulcre MF, Monfort D, Canete F, Domenech E. Risk disease. cohort study of the ENEIDA registry. Sierra M, Barreiro-de Acosta M, Fernandez-Clotet A, de Castro L, Bosca-Watts M, Casanova M, Lopez-Garcia A, Lorente R, Rodriguez C, Carbajo A, Arroyo M, Gutierrez A, Hinojosa J, Martinez-Perez T, Villoria A, Bermejo F, Busquets D, Camps B, Canete F, Mancenido N, Monfort D, Navarro-Llavat M, Perez-Calle J, Ramos L, Rivero M, Angueira T, Camo P, Carpio D, Garcia-de-la-Filia I, Gonzalez-Munoza C, Hernandez L, Huguet J, Morales V, Sicilia B, Vega P, Vera I, Zabana Y, Nos P, Suarez Alvarez P, Calvino-Suarez C, Ricart E, Hernandez V, Minguez M, Marquez L, Hervias Cruz D, Rubio Iturria S, Barrio J, Gargayo-Puyuelo C, Frances R, Hinojosa E, Del Moral M, Calvet X, Algaba A, Aldeguer X, Guardiola J, Manosa M, Pajares R, Piqueras M, Garcia-Bosch O, Lopez Serrano P, Castro B, Lucendo A, SELECTED PUBLICATIONS 1. de-Madaria E, Sanchez-Marin C, Carrillo Vege Chooklin S, Bilyak A, Mejuto R, Mauriz V, Hegyi P, Marta K, Kamal A, Lauret-Brana E, Barbu S, Nunes V, Ruiz-Rebollo M, Garcia- Rayado G, Lozada-Hernandez E, Pereira J, Negoi I, Espina S, Hollenbach M, Litvin A, Bolado-Concejo F, Vargas R, Pascual Moreno I, Singh V, Mira J. Design and validation Sanahuja A, Sanchez A, Trejo G, Herreros B, Pascual I, Mas P, Pena A, Minguez M. Caustic ingestion: F, Rodriguez C, Barreiro- de Acosta M, Martinez-Cadilla J, Arroyo M, Mancenido N, Sierra-Ausin M, Vera-Mendoza I, Casanova M, Nos P, Gonzalez-Munoza C, Martinez T, Bosca Watts M, Calafat M, Busquets D, Girona E, Llao J, Martin-Arranz M, Piqueras M, Ramos L, Suris G, Bermejo F, Carbajo A, Casas-Deza D, Fernandez-Clotet A, Garcia M, Ginard D, Gutierrez-Casbas A, Hernandez L, Lucendo A, Marquez L, Merino-Ochoa O, Rancel F, Taxonera C, Lopez Sanroman A, Rubio Domenech E, Gisbert J. Tofacitinib in ulcerative colitis: real-world evidence from the ENEIDA Registry. J, Cortes D, Cabedo N. products European Journal of Medicinal Montoro M, Castro Ortiz E, Mesonero F, Garcia-Planella E, Fuentes D, Bort I, Delgado-Guillena P, Arias L, Iglesias A, Calvo M, Esteve M, Domenech E, Gisbert J. Effectiveness and safety of ustekinumab in ulcerative colitis: real-world evidence from the ENEIDA registry. RESEARCH Title: Estudio nacional en enfermedad inflamatoria intestinal sobre determinantes gen\u00e9ticos y ambientales (Estudio ENEIDA) Principal Investigator: Miguel M\u00ednguez P\u00e9rez Funding Body: Janssen-Cilag Beneficiary Duration: 2021 Total Budget: \u20ac22.500 Title: Influencia de la actividad inflamatoria en la funci\u00f3n anorrectal de los pacientes con Enfermedad Inflamatoria Intestinal Principal Investigator: Ana Sanahuja Mart\u00ednez Funding Body: Sociedad Valenciana de Patolog\u00eda Digestiva Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: Total Budget: \u20ac5.000THESIS Thesis title: Impacto de la inmunosuppresi\u00f3n y otros factores de riesgo en el desarrollo de infecciones en pacientes con enfermedad inflamatoria intestinal: estudio caso-control Doctoral candidate: Natalia Alicia Garc\u00eda Gimeno Director(s): Miguel M\u00ednguez P\u00e9rez, Joan Tosca Cuquerella, Francisco Mora Miguel defense: 05/11/2021 Grade: en pancreatitis aguda: prevalencia, factores asociados, evoluci\u00f3n cl\u00ednica y utilidad de la cistatina C Doctoral candidate: Paola V\u00e1zquez Fern\u00e1ndez Director(s): Francisco Mora Miguel, Isidro Antonio Torregrosa Maicas, Isabel Pascual Moreno Date of the \"cum Fernandez Moreno M, P\u00e9rez Santiago L, Mart\u00ed Fernandez R, Le\u00f3n Espinoza C, Ortega Serrano J. Is laparoscopic approach still a risk factor for post-appendectomy intra- abdominal abscess?. Journal of Gutierrez A, Gonzalez M. Does primary care intervention have an impact in the place of death for patients in a palliative care program?. Atencion Primaria. 2021 SELECTED PUBLICATIONS 1. Perez Santiago L, Cassinello Fernandez N, Alfonso Ballester R, Diaz Exposito R, Moscardo Navarro A, Ortega Serrano J. Intraoperative scintigraphy with portable gamma camera for the international prospective IF: Martin Arevalo J, Moro Valdezate D, Garcia Botello S, Mora Oliver I, Gadea Mateo R, C\u00f3zar Lozano C, Esp\u00ed Macias A. Impact of the novel powered circular stapler on risk of leakage A, Fernandez-Ramirez M, Tarin J, Cano A, Gomez R. A reassessment of the therapeutic potential of a dopamine receptor hematologists and basic investigators To develop research projects using experimental models (for GvHD, Advanced Therapies) To increase the number of clinical in develop Cellular Therapies in the laboratory throughout colaboration with the Department of Pharmacy and the INCLIVA- IIS La Fe- Centro de Transfusiones CV consortium To enhance new research lines in Thrombophilia, Coagulopathies and Thrombopathies To improve the impact factor in publications resulting from our research and cooperative projects Main lines 1. Huerta O, Cubero I, Gutierrez A, Gonzalez M. Does primary care intervention have an impact in the place of death for patients in a palliative care program?. Atencion Primaria. Amat P, Hernandez-Boluda J, Perez A, Pinana J, Carretero C, Goterris R, Gomez M, Saus A, Ferrer B, Teruel A, Terol M, Solano C. therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature E, Andrade- Campos M, Garcia-Hernandez C, Gomez-Casares M, Garcia-Gutierrez V, Carreno-Tarragona G, Garrote M, Fernandez-Ibarrondo L, Cervera J, Bellosillo B, Cervantes F, Hernandez-Boluda J, Spanish Saus A, Olea B, Gimenez E, Albert E, Lopez-Jimenez J, Andreu R, Garcia D, Fox L, Remigia M, Amat P, Solano C, Navarro D. Cytomegalovirus-specific and DNAemia in patients with PUBLICATIONS 1. Torres I, Albert E, Gimenez E, Olea B, Valdivia A, Pascual T, Huntley D, Sanchez D, Costa RM, Pinto C, Oltra R, Colomina J, Navarro D. Performance of a MALDI-TOF spectrometry-based method for activity lines of research Plasma histones and septic shock. Immunosuppression in sepsis and septic shock: a pilot study. J, Marcos- Garces V, Forteza Oltra R, Vila J, Chorro Bodi V. Overexpression of genes involved in C, Posadas T, Bures E, Banuls P, Fernandez-Presa L, Royo P, Blasco M, Heras La Calle G, Orun O, Chen W, Raman R, Simpson B, Wilson-Linville S, Hinojal Olmedillo B, Vallejo de la Cueva A, van der Jagt M, Navarro Casado R, Leal Sanz P, Orhun G, Ferrer Gomez C, Nunez Vazquez K, Pineiro Otero P, Taccone F, Gallego Curto E, Caricato A, Woien H, Lacave G, O'Neal H, Peterson S, Brummel N, Girard T, Ely E, Pandharipande P, COVID-19 Intensive Care International Study Group. Prevalence and risk factors for delirium in critically ill Sendra E, J, M, C, Pallardo F, 2. Clar J, Oltra MR, Benavent R, Pinto C, Ruiz A, MT, PI19/00994 epigen\u00e9ticos en sepsis y su implicaci\u00f3n en inmunosupresi\u00f3n y futuras comorbilidades en supervivientes Principal Investigator: Jos\u00e9 Luis Garc\u00eda Gim\u00e9nez (Jos\u00e9 Ferreres and Ainhoa L\u00e1zaro as collaborating researchers) Funding Body: Salud Carlos III Body: Ministerio de Ciencia e Valencia Duration: 2020-2023 Total budget: \u20ac181.500 A, Cardenal Alvarez A, Guerrero Jimenez F, Albiol Vinals P, Uso Blasco scale in patients Internal Medicine RESEARCH Title: Diagn\u00f3stico de infecci\u00f3n por clostridioides difficile mediante an\u00e1lisis fecal Principal Investigator: Rosa Sempere Funding Body: Sociedad Valenciana de Medicina Interna Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2021 Total Budget: \u20ac3.000SELECTED PUBLICATIONS 1. Rodriguez-Bano J, Pachon Carratala J, et al. Treatment with tocilizumab or for Albert E, Gimenez E, Olea B, Valdivia A, Pascual T, Huntley D, Sanchez D, Costa RM, Pinto C, Oltra R, Colomina J, Navarro D. Performance of a MALDI-TOF for C, Ruiz A, MT, Sanchez D, Pinto Pla C, De Gracia Leon A, Colomina Rodriguez J. Complicacion infecciosa poco frecuente tras 205 INCLIVA SCIENTIFIC REPORT 1. Fernandez-Cisnal A, Valero E, Garcia-Blas S, Pernias V, Pozo A, Carratala A, Gonzalez J, J, implants high added value through additive manufacturing Innovation in throat pack Main lines of research Cost-effectiveness analysis on the management of oral of care Radiological evaluation of predictive factors of access to pterygopalatine fossa Research on materials involved in bone decision algorithm SELECTED PUBLICATIONS 1. Botella Casas G, Cassinello Fernandez N, Perez Santiago L, Alfonso Ballester R, Ortega Serrano J. Influence of carotid anatomy anomaly joint guided by ultrasonography: C, Ruiz A, MT, Sanchis Director(s): Jorge Miguel Barcia Gonz\u00e1lez, Francisco Javier Romero G\u00f3mez Date of the Lameirinhas A, Simon S, Ortega-Morillo B, Martinez MT, Hernando C, Constancio V, Burgues O, Bermejo B, Henrique R, Lluch A, Jeronimo C, Eroles P, Cejalvo JM. Identification of a two-MicroRNA signature in plasma as for A, de Castro E, Perez-Segura P, Canovas M, Gomez D, Moran L, de Tejada M, Segui E, Lopez G, Adrian S, Campos M, Olmos V, Portero B, Moyano M, Crespo J, Sanchez L, Rebollo M, Rivas P, Altozano J, Lescure A, Munoz-Martin A. Rationale, design and methodology of a registry of thrombosis and neoplasia of SEOM Viala M, Alberich-Bayarri A, L, Santiago-Felipe S, Simon S, Ortega B, Bermejo B, Lluch A, Cejalvo J, Eroles P, JM, I, Martin-Arana J, Tebar- Martinez R, Viala Bruixola G, Hernando C, Blasco I, Papaccio F, Martinez-Ciarpaglini C, Alfaro-Cervello C, Seda- Garcia E, Blesa S, Chirivella I, Castillo J, Monton-Bueno JV, Rosello S, Huerta M, Perez-Fidalgo A, Martin-Martorell P, Insa-Molla A, Fleitas T, Rentero-Garrido P, Zuniga-Trejos S, Cervantes A, Roda D. Molecular profiling of advanced solid tumours. The impact of experimental most common phenotypes of histo-blood antigens (secretory, in culture of enteroids from strains lines of research Phylogenetic genes sequences Romero B, Menendez B, Bernal S, Idigoras P, Colomina J, Martin-Saco G, Leal-Negredo A, Laguna-Goya R, Trujillo H, Caravaca-Fontan F, Gutierrez E, Lopez-Medrano F, Remigia M, Almendro-Vazquez P, Polanco N, Gonzalez E, Ruiz-Merlo T, Parra P, San Juan R, Andres A, Navarro D, Aguado J. SARS- CoV-2-specific Almendro-Vazquez P, Gimenez E, Marcacuzco A, San Juan R, Justo I, Calvo-Pulido J, Garcia- Sesma A, Manrique A, Caso O, Cambra F, Talayero P, Lopez-Medrano F, Remigia MJ, Ruiz-Merlo T, Parra P, Artal E, Jimenez C, Loinaz C, Navarro D, Laguna-Goya to SARS-CoV-2 in Bueno Ferrando F, Huntley Pascual D, Molla E, Fernandez-Fuentes M, Mart\u00ednez L\u00f3pez M, Poujois Gisbert S, Forqu\u00e9 Rodr\u00edguez L, Valdivia Piqueres A, Solano De La Asunci\u00f3n C, Ferrer Dot J, Colomina Rodr\u00edguez F, Navarro Ortega D. Field evaluation of a rapid antigen test (Panbio COVID-19 Ag Rapid Test Device) for Albert E, Torres I, Carbonell-Sahuquillo S, Barres-Fernandez A, Sanchez D, activity4THESIS title: Vigilancia de la antibi\u00f3tica y caracterizaci\u00f3n genot\u00edpica de aislados de Neisseria Gonorrhoeae en la Comunidad Borja Sobresaliente \"cum laude\"Thesis title: Desarrollo de un dispositivo m\u00e9dico tipo \"point of care\" para la detecci\u00f3n r\u00e1pida de infecci\u00f3n urinaria y sensibilidad antibi\u00f3tica en pa\u00edses en v\u00edas de desarrollo Doctoral candidate: Jorge Jover Garc\u00eda Director(s): Javier Colomina \"cum laude\" Department of Nephrology Strategic aims To work together with cardiology Department in order to explore new developments adherence to the current treatments To establish the picture of renal problems detected R, Arnott C, Bakris G, Cannon C, Charytan D, Edwards R, Gorriz J, Jardine M, Levin A, Neal B, De Nicola L, Pollock C, Rosenthal N, Wheeler D, Mahaffey K, Heerspink H. Effects of canagliflozin on Kosiborod J, Rossing P, Correa-Rotter R, Kurlyandskaya R, Stefansson B, 4 Busch R, Xie D, Gansevoort R, Hou F, Gorriz J, Laverman G, De Nicola L, Pascual J, Provenzano M, Pergola P, Tang S, Wanner C, Zaoui P, H, on atrasentan's efficacy - a post-hoc analysis from the SONAR Trial. Journal of the American A, Rodriguez M, Sinha S, Garg R, Perello J, analysis of the randomized, placebo-controlled CaLIPSO study. Clinical Journal of the Comparaci\u00f3n de dos tipos de dializadores (PMMA vs. Polisulfona) sobre la extracci\u00f3n de citocinas en pacientes en hemodi\u00e1lisis con infecci\u00f3n por COVID 19. Estudio prospectivo Principal Investigator : M\u00aa Jes\u00fas Puchades Montesa Funding Body: Sociedad Valenciana de Nefrolog\u00eda Beneficiary Institution : Hospital Universitario de Valencia Duration: 2021 Total Budget: \u20ac3.500 Title: Implicaciones de las alteraciones del metabolismo \u00f3seo- mineral en la mortalidad en pacientes en di\u00e1lisis peritoneal. Proyecto de Big Data: estudio que incluye todos los datos anal\u00edticos de nuestra unidad en los \u00faltimos 10 a\u00f1os Principal Investigator : Elisa P\u00e9rez Bernat Funding Body: Sociedad Valenciana de Nefrolog\u00eda Beneficiary Institution : Hospital Cl\u00ednico Universitario de Valencia Duration: 2021 Total Budget: \u20ac3.500Title: Estudio longitudinal, randomizado, cruzado sobre el efecto del uso de I-SGLT2 en la diuresis, natriuriesis y en la ultrafiltraci\u00f3n y eliminaci\u00f3n peritoneal de sodio en pacientes con di\u00e1lisis peritoneal Principal Investigator Marco Montomoli Funding Body: Sociedad Valenciana de Nefrolog\u00eda Beneficiary Institution : Universitario de Valencia Duration: Total Budget: \u20ac3.500 Title: Respuesta a vacunaci\u00f3n anti SARS-COV2 en pacientes en terapia renal sustitutiva Principal Investigator : Nayama Panizo Gonz\u00e1lez Funding Body: Sociedad Valenciana de Nefrolog\u00eda Beneficiary Institution : Hospital Universitario de Total Budget: \u20ac3.500 Reference : BCM-PD-02-INT Title: Iniciativa la evoluci\u00f3n de los pacientes con Di\u00e1lisis-DP Principal Investigator: Alfonso Miguel Carrasco (Miguel Gonz\u00e1lez Rico and Jes\u00fas Puchades Montesa as collaborating researchers) Funding Body: Fresenius medical care Institution de Valencia Duration: 2015-2021 Budget: \u20ac2.940210 INCLIVA with M, Calopa M, Escamilla- Sevilla F, Freire E, Garcia Ruiz P, Grandas F, Kulisevsky J, Lopez- Manzanares L, Martinez Castrillo J, Mir P, Pagonabarraga J, Perez-Errazquin F, Salom J, Tijero B, Valldeoriola F, Yanez R, Aviles A, Luquin M. Present and Future of Parkinson's Disease in Spain: Giroud lower targets on cardiovascular events after ischemic M, Del Rio M, Lainez J, Leira R, Trochet J, Pozo-Rosich P. outcome Izquierdo G, Meca-Lallana V, Gascon-Gimenez F, Martinez-Gines M, Ramio-Torrenta L, Costa-Frossard L, Fernandez O, Moreno- Garcia S, Medrano N, Maurino J, Casanova B. Short-term data on disease activity, cognition, mood, stigma and Asensio M, Jadraque-Rodriguez R, Garcia-March Moreno- Lopez P. The role Belvis R, Irimia P, Seijo-Fernandez F, Paz J, Garcia March G, Santos-Lasaosa S, Latorre G, Gonzalez-Oria C, Rodriguez R, Pozo-Rosich Neuromodulation in headache and craniofacial neuralgia: guidelines from the Spanish Society of and Spanish Society of Neurosurgery. INCLIVA Medicine Strategic aims Comparison of energy and medium Bustamante J, Martin C, Garcia A, Feldman S, Pastor F, Orellana M, Rubino P, Quesada V. Intra- and extradural anterior clinoidectomy: anatomy Real Pe\u00f1a L, Pastor Escartin F, Talamantes Escriba F. Merkel cell carcinoma mediante los abordajes FAR lateral y retrosigmoideo bajo. An\u00e1lisis comparativo de la superficie expuesta y \u00e1ngulo de ataque Doctoral candidate: Pau Capilla Guasch Director(s): Jos\u00e9 Manuel Gonz\u00e1lez Darder, Vicent sistemas de artrodesis cervical anterior caja-placa Doctoral candidate: F\u00e9lix Pastor Escart\u00edn Director(s): Manuel Gonz\u00e1lez Darder, Jos\u00e9 Florindo Bartolom\u00e9 G\u00f3mez, Vicent Quilis Perez L, Cassinello Fernandez N, Alfonso Ballester R, Diaz Exposito R, Moscardo Navarro A, Ortega Serrano J. Intraoperative scintigraphy with portable gamma camera for the Miguel Martin-Gil of the different available techniques. Revista Espanola de Medicina in cardiovascular infection and inflammation. Revista Espanola Williams MC, Villines TC, Better N, Vitola JV, Cerci R, Dorbala S, Raggi P, Choi V, Kudo T, N\u00f8rgaard L, Allam AH, Bhatia M, Malkovskiy E, Goebel B, Cohen Y, Randazzo M, Narula J, Pascual TNB, Pynda Y, Dondi D, the INCAPS COVID Investigators Group. International Impact of COVID-19 on the Diagnosis of Heart Disease. Journal of the American College Williams M, Lahey R, Villines T, Dorbala S, Choi A, Shah N, Bluemke D, Berman D, Blankstein R, Ferencik M, Narula J, Winchester D, Malkovskiy E, Goebel B, Randazzo M, Lopez-Mattei J, Parwani P, Vitola J, Cerci R, Better N, Raggi P, Lu B, V, Sinitsyn V, Kudo T, Norgaard B, Maurovich- Horvat Cohen Y, Pascual T, Pynda Paez D, Einstein A, INCAPS-COVID Investigators Grp. Impact of COVID-19 on cardiovascular testing in the united states versus the rest of the world. Cuadrado A, Aramburu G, Carduch A, Coma J, Delpech S, Carceles J, Sanchez J, Sanchez P, Castano M, A, A, Ophthalmology Soc. Recommendations for ophthalmologic practice during the easing of COVID-19 control measures. SELECTED PUBLICATIONS 1. Gegundez-Fernandez J, Llovet-Osuna F, Fernandez-Vigo J, del Barrio J, Pablo-Julvez L, Munoz-Negrete F, Zarranz-Ventura J, de la Colina J, Silva V, Jimenez-Alfaro I, Calonge-Cano M, Galindo- Ferreiro A, Castillo-Gomez Toledo-Elizalde J, L, Lopez Montero A, Gil Hernandez I, Garcia Ibor F, Vela Bernal S, Duch Samper AM. Monitoring therapy in anterior necrotizing Angio-OCT,del grosor coroideo y flujo vascular retiniano y su relaci\u00f3n con el espesor de las capas de fibras nerviosas y c\u00e9lulas ganglionares maculares en pacientes con Esclerosis M\u00faltiple Doctoral candidate: Marta Cerd\u00e1 Ib\u00e1\u00f1ez Director(s): Antonio Miguel Duch Samper, Laura of the defense: 27/10/2021 transcutaneous osseointegrated implant in mixed hypoacusia Completion results of unilateral cochlear implantation with the Oticon Neuro System implant Main lines of research Experience of using a Nadia Link Cros device compared to Nadia CI in users of unilateral cochlear implants Publication of the study of results implantation with R, Fernandez-Julian E, Marco-Algarra J, Fons-Font A. Dimensional analysis of the upper airway in obstructive sleep apnea syndrome E, Munoz-Fernandez N, Miguel A, Marco SELECTED PUBLICATIONS 1. Martinez MT, Monton-Bueno J, Simon S, Ortega B, Moragon S, Rosello S, Insa A, Navarro J, Sanmartin A, Julve A, Buch E, Pena A, Franco J, Martinez-Jabaloyas J, Marco J, Forner MJ, Cano A, Silvestre A, Teruel A, Lluch A, Cervantes A, Chirivella Gonzalez I. Ten-year assessment of a A, P, Escudero- Garcia D, Monton C, Aguilera V, Alberich-Bayarri A, Serra Marti-Bonmati Sabater L, Ferrer A, Tarazona N, Roda D, Gambardella V, Alfaro-Cervello C, Garces-Albir M, Cervantes A, Ibarrola-Villava M. Ballester Ferre M, Dorcaratto D, Villagrasa Manzano R, Mu\u00f1oz Forner E, G\u00f3mez Adri\u00e1n J, Sanchiz Soler V, Sabater Orti L, Ortega Surgical of mucinous J, M, T, Martinez-Beneyto P, Alborch M, Ventura A, Monteagudo E, Ribas I, Algarra J. Clinical performance assessment of a new active osseointegrated 1. Martinez Gomez M, L\u00f3pez S\u00e1iz A, Ferrer Gonzalez J, Pin Arboledas G. Meckel's double diverticulum. About a case. Anales de pediatr\u00eda. 2021 Apr;94(4):268-269. doi: M, Fernandez-Escribano A, Fernandez-Maseda M, Espinosa L, Oliet A, Vicente A, G, F, Ribelles A, Heredia A, Guerra- Garcia P, Verdu-Amoros J, Andres M, Canete A, Rives S, Perez-Martinez A, Mora J, Patino-Garcia A, Lassaleta A, Llort A, Ramirez M, Mata C, Gallego S, Martin-Broto J, Cruz O, La Madrid A, Solano P, Romera I, Fernandez-Teijeiro A, Bautista F, Moreno L. The clinical research landscape in Spain: a 13-year multicentre experience of the new agents group of the Spanish Society of Echevarria A, Ramos E, Bueno F, Colomina Crehua-Gaudiza E, Garcia-Rodriguez J, cryptococcosis in a child with multivisceral SELECTED PUBLICATIONS 1. Costa R, Bueno F, Albert E, Torres I, Carbonell-Sahuquillo S, Barres-Fernandez A, Sanchez D, tract SARS-CoV-2 Hazar V, Mellgren K, Osumi T, Fedorova N, Verdu-Amoros J, Andres M, Kabickova E, Attarbaschi A, Chiang A, Bubanska E, Donska J, Niggli F, Csoka M, Krivan G, Palma J, Burke G, Beishuizen A, Koeppen K, Mueller S, Herbrueggen H, Woessmann W, Zimmermann M, Balduzzi A, Pillon M. Treatment and outcome analysis of 639 relapsed non-hodgkin L, de la Cerda-Ojeda F, Fernandez-Fernandez M, de Lucas-Collantes C, Gil M, Luis-Yanes M, Vergara I, Gonzalez-Rodriguez J, 216 INCLIVA RESEARCH Title: Sistema inteligente de apoyo a latoma de decisiones cl\u00ednicas en medicina de precisi\u00f3n Principal Investigator: Jaime Verd\u00fa Amor\u00f3sFunding Body: Agencia Valenciana de la Innovaci\u00f3n-AVI Generalitat Valenciana Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2021-2023 Total Budget: \u20ac107.904,85 Department in patient, aim of optimal and rational use of pharmacological treatment Study of pharmacokinetics of caspofungin in patients under hemodiafiltration. Study approved by the Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios with code MER-CAS-2013-01 Observational Study of population pharmacokinetic stem cell transplantation. Study approved by the Agencia Espa\u00f1ola del medicamento y Productos Sanitarios with code CSV-VOR-2014-01 Study of pharmacokinetics of Ceftolozane in critical patients. Study pending of approval by the Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios with code CEFT-TCRR-2017 Study of Physico-chemical stability of a new mycophenolate mofetil solution in bag at different of Physico-chemical stability of a new ophthalmic eyedrop formulation at different storage conditions Main lines of research Implementation of a new therapeutical drug monitoring system in in patient, aim of optimal and rational use of pharmacological treatment Study of pharmacokinetics of caspofungin in patients under hemodiafiltration. Study approved by the Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios with code MER-CAS-2013-01 Observational Study of population pharmacokinetic stem cell transplantation. Study approved by the Agencia Espa\u00f1ola del medicamento y Productos Sanitarios with code CSV-VOR-2014-01 Study of pharmacokinetics of Ceftolozane in critical patients. Study pending of approval by the Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios with code CEFT-TCRR-2017 Study of Physico-chemical stability of a new mycophenolate mofetil solution in bag at different of Physico-chemical stability of a new Dosing of caspofungin pharmacokinetic/pharmacodynamic Cilag S.A. Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2021 Total Budget: \u20ac22.500SELECTED PUBLICATIONS 1. Lopez Diaz JL, Torrecilla T, Signes-Costa J, Servera E. of treatment M, Garcia J, Cunat A, Canales M, Felix M, Campos S, Canada J, Hernandez J. Characteristics of mucocutaneous A, Antonio Carbonell-Asins J, Canete Nicolas C, Hernandez-Viadel M. Efficacy of vitamin D in the treatment of depression: a systematic review y viabilidad Doctoral candidate: Elvira Ferrando Aparicio Director(s): Eduardo Jes\u00fas Aguilar Garc\u00eda Iturrospe, Francisca Silvestre Pascual Date of the defense: 07/07/2021 Grade: Sobresaliente \"cum laude\"SELECTED PUBLICATIONS 1. Sastre-Buades A, Ochoa S, Lorente-Rovira E, Barajas A, Grasa E, Lopez-Carrilero R, Luengo A, Ruiz-Delgado I, Cid J, Gonzalez- Higueras F, Sanchez-Alonso S, Baca-Garcia E, Barrigon M, Spanish Metacognition Study Grp. Jumping to conclusions and suicidal behavior in Luengo A, Fusalba OR, Aguilar J, Aguilar E. Training psychiatry residents in descriptive psychopathology: a Department of Radiologic Diagnosis Main lines of participate incidence of dehiscence of sutured anastomoses 2. Ballester M, Lluch P, Gomez C, Capilla M, Tosca J, Marti- Aguado D, Guijarro J, Minguez M. Viala M, Alberich-Bayarri A, Estebanez A, Puche-Torres M, Garcia J, Cunat A, Canales M, Felix M, Campos S, Canada J, Hernandez J. Characteristics of mucocutaneous vascular malformations Estebanez A, Peredo A, Ruiz M, C, Quiles by Number of articles5.923IF 5.923Average0 National collaborations 4.342Average1 National collaborations on balance and functional outcome up to 1 year Igual-Camacho C, Diaz-Diaz B, Torrella J, Rodrigo J, Paya Rubio A, Roig-Casasus S, Blasco J. A randomized controlled trial assessing the effects of preoperative Thoracic Surgery collaborations 2. Cilleruelo Ramos A, Figueroa Almanzar S, Lopez Castro R, Martinez Hernandez N, Mezquita Perez L, Moreno Casado P, Zabaleta Jimenez J. Long-term follow-up for operated de la Cruz J, Macia I, Campuzano I, Almanzar S, Roel M, Munoz C, Fontan E, Trueba I, Vielva L, Garcia J, Tellez E, Gonzalez C, Lopez M, Maestre U, Poce R, Lorente D, Kindelan A, Pulla oxidative bone systems of fixation of prostheses applied to Traumatology Main lines of Study the use in urine and tissue in patients with prostate solitary osteochondroma of the scapula: uncommon location for Reference : DTS18/00177 Title: Desarrollo de un nuevo sistema de fijaci\u00f3n intramedular para implantes (pr\u00f3tesis, clavos para fracturas y exopr\u00f3tesis) Principal Investigator: Antonio Silvestre Mu\u00f1oz Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2019-2021 Total Budget: \u20ac99.500 Title: Evaluaci\u00f3n de la eficiencia de la metodolog\u00eda para el seguimiento de pacientes con pr\u00f3tesis de rodilla Principal Investigator: Antonio Silvestre Mu\u00f1oz Funding Body: Fundaci\u00f3n Mutua Madrile\u00f1a Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2020-2022 Total Budget: \u20ac65.000SELECTED PUBLICATIONS 1. Martinez MT, Monton-Bueno J, Simon S, Ortega B, Moragon S, Rosello S, Insa A, Navarro J, Sanmartin A, Julve A, Buch E, Pena A, Franco J, Martinez-Jabaloyas J, Marco J, Forner MJ, Cano A, Silvestre A, Teruel A, Lluch A, Cervantes A, Chirivella Gonzalez I. Ten-year assessment of a of the tibial component in knee arthroplasty: a study of four techniques in the cadaver. C, Diaz-Diaz B, Torrella J, Rodrigo J, Paya Rubio A, Roig-Casasus S, Blasco J. A randomized controlled trial assessing the effects of preoperative strengthening plus balance training on balance and functional outcome up to 1 year following J, Rojas R, Mata D, Silvestre A. Osteosarcoma of the Trapezium. cl\u00ednicas para el screening del c\u00e1ncer de pr\u00f3stata en atenci\u00f3n primaria e identificaci\u00f3n de \u00e1reas de mejora Doctoral candidate: Celia Juli\u00e1 Romero Director(s): Joaqu\u00edn Ulises Juan Escudero, Cristina Dom\u00e9nech P\u00e9rez Date of the defense: 15/07/2021 Grade: Sobresaliente \"cum laude\"SELECTED PUBLICATIONS 1. Martinez MT, Monton-Bueno J, Simon S, Ortega B, Moragon S, Rosello S, Insa A, Navarro J, Sanmartin A, Julve A, Buch E, Pena A, Franco J, Martinez-Jabaloyas J, Marco J, Forner MJ, Cano A, Silvestre A, Teruel A, Lluch A, Cervantes A, Chirivella Gonzalez I. Ten-year assessment of a since strictures: outcomes in an experienced center and factors associated with procedural success or failure. Scandinavian a negative sentinel node exploration. Archivos Main lines of research Usefulness of metabolomic analysis in the diagnosis and prognosis of patients with cancer. certain genetic profile in articles165.091IF 11.006Average3 Corresponding author8 National FOR RESEARCH Reference: PI18/01937 Title: Desigualdades por genero derivadas de la inercia diagnostica en los factores m\u00e1s prevalentes de riesgo cardiovascular: un estudio de cohortes de base poblacional (ESCAARVAL GENERO) Principal Investigator: Jos\u00e9 Mar\u00eda Mart\u00edn Moreno Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico budget: \u20ac33.880 THESIS Thesis title: gestacional: adecuaci\u00f3n de recomendaciones en poblaci\u00f3n gestante de la Comunidad Valenciana Doctoral candidate: Mar\u00eda Faus Garc\u00eda Director(s): Jos\u00e9 Mar\u00eda Mart\u00edn Moreno, Rafael Vila Candel Date of the defense: 20/01/2021 Grade: Sobresaliente \"cum laude\"SELECTED PUBLICATIONS 1. Burgess R, Osborne R, Yongabi K, Greenhalgh T, Gurdasani D, Kang G, Falade A, Busse R, mortality in Europe in 2021: room for hope in Heitor M, Tabernero J, Schuz J, Baumann M, Henrique R, Aapro M, Basu P, Beets-Tan R, Besse B, Cardoso F, Carneiro F, van den Eede G, Eggermont A, Frohling S, Galbraith S, Garralda O, E, Weiderpass E, N, Wren A, Zitvogel L. E. products in patients suffering from Multiple Esclerosis: no new Collection of peripheral blood and derivative products and urine in products in patients suffering from COVID-19 disease: no new of PI: Antonio Ferr\u00e1ndez and services that may be used in biobank they of projects and/or private clinical trials. biobank storage and custody of the samples, as well as the processing of the same in some cases. Amadix Study: processing, conservation and shipment of proces- sed samples the PancreaDIX study: Study for the development and validation of a genetic fingerprint for the diagnosis of CPAP on the of proces- sed samples for translational study within the framework of the ROLANDO trial: Multicenter and uncontrolled phase II clinical trial to evaluate the safety and of the combination of Olaparib and Pegylated Liposomal evaluate the efficacy and safety of ensifentrine over 24 weeks patients assess of liquid biopsy and lung cancerSAF2017-85352-R, de Econom\u00eda, blocks BBI_19/2020: action of complete exomic sequencingCOV20/01334, ISCIIJos\u00e9 Carlos Rodr\u00edguez Gallego, Hospital Universitario de Gran Canarias Dr. Negr\u00ednCOVID-19 Collection: 39 serum aliquots BBI_09/2021 Development of EOSAL technology for its application to genetic diagnosisFDEGENT/2019/006GVAAna B\u00e1rbara Garc\u00eda human infertility: Human Endometrium Implantation; and the subproject: Molecular and of Human Endometrium in Women with EndometriosisP50 HD055764, Center for Research, Innovation and Training in of patients of Friedreich's de Innovaci\u00f3nPilar Gonz\u00e1lez to the following research projects: SERV01/2021: Optimization of tissue simples Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2021 -2023 Total Budget: \u20ac265.650 PUBLICATIONS Note that these are 2021 scientific publications derived from the use of samples or services provided by the biobank. 1. Garrido-Cano I, Pla L, Santiago-Felipe S, Sim\u00f3n S, Ortega B, Bermejo B, Lluch A, Cejalvo JM, Eroles Ortega B, Morag\u00f3n S, Lameirinhas A, Const\u00e2ncio V, Salta S, Burgu\u00e9s O, Bermejo B, Henrique R, Lluch A, Jer\u00f3nimo C, Eroles P, Cejalvo JM. Lameirinhas A, Sim\u00f3n S, Ortega-Morillo B, Mart\u00ednez MT, Hernando C, Const\u00e2ncio V, Burgues O, Bermejo B, Henrique R, Lluch A, Jer\u00f3nimo C, Eroles P, Cejalvo JM. Identification of a two-MicroRNA signature in plasma as Tarazona N, Gambardella V, Cervantes A, L\u00f3pez-Rodas G, Franco L, Castillo J. Epigenetic mechanisms are Crespo M, Alcoceba M, S\u00e1nchez JB, Taz\u00f3n B, Serrano A, \u00c1lvarez MG, Serrano LG, Alonso-Torres P, Villanueva M, Loriente C, Abrisqueta P, Peir\u00f3 M, Garc\u00eda- Marco JA, Gonz\u00e1lez M, Terol MJ. Building a JJ, R, E, Barreiro M, D\u00edaz- Manera J, Turon-Sans J, Cort\u00e9s-Vicente E, Querol L, Ram\u00edrez- Jim\u00e9nez L, Mart\u00ednez-Rubio D, S\u00e1nchez-Monteagudo A, Espin\u00f3s C, Sevilla T, Lupo M, Davalos V, Planas-Serra L, Alvarez-Errico D, Arribas C, Ruiz M, Aguilera-Albesa S, Troya J, Valencia-Ramos J, V\u00e9lez-Santamaria V, Rodr\u00edguez-Palmero D, MJ, Lluci\u00e0-Carol L, Planas AM, P\u00e9rez- Tur J, Fernandez-Cadenas I, Villares P, Tenorio J, Colobran R, Martin-Nalda A, Soler-Palacin P, Vidal F, Pujol A, Esteller M. Epigenome-wide association study of COVID-19 sepsis and septic shock: a pilot study. 14;22(18):9935. 10.3390/ijms22189935. PMID: 34576097 JM, I, Mart\u00edn-Arana J, T\u00e9bar- Mart\u00ednez R, Viala Bruixola G, Hernando C, Blasco I, Papaccio F, Mart\u00ednez-Ciarpaglini C, Alfaro-Cervell\u00f3 C, Seda-Garc\u00eda E, Blesa S, Chirivella I, Castillo J, Mont\u00f3n-Bueno JV, Rosell\u00f3 S, Huerta M, P\u00e9rez-Fidalgo A, Mart\u00edn-Martorell P, Insa-Moll\u00e1 A, Fleitas T, Rentero-Garrido P, Z\u00fa\u00f1iga-Trejos S, Cervantes A, Roda D. Molecular profiling of advanced solid tumours. The impact I, Calatayud M, Gonz\u00e1lez S, Mart\u00ednez-Costa C, Collado MC. Maternal diet shapes the breast milk microbiota composition candidate: Garrido Cano Director(s): Pilar Eroles Asensio, Ram\u00f3n Mart\u00ednez doctors Alba Viala Monle\u00f3n. Hospital Amelia Insa Moll\u00e1. Hospital Bego\u00f1a Bermejo de las Heras. Hospital. University Cristina Herrando Meli\u00e1. Hospital Desamparados Roda P\u00e9rez. Hospital Gema Bruixola Campos. Hospital Isabel Chirivella Gonz\u00e1lez. Hospital. University Jose A. P\u00e9rez Fidalgo. Hospital. University Juan Miguel Cejalvo And\u00fajar. Hospital Marisol Huerta \u00c1lvaro. Hospital Paloma Mart\u00edn Martorell. Hospital Susana Rosell\u00f3 Keranen. Hospital Tania Fleitas Kanonnikoff. Hospital Valentina INCLIVA Oliver. INCLIVA Ana Vercher Grau. INCLIVA Beatriz L\u00f3pez Montero. INCLIVA. Guillermo Moret Peir\u00f3. INCLIVA Ignacio Casta\u00f1o L\u00f3pez. INCLIVA M\u00aa Carmen Mart\u00ednez L\u00f3pez. Manzaneda L\u00f3pez. INCLIVA Paula Petruskevicius Fern\u00e1ndez. Valencia performing Phase I cancer clinical trials, and one of the few in Spain. Phase I trials are those in which a substance or product is tested in humans for the first time. INCLIVA is conducting, through the Oncology Department, 261 clinical trials, 146 of them related to treatment in the early stages of testing (74 phase I or \"first in human\" and 72 phase II). INCLIVA's new facilities provide a full floor and a half specifically dedicated to host the unit. The unit aims to develop and select tumors232 2021scientific implements early 02 saturation) 7 double infusion are located on second floor: Reception and waiting room 2 Consulting rooms Staff room Meeting room Therapy room The third floor Funding Body: Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de budget: de Salud Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Total Budget: \u20ac104.775 Reference: COV20/00279 Title: Detecci\u00f3n r\u00e1pida de COVID19 y del paciente Principal Investigator : Javier Chaves Mart\u00ednez Funding Body: Instituto de Salud III Platform ITEMAS Collaborating researchers: Carlos Guerrero Calatayud. INCLIVA Federico Pallard\u00f3 Calatayud. University Olmo Zurriaga. INCLIVA Indicators in 2021 National collaborations managed by the have been formalized through agreements 15 International collaborations managed by the UAI that have been formalized through agreements 0 Training activities, for IIS personnel, aimed increasing External 2 Actions with companies to promote the innovation portfolio of the IIS 21 Projects requested to competitive national calls for innovation / knowledge Projects awarded through competitive external calls for innovation calls 2 (\u20ac398.125,00) Budget: \u20ac175.000 Reference : Investigator: Rub\u00e9n Artero Allepuz Funding Carlos III - Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: Agente de innovaci\u00f3n INCLIVA para la promoci\u00f3n de la innovaci\u00f3n y transferencia del conocimiento Principal Investigator : Marta del Olmo Zurriaga Funding Body: Agencia Valenciana de Innovaci\u00f3n Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario INCLIVA para para la formaci\u00f3n de espacios de cocreaci\u00f3n hospitalarios con agentes del SVI Principal Investigator : Carlos Guerrero Calatayud Funding Body: Agencia Valenciana de Innovaci\u00f3n Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario Budget: \u20ac126.483,95 Reference: INNVA1/2020/85 Title: Valorizaci\u00f3n, estrategia de protecci\u00f3n y transferencia de un m\u00e9todo de diagn\u00f3stico y pron\u00f3stico de la sepsis y el shock s\u00e9ptico Principal Investigator : Jos\u00e9 Luis Garc\u00eda Gim\u00e9nez Funding Body: Agencia Valenciana de Innovaci\u00f3n Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario un test IVD para el diagn\u00f3stico y pron\u00f3stico de la sepsis y el shock s\u00e9ptico Principal Investigator : Jos\u00e9 Luis Garc\u00eda Gim\u00e9nez Funding Body: Fundaci\u00f3n para la Innovaci\u00f3n y Prospectiva en Salud en Espa\u00f1a (FIPSE) Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario Total Budget: \u20ac30.000Title: Validaci\u00f3n de microRNAs circulantes como biomarcadores de pron\u00f3stico y evoluci\u00f3n cl\u00ednica en Ataxia de Friedreich. Hacia la medicina de precisi\u00f3n en las Enfermedades Raras Principal Investigator : Jos\u00e9 Luis Garc\u00eda Gim\u00e9nez Funding Body: Federaci\u00f3n de ataxias de Espa\u00f1a (FEDAES) Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de 2020-2021 Total Budget: \u20ac6.000 From June 2021, INCLIVA status of of the ITEMAS Platform of the IDIBELL Node. INCLIVA is part of the Alliance for Health Innovation and Industrialization of the Mediter - ranean Axis (AIISEM) IDIBELL Foundation month, both the Technical Commission and the Strategic Com - mission. The Alliance has a 3-year Action or Work Plan divided into 5 key objectives.235 SCIENTIFIC REPORT 2021scientific PI: University Clinical Research INCLIVA Juan Antonio Carbonell Asins. Hospital. INCLIVA Hired in accordance with the applicable regulations and the standards of good clinical practice. Currently, the portfolio of services includes, among Sheet and Informed Consent and all documentation necessary for the correct development of the study in accordance with applicable regulations. 2. Start-up activities: identification and of with the processing of amendments, interim IV (Low intervention clinical trial) Study: SOLIDARITY Title: An additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careEUDRACT: 2020-001366-11 Sponsor: Ministerio de Sanidad, Consumo ESR-17-13447(DAPA-HF) ejection fraction EUCRACT: 2018-002614-12 Sponsor: Fundaci\u00f3n Study: BBLOQ-2017 Title: REPORT activity4Sponsor: Fundaci\u00f3n Valencia Phase: IV Study: ADAMPA Title: Impact of antihypertensive medication in the control of hyper and to treatment. EUCRACT: Cl\u00ednico Universitario IV (Low intervention Colitis ulcerosa (GETECCU) Phase: oral ixazomib in combination with sirolimus and EUCRACT: 2016-002503-26 Sponsor: Fundaci\u00f3n P\u00fablica (FISEVI) Phase: Phase: IVStudy: SECURE Title: - EUCRACT: 2015-002868-17 Sponsor: Fundaci\u00f3n Centro Nacional de Investigaciones Cardio- vasculares, Instituto de Salud Carlos III (CNIC) Phase: III Study: IGR2009/1593 Title: Intergroup NHL or B-AL: evaluation of rituximab efficacy safety in high Sponsor: Fundaci\u00f3n para la Investigaci\u00f3n Phase: III Study: Medical Center Hamburg-Eppendorf Investi - gator 19 infection. Prospective study Sponsor: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Phase: Clinical trial with Sponsor: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Phase: Non Observational with no drugs and periampulars (CETUPANC Study) Sponsor: Fundaci\u00f3n P\u00fablica Andaluza para la Gesti\u00f3n en Salud de Sevilla (FISEVI) Phase: Interventional study Study: FAIR Title: Intravenous double-blind EUCRACT: 2020-000941-15 Sponsor: Fundaci\u00f3n para la Formaci\u00f3n e Investigaci\u00f3n Sanitarias de la Regi\u00f3n de Murcia (FFIS) Phase: III Study: ECACIKAGEL Title: Ensayo Cl\u00ednico Aleatorizado triple ciego para la evaluaci\u00f3n de la seguridad y eficacia de CikaGel \u00ae en el tratamiento de las \u00falceras de pierna en pacientes sin Enfermedad Arterial Perif\u00e9rica Sponsor: Georges Klein Phase: Title: Temociclina vs Meropenem para el Tratamiento de la Bac - tiremia por Enterobacterales Resistentes a Cefalosprorinas de Tercera Generaci\u00f3n: Ensayo Aleatorizado y Pragm\u00e1tico EUCRACT: 2020-000064-39 Sponsor: Fundaci\u00f3n P\u00fablica para la Gesti\u00f3n de la Investigaci\u00f3n en Salud de Sevilla (FISEVI) Phase: III Study: tumor DNA EUDRACT: 2021-000507-20 Sponsor: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia tients with failure history EUDRACT: 2020-003229-47 Sponsor: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de new biotherapies238 INCLIVA SCIENTIFIC REPORT 2021scientific activity4Sponsor: Fundaci\u00f3n Investigaci\u00f3n Valencia Phase: Study: TFK-RAM-2018-01 Title: microbiota and on clinical results Sponsor: Fundaci\u00f3n P\u00fablica Andaluza para la gesti\u00f3n de la Inves - tigaci\u00f3n en Salud de Sevilla (FISEVI) Phase: EPA-SP -DLCO 1 spirometry sufficient in COPD screening? Sponsor: Study: JSC-TAB-2015-01 Title: Effectiveness of an intensive exacerbations of smoking la administraci\u00f3n intravenosa de hierro carboxi- maltosa sobre el rendimiento f\u00edsico, la fatiga y la calidad de vida en pacientes con enfermedad renal cr\u00f3nica no en di\u00e1lisis y d\u00e9ficit de hierro Sponsor: Jos\u00e9 Luis G\u00f3rriz Teruel Phase: EPA-SPStudy: HK-01-21 Title: Evidencia en la vida real del uso de patiromer para el trata- miento de pacientes con hiperpotasemia cr\u00f3nica en una regi\u00f3n de Espa\u00f1a Sponsor: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Phase: EPA-OD Study: FIS-BAZ-2012-01 Title: Acci\u00f3n del bazedoxifeno sobre el metabolismo \u00f3seo y los factores de riesgo cardiovascular Sponsor: Antonio Cano S\u00e1nchez Phase: EPA-SP DURING LAST 5 YEARS During the last five years, the unit has initiated 33 studies (21 clinical trials and 12 observational by year. Clinical trialsObservational StudiesTotal 2017 5 2 7 2018 3 0 3 2019 4 4 8 2020 5 4 9 2021 4 2 6239 INCLIVA maintains an average of 26 active studies, per year, with a clear increasing tendency in the number of studies. Their distribution by type of study and year is detailed in the following table. 2017 2018 2019 2020 2021 Phase I 1 1 1 1 1 PhaseII 0 0 0 0 0 Phase III 7 7 5 3 6 Phase IV 6 8 8 9 10 Other Designs 2 3 4 6 6 Observationals 5 5 8 8 9 Total 21 24 26 27 32 Ongoing Studies Phase I Phase II Phase Designs Observationals2017 2018 2019 2020 202135 30 25 20 15 10 5 0 RESEARCH PROJECTS AND GRANTS FOR RESEARCH Reference: PT20/0100 Title: Spanish Instituto de Salud Carlos III-Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Instituto de Salud Carlos III-Co-financed FEDER Beneficiary Institution: Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Coordinator: Pilar Rentero Garrido. Collaborating researchers: Desamparados Roda P\u00e9rez. Hospital Valentina Gambardella. INCLIVATechnicians: Enrique Seda Garc\u00eda. INCLIVA Laura Gonz\u00e1lez Castillo. INCLIVA Sebasti\u00e1n Blesa Luj\u00e1n. INCLIVA The Precission Medicine Unit was stablished in March 2018. Since then, the group have developed a robust and wide portfolio of services to support research at INCLIVA. To date, the unit closely collaborates with the Oncology Phase I Clinical Trial Unit. Together we have developed an integrated screening system to support personalized patient care and hence implementing the latest the unit currently collaborates in several research projects from different groups at INCLIVA. The group integrates professional profiles from multiple disciplines (Medical Oncology, Molecular Biology, Bioinformatics and Biochemis- try) with large professional experience in Human Genetics and Genomics.ump@incliva.es FUNCTIONS Our mission is to impulse, promote and execute quality transla - tional research offering support Molecular Biology as well as in Data Analysis techniques to the scientific community. LABORATORY EQUIPMENT Two massive sequencers heat blocks, ovens, etc. LOCATION Laboratories: Facultad de Medicina. Avenida Blasco Ib\u00e1\u00f1ez 15, Building 2, 2nd floor, UCIM nanoString platform 5. Chromium Single Cell System Advice and methodological support in writing protocols, re - search project proposals, scientific papers Mentoring of bachelor, master have been molecularly tested to select the best PROJECTS AND RESEARCH ICI20/00009 Title: Circulating Cervantes de Salud Carlos III - Co-financed FEDER Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario 2021-2024 Andr\u00e9s Cervantes and Desamparados Roda Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario 2019-2021 Total budget: de Salud Carlos III - Co-financed FEDER Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2019-2021 Total budget: \u20ac99.000Title: Whole exome sensitivity in the detection of minimal residual disease and new mechanisms Beneficiary Valencia Duration: 2020-2022 Total budget: \u20ac20.000 Title: Beneficiary Institution : 2019-2021 Title: TTD Beneficiary Institution Duration: 2020-2022 Total AECC Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n 2020-2025 Total budget: treatment Principal Tarazona Llavero Funding Body: Fundaci\u00f3n Mutua Madrile\u00f1a Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia 242 INCLIVA SCIENTIFIC REPORT 2021scientific for personalized treatments Body: Fundaci\u00f3n FERO Beneficiary Institution : Fundaci\u00f3n Cl\u00ednico Universitario de Valencia Duration: 2019-2021 Total budget: \u20ac240.000 PUBLICATIONS 1. Gambardella N, Cejalvo JM, I, Martin-Arana J, Tebar-Marti- nez R, Viala Bruixola G, Hernando C, Blasco I, Papaccio F, Martinez-Ciarpaglini C, Alfaro-Cervello C, Seda-Garcia E, Blesa S, Chirivella I, Castillo J, Monton-Bueno JV, Rosello S, Huerta M, Perez-Fidalgo A, Martin-Martorell P, Insa-Molla A, Fleitas T, Rentero-Garrido P, Zuniga-Trejos S, Cervantes A, Roda D. Molecular profiling of advanced solid tumours. The impact INCLIVA Juan Carbonell Asins. INCLIVA Pilar Natividad L\u00f3pez. INCLIVA Bioinformatics and Biostatistics Unit is a core facility created in 2013. The unit is mainly dedicated to collaborate in different research projects, providing support to researchers in the design, workflow implementation, development of computing research results Curation and analysis of RESEARCH PROJECTS AND GRANTS FOR RESEARCH Title: Legacy: CELAC and to Gastric Cancer Principal investigator : and Tania Fleitas Funding Body: European Commission Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital 2019-2022 Andr\u00e9s Cervantes and Desamparados Roda Funding Body: Instituto de Salud Carlos III - Co-financed FEDER Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de ValenciaFUNCTIONS Our mission is to drive, promote and execute quality translational research through methodological and analytical has a computing facility with 100 cores, 400GB of RAM memory 80TB of redundant network storage and 20TB of fast non-redundant local storage to the nodes for high I/O processes such as those applied to omics data analysis. In addition, and as part of the Valencian biomedical research community, we also have access to a large computing facility hos- ted at the Centro de Investigation Pr\u00edncipe Felipe to cope with large projects. SERVICES 1. Bioinformatics services: Analysis of Next-Generation Sequencing de Salud Carlos III - Co-financed FEDER Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2019-2021 Total budget: \u20ac99.000 sensitivity in the detection of minimal residual disease and new mechanisms Beneficiary Valencia Duration: 2020-2022 Total budget: \u20ac20.000 Title: Beneficiary Institution : 2019-2021 Title: TTD Beneficiary Institution de Valencia Duration: 2020-2022 Title: Precission medicine in oncology: Fundaci\u00f3n FERO Beneficiary Institution : Fundaci\u00f3n 2019-2021 Total budget: treatment Principal Tarazona Llavero Funding Body: Fundaci\u00f3n Mutua Madrile\u00f1a Beneficiary Institution : Fundaci\u00f3n Investigaci\u00f3n Hospital Cl\u00ednico Universitario de Valencia Duration: 2020-2023 Total budget: \u20ac130.000 PUBLICATIONS E, Escrig-Sos J, Poves-Prim I, Fabregat-Prous J, Larrea Y Olea J, no Anto- nio Carbonell-Asins J, Canete Nicolas C, Hernandez-Viadel M. Efficacy of vitamin D in the treatment of depression: a system - atic review JM, I, Martin-Arana J, Tebar-Marti- nez R, Viala Bruixola G, Hernando C, Blasco I, Papaccio F, Martinez-Ciarpaglini C, Alfaro-Cervello C, Seda-Garcia E, Blesa S, Chirivella I, Castillo J, Monton-Bueno JV, Rosello S, Huerta M, Perez-Fidalgo A, Martin-Martorell P, Insa-Molla A, Fleitas T, Rentero-Garrido P, Zuniga-Trejos S, Cervantes A, Roda D. Molecular profiling of advanced solid tumours. The impact Lam - eirinhas A, Simon S, Ortega-Morillo B, Martinez MT, Her-245 INCLIVA SCIENTIFIC REPORT 2021scientific activity 4nando C, Constancio V, Burgues O, Bermejo B, Henrique R, Lluch A, Jeronimo C, Eroles P, Cejalvo JM. Identification of a Two-MicroRNA signature in plasma as for Gambardella C, Carbonell Asins J, Dell'isola Tolone Eid CM, R, Uribarri A, Fern\u00e1ndez-Rozas I, Aguado MG, Becerra-Mu\u00f1oz VM, Huang J, Pepe M, Cerrato E, Rapo- seiras S, Gonzalez A, Franco-Leon F, Wang L, Alfonso Ugo F, Garcia-Prieto JF, Feltes G, Abumayyaleh M, hospitalized of the Committee for investigation with medicinal products (CEIm) 5.2 I 1 Phase II 6 Phase III 6 Phase IV 0 CLINICAL TRIALS WITH MEDICAL 0 12 OBSERVATIONAL STUDIES WITH MEDICAL DEVICES 5 RESEARCH PROJECTS 192 TOTAL 2305.1. Activity of the Ethical Committee for investigation with medicinal products (CEIm) The Ethical Committee for Investigation with Medicinal Products are an independent board with a multidisciplinary composition whose main purpose is to oversee the safety well-being of subjects participating in clinical studies and biomedical As a result of its activity along 2021, the CEIm has processed total of trials and observational studies): 37 were is in process of evaluating the response to the requested clarifications. Of the 38 approved studies, 19 were approved in the first evaluation and 19 after requesting clarification to the STUDIES WITH RESEARCH PROJECTS 2021clinical trials5Distribution of the clinical studies depending on the they are following: CLINICAL TRIALS Medicine General 1 5 Pharmacy 3 Rheumatology 1 Tutelage 3 Urology 1 TOTAL 38 Distribution of the research projects depending on the department where they are performed is the following: RESEARCH PROJECTS BY DEPARTMENT N\u00ba Anesthesiology and Reanimation 6 9 General Surgery Gynecology 5 Haematology 6 INCLIVA Research Groups 11 Intensive Medicine 1 Internal Medicine 6 Microbiology 11 Nephrology 3 Neumology 9 Neurology 3 Nuclear Medicine 1 Nursery 6 Oncology 10 Ophthalmology Oral Primary Care 1 Psychiatry 2 Psychology 1 Physical Medicine and Rehabilitation 2 Public Health 1 Rheumatology 1 Tutelage 2 University 2 Urology 2 TOTAL 192 5.2. Clinical research activity studies, and research projects) carried out by the Hospital Cl\u00ednico Universitario de Valencia and the Valencia Cl\u00ednico-Malvarrosa Health Department researchers. As a result of its activity along 2021, the has studies trials I Phase III Phase IV Others Observational TOTAL Cardiology - 2 6 1 2 12 23 Digestive Medicine - 5 2 - 1 7 15 Haematology 3 3 9 - - 5 20 Internal Medicine - - 2 - - - 2 Nephrology - 4 5 - - 3 12 Neurology - - 4 - - - 4 Oncology 20 36 30 - - 7 93 Others1 6 9 2 1 23 42 TOTAL24 56 67 3 4 57 211252 INCLIVA SCIENTIFIC REPORT 2021clinical trials5The Haematology, Neurology, Digestive Medicine and Internal Medicine. These six services make over 75 % of the total processed trials. PROMOTOR N\u00ba HOSPITAL CL\u00cdNICO UNIVERSITARIO DE VALENCIA RESEARCHERS AND INCLIVA 3 INDEPENDENT CLINICAL RESEARCH 67 COMERCIAL RESEARCH 141Regarding the distribution of studies per promoter, 67 trials are considered as Independent Clinical Research (trials from associations, groups, foundations, and private individuals), 3 of which have been promoted by researchers from the Hospital Cl\u00ednico Universitario de Valencia and INCLIVA and the rest of them have been promoted by pharmaceutical Internal Medicine Nephrology Neurology Oncology Others 0 5 10 15 20 25 30 35 40 Phase I Phase II Phase III Year Processed studies 2017 143 2018 172 2019 159 2020 206 2021 211 One of INCLIVA's main goals is to develop clinical research at its early stages, thus contributing to translational research that moves scientific knowledge from bench to bedside. With this regard, during the period 2017-2021, Phase I and Phase II trials are prioritized and its number remains the PHASE 2017 2018 2019 2020 2021 Phase 0 - 2 - 1 - Phase I 13 20 17 32 24 Phase II 31 25 43 43 56 Phase III 46 67 43 64 67 Phase IV 6 5 7 8 3 Observational 43 51 42 50 57 Others 4 2 7 8 4 Evolution of clinical trial distribution by phase Phase per department analyzed below uses a semilogarithmic scale due to the great difference between the Department of Medical Oncology and the rest of the Departments. DEPARTMENT N\u00ba Anesthesiology and Reanimation 20 Cardiology 8 Haematology Infectious 23 Neurology 35 6 Health Care 1 Respiratory Diseases 10 Urology Others TOTAL 64 124 Phase 210 Phase IV 30 Observational 139 Other 12 Phase I Phase II Phase III Phase IV Observational Other 0 20 40 60 80 100 120 140 160 220initia- tives INCLIVA SCIENTIFIC REPORT activities259 INCLIVA SCIENTIFIC REPORT 2021initiatives 6Ana Aliaga Chueca University of San Francisco. California (USA) M\u00aa Pilar Ballester Ferr\u00e9 UCL Medical School-Royal Free Hospital. London (United Kingdom) Manuel Ballesteros Redondo Hospital Universitario Ram\u00f3n y Cajal. Madrid Silvia Bus\u00f3 Gil Hospital Cl\u00ednic Barcelona. Barcelona Guillermo Cervera Ygual Hospital Universitario Virgen del Roc\u00edo. Sevilla Leopoldo Fern\u00e1ndez Domper Hospital Universitario Ram\u00f3n y Cajal. Madrid Ana M\u00aa G\u00e1lvez Llompart Hospital Universitario de Gran Canaria Dr. Negr\u00edn. Gran Canaria Francisco Gimeno Valiente University College of London. London (United Kingdom) Concepci\u00f3n G\u00f3mez Medina University of Pittsuburgh Medical acquire for research every year INCLIVA sponsors its Grants for research internships in centers of excellence. Since the establishment of this scholarship program, over 158 professionals have visited national In 2021 of IIS INCLIVA Training Stays during Mariola Hern\u00e1ndez Mart\u00ednez Complejo Quir\u00f3n Salud (HRJB y HQSJ). Madrid H\u00e9ctor Manuel Merenciano Gonz\u00e1lez Hospital Universitario de Bellvitge. Barcelona Iria Mestre D\u00edaz Hospital Santa Cristina. Madrid Marina Miralles Sancho Hospital Psiqui\u00e1trico Rom\u00e1n Alberca. Murcia Alejandro P\u00e9rez Mora Hospital Universitario Santa Cristina. Madrid Andr\u00e9s Piolatti Luna Hospital Universitario Infantil Ni\u00f1o Jes\u00fas. Madrid Serena Pisoni Istituto Auxologico Italiano. Milan (Italy) Mario Rodr\u00edguez Rivas Hospital Universitario 12 de Octubre. Madrid OUTGOING INTERNSHIPS Researchers from following Juan Antonio Carbonell Asins Universidad de Puerto Rico. ZNA (Ziekenhuis NETWERK Antwerpen). Belgium Laura Robles Rodr\u00edguez University of Colonia. Colonia (Germany)David Mart\u00ed Aguado University of Pittsburgh Medical Center. Pittsburgh (USA) C\u00e9sar R\u00edos Navarro Universit\u00e4tsklinikum Essen. Essen (Germany) David Mart\u00ed Aguado Centro Nacional de Investigaciones Cardiovasculares (CNIC). Madrid Ezequiel Monferrer Garzar\u00e1n Centre for the (United who benefited from the Sanec 2021 Scholarship for Dual Training program for the academic years 2020-2021 and 2021- 2022, promoted by the Bankia Foundation and several Research Institutes, including INCLIVA. There were a total of 5 beneficiaries.34 Bachelor Degree students at the University of Valencia students) 23 Bachelor Degree (including TFG students) 22 Master's TFM students) 6 Master's Degree Community (10 of them were beneficiaries of the Sanec 2020 Program y 5 of them were beneficiaries of the Sanec 2021 Program) 1 ESO students Program for acquiring knowledge about the world of workFrancisco Lara Hern\u00e1ndez University of Valencia (Genomics and Diabetes Unit) Selene Valero Moreno University of Valencia (Research Group on Rare Respiratory Diseases (RRD)) Estrella Christabel Porr\u00e1s N\u00fa\u00f1ez Universit\u00e0 Nazionale di Piura (Per\u00fa) (Genomics and Diabetes Unit)Granted by Conselleria de Innovaci\u00f3n,Universidades, Ciencia y Sociedad Digital Juan Jos\u00e9 Gallego Roig Imperial College London. London (United Kingdom) INCOMING INTERNSHIPS The researchers in following table: Gosp - Research Group on Rare Respiratory Diseases (RRD) - Mr. Francisco Das\u00ed Fern\u00e1ndez Alba Gallardo Asunci\u00f3n - Genomics and Diabetes Unit - Mr. Felipe Javier Chaves Mart\u00ednez Adri\u00e1n P\u00e9rez Andr\u00e9s - Research Group on Neurological Impairment - Mrs. Carmina Montoliu F\u00e9lix Alejandra Guti\u00e9rrez P\u00e9rez - Research Group on Lymphoproliferative Disorders - Mrs. Blanca Ferrer Lores Mar\u00eda Fern\u00e1ndez Calduch - Group on Translational Research in Ischemic Heart Disease - Mrs. Amparo Ruiz Saur\u00edVlad Stefan Hancig Polytechnic University of Valencia (Research Group Noce INCLIVA. in different research groups:Ariadna Bargiela Sch\u00f6nbrunn University of Oxford. Oxford (United 2021initiatives 66.2 Training and teaching activities Courses (14) La Diabetes Tipo 2 desde la Perspectiva de la Multimor - bilidad VII Workshop Internacional Ecograf\u00eda y Resonancia Ano- rrectal C19_SPACE Curso de Preparaci\u00f3n de Habilidades Curso te\u00f3rico pr\u00e1ctico Leucemia Linfoc\u00edtica Cr\u00f3nica-LLC I Curso de Laparoscopia Experimental para Residentes de Urolog\u00eda Estad\u00edstica Aplicada a la Medicina Curso Online en Atenci\u00f3n Sanitaria Basada en Valor Curso Cat\u00e9ter Venoso Central de Inserci\u00f3n Perif\u00e9rica-PICC Formaci\u00f3n Progresiva Cirug\u00eda Laparosc\u00f3pica Colorrectal Curso Buenas Pr\u00e1cticas Cl\u00ednicas para Investigadores I Curso sobre Gesti\u00f3n de la CronicidadNEW INITIATIVES The first call for applications for TFD and TFM Tutorials was opened in 2021. The aimed at university students enrolled in University Degrees and Masters in the Area of Health and Allied Sciences. The following list shows the students who are going to do their TFD or TFM: TFG Malena Parlatore - Genomics and Diabetes Unit - Mrs. Ana B\u00e1rbara Garc\u00eda Garc\u00eda Mar\u00eda Janini Vilarrasa - Research Group on the Study of Cardiometabolic and Renal Risk - Mr. David Mart\u00ed Aguado Alexandre Ruix Morell - Research Group of Innovative Diagnostic and Therapeutical Developments in Solid Tumors - InDeST - Mr. Andr\u00e9s Cervantes Laura Arias Blanco - Research Group on Breast Cancer Biology - Mrs. Pilar Eroles Asensio In\u00e9s Escobedo Camacho - Research Group on the Study of Cardiometabolic and Renal Risk - Mrs. Raquel Cort\u00e9s Vergaz TFM Victoria Muriach P\u00e9rez - Research Group on - Mrs. Carmina Montoliu F\u00e9lix Adri\u00e0 L\u00f3pez Group on Impairment - Mrs. Carmina Montoliu F\u00e9lix Carmen Costa Gregori - Genomics and Diabetes Unit - Mrs. Ana B\u00e1rbara Garc\u00eda Garc\u00eda Celeste Moya Valera - Genomics and Diabetes Unit - Mr. Felipe Javier Chaves Mart\u00ednez Antonio P\u00e9rez-Cardona Garc\u00eda - Research Group on the Study of Cardiometabolic and Renal Risk - Mr. Josep Red\u00f3n i Mas Cristian Mart\u00ednez Fajardo - Research Group on Healthy Aging - Mr. Juan Gambini Buch\u00f3n Noelia Ruiz Alonso - Research Group on Breast Biology - Mrs. Pilar Eroles Asensio Ana Roca - Research Group on Breast Cancer Biology - Mr. Juan Miguel Cejalvo And\u00fajar Ana Puertes Espada - Research Group on the Study of Cardiometabolic and Renal Risk - Mrs. Raquel Cort\u00e9s Vergaz Carme Mar\u00eda Ortega Albiach - Bioinformatics and Biostatistics Unit - Mrs. Sheila Z\u00fa\u00f1iga Trejos Curso Aspectos B\u00e1sicos Protecci\u00f3n de Datos 9\u00aa Edici\u00f3n Curso de Anatom\u00eda Quir\u00fargica Aplicada HBP VII Workshop Cirug\u00eda Laparosc\u00f3pica Colorrectal Avanzada Scientific Conferences (24) Jornada Personal de Enfermer\u00eda Hematolog\u00eda Nueva Normativa de Estudios Observacionales con medicamentos Jornada Estrat\u00e9gica de Investigaci\u00f3n EERR Normativa de Protecci\u00f3n de Datos en los Proyectos Reuni\u00f3n Virtual THP Domiciliario-Jornada Ruta Asistencial Visualizaci\u00f3n del Personal Investigador en Redes Sociales Con la Igualdad Siempre Ganas 1\u00aa sesi\u00f3n Requisitos para la presentaci\u00f3n de proyectos de investigaci\u00f3n262 INCLIVA SCIENTIFIC REPORT 2021initiatives6 Proyecto Formativo para Atenci\u00f3n Primaria Programa de Formaci\u00f3n en Hemopatolog\u00eda 2021 Proyecto Marco Polo I (3 sesiones) Jornada Formativa Acceso a HC en Investigaci\u00f3n Biom\u00e9dica Innovaci\u00f3n y Transferencia de Conocimientos Nuevas tecnolog\u00edas aparatos W8 Jornada Enfermedades Raras en Pediatr\u00eda y Atenci\u00f3n Primaria Proyecto Marco Polo II (4 sesiones) Post-ESMO 2021 Innova HUB SALUD LANZADERA Con la Igualdad Siempre Ganas 2\u00aa Sesi\u00f3n Formaci\u00f3n Sanitaria Especializada Actualizaci\u00f3n C\u00e1ncer de Pr\u00f3stata 2021 Jornada Papel del m\u00e9dico residente en la lucha contra el VIH T\u00e9cnicas de abordaje del paciente con espasticidad post ictus Jornada Formativa sobre Patolog\u00eda Hematol\u00f3gica y Oncol\u00f3gica. Evoluci\u00f3n de Enfermer\u00eda: estudio de un casoINCLIVA Seminars / Meet the Expert (10) Los biomarcadores para la Enfermedad de Alzheimer en la pr\u00e1ctica cl\u00ednica La Investigaci\u00f3n Biom\u00e9dica del Dolor con Perspectiva de G\u00e9nero 2\u00aa Reuni\u00f3n \"Los biomarcadores para la Enfermedad de Alzheimer\" Mitos frente a realidades en el c\u00e1ncer de pr\u00f3stata avanzado Visitas de observaci\u00f3n \"Shadow Visit\" Seminarios Cient\u00edficos Deterioro Neurol\u00f3gico Proyecto THP Domiciliario Seminario Incliva-BIOBANCO Seminario INCLIVA Dr. Batlle I Reuni\u00f3n Matriz extracelular en el sistema nervioso Social Dissemination Days (5) D\u00eda Mundial EERR 2021 Encuentro on-line Club Triple Negativo C3 Coloquio Visi\u00f3n de la Ciencia de Investigadoras Valencianas Celebraci\u00f3n: D\u00eda del Prematuro Prevenci\u00f3n y Tratamiento de \u00dalceras por Presi\u00f3n-UPPcom- muni- cation INCLIVA January INCLIVA coordinates an international and multicenter study on the prevalence of coma and delirium in ICU patients with COVID-19 INCLIVA participates in a European project to analyze and and its impact on health Igenomix-INCLIVA researchers decode for the first endometrium senior female scientists in the field of physical activity and health analyzes the effectiveness of of Valencian agricultural products An INCLIVA study shows that the increase in potassium level after an episode of severe hyperkalaemia is associated with the risk of death INCLIVA research confirms the efficacy of circulating marker for breast cancer An points therapeutic target for satisfactory aging An INCLIVA study identifies a molecular profile associated with the development of kidney disease in early stages in patients with hypertension April An INCLIVA study demonstrates the importance of a new molecular target in the treatment of obesity and diabetes An INCLIVA investigation opens the doors to a new DAAT study model INCLIVA develops, with the support of the AVI, a test that detects early and predicts the evolution of sepsis, one of the main causes of death in hospital An INCLIVA study shows that stress in childhood and adolescence can modify the brain May INCLIVA develops a rapid detection kit for COVID-19, highly sensitive and easy to use INCLIVA receives funding from FIPSE for the development of a rapid diagnostic and prognostic test for sepsis and septic shock and CIBERBBN develop a breast cancer June Professor Cervantes warns of the impact of COVID-19 on women oncologists and highlights the need for more measures to guarantee equality College confirm absence of COVID 19 and the presence of defenses against the virus in breast milk INCLIVA participates in a pioneering clinical trial to validate the efficacy of immunotherapy in 29 types of tumors266 266 INCLIVA SCIENTIFIC REPORT 2021communication7July INCLIVA renews its accreditation as a AI: Actionable Insights Transforming European Healthcare shows the results of 12 big data and artificial intelligence pilots that make up this BigMedilytics Project II Ideas Contest to stimulate the innovative culture of the Hospital Cl\u00ednico Universitario de Valencia and its department, through the INCLIVA Innovation Support Unit INCLIVA and IIS La FE European INCLIVA the influence of signals on memory generated in the shows the relevance personalized Artificial Intelligence techniques in health INCLIVA demonstrates the usefulness Boehringer Ingelheim to promote and health and IBV will bring a custom-made maxillo-mandibular prosthesis to the market in collaboration with the 3DSolutions Group An international trial shows, for the first time, that associating an immunotherapy with admitted moderate or severe pneumonia due to COVID-19 in function months after hospital defends shift that cause cancer rather than on the tumor in a specific organ December INCLIVA and the International University of Valencia (VIU) sign an agreement to collaborate in training and research activities Professor Cervantes conveys to the deputies and senators of Health commissions the Congress and Senate challenges Unit in Oncology267 267 INCLIVA SCIENTIFIC REPORT 2021communication Total press total of 149 press releases on the Web. 350 300 250 200 150 100 18 16 8 12 33 18 5 9 7 6 12 5 Total media appearances 143 112 199 245 319 157 112 115 171 166 194 84 Social Media users 2021 10.688 5.165 releases 112 Newspieces on INCLIVA's website 19 News on Radio 14 News on TV In may was held MedNight 2021: Nit Mediterr\u00e0nea de associated with the European Union's No- che Europea de los Investigadores initiative, funded by the Marie Skodowska-Curie actions of role of women in scien- tific and technological research in the Region of Murcia and the Valencian Community for the first time jointly, and tific vocations through formats and attractive activities for ages and all types of audiences like talks, workshops, INCLIVA social initiatives In 2021, the Institute of Health Research at the Hospital Cl\u00ednico Universitario de Valencia, INCLIVA, launched an awareness campaign on the importance of health research to guarantee first-rate assistance in the field of public health, and thus save more lives every year. Under the slogan I support research, which is part of its Patronage Plan, INCLIVA underlines the essential nature of medical advances that translate into improved quality of life for all citizens. These are the main highlights: 18 March, 2021. AVA-ASAJA association of agricul - tural products and promoting them within society. This agreement shows the commitment of the agricultural and health sectors to offer - ing consumers a healthy the INCLIVA Clinical Hospital of Valencia launched the campaign 'Give research as a gift this Christmas', inviting people to make donations to health research as a Christmas present. Running until 6 January, the objective of this campaign was to raise public awareness of the importance of health research and the possibility that by donating, anyone can contribute individually and within their means to the advancement of childhood cancer, neuroblastoma\". The Research Group led by Dr Rosa Noguera launched a fundraising campaign for research into neuroblastoma, the childhood. The campaign invited everyone making a donation to this cause to enter a competition to draw a painting by urban artist Dridali. The prize-winner who won the painting was the Iraila women by Group to coincide with Mother's Day, the initiative involved mothers with breast cancer explaining their experience and highlighting the importance of both the medical team to overcome the challenges involved, and of research to help other women with this disease become mothers. The aim of the campaign was to advance knowledge of the relationship between breast cancer and pregnancy via the patients themselves, and help women with this disease who are trying to conceive by providing them with the best and most appropriate advice. June 2021 . The Colegio de Agentes de Aduanas (Association of Customs Agents) and ATEIA-Oltra (Business Association of Freight Forwarders proceeds the about customs and customs to be like you\" supporting childhood cancer research. Promoted by Mar\u00eda raise funds for childhood various collaborating restaurants and shops, mainly in the Marina Alta area. The campaign started on July 10 and ran until the end of the Christmas holidays. This campaign aims raise this and give children with cancer the opportunity to grow up healthy. The collection tins, prepared by hand by Mar\u00eda and her children, will raise life expectancy and hope for children suffering from Neuroblastoma, the most common childhood cancer. Today these children are ill, but thanks to research, we hope that they will become healthy adults who can enjoy life and contribute their 2021social 2021. INCLIVA Research at of Valencia joined the 'ADN Mestalla Solidari' campaign of Valencia CF Foot - ball club and Foundation, which gives visibility to the important Protection, Hogares Compartidos and Lamna in receiving support and promotion from Valencia CF and the VCF Foundation during La Liga matches collaborated INCLIVA as part of its EN VENA initiative. Thanks to the campaign carried out and the their institute. March 2021 . ASPANION (Association of Parents of Children with Cancer in the Valencian Community), together with the charity initiative Contigo por la Batalla, made a donation to the INCLIVA Health Research Institute towards development of health research in childhood cancer, from an idea put forth by two women from Castell\u00f3n with children affected by cancer. The donation of \u20ac3,009.64 Tumor Translational Research Group, co-directed by Drs. Samuel Navarro and Rosa Noguera from the CIBER Cancer group (CIBERONC), towards research which although it can occur at any age, is more common in children and adolescents. 15 March, 2021 . The Esperan\u00e7a de donation \u20ac3,000 for breast cancer research, adding to a contribution made last year to support ovarian cancer research. This year funds were raised through association member Carlos Siscar Bay. This athletics fan set himself the challenge of running 12 charity marathons in 12 months. Beyond raising money for this cause, he also helped raise awareness of the importance of everyone living INCLIVA Health Research Institute, making a donation this year of \u20ac12,250 euros to research projects in ovarian cancer, by INCLIVA director Dr. Andr\u00e9s Cer - vantes and the president of Amunt Contra el Cancer, M\u00aa Isabel Llorca, will increase the Special Section Fallas Federation have awarded the second annual \"Specialist Award\" to Dr. Ana Lluch, and have made a donation of \u20ac1,000 for research in breast cancer. This award, which acknowledges excellence of work in art, science or sports, this year went to our researcher Ana Lluch for her professional dedication and research effort in the fight against breast cancer. Held at the headquarters of of Valencia-Castell\u00f3n, this emotive ceremony was attended by the principal falleras of Valencia in 2021, Consuelo Llobell and Carla Gracia, as well as political representatives of the Consell, the Corts and Valencia City Council, the Association of Property Administrators and the Special Selection Fallas Federation. October The Le Cad\u00f3 into breast cancer. Founded in 2010, the foundation aims to finance projects for breast cancer research, and in addition to ours, of hereditary breast cancer\" at the Provincial Hospital of Castell\u00f3n in conjunction with La Fe Hospi- tal in Valencia, led by Dr Mar\u00eda Fonfr\u00eda Esparcia and Dr Eduardo Mart\u00ednez de Due\u00f1as, and most recently the BAFC (Benefits of Physical Activity in Cancer) directed at women with currently at from Bancaja on renewal of the agreement. The unit is focused on molecular screening of cancer patients for genetic experimental therapeutic The Solidario Association presented used for the cancer project, collaboration agreement with the entity in 2020, be - coming the only organisation that receives funds from this Association..July 2021 . ASPANION Children in the Valencian Community), together with the solidarity initiative Painting the way in pink made a donation to the INCLIVA Health Research Institute at the Hospital Clinical of Valencia to contribute to the development of health research in childhood cancer. through \u20ac10,000 will be used FUNDACI\u00d3N LE CAD\u00f3 Fundaci\u00f3n Le Cad\u00f3 was created in 2010 under the leadership of its president Elvira Monferrer Daudi. This initiative seeks to unite efforts and resources in supporting this kind of tumor research, which is currently the fourth leading cause of death in women. Fundaci\u00f3n Le Cad\u00f3 collaborates with INCLIVA in funding the research project cancer young women under 35 years\", conducted by Dr. M\u00aa Teresa Mart\u00ednez Mart\u00ednez. It also involves other researchers Dr. diagnosis specialist physician) and the entire team led by the oncologists Dr. Ana Lluch and Dr. Pilar Eroles. FUNDACI\u00d3N NEOBLASTOMA The Neuroblastoma Foundation, cancer that affects nervous system. Survival figures have improved in years. through numerous campaigns. funds are destined to research projects and clinical trials in Spanish laboratories and hospitals, this year this year the donation received has been \u20ac14.000.ASOCIACI\u00d3N NACIONAL DE ALPHA 1 The Alfa-1 Spain Association defends the interests of patients affected by the Deficit, their families and their caregivers, and pro- motes the research and training of health personnel who treat these patients. The defense of early diagnosis, access to available medical treatments and the daily support patients and di- are - ation and INCLIVA had signed a CV. The Research Group on Rare Respiratory Diseases (RRD) has been awarded CONTRA Amunt el C\u00e0ncer is an association based in Denia, provin- ce of Alicante, that carries out different services and actions aimed at improving the to raise funds for research. year this year the donation received has been \u20ac12.250. 275 275 INCLIVA SCIENTIFIC REPORT 2021social initiatives 8FUNDACION SANDRA IBARRA The Sandra Ibarra Foundation is a non-profit organization with a history of twelve years joining efforts against cancer. During these years, the Foundation has its time in promoting campaigns and financing research, awareness and prevention projects against cancer, as well as the development of the humanization of health. This year this year the donation received has been \u20ac10.500. CORAZ\u00d3N SOLIDARIO Coraz\u00f3n Solidario is an Association born out of the joint project of five colleagues, who having collaborated in various NGOs decided to pool their work to fundraise for the fight against cancer. All profits of this association go to INCLIVA. 276 276 INCLIVA SCIENTIFIC REPORT 2021social and acknowledgments On behalf of INCLIVA, we want to thank all the people who have helped our research through their donations, for their support and soli- darity. For us, this collaboration means much more than an economic contribution: it is the encouragement we need to keep investigating and working in research. Private donations Abarca Briones, Isabel Aguilar Aguilar, Susana Ahullana S\u00e1nchez, Adri\u00e1n Amor Fuentetaja, Estrella Andreu Bover, Teresa Baviano Rodr\u00edguez, Julia Bayarri Esteve, Gonzalo Blasco Garc\u00eda, Carmen Bosch S\u00e1nchez, Susana Botella Aparicio, Francisco Cambronero L\u00f3pez, Noema Carbonell Beltr\u00e1n, Santiago Casas Tar\u00edn, Iv\u00e1n De Vargas Montesinos, Mar\u00eda Luisa Dinnbier Escuder, Enriqueta Doria Ca\u00f1izares, Eva Far\u00edas Far\u00edas, Angelo Alejandro Francisca Ferrando, Natalia Fraile Bohoyo, Silvia Fresneda Reche, Federico Gallego-Casilda Pastor, Valeriano Garc\u00eda Alca\u00f1iz, Mar\u00eda del Carmen Garc\u00eda Escarda, Rosana Garc\u00eda Garc\u00eda, Mar\u00eda del Carmen Garc\u00eda Mart\u00ednez, Luis Gil Portero, Aurelia Gimeno Gil, Ohaine G\u00f3mez Mansilla, Enrique Guardiola Huertas, Emilio Herreras Monz\u00f3, Enrique Hueso Mart\u00ed, Inmaculada Jord\u00e1 Milligan, Silvia L\u00e1zaro Ballester, AmparoL\u00e1zaro Romero, Cristela Asunci\u00f3n L\u00f3pez Bermejo, Antonio Madrid Reques, Gema Mart\u00ednez Romero, Eva Mart\u00ed Morell, Cristina Martinetti Mieusset, Vanessa Mart\u00ednez Hern\u00e1ndez, Alberto Mart\u00ednez Vaya, Cristina Martorell Pe\u00f1alba, \u00d3scar Mieusset Mieusset, Yvette-Isabelle Miret Bernal, Francisco Monedero Ca\u00f1ada, Cristina Moreno Dur\u00e1n, In\u00e9s Moreno Garc\u00eda, Herminia Morgado G\u00f3mez, Emilia Moya S\u00e1nchez, Francisco Nicol\u00e1s Garrido, Francisco Noguera Salv\u00e1, Inmaculada Pascual Revert, Diego Pavia Estrella, Laura Puigdengolas Rosas, Amalia Queralt Pesudo, Isabel Queralt Pesudo, Zaida Requena Castell\u00e0, Alba Rodr\u00edguez Deval, M\u00aa Dolores Rodr\u00edguez M\u00ednguez, Virginia Rodr\u00edguez Rodr\u00edguez, Isabel Mar\u00eda Rom\u00e1n Veiras, Lorena Ruiz Mar\u00edn, Noem\u00ed S\u00e1inz Candel, Valvanera Sales Fornes, M\u00aa Asunci\u00f3n S\u00e1nchez Garc\u00eda, Adri\u00e1n S\u00e1nchez Gonz\u00e1lez, Mar\u00eda Jos\u00e9 S\u00e1nchez Mu\u00f1oz, Vicenta277 277 INCLIVA SCIENTIFIC REPORT 2021social initiatives 8Santaf\u00e9 Moreno, Francisca Sanz Canet, F\u00e1tima Sanz Moliner, Ana Sarabia Navarrete, Francisca Colegio Territorial de Administradores de Fincas de Valencia-Castell\u00f3n Eurol\u00edneas Personales SL Falla Els Generals Fondo Solidariet\u00e0 Cavit SC Fresenius Kabi Espa\u00f1a SA Fundaci\u00f3n Espa\u00f1ola de Hematolog\u00eda y Hemoterapia Fundaci\u00f3n Lecad\u00f3 Fundaci\u00f3n Sandra Ibarra de Solidaridad frente al C\u00e1ncer GE Healthcare Biosciences SA Glaxosmithkline SA Iraila, Iniciativas para la Financiaci\u00f3n de la Investigaci\u00f3n del C\u00e1ncer Infantil Junta Local Contra el C\u00e1ncer Montesa Laboratorios Ordesa Laboratorios Viiv Healthcare SL Paspalmarvi SL Raminatrans SL Valencia Club de F\u00fatbol SAD Vifor Fresenius Medical Renal Pharma Espa\u00f1a Neuroblastoma Asociaci\u00f3n Alfa-1 de Espa\u00f1a Asociaci\u00f3n Coraz\u00f3n Solidario Contra el C\u00e1ncer Asociaci\u00f3n de Padres de Ni\u00f1os con C\u00e1ncer ASPANION Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer Asociaci\u00f3n Local Contra el C\u00e1ncer Onil Iris Asociaci\u00f3n para el Estudio e Investigaci\u00f3n de Patolog\u00eda en Urgencias M\u00e9dicas Asociaci\u00f3n para el Fomento del Estudio en Ciencias Biom\u00e9dicas (AFEMED) Associaci\u00f2 Contra el C\u00e0ncer De Pego (Associaci\u00f2 Esperan\u00e7a) Associaci\u00f3 d'Alumnes del Consell Municipal de Formaci\u00f3 de Persones Adultes Associaci\u00f3 de Dones Clara Campoamor de la Vall D'Uix\u00f3 ATEIA-Oltra Valencia Biomed Central Limited Boston Scientific Iberica SA CAVIT SC Club N\u00e1utico J\u00e1vea Colegio Oficial de Agentes de SCIENTIFIC REPORT 2021publication list9List of 834 scientific publications derived from the activity of the IIS 1. Casans-Tormo I, Alcala-Lopez J, Espinet-Coll cardiovascular infection and inflammation. Revista Espanola remnie.2021.09.008. S, Ezpeleta D, Garcia-Azorin D, Gonzalez-Oria C, Guerrero A, Gui - llem A, Holle-Lee D, Huerta-Villanueva M, Irimia P, Leira J, Porta-Etessam J, P, J, 1st Post-European Hea a developments presented the 2020 European Headache E, Persu A, and out-of-office blood Journal Hyperten - loge S, Martin M, Kelly CM, Ruiz-Borrego M, Gil-Gil M, Arce-Salinas CH, Brain EGC, Lee ES, D, Pusztai L, Hortobagyi GN. 21-Gene as - say inform chemotherapy benefit in node-positi - ve breast cancer. F, Navarro J. A bench Henderson M, Di Giacomo S, Russell A, Pigini P, Murray J, Valli E, Milazzo G, Giorgi F, Cowley M, Ashton L, Bhalshankar J, Schleiermacher G, Rihani A, Van Maerken T, Van desompele J, Speleman F, Versteeg R, Koster J, Eggert R, Tonini G, Fong K, Vaksman Z, Diskin S, Maris J, London W, Marshall G, Ziegler D, Hogarty M, Perini G, Norris M, Haber M. A G316A J, Silva E, Velasco R, Cuesta A, Monteagudo C, Martin J. A hetero - zygous mutation in 34096685 9. Gasso P, Rodriguez N, Martinez-Pinteno A, Mez - quida G, Ribeiro M, Gonzalez-Penas J, Zorrilla I, Martinez-Sadurni L, Rodriguez-Jimenez R, Corripio I, Sarro S, Ibanez A, Usall J, Lobo A, Moren C, Cues - ta M, Parellada M, Gonzalez-Pinto A, Berrocoso E, Bernardo M, Mas S, 2EPs Grp. A longitudinal study of gene expression in Alberich S, Fernandez-Sevillano J, Barbeito S, Balanza-Marti - nez V, Vieta E, Lorente-Rovira E, Luengo A, Cerrillo E, Crespo J, Matute C, Gonzalez-Pinto A. A multi - centre, randomised, controlled trial of a combi - ned clinical treatment for first-episode psychosis. International Journal of Environmental Lopez-Martinez S, Campo H, de Miguel-Gomez L, Faus A, Navarro A, Diaz A, Pellicer A, Ferrero H, Cervello I. A natural xenogeneic endometrial extracellular matrix hydrogel toward improving current human in models and future in vivo applications. Frontiers in Bioengineering and Bio M, Banuls C, Estan N, Botello-Marabotto M, Aznar E, Saez G, Santiago-Felipe S, F, Urios A, Benlloch S, Marti-Aguado D, San-Miguel T, Tosca J, Rios M, Monton C, Durban L, Escudero-Garcia D, Aparicio L, Felipo V, Montoliu C. A unveils a J, Algarra L, Tormo M, Martinez-Sanchez M, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Lopez- Lorenzo J, Gil C, Vidriales B, Falantes J, Serrano A, Labrador J, Sayas M, Foncillas M, Amador Barcie - la M, Olave M, Colorado M, Gascon A, Fernandez M, Simiele A, Perez-Encinas M, Rodriguez-Veiga R, Garcia O, Martinez-Lopez J, Barragan E, Paiva B, Sanz M, Montesinos P, PETHEMA Group. A phase 3 trial of azacitidine versus robia A, Carcas A, Queiruga-Parada J, Vicario J, Mirones I, Solano Vercet C, Eguizabal Soria B, A phase dose-escalation multi-center study to evaluate the safety of infu - sion of natural killer cells or memory T cells as adoptive therapy in coronavirus P, Sablin M, Bergh J, Im S, Lu Y, Martinez N, Neven P, Lee K, Morales S, Perez-Fidalgo J, Adam - son D, Goncalves A, Prat A, Jerusalem G, Schlieker L, Espadero R, Bogenrieder T, Huang D, Crown J, Cortes J. phase study A, Igual- Camacho C, Diaz-Diaz B, Torrella J, Rodrigo J, Paya Rubio A, Roig-Casasus S, Blasco J. A randomized assessing the effects of preopera - tive balance training on balan - ce and functional outcome up to 1 year M, Santos-Llamas A, Fernandez-Ramirez M, Tarin J, Cano A, Gomez R. A reassessment of the therapeutic potential of a dopamine receptor - bres-Herraiz R, Palomares L, Butcher L, Erusalim - sky J, Garcia-Garcia F, Carnicero J, Hardman T, Mis - chak H, Zurbig P, Hackl M, Grillari J, Fiorillo E, Cucca F, Cesari M, Carrie I, Colpo M, Bandinelli S, Feart C, Peres K, Dartigues J, Helmer C, Vina J, Olaso G, Garcia-Palmero I, Martinez J, Jansen-Durr P, Grune T, Weber D, Lippi G, Bonaguri C, Sinclair A, Tegner J, Rodriguez-Manas L. A robust machine learning fra to identify signatures Deng Y, Chen J, Simion V, Yang D, Sukhova G, Shvartz E, Wara C, Sausen G, R, - chondroma of the scapula: uncommon location for Mata-Roig re veals model organisms and PMID: 33562654 24. Lopez-Riera M, R, L, Montesinos MC, Gomez-Cabrera MC, Sanz MJ, Real JT, Pique - ras of the inhibits leukocyte adhesiveness to - M, Ayesta A, Ariza-Sole PMID: 34575243 26. Olea B, Albert E, Torres I, Amat P, Remigia M, Go - zalbo-Rovira R, Rodriguez-Diaz J, Buesa J, Blasco M, Redon J, Signes-Costa J, D. Werf S, Blaise D, Kanfer E, Milpied N, Remenyi P, Ciceri F, Bourhis J, Chevallier P, Solano C, Socie G, Bruno B, Rambaldi A, Castagna L, Kroger N, Corradini P, Afa - nasyev B, Ladetto M, Niederwieser D, Scheid C, Sen H, Koenecke B, Viale G, Fumagalli D, Rastogi P, Gelber R, de Azambuja E, Fielding Balmana Domchek S, Gelmon K, Hollingsworth S, Korde Z, Pippas A, Nowecki Z, Huzarski T, Ganz P, Lucas P, Baker N, Loibl S, McConnell R, Piccart M, Schmutzler S, G, - Rodriguez-Arias M, Gavito A, Sanchez-Perez A, Vi\u00f1a Ribes J, Medina Vera D, Rodriguez De Fonseca F, Minarro J. Ado - lescent Guerreiro M, Aguilar-Gallardo C, Montoro Fran - ces-Gomez C, Latorre V, Luna I, Planelles D, Carras - co M, Gomez M, Maria Gonzalez-Barbera E, Aguado C, Sempere A, Solves P, Gomez-Segui I, Balaguer- Rosello A, Louro A, Perla A, Larrea L, Sanz J, Arbo - na C, de la Rubia J, Geller R, Sanz M, Sanz G, Pinana J. Adoptive transfer of ex-vivo tid.13602. PMID: 33728702 31. Salazar J, Navarro C, Ortega A, Nava M, Morillo D, Torres W, Hernandez M, Cabrera M, Angarita L, Or - tiz R, Chacin M, D'Marco L, Bermudez V. Advanced glycation end products: new clinical and molecular perspectives. International Journal of Environmental I, De Mucio B, Arevalo-Rodriguez I, Aleman A, Castro J, Ropero Al - varez A. Adverse events associated with the use of recommended vaccines during pregnancy: an over Fuster-Tormo F, Haferlach C, Meggendorfer M, Montesinos P, Bar - ba P, Gil C, Coll R, Moreno MJ, Martinez-Carballeira D, Garcia-Cadenas I, Vives S, Ribera J, Gonzalez-Cam - pos J, Diaz-Beya M, Mercadal S, Artola MT, A, Tormo M, A, Vall-Llovera F, Martinez- Sanchez P, Amigo ML, Monsalvo S, Novo A, Cervera M, Garcia-Guinon A, Ciudad J, Cervera J, Hernandez- Rivas JM, Granada I, Haferlach T, Orfao A, DHS, Caldonazo TMM, Polegato BF, Fernandes DC, Laurin - do Fernandes AAH, Lloret A, Cicogna AC, Okoshi MP, Okoshi K. Aerobic M, de Llano J, Roca F, Martinez-Ramos C, Carda C, Mata M. Alginate- agarose hydrogels improve the in vitro differentiation of human dental pulp stem cells in chondrocytes. A his - H, Ditschkowski M, Moonim M, Polvere - lli N, Robin M, de Witte Wilson Platzbecker U, Sengeloev H, Blaise D, Einsele H, Sockel K, Kruger W, Lenhoff S, Sala - roli A, Martin H, Garcia-Gutierrez V, Pavone V, Alvarez-Larran A, Raya JM, Zinger the Chronic Malignancies Working Party of EBMT and the Spanish Aguilar-Gallardo C, Lorenzo J, Montoro J, Sanz J, Balaguer A, Go - mez I, Solves P, Perez A, Blanquer M, Espigado I, Solano C, Pinana J, Grupo Espanol de Trasplan - te 39. Bento Gutierrez A, Novelli S, Montoro J, Pi - nana J, Lopez-Corral L, Cabrero M, Martin-San - cho A, Gutierrez-Garcia G, Ortiz-Moscovich M, Bastos-Oreiro M, Dorado N, Perez A, Hernani R, Ferra C, Parody R, Garcia-Cadenas I, Herre - ra P, Rodriguez G, Rodriguez N, Martin C, Yanez L, Zanabili J, Varela M, Lopez-Godino O, Heras I, Espanol I, Martinez C, Perez-Simon J, Sola - no C, Sureda A, Sierra J, Sampol A, Caballero D, GETH, Grp PMID: Albert Vicent E, Ferrer Lores B, Torres Fink I, Serrano Alcal\u00e1 A, Alcaraz Soriana M, Buesa Go - mez J, Solano Vercet C, Colomina Rodr\u00edguez F, Bueno Ferrando F, Huntley Pascual D, Olea Mi - guel B, Valdivia Piqueres A, Navarro Ortega D. Amplification of human beta-glucoronidase gene appraising the PMID: R, Launet L, Colomer A, Moscardo A, Mosquera-Zamudio A, Monteagudo C, Naran - jo V. Gimenez Pinana J, Perez A, Gomez M, Hernandez-Boluda J, Gonzalez-Barbera E, Montoro J, Buesa J, Guerreiro M, Balaguer- Rosello A, Hernani R, Sanz J, Solano C, Navarro D. An investigation of the potential association bet - ween gastrointestinal viral and bacterial infection and development of intestinal allogeneic An updated over - view of e-cigarette impact on human health. Badenes R, following Gi -menez A, Gil-Guillen V, Correig X, Masana L, Mon - leon Salvado D, Red\u00f3n Mas J, Pascual R, Carra - tala-Munuera C. Analysis of LDL and HDL size and number by nuclear magnetic resonance in a healthy working population: the LipoLab Study. International Journal of Clinical D, Hay S, Local Burden Dis Anae - mia Collab. Anemia prevalence in women repro - ductive age in low- and middle-income countries 01498-0. PMID: 34642490 47. Marcos Garc\u00e9s V, Lorenzo Hern\u00e1ndez M, Mart\u00ed - nez M\u00e1s M, Parrilla Mu\u00f1oz C, Pernias Escrig V, Bod\u00ed A, Dura-Gil J, Martinez-Her - vas S, Redon J, Real J. Anthropometric indicators as a tool for diagnosis of obesity and other health risk factors: a literature J, de la Espriella R, Minana G, Santas E, Lla - cer P, Nunez E, Palau P, Bodi V, Chorro F, Sanchis J, Lupon J, Bayes-Genis A. Antigen carbohydrate 125 as a biomarker in heart failure: a Navas-Acien 9and mineral density-related endpoints: Reid J, H, Prikazsky V, Siep - mann I, Martin-Moreno JM, Middleton J. ASPHER Statement: deja vu?. Planning for the Covid-19 third wave and planning for the winter 2021-22. International Journal of Public Health. 2021 Aug 23;66:1604361. doi: 10.3389/ijph.2021.1604361. PMID: 34497482 54. Albert E, Bracho M, Serrano A, Ferrer B, Gonzalez- Candelas F, Navarro D. Assessing the potential association between SARS-CoV-2 RNA load in the respiratory tract and COVID-19 mortality. doi: 10. 1002/jmv.26644. 33135804 55. Bueno F, Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, Rovira M, Espigado I, Martin Calvo C, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, I, Gonzalez-Huerta AJ, Torrado T, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta MA, Duar - te R, Pinana JL, Navarro D. Assessment plantation: the S\u00e1nchez V, Vidal J, Prieto-Sanchez L, Ros E, Razquin C, Mestres C, Sorli JV, Cuenca-Royo AM, Rios A, To - rres-Collado L, Vaquero-Luna J, P\u00e9rez-Farin\u00f3s N, Zu - let MA, Sanchez-Villegas A, Casas R, Bernal-Lopez MR, Santos-Lozano JM, R, Forcano-Gamazo L, L\u00f3pez M, Sempere-Pascual MA, Moreno-Rodriguez A, Gea A, de la Torre-Fornell R, Salas-Salvad\u00f3 J, PREDIMED-Plus Investigators. Association A, Badia-Guillen R, Escobar E, Garcia-Serrano S, Garcia-Vivanco M, Garrido JL, Theobald MR, Gil V, Martin-Llorente F, Ca - lle-Pascual A, Bordiu E, Castano L, Delgado E, Franch- Nadal Chaves Galan-Garcia long term exposure to particulate matter and Aparisi Arroyo-Espligue - ro R, Eid C, Romero R, Becerra-Munoz V, Feltes G, Molina M, Garcia-Aguado M, Cerrato E, Capel- Astrua T, Alfonso-Rodriguez E, Castro-Mejia A, Raposeiras-Roubin S, Espejo Perez-Sole N, Bardaji A, Marin F, Fabregat-Andres O, D'ascenzo F, Santoro F, Akin I, Estrada V, Fernandez-Ortiz A, Macaya C, en representacion de los investiga - dores del HOPE COVID-19. Atrial fibrillation in pa - tients with COVID-19. Usefulness of the CHA2DS2- VASc score: an analysis of the international HOPE COVID-19 registry. Revista Espanola de Cardio - Torre M, Hernandez D, - bodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for left volume calculation with explainability through a deep learning weak-super - vision methodology. Computer MJ, Botija P, Amat P, Remigia MJ, Beltran MJ, Rodado C, Hunt - ley D, Olea B, Navarro D. B and T cell immune res - ponses elicited by the Comirnaty D, Bodi V, Sanchis J, Navarro D, Nunez J. Bacterial metaboli - tes trimethylamine N-oxide and butyrate as surro - gates of small intestinal bacterial overgrowth in patients with a recent decompensated 10.1038/s41598-021-85527-5. PMID: 33731747 64. Ravel J, Moreno Gimeno I, Simon Valles C. Bac - terial vaginosis and its association with infer - A, J. BASCULE with presyncopal episodes and first-degree atrio Derma - P, Vera A, Ariza-Sole A, Formiga F, Martinez-Selles M, Alegre O, Sanchis J, Marin F, Vi - dan M, Lopez-Palop R, Abu-Assi E, Bueno H, Dudenko D, Cano A. Bazedoxifene increases the prolife - ration of human arterial endothelial cells but does not affect the expression of cyclins A, B, and modu - lator of senescence and aging. International Jour - . havioural Fuentes-Trillo A, Monzo C, Manzano I, Santiso-Be - llon C, da Silva Ribeiro de Andrade J, Gozalbo-Rovi - ra R, Garcia-Garcia AB, Rodriguez-Diaz J, Chaves FJ. Benchmarking different approaches for No - rovirus genome assembly Mateo J, Curigliano G, Banerjee S, Giuliani R, Lordick F, Cervantes A, Tabernero J, Peters S. Beyond the learned U, Amaral T, Barriu - so J, Bogaerts J, Calles A, Curigliano G, Gomez- Roca C, Kiesewetter B, Oosting S, Passaro A, Pentheroudakis G, Piccart M, Roitberg F, Taberne - ro J, Tarazona N, Trapani D, Wester R, Zarkavelis G, Zielinski C, Zygoura in - design, and data analysis that distort the appraisal V, Herrera G, Ce - jalvo J, Lluch A, Marcos M, Sancenon F, Eroles P, R. Miguel- Gomez L, Frances-Herrero E, Faus A, Diaz A, Pelli - cer A, Ferrero H, Cervello I. Bioengineered endo - E, Artero R, Fernandez- Costa JM, Ramon-Azcon J. Bioengineered in vi - tro 3D model of myotonic dystrophy type 1 L, Goterris R, Perez A, Lo - pez O, I, Arbona C, Viguria MC, Hernandez- Boluda of men with previous of ankle Corpas-Burgos F, Fernandez SF, Hernandez CS, Saez G, Perez-Zafra E, Mora-Herranz A, Pardo O, C, Lopez A, International Journal of Envi E, Insa A, Garcia-Campelo M, Huidobro G, Domine M, Ma - jem M, Rodriguez-Abreu D, Martinez-Marti A, Car -peno J, Cobo M, Vivanco G, Del Barco E, Caro R, Vi - nolas N, Aranda I, Viteri S, Massuti B, Casarrubios M, Sierra-Rodero B, Tarin C, Garcia-Grande A, Ha - ymaker C, Wistuba I, Romero A, Franco F, Proven - cio M. Blood biomarkers associated to Subedi P, Riffo- Campos A, Xia R, Gomez L, Haack K, Goldsmith J, Howard B, Best L, Devereux R, Tauqeer A, Zhang Y, Fretts A, Pichler G, Levy D, Vasan R, Baccarelli A, Herreros-Martinez M, Tang W, Bressler J, For - nage M, Umans J, Tellez-Plaza M, Fallin M, Zhao J, Cole S. Blood DNA methylation and incident coro - nary heart disease evidence from the strong heart study. C, Gardeazabal I, Llorca J, Gea A, Santisteban M, Mart\u00edn Moreno J, Toledo E. Body shape trajectories and risk of breast cancer: results from the SUN ('Seguimien - Project. Public Espi A, E, Sanchiz V, Ferriols FL, Almela P, Hernan dez toxin - Rec 1;64(12):1521-1530. doi: 10. K, Weber MS, Green K, Rizzoli S, Nacher J, Nave KA, Ehrenreich H. Brain a counterbalance between J, Izquierdo G, Meca-Lallana V, Gascon-Gimenez F, Mar -288 288 INCLIVA SCIENTIFIC REPORT list9tinez-Gines Ramio-Torrenta L, Fernandez O, Moreno-Garcia S, Maurino J, Carreres- Polo J, Casanova B. Brain region volumes and their relationship with disability progression and cognitive milk Crespo M, Alcoceba M, San - chez J, Tazon B, Serrano A, Alvarez M, Serrano L, Alonso-Torres P, Villanueva M, Loriente C, Abrisque - ta P, Peiro M, Garcia-Marco J, Gonzalez M, Terol M. Building 33409623 88. Nunez-Marin G, de la Espriella R, Santas E, Lorenzo M, Minana G, Nunez E, Bodi V, Gonzalez M, Gorriz C, A, Nunez J. CA125 but NT-proBNP predicts congestive venous patients with acute G, McMurray J, Metra M, Solomon S, Adams K, Anand I, Arias-Mendoza A, Biering-Sorensen T, Bohm M, Bonderman M, Dahlstrom U, Echeverria L, Fang J, Filippatos G, Fonseca C, Goncalvesova E, Goudev A, Howlett J, Lanfear D, Li J, Lund M, Macdonald P, Mareev V, Momo - mura S, O'Meara J, Varin C, with omecamtiv mecarbil England Journal of Medicine. 2021 Jan 16. JL. cardiovascular disease: a systematic review and meta-analysis. Journal of Sport Ramasun - darahettige C, Pratley R, Lopes R, Lam C, Khur - mi N, Heenan L, Del Prato S, Dyal L, Branch K, AMPLITUDE-O Trial Investigators. Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes. New England Journal of Medicine. Sep 2;385(10):896-907 . doi: 10.1056/NEJ - Moa2108269. Boehm M, Schumacher H, Teo KK, Lonn EM, Lau - der L, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Williams B, Yusuf S, Mann JF, Mahfoud F. Cardiovascular outcomes in patients at high cardiovascular risk with previous myo - cardial infarction or stroke. Journal L, Torra R, Tomas P, Pu - chades M, Panizo N, Pantoja J, Montomoli M, Llis - terri J, Pallares-Carratala V, Valdivielso J. - risk REPORT Cardiovascular system in the sars- CoV-2: impact of Journal 1097 / HJH.0000000000002860. PMID: 34074967 Hernani Sancho A, Amat P, Hernandez-Boluda J, Perez A, Pinana J, Carretero C, Goterris R, Gomez M, Saus A, Ferrer B, Teruel A, Terol M, Solano C. CAR- T with post- transplant lymphoproliferative disease: case report and review. Current lational Marti R, Sanahuja A, Sanchez A, Tre - jo G, Herreros B, Pascual I, Mas P, Pena A, Min - guez M. Caustic ingestion: development Fink I, Huntley Pascual D, Alcaraz Soriana M, Albert Vicent E, Solano de la Asunci\u00f3n C, Gonz\u00e1lez Padr\u00f3n C, Ferrer Dot J, Navarro Ortega D. Caveats in interpreting SARS- CoV-2 in the tumor microenvironment. Ad - G, Zanza C, Mes - sina A, Godoy D, Dabrowski W, Li X, Czosnyka M, Pelosi P, Badenes R, R, Jaroszynski A, Piasek Puche-Torres M, Garcia J, Cunat A, Canales M, Felix M, Campos S, Canada J, Hernan - dez J. Characteristics of mucocutaneous vascular malformations drawn from a decade experience. Dermatologic of Diaz-Martin J, Diaz-Lagares A, Jacome MA, Salguero-Aranda C, Garcia Ros D, Davidson B, Lopez R, Melero I, Navarro S, Ramon y Cajal S, de Alava E, Matias- Guiu X, Noguera R. Characterizing the invasive cos I, Claramunt X, P, Grp Trabajo Diabet SemFyC. Checklist for patients with G, Ruiz Borrego M, Stradella A, Bermejo B, Schmid P, Marme F, Escriva-de-Romani S, Calvo L, Ribelles N, Martinez N, Albacar C, Prat A, Dalenc F, Kerrou K, Colleoni 290 290 INCLIVA SCIENTIFIC REPORT 2021publication list9M, Afonso N, Di Cosimo S, Sampayo-Cordero M, Malfettone A, Cortes J, Llombart-Cussac Morgades M, Ciudad J, Montesinos P, Esteve J, Genesca E, Barba P, Ribera J, Garcia Cadenas I, Moreno M, Martinez-Carballeira D, Torrent A, Martinez-Sanchez P, Monsalvo S, Gil C, Tormo M, Artola M, Cervera M, Gonzalez-Cam - pos J, Rodriguez-Medina C, Bermudez A, Novo A, Soria B, Coll R, Amigo M, Lopez A, Fernandez Martin R, Serrano J, Mercadal S, Cladera A, Gimenez-Conca A, Penarrubia M, Hernandez-Rivas Garcia A, Bergua Burgues J, de Rueda B, Sanchez-Sanchez M, Se - rrano A, Calbacho M, Alonso Vence N, Mendez- Sanchez J, Garcia-Boyero R, Olivares M, Barre - na S, Zamora L, Granada I, Lhermitte L, Feliu E, Orfao A. Chemotherapy or allogeneic 32620426 112. Salinas P, Gonzalo N, Moreno V, Fuentes M, San - tos-Martinez S, Fernandez-Diaz J, Amat-Santos I, Ojeda F, Borrego J, Cuesta J, Hernandez J, Diego- Nieto A, Dubois D, Galeote G, Goicolea J, Gutierrez A, Jimenez-Fernandez M, Jimenez-Mazuecos J, Jurado A, Lacunza J, Lee D, Lopez M, Lozano F, Martin-Moreiras J, Martin-Yuste V, Millan R, Mina - na G, Mohandes M, Morales-Ponce F, Nunez J, Oje - da S, Pan M, Rivero F, Robles J, Rodriguez-Leiras S, Rojas S, Rondan J, Rumiz E, Sabate M, Sanchis J, Vaquerizo B, Escaned J. scores to success in clinical practi - ce. A comparison of 4 different CTO PCI scores in a comprehensive national registry including expert Martin de Llano J, Milian L, Oliver M, Mata M, Carda C, Sancho-Tello M. Chondrogenic potential of human dental pulp stem cells cultured as Cells S, Edvar - sen H, Tadeo-Cervera I, Eroles P, A, Tabares- Seisdedos R, S, Ortega B, Moragon S, Lameirinhas A, Constancio V, Salta S, Burgues O, Bermejo B, Henrique R, Lluch A, Je - ronimo C, Eroles P, Cejalvo J. Circulating plasma a for early Codina P, Do - mingo M, Revuelta-Lopez E, Zamora E, Spitaleri G, Santesmases J, Nunez J, Bayes-Genis A. Circula - neprilysin hypothesis: a new opportunity for sacubitril/valsartan Rosello Sabater L, Ferrer A, Tarazona N, Roda D, Gambardella V, Alfaro-Cervello C, Gar - ces-Albir M, Cervantes A, Ibarrola-Villava M. Circu - lating J, Garcia-Trevijano E. Cleavage and activation of LIM kinase 1 as a novel mechanism for cal - pain 2-mediated regulation of Nadal E, Ga - ritaonaindia Y, Insa A, Mosquera J, Casal-Rubio J, Domine M, Majem M, Rodriguez-Abreu D, Martinez-Marti A, De Castro Carpeno J, Cobo M, Lopez Vivanco G, Del Barco E, Bernabe Caro R, Vinolas N, Barneto Aranda I, Viteri S, Massuti B, Laza-Briviesca R, Casarrubios M, Garcia-Grande A, Romero A, Franco F, Provencio M. Clinical and molecular parameters associated to pneumoni - tis development in non-small-cell lung cancer pa - tients receiving chemoimmunotherapy from NA A, Arana C, Molina P, Lloret MJ, Ochoa J, Berna G, Gutierrez-Maza YG, Rodrigues N, Poorvu P, Carrasco E, Grinshpun A, Punie K, Rousset-Ja - blonski C, Ferrari A, Paluch-Shimon S, Toss A, Se - nechal C, Puglisi F, K, J, Villarreal-Garza F, Duhoux F, Gra - ffeo R, Teixeira L, Cordoba O, Sonnenblick A, Ferrei - ra A, Partridge A, Di Meglio A, Saule C, Peccatori F, Bruzzone M, t'Kint de M, Ruipe - rez A, Stahel R, Eniu A, Cavalli F, Mateos-Moreno MV, Ausina-Marquez Gar - cia-Vazquez E, Puche-Torres M, Giner MJ, Campos Gonzalez Auba Cenjor Espanol C, Lo - pez Velasco A, Santolaya Abad D, Garcia-Esteban S, Artacho A, Garcia-Blas Per - nias V, Pozo A, Carratala A, Gonzalez J, Noceda J, Minana G, Nunez Re - fsgaard A, O'Connor L, Patel M, Pieske B, Ans - trom K, Armstrong P, Study Grp. Clinical outcomes and to vericiguat according to failure event: insights from the VIC - TORIA trial. 1;6(6):706- 712. doi: PMID: 33185650 127. Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, Rovira M, Espigado I, Calvo C, Lopez-Ji - menez J, Suarez-Lledo M, Chinea A, Esquirol A, Pe - rez A, Bermudez A, Saldana R, Heras I, Gonzalez- Huerta A, Torrado T, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta M, Pinana J, Navarro D, Spanish Group of Hematopoietic Transplantation and Martinez-Be - neyto P, Alborch M, Ventura A, Monteagudo E, Ri - bas I, Algarra J. Clinical performance assessment of a new active osseointegrated system Becerra-Munoz V, Nunez-Gil I, Eid C, Aguado M, Romero R, Huang J, Mulet Arabi A, Ugo F, Ra - metta F, Liebetrau C, Aparisi A, Fernandez-Rozas I, Viana-Llamas M, Feltes G, Pepe M, Moreno-Ron - don L, Cerrato E, Raposeiras-Roubin S, Alfonso E, Carrero-Fernandez A, Buzon-Martin L, Abumayya - leh M, Gonzalez A, Ortiz A, Macaya C, Estrada V, Fernandez-Perez Cassinello Fernandez N, Mar - tin Arevalo J, Sanchiz Soler V, Alfonso Ballester R, Ortega Serrano J. Clinical symptoms are correla - ted with gastrojejunal anastomosis Llacer P, Dominguez E, Ventu - ra B, Nunez G, Minana G, Solsona J, Santas E, De La Espriella R, Bodi V, Nunez E, Sanchis J, length of stay in acute heart failure. European Journal of Inter - L, Patassini C, Favero F, Cimadomo D, Vaiarelli carrier for the management of reproductive genetic risk in IVF and Chic N, Braso-Maristany F, Pare L, Pas - cual T, Conte B, Martinez-Saez O, Adamo B, Vidal M, Barnadas E, A, Farre Sanfeliu E, Cejalvo Perrone Sabarese Zalfa F, Peg V, Fasani R, Villagrasa P, Gavila J, Ba - rrios C, Lluch A, Martin M, Locci M, De Placido S, Prat A. Clinical, pathological, and Bernabeu - rales R, Salvatore L, Tortora G, Ribelli M, Ni - gro O, Gelsomino F, Spallanzani A, Zurlo V, Leo S, Dell'Aquila E, Claudia F, Lombardi P, Keranen S, Ai - mar G, Depetris I, Giampieri R, Morelli C, De Tursi M, Tinari N, Di Pietro F, De Galitiis F, Zanaletti N, Troiani T, Vitale P, Garajova Beneto Pallardo F, Gonzalez-Cabo P. Cofi - lin and neurodegeneration: new functions for an old but gold protein. Brain 2021 de Haan L, Ger - meys I, Glahn D, Arango C, van der Ven E, Di Forti M, Bernardo M, Guloksuz S, Delespaul P, Mezqui - da G, Amoretti S, Bobes J, Saiz P, Garcia-Portilla 293 293 INCLIVA SCIENTIFIC REPORT 2021publication list 9M, Santos J, Jimenez-Lopez E, Sanjuan J, Aguilar E, Arrojo M, Carracedo A, Lopez G, Gonzalez-Pe - nas J, Parellada M, Atbasoglu C, Saka N, Mihaljevic M, Petrovic S, Mirjanic T, Del-Ben C, Ferraro L, Gayer-Anderson C, Jones P, Jongsma H, Kirkbri - de J, La Cascia C, Lasalvia A, Tosato S, Llorca P, Menezes P, Morgan C, Quattrone D, Menchetti M, Selten J, Szoke A, Tarricone A, McGui - re P, Valmaggia L, Kempton M, van der Gaag M, Riecher-Rossler A, Bressan R, Barrantes-Vidal N, Nelson B, McGorry P, Pantelis C, Krebs M, Ruhr - mann S, Sachs G, Rutten B, van Os J, Alizadeh B, van Amelsvoort T, Bartels-Velthuis A, Brugge - man R, van Beveren N, Luykx J, Cahn W, Simons C, Kahn R, Schirmbeck F, van Winkel R, Reichen - berg A, EU-GEI High Risk Study. Cognitive functio - ning Andrea R, Ariza A, Berga G, Cid B, Lo - pez de Sa E, Martinez-Selles M, Moreno R, Ojeda S, Sanchis J, Huelmos A, Jimenez Quevedo P, Juarez M, Martin Asenjo R, Pedreira M, Rodriguez Leor O, Roldan I, Romaguera R, Avanzas P, Berga Con - gost G, Boraita A, Bueno H, Calvo D, Campuzano R, Delgado V, Dos L, Ferreira-Gonzalez I, Gomez Doblas J, Pascual Figal D, Sambola Ayala A, Viana Tejedor A, Luis Ferreiro J, Alfonso F. Comments on the 2020 ESC guidelines for the management coronary De Puerta R, Montoro J, Aznar C, Lorenzo I, Gonz\u00e1lez-Barber\u00e1 EM, Balaguer-Rosell\u00f3 A, Gue - rreiro M, Dom\u00ednguez L, Salavert M, Aguilar C, de la Rubia J, Sanz J, G\u00f3mez MD, Pi\u00f1ana JL. Com - mon seasonal Raposeiras S, Barrabes J, Cordero A, Martinez-Selles M, Bar - daji A, Diez-Villanueva P, Marin F, Ruiz-Nodar J, Vi - cente-Ibarra N, Alonso Salinas G, Rigueiro Abu- Assi J, Rodriguez-Gimillo M, Garces C, Pallardo F, Garcia-Gimenez J, C. analysis chro shock: a pilot study. Interna 14;22(18):9935. doi: 34576097 142. Llacer P, Gallardo M, Palau Sampio P, Moreno M, Castillo C, Fernandez C, De La Espriella Juan R, Mollar Fernandez A, Santas Olmeda E, Mi\u00f1ana Escriva G, Manzano L, Bayes-Genis A, Ortiz E, Alcazar of three-step J, Moya-Mata - mez-Gonzalvo F, Castillo-Corullon S, Escribano A. Comparison of physical activity and sedentary behaviour between schoolchildren with cystic fibrosis and healthy controls: a gender analysis. International Journal of Environmental May 18;18(10):5375. doi: 10.3390/ijerph18105375. PMID: 34070042 145. Sanchez Ramos D, Pinto Pla C, De Gracia Leon A, Colomina Rodriguez J. Rare infectious complica - tion after intramuscular Revista Es Royuela A, Insa A, Cruz P, Collazo A, Altozano J, Vidal O, Diz P, Cobo M, Hernandez B, Estevez S, Benitez G, Guirado M, Majem M, Bernabe R, Ortega A, Blasco A, Bosch-Barrera J, Jurado J, Gonzalez J, Viteri S, Giron C, Massuti B, Martin A, Oncology. 2021 J a n ;15(1):4 3 - 56. d o i : 10.10 02/1878 - 0261.12832. PMID: 33107189 147. Gambardella V, Fleitas T, Comprehensive genomic and transcriptomic analysis for guiding Frail-VIG with the EQ-5D-3L in index with the EQ- 5D-3L cared Artime E, Diaz S, Rubio M, Revi - riego J, Mitchell B, Osumili B, Peyrot M, Pokrzyw - inski Hypoglycaemia (CRASH): Spanish results of a global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers. G, Bayes-Genis A, Husser O, J, Agustin-Panadero Fons-Font Garcia-Selva - lation between polysomnographic parameters and tridimensional changes in the of obstructive sleep apnea patients treated with mandibular advancement devices. Journal of Cli M, Navarro-Perez J, Gorriz J, Vivas-Consuelo D, Redon J. Cost in Spain. International Journal of Environmental Research Public Health. 2021 Sep 18;18(18):9853. doi: 10.3390/ijerph18189853. 34574782 la R, Mikulska M, Tridello G, Aguado B, Al Zahrani M, Apperley J, Berceanu A, Bofarull RM, Calbacho M, Ciceri F, chard K,Porras RP, Vallisa N, A, Fernandez-Rozas I, Feltes G, Arroyo-Espliguero R, Trabattoni D, Lo - pez-Pais J, Pepe M, Romero R, Castro-Mejia A, Ce - rrato E, Astrua T, D'Ascenzo F, Fabregat-Andres O, Signes-Costa A, Tellez M, Fernandez-Ortiz A, Macaya C, Akin I. COVID-19 and the impact of arterial hypertension-295 295 INCLIVA SCIENTIFIC REPORT 2021publication list 9An analysis of the international HOPE COVID-19 European D, F, Roilides E, Antonelli G. COVID-19 infodemics: the role of mainstream and social B, Sanchez LO, Luengo A, Fu - salba OR, Aguilar EJ. COVID-19 lockdown influence Psiquiatria Salud 18. doi: Crespo J, Alfonso-Sanchez El-Mohandes A, Lazarus JV. Spain: public perceptions of key government CO - measures. European zalez-Munoz JF, cells, and - nal D, Sanz J, Lozano A, Pecci-Lloret M, Melo M, Lopez-Gines C, Forner L. Cytocompatibility Vazquez L, Gimenez Quiles E, De La Camara R, Albert Vicent E, Rovira M, Espigado I, Calvo C, Lopez-Jimenez J, Suarez-Lledo M, Chi - nea A, Esquirol A, Perez Martinez A, Bermudez A, Saldana R, Heras I, Gonzalez-Huerta A, Torrado T, Bautista G, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta M, Pinana J, Navarro Ortega D. Cytomega - lovirus DNAemia of mortality in Asuncion C, Terol M, Saus A, Olea B, Gime - nez E, Albert E, Lopez-Jimenez J, Andreu R, Garcia D, Fox L, Remigia M, Amat P, Solano C, Navarro D. Cytomegalovirus-specific T-cell immunity and Journal of Soledad Noya M, Teresa Gomez-Casares M, Cue - vas B, Caballero G, Garcia-Hernandez C, Garcia- Gutierrez V, Palomino A, Ferrer-Marin F, Isabel Mata-Vazquez M, Moreto A, Magro E, Murillo I, Alonso-Dominguez J, Maria Guerra J, Guerrero L, Maria Raya J, Perez-Encinas M, Carreno-Tarrago - na G, Fox L, Pastor Galan Hernandez from the Spanish A, Gea A, Sanchez-Bayona R, Martin-Moreno J, Martinez-Gonzalez E. E, Simon C. Darwin meets Men - del in the reproductive medicine field: Homo Sapiens 2.0 is inevitable. Fertility and K, Kamarajah al. Death fo - llowing pulmonary complications of surgery before and during J, Aixela Corchon-Peyrallo A, Vinyals- Bellido I, Calvo A. Decision support system through automatic algorithms and electronic request in diagnosis of anaemia E, P, G, Vacas Lupon J. Decoding empagliflozin's molecular me - chanism action in heart failure with preserved ejection fraction Ix J, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos M, Cannon C, Mueller G, Birkhahn R, Taub P, Vilke G, Duff S, McDonald K, Mahon N, Nunez J, Briguori C, Passino C, Maisel renal function in acute heart failure. Euro - pean Estrada- Tejedor Gallego-Duran R, Crespo J, Abad J, Gonzalez-Rodriguez A, Gomez-Camarero J, Caballeria J, Lo Iacono O, Ibanez L, Garcia-Sa - maniego J, Martin-Mateos R, Frances R, Fernan - dez-Rodriguez C, Diago M, Soriano G, Andrade RJ, Latorre R, Jorquera F, Morillas RM, Escudero D, Estevez P, Hernandez-Guerra M, Augustin S, Pare - ja-Megia similar 174. Sanz J, Rodriguez-Lozano F, Lopez-Gines C, Mon - leon D, Llena C, Forner L. Dental stem cell signa Chooklin S, Bilyak A, Mejuto R, Mauriz V, He - gyi P, Marta K, Kamal A, Lauret-Brana E, Barbu S, Nunes V, Ruiz-Rebollo M, Garcia-Rayado G, Lozada-Hernandez E, Pereira J, Negoi I, Espina S, Hollenbach M, Litvin A, Bolado-Concejo F, Vargas R, Pascual Moreno I, Singh V, Mira J. Design and validation of a patient-reported Garibotto F, Siano AS, Vila L, Cabedo 10.1039/d1nj00345c 7. Hernandez Boluda J, Pereira Kroeger N, Beelen D, Robin M, Bornhaeuser M, Angelucci E, Vitek A, Blau I, Niittyvuopio R, Finke J, Cornelissen J, Pas - sweg J, Dreger P, Petersen E, Kanz L, Sanz J, Zuc - kerman T, Zinger N, Iacobelli S, Hayden P, T, Morata Trillo-Mata J, Mu - noz R, Gonzalez J, Tort M, Badia X. diseases caused by Fernandez A, Jovani Ca - sano C, Latorre Tejerina M, Largo Blanco E, More - no Ruiz M, Berghezan Suarez A, Garcia-Peris M, Gil Piquer R, Coret Sinisterra Martinez-Barona S, Salido-Capilla C, Requena of celiac performance of muscle A, Torres Fink I, Huntley Pascual D, Alcar\u00e1z Soriana M, Albert Vicent E, Gonz\u00e1lez Padr\u00f3n C, Colomina Rodr\u00edguez F, Navarro Orte - ga D. Diagnostic rences and similarities in neuropathy in type 1 and 2 diabetes: a systematic review. Journal of B, Marce S, Garrido A, Tormo M, Arenillas L, Coll R, Borras J, Jimenez M, Hoyos M, Valcarcel D, Escoda L, Vall- Llovera F, Garcia A, Font L, Ramila Buschbeck Zamora L, CETLAM Herreros-Pomares A, Llorens C, Soriano B, Bagan L, Moreno A, Calabuig-Farinas S, Jantus-Lewintre Gomez- Adrian J, Ferrandez-Izquierdo A. Diffuse J, Ferrandez A, Alemany-Monraval P, Escudero-Garcia D, C, Aguilera V, E, Marco-Algarra J, Fons-Font A. Dimen - sional analysis airway in obstructive sleep apnea syndrome patients treated three-dimen - sional evaluation. SCIENTIFIC C, dez-Olmo Diez-Villanueva Ariza-Sole L, Vivas D, Gabaldon-Perez A, Bodi V, Nunez J, Cordero A. Direct oral anticoagulants versus warfarin in oc - togenarians with nonvalvular Molina M, Pallardo L, Torralba J, Escudero V, Alvarez L, Peris A, Sanchez-Perez P, Gonzalez-Ri - co M, Puchades M, Fernandez-Najera J, Gimenez- Civera E, D'Marco L, Carrero J, Gorriz J. Disorders in bone-mineral parameters and the risk of death in persons with chronic kidney disease stages 4 and T, I, A, Jimenez- Almazan J, Monfort-Ortiz R, Aguilar-Ballester M, Vinue A, Piqueras L, Martinez-Hervas S, Gonzalez- Navarro Dissecting abdominal aortic L, Veerla K, S, Borgquist S, Borg A, Perez- Fidalgo A, Ditzel H, Bosch A, Honeth G. Distinct me - chanisms of resistance to fulvestrant treatment dictate of Monzo Catalu\u00f1a C, Albert Vicent E, Fuentes Trillo A, Seda Garc\u00eda E, Pinana J, Hernan - dez Boluda J, Solano Vercet C, Chaves Mart\u00ednez F, Navarro Ortega D. Diversity and dynamic changes of anelloviruses in plasma following allogeneic - t\u00f3n I, Beltr\u00e1n-Garc\u00eda J, Osca-Verdegal R, T, Haack K, Riffo-Campos A, Levy D, Fallin M, Terry M, Zhang Y, Rhoades D, Herreros-Martinez M, Garcia-Esquinas E, Cole S, methylation cancer incidence: Diaz-Insa S, Guerrero-Peral A, Huerta M, Irimia P, Lainez Andr\u00e9s J, Latorre G, Leira R, Oterino A, Pascual J, Porta-Etessam J, Pozo-Rosich P, Sanchez del Rio M, Santos-Lasaosa of and updating of medication C, Car - bonell Asins J, Dell'isola F, D'Antonio D, Lucido F, Gambar - della C, Carbonell Asins J, Dell'isola C, Tolone S. Does antrum sleeve A pros - pective randomized study (vol 46, pg 861, 2020). Gonzalez M. Does primary care intervention have an impact in the place of death for patients in a palliative care pro Becerra-Munoz Aparisi Fernandez-Rozas I, Feltes G, Arroyo-Espliguero R, Trabattoni D, Lopez- Pais J, Pepe M, Romero R, Garcia D, Biole C, Astrua T, Eid C, Alfonso E, Fernandez-Presa L, Espejo C, Buonsenso D, Raposeiras S, Fernandez C, Macaya C, Akin I, HOPE COVID-19 Does there exist P, Mas Bargues Artigas P, Valero MA, Bargues MD. Domestic pig prioritized in one health Fernandez I, Negrete E, Gullon G, Rol - dan F. Double nail of the second toe: a case report with radiological di Forti M, Vassos E, Arango C, Berardi D, Bernardo M, Bo - bes J, de Haan L, Del-Ben CM, Gayer-Anderson C, Jongsma J, Selten Tarricone I, D'Andrea G, Ri - chards A, Tortelli A, Velthorst E, Jones PB, Arrojo Romero M, La Cascia C, Kirkbride JB, van Os J, O'Donovan psychosis in A, Castro P, Candela-Toha A, Her - nandez-Sanz M, Arruti E, Villar J, Ferrando C, CO - VID-19 Spanish ICU Network. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort Segui R, Botija Beltran M, Albert E, To - rres I, Lopez-Fernandez P, Orti R, Maestre J, San -300 300 INCLIVA SCIENTIFIC REPORT 2021publication list9chez G, Navarro D. detection of SARS-CoV-2 Rodriguez-Ra - mos M, Gomez Zafra R. Early symptomatic con - genital syphilis in La Espriella Juan R, Nu\u00f1ez Benito E, Ll\u00e0cer P, Garcia Blas S, Ventura Haro S, N\u00fa\u00f1ez J, S\u00e1nchez R, Facila De La Esperanza R, Vaquer Santamaria J, Santas Olmeda E, Mi\u00f1ana Escriva G, Mollar Fernandez A, N\u00fa\u00f1ez Mar\u00edn G, Chorro Gas - c\u00f3 F, G\u00f3rriz Teruel J, Sanchis Fores in failu - re and renal dysfunction. Revista Espanola animal models of - or - ganization and year follow-up study of the PAFIP cohort. Psycho - logical Medicine. May 6;1-12. doi: 10. 1017 / S0033291721001112. PMID: 33952364 216. Palau P, Seller J, Dominguez E, Sastre C, Ramon JM, Espriella R, Santas E, Minana G, Bodi V, San - chis J, Valle A, Chorro FJ, P, failure and preserved fraction. Journal for 15 Huang J, Romero R, Becerra-Munoz V, Uribarri A, Feltes G, Trabatoni D, Fernandez-Rozas I, Viana- Llamas M, Pepe M, Cerrato E, Bertaina M, Capel Astrua T, Alfonso E, Castro-Mejia Espejo Paeres C, Costa Bardaji A, Fernandez-Perez C, Marin F, Fabregat-Andres O, Akin I, V, C. Effect of on ability and symptoms redu - ced and preserved ejection fraction, with and without Sancho J, Ferrer S, Bures E, Diaz JL, Torrecilla T, Signes-Costa J, Servera E. Effect of one-year Cannon C, Leiter L, Mc - Guire D, Lewis J, Riddle M, Voors A, Metra M, Lund L, Komajda M, Testani J, Wilcox C, Ponikowski P, Lopes R, Banks P, Tesfaye E, Ezekowitz J, S, Pitt sotagliflozin on total hospitalizations type 2 diabetes and worsening heart Ballester R, Mora Oliver I, Cassinello Fern\u00e1ndez N, Ortega Serrano J. Effec - tiveness and efficiency of a special program to re -301 301 INCLIVA SCIENTIFIC REPORT 2021publication list 9duce the M, Barrei - ro-de Acosta M, Fernandez-Clotet A, de Castro L, Bosca-Watts M, Casanova M, Lopez-Garcia A, Lorente R, Rodriguez C, Carbajo A, Arroyo M, Gu - tierrez A, Hinojosa J, Martinez-Perez T, Villoria A, Bermejo F, Busquets D, Camps B, Canete F, Man - cenido N, Monfort D, Navarro-Llavat M, Perez- Calle J, Ramos L, Rivero M, Angueira T, Camo P, Carpio D, Garcia-de-la-Filia I, Gonzalez-Munoza C, Hernandez L, Huguet J, Morales V, Sicilia B, Vega P, Vera I, Zabana Y, Nos P, Suarez Alvarez P, Cal - vino-Suarez C, Ricart E, Hernandez V, Minguez M, Marquez L, Hervias Cruz D, Rubio Iturria S, Barrio J, Gargayo-Puyuelo C, Frances R, Hinojosa E, Del Moral M, Calvet X, Algaba A, Aldeguer X, Guardiola J, Manosa M, Pajares R, Piqueras M, Garcia-Bosch O, Lopez Serrano P, Castro B, Lucendo A, Monto - ro M, Castro Ortiz E, Mesonero F, Garcia-Planella E, Fuentes D, Bort I, Delgado-Guillena P, Arias L, Iglesias A, Calvo M, Esteve M, Domenech E, Gis - bert J. Effectiveness and safety of ustekinumab in ulcerative colitis: real-world evidence from the ENEIDA registry. of A fibromyalgia: S, in patients with chronic low pain: a literature review with meta-analysis. Bra - zilian Journal V, Hernandez-Mal - donado M, Lameiras-Azevedo A, Sepulveda N, Sotero I, Villanueva-Ruiz C, Barrenengoa-Sanudo J, M, S, Rodriguez-Diaz Gil-Carbonell L, Galiana-Ivars M, Jaime-Sanchez F, Margarit-Ferri C, Gonzalez-deDios G, Garcia-Alonso M, Sanchez-Vela P, Sanchez-Paya J. Effectivity of a program for the control and preven - tion of COVID-19 healthcare-associated infections in a Spanish hospital. of training on functionality, ankle instability, outcomes Ar - nott C, Bakris G, Cannon C, Charytan D, Edwards R, Gorriz J, Jardine M, Levin A, Neal B, De Nicola L, Pollock C, Rosenthal N, Wheeler D, Mahaffey K, Heerspink H. Effects of canagliflozin on serum potassium in people with diabetes and chronic kid - ney disease: the CREDENCE trial. European Heart Ko - M, F, J, Rossing P, Correa- Rotter R, Kurlyandskaya R, Stefansson Espriella R, Minana G, Santas E, Nunez G, Lo - renzo M, Nunez E, Bayes-Genis A, J. patients with chronic heart Sep 15;339:102-105. doi: 10.1016/j.ijcard.2021.06.045. PMID: J, JM, Navarro J, von Wichmann MA, Tellez MJ, Quereda C, I, Sanz Jimenez Sousa MA, Perez Latorre JM, Resino S, Esteban H, Martinez E, Gonzalez Garcia J. Effects of HCV A, Rodriguez M, Sinha S, Garg R, Perello J, of inositol receiving hemodialysis: an analysis of the randomized, placebo-controlled Ca - LIPSO study. Clinical Journal of N, Miguel A, Marco Algarra J, Palop-Cervera M, Pi - nero A. Effects of T, Edelman S, Frias J, Ampudia-Blasco F, Banks P, Jiang W, Davies M, Sawhney S. Efficacy and safety of adding sotagliflozin, a dual and SGLT2 inhibitor, to optimized in 27 kg/m2. Diabetes, Obesity & Metabolism. 2021 m.14271. PMID: 33289297 239. Marconi V, Ramanan A, de Bono S, Kartman C, Krishnan V, Liao R, Piruzeli M, Goldman J, Alato - rre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams D, Ely E, COV-BARRIER Study Group. Efficacy and safety of baricitinib for the treatment of hospitalised adults with randomised, 10. 1016/S2213-2600(21)00331-3. PMID: 34480861 240. Civera J, de la Espriella R, Heredia R, Minana G, Santas E, Conesa A, Mollar A, Sastre C, Martinez A, Villaescusa A, Nunez J. Efficacy and safety of subcutaneous infusion of non-formulated furose - mide in patients with heart failure: a real-world study. Journal Trans - lational s12265-021-10173-1. 34642870 241. Esp\u00ed L\u00f3pez G, Aguilar Rodr\u00edguez M, Zarzoso Mu - \u00f1oz M, Serra A\u00f1o M, Martinez De La Fuente J, Ingl\u00e9s De La Torre M, Marques-Sule E. Efficacy of a proprioceptive exercise program in contro - lled trial. European J, Cabezon-Gutierrez L, Tain P, Hernandez A, Alonso M, Blanco R, Gal - vez E, Insa A, Mielgo X, Moran T, Ponce S, Roa D, Sanchez J, Majem M. Efficacy of nintedanib plus docetaxel in patients with advanced Jose Gonzalez- Teruel A, Antonio Carbonell-Asins J, Canete Nico - las C, Hernandez-Viadel M. Efficacy of vitamin D in the treatment of depression: a systematic review and hry D, Desai A, Edwards JG, Evans JP, Fiore M, Vide - ria JF, Ford SJ, Ganly I, Griffiths EA, Gujjuri RR, Kolias AG, Kaafarani HMA, Minaya-Bravo A, McKay SC, Mo - han HM, Roberts KJ, San Miguel-M\u00e9ndez C, Pockney P, Shaw R, Cervera-Ferri A, Lloret MA, Esteve D, Lo - pez B, Leon JL, Lloret A. Electroencephalography as a non-invasive biomarker - substitute CSF mo - lecules? . supported psychological treatments C. Endometrial factor testing is a use - ful tool in clinical infertility management. Re - productive - tures: outcomes in an experienced center and factors associated with procedural success or failure. JV, Dios Oltra R, resonan ce study. J, Navarro-Lleo N, S, Rodriguez- Diaz J, Buesa J. Epidemiological and genetic cha - racterization of sapovirus in patients A, Torres L, Tara - zona N, Gambardella V, Cervantes A, Lopez-Rodas G, Franco L, Castillo J. Epigenetic mechanisms are involved Baner - jee S, Giuliani R, Lordick F. ESMO pays tribute to A, Banerjee S, Giuliani R, Lordick F. ESMO pays tribute to 304 Eniu A, Stahel R, Cervantes A, Cavalli F, Costa A. ESO-ESMO master - class in clinical oncology: analysis and evaluation of the J, Lopez- Grueso R, Edo Estrogen replacement therapy induces - sentacion del Consorcio HyperChildNET. European Network for blood pressure research in children and adolescents (COST Action CA 191 15). Anales HyperChild - NET Consortium. European Network for blood pressure research in children and adolescents (COST Action CA 191 15). Anales Ca - macho J, Barres-Fernandez A, Albert E, Torres I, Breton-Martinez J, Martinez-Costa C, Navarro D. Evaluation of a rapid antigen detection test (Panbio (TM) COVID-19 Ag Rapid Test Device) as a point- of-care diagnostic tool for COVID-19 in a pediatric S, Albert E, Colomina J, Navarro D. Evaluation of a rapid antigen test (Panbio CO -VID-19 Ag rapid test device) for SARS-CoV-2 detec X. Evaluation - biota in Blasco JM. Evaluation of interface pressure and temperatu - re management in five wheelchair seat cushions and their effects on user M, Bracho G, Martinez-Priego L, - tero-Alonso M, Gomez MD, Pinana JL, Gonzalez- Candelas F, Comas I, Marina A, Geller R, Coscolla M. Evolutionary and phenotypic characterization of Algarra Sayas M, Acuna-Cruz E, Blanco A, Marco-Ayala J, DeLapuerta R, Diaz-Gonzalez A, Tormo M, Ro - driguez-Veiga R, Garcia R, Pinana J, Lopez-Pavia M, Barragan E, Amigo M, Sargas C, Lopez A, Solana-Altabella A, Gil C, Megias-Vericat J, Sanz M, Montesinos P. Evolving patterns Gil C, Tormo M, Martinez-Sanchez P, Perez-Simon J, Garcia-Boyero R, Rodriguez-Medina C, Lopez-Pavia M, 305 INCLIVA SCIENTIFIC REPORT 2021publication list 9C, Bergua J, Lavilla-Rubira E, Amigo M, Herrera P, Alonso-Dominguez J, Bernal T, Colorado M, Sa - yas M, Algarra L, Vidriales M, Rodriguez-Macias G, Vives S, Perez-Encinas M, Lopez A, Noriega V, Garcia-Fortes M, Ramos F, Rodriguez-Gutierrez J, Costilla-Barriga L, Labrador J, Boluda B, Rodri - guez-Veiga R, Martinez-Lopez J, Sanz M, Montesi - P. Evolving treatment patterns and outcomes in older patients Boixeda P. Ex vivo dermoscopy in demodicosis. Journal of the American Academy of doi: Roldan E, Pinana J, Barba P, Chorao P, Quintero A, Hernani R, Orti G, Lorenzo J, Balaguer- Rosello A, Salamero O, Fox L, Solves P, Gomez I, Guerreiro M, Boluda J, Sanz G, Solano C, Sanz M, Valcarcel D, Sanz J. Ex vivo T-cell European Journal of Hae - ma t o l o g y. 2021 Ja n;106(1):114 Fusar-Poli L, Delespaul P, Kenis G, Luykx J, Lin B, Richards A, Akdede B, Binbay T, Altinyazar V, Yalincetin - nardo M, Mezquida G, Amoretti S, Bobes J, Saiz P, Garcia-Portilla M, Sanjuan J, Aguilar E, Santos J, Jimenez-Lopez E, Arrojo M, Carracedo A, Lopez G, Gonzalez-Penas J, Parellada M, Maric N, Atba - soglu C, Ucok A, Alptekin K, Saka C, M, B, Risk and investigators. the between S, Gueritat J, Wong CP, Isanejad A, Ho E, Serna E, Gomez-Cabrera MC, Rebillard A. Exerci - se training as Nacher Desco M, Soto-Montenegro M. Exploratory study of the long-term footprint of deep brain stimulation on brain metabolism and neuroplasticity in an animal - brera M, Pesce older adults: physical fitness to mental health. International Journal of Environmental Research and Public Health. 2021 ph18189645. PMID: 34574570 Luque M, Santos A, Zazo S, Madoz-Gurpide J, Carames C, Chiang C, Garcia-Foncillas J, Eroles P, Albanell J, Rojo F. Ex - pression of phosphorylated BRD4 is markedly as - sociated with the activation the PP2A pathway and A, Guerra I, Ricart E, Iglesias E, Manosa M, Gisbert J, Guardiola J, Minguez P\u00e9rez M, Castro B, de Francisco R, Nos P, Bertoletti F, Mesonero F, Barrio J, Dolores Martin-Arranz M, Calvet X, Garcia-Lopez S, Sicilia B, Alcain G, Esteve M, Mar - quez L, Piqueras M, Jimenez L, Perez-Calle J, Bu - janda L, Garcia-Sepulcre M, Fernandez A, Moraleja I, Humberto Lorente R, Garcia-Bosch O, Lamban A, Blazquez I, Rodriguez E, Huguet J, Lucendo A, Al -306 306 INCLIVA SCIENTIFIC REPORT 2021publication list9mela P, Busquets D, Ramirez de la Piscina P, Perez M, Domenech E, Bermejo F, Spanish 2021 M, modifying of Soriguer Urrutia-Etxebarria I, Maldonado-Araque C, Ortega E, Ocon P, Montanya E, Menendez E, Lago-Sampe - dro A, Gonzalez-Frutos T, Gomis R, Goday A, Gar - cia-Serrano S, Galan-Garcia J, Castell C, Bordiu E, Badia R, Aguilera-Venegas G, Girbes J, Gaztambide S, Delgado E, Chaves F, Castano L, Calle-Pascual A, Rojo-Martinez G, Franch-Nadal J. Fatty liver in - dex as a predictor for type 2 diabetes in subjects with normoglycemia in J, B, Ripoll C. state and context of narcissism International of Environmental Re - search Public Health. 2021 Jul 10.3390/ijerph18137195. PMID: 34281134 281. Liello R, Bermejo B, Hernando C, Olcina E, Chirivella I, Lluch A, Cejalvo JM, Martinez MT. Fertility and breast cancer: a literature review of counseling, preservation and mes. Ferrando F, Huntley Pascual D, Molla E, Fernandez-Fuentes M, Mart\u00ednez L\u00f3pez M, Poujois Gisbert S, Forqu\u00e9 Rodr\u00edguez L, Valdivia Piqueres A, Solano De La Asunci\u00f3n C, Ferrer Dot J, Colomina Rodr\u00edguez F, Navarro Ortega D. Field evaluation of a rapid antigen test (Panbio COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary health M, Isakoff S, Im S, Espie M, Blau S, Tan A, Saura C, Wongchenko M, Xu N, Bradley D, Reilly S, Mani A, Kim S, LOTUS Investigators. Fi - nal results of the double-blind placebo-controlled randomized phase 2 LOTUS Rodon J, Burgues O, Nuciforo P, Canes J, Pare L, Duenas M, Vidal M, Cejalvo J, Perello A, Llomm - bard-Cussac A, Dorca J, Montano A, Pascual T, Oli - veira M, Ribas G, Rapado I, Prat A, Ciruelos E. First nationwide molecular screening program in Spain for patients with advanced breast cancer: results from Atkinson V, Carpentier AF, Lohr M, Redman R, Mason W, Cervantes A, Le Rhun E, Ochsenreither S, Warren L, Zhao Y, Callies S, Estrem ST, Man M, Gandhi L, Avsar E, Melisi D. First-in-human phase I study of receptor 1 A, Massuti B, Ortiz-Morales M, Mozo J, Munoz A, Duran G, Sastre J, Safont M, Ferreiro R, Rivera 307 307 INCLIVA SCIENTIFIC REPORT list Gonzalez C, C, Muriel J, Moreno L, Peiro A. Fluorescent in situ hybridization (FISH): a and come - in a 14-year-old boy. American Journal of Perez-Soriano Priego-Quesada J. Footwear outsole temperature may be to run of the WAIS-IV for assessment of patients with schizophrenia. Revista de PMID: 34362715 291. Dasi Vivo Dura I, Ruiz J, Navarro M. Four- subtest short-form of the WAIS-IV for assessment of patients with schizophrenia. Revista de Gonzalez-Fernandez J, R, Meana L, Nacher Rosell\u00f3 J, Sebastia Ortega N, Gilabert Juan J, Molt\u00f3 Ruiz M. FOXP2 expression and gray matter density in the male with 293. Naval E, Cruz Gonzalez M, Giraldos S, Calatayud J, Jornet M, Lluch De A, Martinez- Hervas S, Gomez-Cabrera MC, Real JT. Frailty oxidative stress in older pa Ruescas-Nicolau M, D'Gregorio J, Valero E, Minana G, Palau P, Tarazona-Santa - balbina F, Ros V, Nunez J, Sanchis J. Frailty sca - les for prognosis assessment of older adult - V, Lapouble E, Bau - lande S, Ambros PF, Auger N, Beiske K, Bernkopf M, Betts DR, Bhalshankar J, Bown N, de Preter K, Clement N, Combaret V, Font de Mora J, George SL, Jimenez I, Jeison M, Marques B, Martinsson T, Mazzocco - guera R, Pierron G, Rossing M, Taschner-Mandl S, Van Roy N, Vicha A, Chesler L, Balwierz W, Castel V, Elliott M, Kogner P, Laureys G, Luksch R, Malis J, Popovic-Beck M, Ash S, Delattre O, Valteau-Coua - net D, DA, Ladenstein and prognostic impact - cations and mutations in European Neuroblas - toma Study Group (SIOPEN) High-Risk Neuroblas F, Pagano G, Rodriguez Mel - guizo L, Gonz\u00e1lez Cabo P, Lyakhovich A, Trifuoggi 308 SCIENTIFIC Guarque-Chabrera J, Olucha Bordonau F, Miquel M. From back to front: a functional model for the cerebellar modulation in Martinez-Martinez L, Navarro Ortega D, Vila J. Fundamentals and implementa - tion of microbiological diagnostic of dyslipidemia: ESCARVAL-GENERO. International Journal of Envi - Spirito A, Raposeiras Roubin Fernandez- Perez C, Uribarri Ugo F, Guerra F, Feltes G, Akin I, Fernandez-Rozas I, Blas - co-Angulo N, Huang J, Garcia Aguado M, Pepe M, Romero R, Becerra-Munoz VM, Estrada V, Maca - ya C. Gender differences in the presentation and outcomes of hospitalized patients COVID-19. Journal around the three prevalent cardiovascular risk studies: protocol for a population-based cohort study. International Journal of Roma- Mateo C, Sanz P, Perez B, Gallego D, Seoane P, Ranea J, Perkins J. expression analysis Goessler W, Franceschini N, J, M, Garcia-Hernandez C, Gomez- Casares M, Garcia-Gutierrez V, Carreno-Tarrago - na G, Garrote M, Fernandez-Ibarrondo L, Cervera J, Bellosillo B, Cervantes F, Hernandez-Boluda J, Spanish G, Pata E, Caruso R, Gra - vante G, Di Saverio S, Moro Valdezate D. Global at - titudes in the management of acute appendicitis during COVID-19 726. doi: 34157090 3 0 7. Rees M, Bitzer J, Cano Ceausu I, Chedraui P, R, Geukes A, Goulis DG, Griffiths A, Hardy C, Hickey M, Hirsch - berg AL, Hunter M, Kiesel L, Jack G, Lopes P, Mishra G, Oosterhof H, Pines A, Riach K, Shufelt C, van Trotsenburg M, Weiss R, Lambrinoudaki I. Global consensus recommendations on me - nopause in the workplace: a list 9308. Cannon J, Bonifacio J, Bucardo F, Buesa J, Bru - ggink L, Chan M, Fumian T, Giri S, Gonzalez M, Hewitt J, Lin J, Mans J, Munoz C, Pan C, Pang X, Pietsch C, Rahman M, Sakon N, Selvarangan R, Browne H, Barclay L, Vinje J. Global trends in no - rovirus distribution among children Global, regio - nal, and national burden of respiratory tract can - cers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease bal, regional, and national progress towards Sus - tainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Olaso-Gonzalez G, Correas A, Serna E, Brioche T, Chopard A, Fernandez-Marcos P, Serra - no M, Serrano A, Munoz-Canoves P, Sebastia V, Vina J, Carmen E, Portella MJ, Aguilar EJ, Nunez-Marin F, Gomez-An - son B, Corripio I. Grey matter microstructural alte - rations in schizophrenia with al. Guidelines for use I, Lo Cascio A, Gandini S, Lizier M, Braga D, Asnicar F, Segata N, Klaver C, Brescia P, Rossi E, An - selmo A, Guglietta S, Maroli A, Spaggiari P, Tarazo - na N, Cervantes A, Marsoni S, Lazzari L, Jodice M, Giovanna L, Chiara E, Marco PS, Di Fiore PP, Viale G, Spinelli A, Pozzi C, Penna G, Rescigno M. Gut Cediel G, Domingo M, Simpson J, Levy WC, Santiago-Vacas E, Zamora E, Buchaca D, Subirana I, Santesmases J, Diez-Quevedo C, Troya MI, Boldo M, Altmir S, Alonso N, Gonzalez B, Rivas C, J, McMurray J, Bayes-Genis comparison of contemporary Health literacy of patients on oral anticoagulation treatment- individual and social determinants and effect on health outco - mes and pre treatment after st-elevation infarction: a for older adults, where are we moving towards?. International Journal of En - vironmental Research 2021 professionals and tobacco Kahan Gil-Gil M, Ruiz-Borrego M, Carrasco E, Ci - ruelos E, Munoz M, Bermejo B, Margeli M, Anton A, Casas M, Csoszi T, Murillo L, Morales S, Calvo L, Lang I, Alba E, de la Haba-Rodriguez J, Ramos M, Lopez I, Gal-Yam E, Garcia-Palomo A, Alvarez E, Gonzalez-Santiago S, Rodriguez C, Servitja S, Cor - saro M, Rodrigalvarez G, Zielinski C, Martin M. Health-related ejection fraction: an urgent M, Citerio G, Zona G, Pelosi P, Robba C. Hemo - dynamic monitoring in patients subara - chnoid Garc\u00eda D, Sebasti\u00e1n Cuevas F, Crehu\u00e1 Gaudiza E. Hepatitis C and beta-thalassemia major in children: experience with glecaprevir/pibren - in population distri - bution of body mass index to Masciulli A, Carobbio A, Ghirardi A, Ferrari A, Rossi G, Elli E, Andrade-Campos M, Kabat M, Kiladjian J, Palandri F, Benevolo G, Garcia-Gutierrez V, Fox M, Foncillas M, Morcillo C, Rumi E, Osorio S, Papado - poulos P, Bonifacio M, Cervantes K, Serrano M, Carreno-Tarragona G, Sobas M, Lunghi F, Patriar - ca A, Elorza B, Angona A, Mazo E, Koschmieder S, Ruggeri M, Cuevas B, Hernandez-Boluda J, Abadia E, Cirici B, Guglielmelli P, Garrote M, Cattaneo D, Daffini R, Cavalca F, Bellosillo B, Benajiba L, Curto- Garcia N, Bellini M, Betti S, De Stefano V, Harrison C, Rambaldi A. High mortality rate in F, Her - nandez-Sanz M, Arruti E, Torres A, Villar J, Bro - chard L, Ferrando C, COVID-19 Spanish ICU Net - work. High-flow nasal oxygen in patients with COVID-19-associated study Virgili Casas N, Cuerda Com - pes C, et al. Home and Ambulatory Artificial Nu - trition (NADYA) Group report: home parenteral Es peranza R, Bod\u00ed Peris V, Valero Picher E, Mollar Fernandez A, Marco M, Garcia-Ballester T, Zo - rio B, Marti-Cervera J, Nu\u00f1ez Benito E, Chorro Gasc\u00f3 F, Sanchis Fores 330. Domingo O, Alberto G, Ana Maria C, Jorge N, Vicente G, Quesada-Rico Jose A, Pomares- Gomez Francisco J, Adriana L, Concepcion C. Hospital admissions trends for severe hypo - glycemia in diabetes patients in Spain, 2005 to 2015. Diabetes Research and Clinical Practi - E, Urtaran-Laresgoiti M, no-Solinis R, Lazaro-Perez E, Vazquez L, Pascual- Cascon M, Solano C, Kwon M, Gallego C, Fernan - dez-Aviles F. Hospital and outpatient models for Hematopoietic Stem Cell Transplantation: a sys - tematic review of comparative studies for health outcomes, experience Lockwood C. How to 333. Binia A, Lavalle L, Chen C, Austin S, Agosti M, Al- Jashi I, Pereira A, Costeira M, Silva M, Marchini G, Martinez-Costa C, Stiris J, Domellof M, Adams R, Castaneda-Gutierrez E, Sprenger N. Human milk oligosaccharides, infant growth, and adiposity over the first 4 months of lactation. Garcia-Llatas G, Barbera R, Martinez-Cuesta MA, JT, Godoy Hyper - ventilation in severe traumatic brain injury has something in last or uncer - tainty continues?. A Brief Review. J, Chorro Gasc\u00f3 FJ, Santas E. Hypoplasia of the posterior mitral valve Adam-Artigues JA, Lameirinhas A, Simon S, Ortega-Morillo B, Martinez MT, Hernando C, Constancio V, Burgues O, Bermejo B, Henrique R, Lluch A, Jeronimo C, Eroles P, Cejalvo JM. Identification of a croRNA signature in plasma as a novel biomarker for very early diagnosis of using Galvez F, Obispo B, Paez D, Quilez A, Quintanar T, Ramchandani A, Remon J, Sanchez D, Sanchez-Canovas M, Sanz-Garcia E, Sesma A, Ta - razona N, Cotes A, Gonzalez E, Bosch-Barrera J, Fernandez A, Felip E, Vera R, Rodriguez-Lescure A, Elez E. Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era: a study of the Spanish So - ciety of Medical Oncology (SEOM). Torregrosa I, D'Marco L, Juan I, Terra - dez L, Solis M, Moncho F, Carda-Batalla C, Forner M, Zubeldia a B, Trilla-Fuertes L, Bagan L, G, Pascual T, Fasani R, Guardia X, Chic N, Pare L, Pernas S, Munoz M, Oliveira M, Vidal M, Llombart-Cussac A, Cortes J, Galvan P, Bermejo B, Martinez N, Lopez R, Morales S, Garau I, Manso L, Alarcon J, Martinez E, Villagrasa P, Prat A, Nu - ciforo P. V, Blas S, Fores J, Romano J, Baena J, Giner M, Suarez N, Chorro F, Fornas F. Immunoglobulin G4-related aortitis transcatheter aortic valve replacement Iacoboni Terol genetic kinetics - rrasco A, Farinas F, Villatoro A, Abanades S, Ma - nes S, de la Cruz-merino L, Noguera R, Naranjo T. Immunometabolism Sanchez O, D'Marco L, Gorriz Teruel J. Impact of an article in the social age: is tweeting Estrada N, Velez P, Boque C, Sagues M, Angona A, Teruel-Mon - toya R, Ferrer-Marin F, Amat P, Hernandez-Boluda J, Ibarra M, Anguita E, Cortes M, Fernandez-Ruiz A, Fontanals S, Zamora L, Grp Espanol Leucemia Mie - loide Gross M, Espin A, Aznar S, Serrano-Sanchez J, Vera-Garcia F, Gonzalez-Lamuno D, Ara I, Carras - co-Paez L, Castro-Pinero J, Gomez-Cabrera M, Marquez S, Tur J, Gusi N, Benito P, Moliner-Urdia - les D, Ruiz J, Ortega F, Jimenez-Pavon D, Casajus J, Irazusta J. Impact of COVID-19 confinement on physical activity and sedentary behaviour Spa - nish university students: role of gender. Internatio - nal Journal Jan 6;18(2):369. doi: 10.3390/ijer - ph18020369. PMID: 33418907 L, Williams M, Lahey R, Villines T, Dorbala S, Choi A, Shah N, Bluemke D, Berman D, Blankstein R, Ferencik M, Narula J, D, E, B, M, Lopez- Mattei J, Parwani P, Vitola J, Cerci Better Raggi P, Lu B, Sergienko V, Sinitsyn V, Kudo T, Nor - gaard B, Maurovich-Horvat P, Cohen Y, Pascual T, Pynda Y, Dondi M, Paez D, Einstein A, INCAPS- COVID Investigators Grp. Impact of COVID-19 on cardiovascular testing in the united states versus the rest of the world. JACC-Cardiovascular Ima E, O, Formiga F, Sanchis J, Lopez-Palop R, Martinez Selles M, Vidan M, Bueno H, Diez-Villanueva P, Abu Assi E, Ariza-313 313 INCLIVA SCIENTIFIC REPORT 2021publication list 9Sole A, Marin F, Castillo Dominguez J, LONGEVO- SCA Registry Impact P, Kim JS, - roud M, Lee BC, Lavall\u00e9e PC, Mahagne lower targets on cardiovascular events after Bushljetikj O, et al. Impact on patients mechanical reperfusion: in sight from 2021 1016/j.biopha.2021. 1 1 1469. PMID: 33740523 3 57. De Luca G, Debel N, Cercek Beelen D, Beauvais D, Chevallier P, Mohty M, Passweg J, Rubio M, Maertens E, Karakasis D, Rifon J, Sirait T, Rus - so D, de Wreede L, Czerw T, Hernandez-Boluda J, chronic malignancies working party on behalf of European Society for Martin Arevalo J, Moro Valdezate D, Garcia Botello S, Mora Oliver I, Gadea Mateo R, C\u00f3zar Lozano C, Esp\u00ed Macias A. Impact of the novel powered circular stapler on risk of leakage M, M, Arumi E, Torrent-Vernetta A, De Mir Messa I, Gartner S, Iglesias Serrano I, Caballero-Rabasco M, Asensio De La Cruz O, Vizmanos-Lamotte G, Martin De Vicente C, Martinez-Colls M, Reula Martin A, Es - cribano Montaner A, Fern\u00e1ndez F, Armengot Carceller M, Ama Garrido-Pontnou - mats-Tarruella N, Fernandez-Cancio M, Moreno- Galdo A. Implementation ty through epigenetic biomarkers. International Journal of 33781893 363. Padilla M, Coll E, Fernandez-Perez C, Pont T, Ruiz A, Perez-Redondo M, Oliver E, Atutxa L, Mancino JM, Daga D, Minambres E, Moya J, Vidal B, Due - nas-Jurado JM, Mosteiro F, Rodriguez-Salgado A, Fernandez-Garcia E, Lara D, Estebanez B, Rodriguez-Ferrero ML, Barber M, Garcia-Lopez F, Andres A, Santiago C, Zapate - ro A, Badenes R, Carrizosa F, Blanco JJ, Bernal JL, Elola FJ, Vidal C, Terron C, Castro P, Comas J, 314 314 INCLIVA SCIENTIFIC 2021publication of death with the use of normothermic Journal of Transplantation. tibial compo - nent in knee arthroplasty: a study of four techni - ques in the - della V, Cejalvo J M, Cervantes Cejalvo M, Cervantes A. In the August ESMO Ibarrola-Villaba N, Cer - vantes A. In the literature: December 2020. Cejalvo Candia Tapia JM, Cervantes A. the Rumiz E, Cubillos A, Vilar J, Garcia P, Berenguer A, Facila L, Valero E, Vidal V, Morell S, Nunez J. Inaccu - racy to screen I, Latorre V, Frances-Gomez C, Albert E, Gozalbo-Rovira R, Alcaraz M, Buesa J, Rodriguez-Diaz J, Geller R, Navarro D. Inference of SARS-CoV-2 antibo - commercial their G, Cassinello Fernandez N, Pe - rez Santiago L, Alfonso Ballester R, Ortega Se - rrano J. Influence of carotid anatomy F. Inhaled Bueno F, Gimenez E, Bracho A, Albert E, Carretero D, de Michelena P, Martinez-Costa C, Gonzalez-Candelas F, Navarro D. Initial viral load and decay kinetics of SARS-CoV-2 lineage B. 1. 1.7 in the upper respiratory tract of adults and into glomerular filtration and albuminuria. PMID: 34320301 381. Zorrilla-Vaca et al. Ins - titutional factors associated with adherence to en - hanced for colorectal surgery: diabetic kidney disease: what are we waiting for?. International Journal of Environ - mental Research and Public 2021 Tonini G, Zin A, Fran - cescato S, Rossi B, Trevisson E, Pinato C, Monferrer E, Noguera R, Alino S, Herrero M, Biffi A, Viscardi E, Este - ve D, Merino E, Teruel-Sanchis A, Cervera-Ferri A, Martinez-Ricos J, Lloret A, Lanuza E, Teruel-Marti V. Integrating pheromonal and spatial informa - tion in the amygdalo-hippocampal network. Natu - - llon C, Vila-Vicent S, Buesa J, Delgado S, Molinero N, Margolles A, Yebra M, Collado M, Monedero V, Rodriguez-Diaz J. Interaction of intestinal bacteria with human rotavirus during infection in children. International Journal Jan 20;22(3):1010. doi: 10.3390/ijms22031010. PMID: 33498321 386. Einstein A, Shaw L, Hirschfeld C, Williams M, Villi - nes T, Better N, Vitola J, Cerci R, Dorbala S, Raggi P, Choi A, Lu B, Sinitsyn V, Sergienko V, Kudo T, Nor - gaard B, Maurovich-Horvat P, Campisi R, Milan E, Louw L, Allam A, Bhatia M, Malkovskiy E, Goebel B, Cohen Y, Randazzo M, Narula J, Pascual T, Pynda Y, D, INCAPS COVID Investigators Grp. impact of COVID-19 on the diagnosis of heart disease. Journal of the American Colle Arnould L, Balkenhol M, Broeckx G, Burgues C, De - deurwaerdere F, Dessauvagie B, Duwel V, Floris G, Fox S, Gerosa C, Hastir D, Jaffer S, Kurpershoek K, MacGrogan G, Marchio C, Martinez M, Nofech-Mozes S, Peeters D, Ravarino A, Reisenbichler E, Resetkova E, Sana - ti S, Schelfhout A, Schelfhout V, Shaaban A, Sinke R, Stanciu-Pop C, van Deurzen C, van de Vijver K, Van Rompuy A, Vincent-Salomon A, Wen H, Wong S, Bouzin C, Galant F, Bustamante J, Martin C, Garcia A, Feld - man S, Pastor F, Orellana M, Rubino P, Quesada V. Intra- and extradural anterior clinoidectomy: anatomy M, Meyfroidt G, Helbok R, Taccone F, Pris - co L, Vincent J, Suarez J, Stocchetti N, Citerio narrative review. International Journal Mar 33799976 392. Perez N, Alfonso Ballester R, Diaz Exposito R, Moscardo Navarro A, Ortega Serrano J. Intraoperative scintigraphy with portable gamma camera for the localization of - teraortocaval Blan - quer-Maceiras M, Castel V, Navarro S, DK, Meseguer M, Mi - ller KA, Montag M, Palermo Cheung S, Keating P, Rosenwaks Z, Rienzi Innocenti F, Cimado MJ, L. M, Miller KA, Montag M, Palermo GD, Cheung Keating D, Xie Colomo C, Goday-Arno A, Calle-Pascual A, Castano L, Castell C, Delgado Alvarez E, Menen - dez Torre E, Franch-Nadal J, Gaztambide S, Girbes J, Chaves Mart\u00ednez F, Soriguer P, Dominguez E, Tormo J, Zakarne R, Mollar A, Martinez A, Minana G, Santas E, Al - menar L, Facila L, de la Espriella R, Nunez E, Man - zano L, Bayes-Genis A, Nunez J. deficiency and events Iron deficiency testing and treatment in heart failure: the eyes are useless when the mind is blind. European Journal of Heart Sequera P, Quiroga B, Martin-Rodriguez L, Gorriz J, Portoles J, en repre - sentacion del Grupo de Anemia de la S.E.N. Iron re - placement therapy in the management of in non-dialysis chronic failure patients: pers - pective 33516607 Davison Sama I, Koch G, Mebazaa A, Dickstein K, Samani N, Metra M, Anker S, Cleland J, Ng L, Mordi I, F, Filippatos G, Hillege H, Ponikowski P, van Veldhuisen D, Lang C, van der Meer P, Nunez J, Bayes-Genis A, Edwards C, Voors A, Cotter G. Is acute heart failure a distinctive di - sorder?. An analysis from BIOSTAT-CHF. G, Buch E, Ripoll F, Adrianzen M, Berme - jo B, Burgues O, Julve A, Ortega J. Is axillary as - sessment of ductal carcinoma in situ of the breast necessary in all cases?. Journal of Surgical 10.006. PMID: 34902737 403. Fernandez Moreno M, P\u00e9rez Santiago L, Mart\u00ed Fernandez R, Le\u00f3n Espinoza C, Ortega Serrano J. Is laparoscopic approach still a risk factor for post-appendectomy intra-abdominal abscess?. The Journal of Trauma and Acute Is mHealth a useful the - rapy for physical health in adolescents with fibrosis?. systema 10.1007 /s12144-021-02452-6. Lloret A, Esteve D, Lloret MA, Monllor P, Lopez B, Leon JL, Cervera-Ferri A. Is oxidative stress the link between cerebral small vessel disease, sleep oligodendrocyte dysfunction in Vera G, Salazar-Fraile J, Cardoner N, Ruiz-Veguilla M, Livianos L, Tabares-Seisdedos R, Balanza-Mar - tinez. Is processing speed a valid neurocognitive endophenotype in bipolar disorder?. Evidence from a longitudinal, family study. Journal of Psychiatric Research. 2021 L, Roger J. Perez Lopez-Menendez J, Hornero Sos F, Silva-Guisasola J, Pe rez-Camargo national trends and from 1998 to Lorente-Rovira E, Barajas A, Grasa E, Lopez-Carrilero R, Luen - go A, Ruiz-Delgado I, Cid J, Gonzalez-Higueras F, Sanchez-Alonso S, Baca-Garcia E, Barrigon M, Spanish Metacognition Study Grp. Jumping to conclusions and suicidal behavior in and Journal G, Quattrone D, Ferraro L, Gayer-Anderson C, Rodriguez V, La Cascia C, La Barbera D, Sarto - rio C, Seminerio F, Tarricone I, Berardi D, Szoke A, Arango C, Tortelli A, Llorca P, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuan Arias J, Santos J, Arrojo M, Del-Ben C, Menezes P, Selten J, Jo - nes P, Jongsma H, Kirkbride J, Lasalvia A, Tosato S, Richards A, O'Donovan M, Rutten B, Os J, Mor - gan C, Sham P, Murray R, Murray G, Di Forti M, EU-GEI WP2 Group. Jumping to conclusions, ge Bover J, Bosch R, Urena P, Trinidad P, Jara A, Go - rriz J, Furlano M, Garcia-Trabanino R, Gelpi R, Or - tiz A, Restrepo C, Sanchez-Baya M, Arana C, Goi - coechea M, Coll V, Segura J, Gutierrez O, Sanchez E, Ferreiro A, Garcia-Maset R. L, Rivero A, Serrano M, Rios MJ, Vera-Mendez FJ, Santos M, Real LM, Palacios R, Santos I, Geijo P, Imaz A, Merino D, Galindo MJ, Reus-Banuls S, Lopez-Ruz MA, Galera C, Pineda JA. Kinetics emergence of liver com - plications in HCV-infected patients and fibrosis, Albert Vicent E, Pinana J, Perez Martinez A, Ubeda C, Gomez M, Hernandez J, E, Montoro J, Gimenez Quiles E, Guerreiro M, Balaguer-Rosello A, Hernani Mora - les R, Sanz J, Solano Vercet C, Navarro Ortega D. Kinetics of Torque Teno virus DNA in stools may predict occurrence of acute intestinal 416. Est\u00e9banez A, Verd\u00fa-Amor\u00f3s J, Silva E, Velasco R, Cuesta A, Monteagudo C, Mart\u00edn JM. Kutane und systemische de Vries S, Busch R, Xie D, Gansevoort R, Hou F, Gorriz J, Laverman G, De Nicola L, Pas - cual J, Provenzano M, Pergola P, Tang S, Wanner C, Zaoui P, H, on atrasentan's efficacy - a post-hoc analysis from the SONAR Trial. Journal of the American Society of Nephro MT, Rosinol L, Gonzalez E, de Arriba F, Oriol A, Gonzalez-Calle V, Escalante F, de la Rubia J, Gironella M, Rios R, Garcia-Sanchez R, Arguinano JM, Alegre A, Martin J, Gutierrez NC, Calasanz MJ, Martin ML, Couto MC, Casanova M, Arnao M, Perez-Persona E, Garzon S, Gonzalez MS, Martin-Sanchez G, Ocio EM, Coleman M, Encinas C, Vale AM, Teruel AI, Cortes-Rodriguez M, Paiva B, Cedena MT, San-Miguel JF, Lahuerta JJ, Bla - de J, Niesvizky R, Mateos MV. Lenalidomide and dexamethasone with or without clarithromycin in patients with myeloma ineligible for auto - logous transplant: a randomized trial. Can - Arboleya S, Martinez- Costa C, Solis G, Suarez M, Fernandez N, de los Reyes-Gavilan C, Diaz-Coto S, Martinez-Camblor P, Collado M, Gueimonde Gambini J, Jove M, Lopez-Grueso R, Mas-Bargues C, Monleon D, Pamplona R, Vina J. Lifelong soya consumption in males does not health span under a metabolic as type diabetes mellitus. Mechanisms Development. 2021 Dec;200:1 . a d . 2021.111596. P MID : 3 4774 60 6 421. Cervera-Martinez J, Atienza-Carbonell B, Mota JC, Bobes-Bascaran T, Crespo-Facorro B, Pinto Jaen-Moreno Vieta De Boni RB, Balanza-Martinez V. Lifestyle health during the J, Bobes-Bascaran T, Crespo-Facorro B, De Boni R, Esteban C, Garcia-Portilla M, Gomes- da-Costa S, Gonzalez-Pinto F, Seisdedos Zorrilla I, Balanza-Martinez Lifestyle undergraduate students and de controls during the CO - VID-19 pandemic in Spain. International Journal of Environmental Research 2021 Jul M, G, Persu A, Polonia J, Rajzer M, de Timary P, Weber T, Weisser B, Tsioufis Mancia A. Cossio A, Ballesteros D, Recena P, Tizon A, Palomo M, Misis Del Campo M, Freita S, Duerto J, Mas Bilbao N, Vidal B, Gonzalez-Romero D, Diaz-Domin - guez F, Revuelto J, Blasco M, Domezain M, Pavia- Pesquera M, Perez Ruiz M, Pobo A, Gomez-Acebo I, Gonzalez-Castro A, Grupo Trabajo ADENI. - V, Segarra A, Polaina M, Martin-Reyes G, Robles N, Escudero V, Orellana C, Bea Granell S, de Juan-Ribera J, Fernandez Lucas M, Grana J, Reque J, Sanchez Hernandez R, Villamayor of J, Morano L, Rivero A, Tellez F, Rios MJ, Santos M, Serrano M, Palacios R, Merino D, Real LM, De Los Santos I, Vera Mendez J, Sandi C, E, Nacher J. Long term varro C, Valente F, Monmeneu J, Lopez-Lereu M, Ferreira-Gonzalez I, Garcia Del Blanco B, Otaegui I, Canoves Femenia J, De Dios Lluch E, P\u00e9rez Sol\u00e9 N, Racugno P, Bonanad Lozano C, Mi\u00f1ana Escriva G, Marcos Garc\u00e9s V, Barrabes J, Evangelista A, Mora - tal D, Bayes-Genis A, Nu\u00f1ez Villota J, Chorro A, Masciulli Ghirardi A, Rossi G, Harrison C, Alvarez-Larran A, Elli E, Ki - ladjian J, Kabat M, A, Palandri F, Andrade- Campos M, Vannucchi A, Carreno-Tarragona G, Papadopoulos P, Cervantes K, Foncillas M, Fox M, Serrano M, Rumi E, Osorio S, Benevolo G, Patriar - ca A, Elorza B, Garcia-Gutierrez V, Mazo E, Lunghi F, Bonifacio M, De Stefano V, Hernandez-Boluda J, Abadia E, Angona A, Cirici B, Ruggeri M, Kosch - mieder S, Sobas M, Cuevas B, Cattaneo D, Daffini R, Bellini M, Curto-Garcia N, Garrote M, Cavalca F, Benajiba L, Bellosillo C, Fernandez-Cisnal A, Valero E, Minana G, Mollar A, 320 320 INCLIVA SCIENTIFIC REPORT 2021publication J, E, Garcia-Fernandez A, Canadas-Godoy M, Jimenez-Ramos V, Oloriz T, Basterra N, Calvo D, Pe - rez-Alvarez L, Arias M, Exposito V, Aleman A, Diaz- Infante E, Guerra-Ramos J, Fernandez-Armenta J, Arce-Leon A, Sanchez-Gomez J, Sousa P, Bolao Baluja A, Campuzano O, Sarquella-Brugada G, Martinez-Sande J, J, Brugada J, C, Garcia-Blas S, Ruiz V, Fer - nandez-Cisnal A, Sastre C, Ruescas A, Valero E, Gonzalez 33498816 436. Olea B, Albert E, Torres I, Gozalbo-Rovira R, Car - bonell N, Ferreres J, Poujois S, Costa R, Colomina J, Rodriguez J, Blasco M, Navarro D. Lower res - piratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: relationship with biomarkers Collado Sanchez A, Davies J, Rzeniewicz K, Abukscem S, Joachim J, Hoskins Green H, Ki - llock D, Sanz M, Charras G, Parsons Girerd N, Conangla L, de An - tonio M, Moliner P, Santiago-Vacas E, Codina P, Ce - diel G, Spitaleri G, Gonzalez B, Diaz V, Rivas C, Ve - layos P, Nunez J, Bayes-Genis A. Lung ultrasound in outpatients with heart N, Camps C, Insa A, Juan O, Massuti B, Paredes A, Artal A, Lopez-Brea M, Palacios J, Felip E. LungBEAM: a prospective multicenter study to monitor Canoves of subsequent events in a multicenter STEMI Registry. Journal of - lance in older patients with disease 9443. Suria C, Bosca-Watts MM, Navarro P, Tosca J, Anton R, Sanahuja A, Revaliente M, Minguez M. Management of patients with Intestinal Bowel Di - sease and COVID-19: a review of current evidence and future perspectives. Gastroenterologia y He - E, M, A, J, Cano San - chez A, Ceausu I, Chedraui P, Durmusoglu F, Erkko R, Goulis D, Kiesel L, Lambrinoudaki I, Hirschberg A, Lopes P, Pines A, Rees M, van Trotsenburg M, Simoncini T. Mantrana I, Calatayud M, Pa - rra-Llorca A, Martinez Costa C, Collado M. Mater - nal diet during pregnancy and intestinal markers are associated with early microbiota. Euro - pean Journal of na I, Calatayud M, Gonzalez S, Martinez-Costa C, Collado M. Maternal milk microbiota composition mode of and P, A, Dominguez E, Ram\u00f3n Ferrandis J, Lopez L, Mollar Fernandez A, Chorro Gasc\u00f3 F, Sanchis Fores J, Nu\u00f1ez J. Ma a predictor al, MAPBM Working Group. Maturity assessment model for patient Bergua J, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lopez J, Vidriales M, Labrador J, Falantes J, Sa - yas M, Ayala R, Martinez-Lopez J, Villar S, Calasanz M, Prosper F, San-Miguel J, Sanz M, Montesinos residual 450. Chinesta J, Bures E, Ferrer Espinosa S, Lahosa C\u00f3rdoba C, Signes-Costa Mi\u00f1ana J, Ser - vera Pieras E. Mechanical insufflation-exsufflation with oscillations in Amyotrophic Lateral Sclerosis with home PMID: 33082217 451. Martinez Gomez M, L\u00f3pez S\u00e1iz A, Ferrer Gon - zalez J, Pin Arboledas G. Meckel's double di - verticulum. About a case. Anales Carballo Perez-Sayans M. Medication-rela - ted osteonecrosis of the jaw: a critical narrative les hyperactiva - tion simulating an 454. Oriola G, Real Pe\u00f1a L, Pastor Escartin F, Talamantes Escriba F. Merkel cell carcinoma spi - - rinas F, Abanades S, de la Cruz-Merino L, Noguera 322 322 INCLIVA SCIENTIFIC REPORT 2021publication list9R, Alvaro Naranjo T. Metabolic classification M, Hilpert M, Navas-Acien A, Tellez-Plaza M, Pla 1 S, Zhou H, Perez-Cremades D, Sun X, Chen L, Li J, Haneo-Mejia J, Yang T, Hollan I, Feinberg - bio-del-Campo A, Vila-Vicent S, Munoz C, Yebra M, Monedero de - pletion promotes human rotavirus R, Bustos B, Simo G, Farinos J, Navarro I, de Miquel V, Sanchez R, Marco V, Ros M, Suela S, Estrada R. MicroRNAs expression associated J. Mid-term prognostic implication of hospitalized COVID-19 Ga - yer-Anderson C, Stilo S, Suprani F, Iyegbe C, van der Ven E, Quattrone D, di Forti M, Velthorst E, Rossi Menezes P, Arango C, Parellada M, Lasalvia A, La Cascia C, Ferraro L, Bobes J, Bernardo M, San - juan I, Santos J, Arrojo M, Del-Ben C, Tripoli G, Llor - ca P, de Haan L, Selten J, Tortelli A, Szoke A, Mu - ratori R, Rutten B, van Os J, Jones P, Kirkbride J, Berardi D, Murray R, Morgan C. Migration history and risk of psychosis: results from the 464. Tarazon E, Bustos B, Estal R, Simo G, Torralba A, Simarro J, Suela S, Estrada R. MiR-138-5p sup - presses Bestepe F, Ozdemir D, Niosi angiogenesis and insulin resistan - L, Tri - fuoggi consumption - the R, Lorente-Rovira E, Ayesa-Arriola R, Setien-Suero E, Barajas A, Grasa E, Ruiz-Delgado I, Gonzalez-Higueras F, Cid J, Ochoa S. Moderators insight in Mas A. Molecular and cellular insights into the development of ute - rine fibroids. International Journal of Cejalvo JM, Gonzalez-Barrallo I, Mar - tin-Arana J, Tebar-Martinez R, Viala A, Bruixola G, Hernando C, Blasco I, Papaccio F, Martinez-Ciar - paglini C, Alfaro-Cervello C, Seda-Garcia E, Blesa S, Chirivella I, Castillo J, Monton-Bueno JV, Rose - llo S, Huerta M, Perez-Fidalgo A, Martin-Marto - rell P, Insa-Molla A, Fleitas T, Rentero-Garrido P, Zuniga-Trejos S, Cervantes A, Roda D. Molecular profiling of advanced solid tumours. The impact 01502-x. PMID: Oliver L, Lopez Montero A, Gil Hernandez I, Garcia Ibor F, Vela Bernal S, Duch Samper AM. Moni - toring therapy in anterior necrotizing - banez A, Ramon Quiles MD. Morpheaform plaques and an - banez A, Ramon Quiles MD. Morpheaform plaques and an infiltrated scar: challenge. American - Morphological variations of the conduction sys - tem in the atrioventricular zone and its clinical re - lationship in Anatomical analysis horses comparative histological and immunohistochemical study with findings in human the and other Santiago-Vacas E, Codina P, Zamora E, Cediel G, Santesmases J, Diez-Quevedo C, Troya M, Boldo M, Altmir S, Alon - so N, - ty trends in an ambulatory multidisciplinary heart failure unit from to 2018. M, Cimadomo D, Benini F, Farcomeni A, Cuzzi J, Rubio C, Albani E, Sacchi L, Vaiarelli A, Fi - gliuzzi M, Findikli N, Coban O, Boynukalin FK, Vogel I, Hoffmann E, Livi C, Levi-Setti PE, Ubaldi FM, Si - mon C. Mosaic human preimplantation embryos and their developmental potential in a prospecti - non-selection clinical M, Lecumberri P, Moreno-Izco L, Lopez- Ilundain J, Ribeiro M, Cabada T, Lorente-Omena - ca R, de Erausquin G, Garcia Marti G, Sanjuan 324 324 INCLIVA SCIENTIFIC REPORT 2021publication list9Arias J, Sanchez-Torres A, Gomez M, Peralta V. Motor and basal ganglia in first- Gonzalez- Bermejo J, Benditt J, McKim D, Sancho J, Hov B, Sansone V, Prigent H, Carlucci A, Wijkstra P, Ga - rabelli B, Escarrabill J, Pinto T, Audag N, Verweij- van den Oudenrijn L, Ogna A, Hughes Devaux Artigues E, Escri - va J, Morcillo E, Cortijo J. MUC4 is overexpressed in idiopathic pulmonary B, Alegria E, Fernandez-Cis - nal A, Escribano D, Bautista J, Juskova M, Trillo R, Bertomeu-Gonzalez V, Ferreiro J. in brain injured pa - tients: the VENTIBRAIN BMJ CB, Dare LR, Lima KR, Lopes LF, Santos A, Garcia Dos A, Schimidt HL, Carpes FP, Lloret A, Vina J, Mello-Carpes P. Multicomponent training pre - vents memory deficit related Pastorelli R, Escudero-Garcia D, Tosca J, Urios A, Conesa A, Montoliu C. Multi-omic analysis unveils bio - logical Teruel A, Doracratto D, Munoz-Forner Ortega-Serrano J, Sabater L. Multiple perforations intestinal extranodal na 87. Sabater-Arcis M, Garcia J, Vilchez M, Segales J, Oliveira L, Garcia-Dominguez E, Gomez-Cabrera M, Serrano A, Gomes E, Munoz-Canoves P. Mus - cle repair after physiological damage R, Calasanz M, Irigoyen A, Sanz G, Such E, Mora E, Gutierrez M, Collado R, Garcia-Serra R, Vara M, Blanco M, Oiartzabal I, Alvarez S, Bernal T, Granada I, Xicoy B, Jerez A, Calabuig M, Diez R, Gil A, Diez- Campelo M, Solano C, Tormo M, Spanish Grp the Drug Discovery I, Pla L, Santiago-Felipe S, Simon S, Ortega B, Bermejo B, Lluch A, Cejalvo J, Eroles P, la Merenciano- Gonzalez H, Santas E, Chorro F. Native Ferri J, Cortes D, Cabedo N. Natural products and ana - Romero B, Menendez B, Bernal S, Idigoras P, Colomina J, Martin-Saco G, Leal-Negredo A, To - rreblanca A, O, J. resistance in Spain: T, Oliveira M, Villagrasa P, Ortega V, Pare L, Bermejo B, Morales S, Amillano K, Lopez R, Gal - van P, Canes J, Salvador F, Nuciforo P, Rubio IT, Llombart-Cussac A, Di Cosimo S, Baselga J, Har - beck N, Prat A, Cortes Chillon Larrayoz M, Carri - llo-Cruz E, Bilbao C, Yebenes-Ramirez M, Llop M, Rapado I, Garcia-Sanz R, Vazquez I, Soria E, Flori - do-Ortega Y, Janusz K, Botella C, Serrano J, Marti - nez-Cuadron D, Bergua J, Amigo M, Martinez-San - chez P, Tormo Diaz M, Bernal T, Herrera-Puente P, Garcia R, Algarra L, Sayas M, Costilla-Barriga L, Perez-Santolalla E, Marchante I, Lavilla-Rubira E, Noriega V, Alonso-Dominguez J, Sanz M, Sanchez- Garcia J, Gomez-Casares M, Perez-Simon J, Ca - lasanz M, Gonzalez-Diaz M, Martinez-Lopez J, Ba - rragan E, Montesinos P. Networking for advanced molecular diagnosis in Navarro Lopez-Guerrero J, Verdini L, Picci P, Giner F, Llombart-Bosch A. Neuroendocri - ne differentiation in a large series genetically- Ewing's M, de Filippis R, Ayesa-Arriola R, Gonzalez-Vivas C, Setien-Suero review and meta-analy - sis. Revista Psiquiatria y P, Seijo-Fernandez F, Paz J, Garcia March G, Santos-Lasaosa S, Latorre G, Gonzalez- Oria C, Rodriguez R, Pozo-Rosich J. Neuromodulation in headache and craniofacial neuralgia: guidelines from the Spanish Society of Neurology and Spanish Society of Rubio C, Racowsky Barad D, Scott R, Simon C. aneuploidy in C. aneuploidy: L, Rozas I, Arroyo-Espliguero R, Viana-Llamas M, Romero R, Eid C, Uribarri A, Becerra-Munoz V, Huang J, Alfonso E, Marmol-Mosquera F, Ugo F, Cerrato E, Fernandez-Presa L, Roubin S, Guzman G, Gon - zalez A, Abumayyaleh M, Fernandez-Ortiz A, Ma - caya C, acute doi: 10.1136/emer - 33727235 510. Cases A, Gomez P, Broseta J, Bernat E, Barrio - nuevo J, Portoles J, Gorriz J. Non-valvular atrial fibrillation in oral anticoagulants. A, Quintero-Garcia D, Mendez-Echevarria A, Ramos E, Bueno F, Colo - mina J, Mari-Lopez J, Crehua-Gaudiza E, Garcia- Rodriguez J, Martinez-Costa C. Non-wild-type cryptococcosis in a child with multivisceral Ivorra M, No - guera M, Zambrano A, Sirerol-Piquer M, Requena A, Garcia-Alonso M, Tejerina T, Real J, Farinas I, perative outcomes in enhanced recovery colorec - tal Alegre- Rodr\u00edguez-Arribas Camello PJ, Pedro Perez-Castillo RA, Fuentes JM, Reula A, Pellicer D, Castillo S, Magallon M, Armen - got M, Herrera G, O'Connor J, Banuls L, Navarro- Garcia M, Escribano A, Dasi F. New laboratory protocol to determine the oxidative stress profi - le of human nasal epithelial cells flow cyto - metry. Journal - menez-Galanes S, Mora-Oliver I, Sabater L, Huber T, Lang H, Brusadin R, Lopez Conesa A, Melendez R, Castro Santiago MJ, T, Puig-Perez S, Nacher J, Hidalgo V, Salvador A. No effects of acute psychosocial stress on working memory in older people with - crig-Sos J, Poves-Prim I, Fabregat-Prous J, Larrea Y Olea F, Carretero- Ribon C, Aicart-Ramos M, Valenzuela J, Alonso- Lazaro N, Luis Martin-Lorente J, Galvez Castullo C, Pons-Beltran V, Fernandez-Urien I, Gonzalez-Sua - rez B, SEED group of capsule endoscopy and ente - roscopy. Oral ingestion versus endoscopic delivery Soriano B, Zhang F, Gallach S, Bagan L, Murillo J, Jantus-Lewintre E, Bagan Tapia M, Moragon S, Martinez M, Eroles P, Garrido-Cano I, Adam-Ar - tigues A, Lluch A, Bermejo B, J. Oral Selec - tive a present and future from a clinical perspective. Molecular Sciences. 2021 Jul 22;22(15):7812. 10.3390/ijms22157812. PMID: 34360578 522. Collado E, Marques P, Perello E, Mar - t\u00ednez-Herv\u00e1s S, Piqueras L, Ascaso JF, Real JT, Sanz MJ. unsaturated J, Rojas R, Mata D, Silvestre A. Osteosarcoma of the trapezium. using RB, Murugappan G, La - barta E, Vidal C, Giles J, Cabanillas S, Marzal A, Ga - lliano D, Ruiz-Alonso M, Simon C, D. Obe - Alvarez-Pitti J, Wojcik - bianelli R, Mazur A, Herceg-Cavrak V, Gonzalez Lopez-Valcarcel E, Garcia Y, Igle - sias M, Bohn Sarmiento U, Calvo Garcia E, Manso Sanchez L, Santaballa A, Oaknin A, Redondo A, Ru - bio M, Gonzalez-Martin A. F, Tolone S, Docimo C, Mata M. Optimiza of decellularization cryopreserva A 328 INCLIVA SCIENTIFIC REPORT 2021publication list9529. Hidalgo-Mora J, Tarin J, Cano A. Ovarian and cancer: news on the Gavara J, Marcos-Garces V, Forteza M, Oltra R, Vila J, Chorro F, Bodi V. Overexpression of genes invol - ved in and are Gonza - lez-Navarro function late Free Radical Biology & tion, validation of the bioche - mical pathways involved. Cas - tillo S, S, - mos-Munoz M, Saez G, Torregrosa I, Estan-Capell N, Miguel E, Poire X, Passweg J, Radujkovic A, Platzbecker U, Robinson S, Rambaldi A, Petersen S, Stolzel F, Stelljes M, Ciceri F, Mayer J, Ladetto M, Wreede Koster Hayden E, Maciejews - J, Cirici B, Kaivers J, Ungerstedt J, Heibl S, Patiou P, Hunter A, Mora E, Geissler K, Dimou M, Ji - menez Lorenzo M, Melchardt T, Egle A, Viniou A, Pa - tel B, Arnan M, Valent P, Roubakis C, Bernal Del Cas - tillo T, Galanopoulos A, Calabuig Munoz M, Bonadies N, Medina de Almeida A, Cermak J, Jerez A, Mon - toro M, Cortes A, Avendano Pita A, Lopez Andrade B, Hellstroem-Lindberg E, Germing U, Sekeres M, List A, Symeonidis A, Sanz G, J, de la Cruz J, Macia I, Campuzano I, Al - manzar S, Roel M, Munoz C, Fontan E, Trueba I, Vielva L, Garcia J, Tellez E, Gonzalez C, Lopez M, Maestre U, Poce R, Lorente D, Kindelan A, Pulla Paraneoplastic J. - Morillo V, Manzano A, Suarez M, Parra H, Lameda V, Nava M, D'Marco L, Puchades M, Me - dina O, Guerra-Torres clinical and molecular perspective. Ana - les del Sistema Sanitario de Navarra. 2021 Dec 27;44(3):445-456. doi: 10.23938/ASSN.0973. PMID: 34664556 F, Saldana R, Carpio D, Minguez M, Vera I, Marin L, Julia B, GETECCU G. Patient- evaluated quality of care Bosnyak Z, Climens AR, Bigot G, Peters Renard E, Berard L, - lliari LE, Seufert J. Patient-reported outcomes in adults with diabetes global clinical practice: Penaranda N, Urios A, Gallego J, Gimenez-Garzo C, Casanova F, Fiorillo A, Cabrera- Pastor A, San-Miguel T, Ipiens C, Escudero-Garcia D, Tosca J, Monton C, Ballester M, Ballester J, Aparicio L, Rios M, Durban L, Mir A, Kosenko E, Cases P, Felipo V, Montoliu C. Patients with mini - mal International Journal of Journal of Cutaneous Medicine and Sur - S, Garcia-Vazquez A, Canales I, Monteagudo C. Painful cu - taneous lesions on the hand coronary angiography. Clinical 33091167 539. Martin M, Zielinski C, Ruiz-Borrego M, Carrasco E, Turner N, Ciruelos E, Munoz M, Bermejo B, Margeli M, Anton A, Kahan Z, Csoszi T, Casas M, Murillo L, Morales S, Alba E, Gal-Yam E, Guerrero-Zotano A, Calvo L, Haba-Rodriguez J, Ramos M, Alvarez I, Garcia-Palomo A, Bartlett C, Koehler M, Caballe - ro R, Corsaro M, Huang X, Garcia-Saenz J, Cha - con J, Swift C, Thallinger C, Gil-Gil M. Palbociclib in combination with endocrine ca Oki E, Martinelli E, Taniguchi H, Arnold D, Mishima S, Li Y, Smruti B, Ahn J, Faud I, Chee C, Yeh K, Lin P, Chua C, Hasbullah H, Lee M, Sharma A, Sun Y, Curigliano G, Bando H, Lordick F, Yamanaka T, Tabernero J, Baba E, Cervantes A, Ohtsu A, G. Pan-Asian Clinical Guideli - nes the treatment and follow-up of pa - tients Koenen K, Borba C, Quattrone D, Di Forti M, Tripoli G, La Cascia C, La Barbera D, Ferraro L, Tarricone I, Berardi D, Lasalvia A, Tosato S, Szoke A, Llorca P, Arango C, Tortelli A, de Haan L, Velthorst E, Bobes J, Bernar - do M, Sanjuan J, Santos J, Arrojo M, Del-Ben C, Menezes P, Selten J, Jones P, Jongsma H, Kirkbri - de J, Rutten B, van Os J, Murray R, Gayer-Ander - son C, Morgan C. Perceived major experiences of discrimination, ethnic group, and risk of psycho - sis in a six-country case-control study. Psycho - logical Medicine. 2021 Mar 2;1-9. doi: 10. 1017 / S0033291721000453. PMID: 33648622 553. Torres I, Albert E, Gimenez E, Olea B, Valdivia A, Pascual T, Huntley D, Sanchez D, Costa RM, Pin - to C, Oltra R, Colomina J, Navarro D. Performan - ce of a MALDI-TOF spectrometry-based method detection of M, M, Agustin-Panadero R. Periodontal behavior and pa Revilla-Leon M, Agustin-Panade ro Di Martino M, Primavesi F, Syn N, Dorcaratto D, de la Hoz Rodriguez A, Dupre A, Piardi T, Rhaiem R, Blanco Fernandez G, Prada Villaverde A, Rodri - guez Sanjuan J, Fernandez Santiago R, Fernandez- Moreno M, Ferret G, Lopez Ben S, Suarez Munoz M, Perez-Alonso A, Koh Y, Jones Vega-Diez D, Garcia-Muret P, Haya L, Penate Y, Acebo E, Fernandez de Misa R, Blanes M, Suh-Oh HJ, Izu R, Silva-Diaz E, Sarriugarte J, R, Mateu-Puchades A, Prieto- Torres L, Morillas V, Morillo M, Sanchez-Caminero P, Calzado L, Perez-Ferriols A, Perez A, Dominguez M, Muniesa PL. with primary cutaneous lymphoma are at risk severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry. Journal of Asensi Monzo M, Julia Benito J, Ortega Casanueva C, Paniagua Calzon N, Perez Garcia M, Rodriguez Fernandez-Oliva C, Sanz Ortega J, Val - desoiro Navarrete L, Valverde-Molina J. Pediatric Lopez-Miranda E, Alonso JL, Bermejo B, Calvo L, Caranana V, de la Cruz Sanchez S, Vaz - quez RM, Prat A, Borrego MR, Sampayo-Cordero M, Segui-Palmer MA, Soberino J, Malfettone A, Schmid senti - nel Uro - 2021 33650543331 Diaz E, Amezaga Menendez R, Vidal Cortes P, Es - capa M, Suberviola B, Serrano Lazaro A, Marcos Neira P, Quintana Diaz M, Catalan Gonzalez M. Pharmacological treatment of COVID-19: narrative review of the Working Group in Infectious Disea - ses and Sepsis (GTEIS) and the Working Groups in Transfusions and C, Gambardella V, Melnyk A, Patel M, Ribrag V, Ma C, Aljumaily R, Bedard P, Sachdev J, Dunn L, Won H, Bond J, Jones S, Savage H, Scaltriti M, Wilson T, Wei M, Hyman D. Phase I Basket study of taselisib, - ga L, de la Cerda-Ojeda F, Fernandez-Fernandez M, de Lucas-Collantes C, Gil M, Luis-Yanes M, Vergara I, Gonzalez-Rodriguez J, Ferrando S, Anton-Game - ro M, Carrasco Hidalgo-Barquero M, Fernandez- Escribano A, Fernandez-Maseda M, Espinosa L, Oliet A, Vicente A, Ariceta G, Santos F, Renal Tube Phenotypic I, Gil-Calvo M, Aparicio I, de Anda R, Perez-Soriano P. Plantar pressure distribution during running with a self-customized foot ortho - sis in a home microwave. Navarro D, Martin-Latil S, Rodriguez Padial L, Barbera J, Lopez-Meseguer M, Lopez- Reyes R, Sala Llinas E, Alcolea S, Blanco I, Escri -E. Catena F, Tac - cone F, Fornaciari A, Votta D, Badenes R, Bilotta F. management - going emergency surgery: narrati - Dec 21;11(1):18. doi: 10.3390/jcm11010018. PMID: A, Sanz MJ, Ascaso JF, Piqueras L, Real JT. blood for diabetic polyneuropathy in subjects with type - neal invasion and metachronous peritoneal me - Birules I, Barajas A, Lorente-Rovira E, Diaz-Cutra - ro L, Verdaguer M, Garcia-Mieres H, Sevilla-Llewe - llyn-Jones J, Gutierrez-Zotes A, Grasa E, E, Pelaez T, Barrigon ML, Gonzalez- Higueras F, Ruiz-Delgado I, Cid J, Moritz S, Ochoa S. Persons with first episode psychosis have distinct profiles of in vitro studies, Pinana J, Montoro J, Oar - beascoa G, Dorado N, Gomez-Centurion I, Munoz C, Martinez-Laperche C, Anguita J, Kandimalla R, Casa - nova B. Potential biomarkers associated with mul - tiple sclerosis pathology. International Journal of Molecular Sciences. 2021 Sep 25;22(19):10323. PMID: Lyakhovich A, Tiano L, Trifuoggi M. Potential - adjuvant mitigation of proinflammatory acute in the case and pneumo - nia. Inflammation Mueller C, Filippatos G, Nowak R, Hogan C, Kon - tos M, Cannon C, Mueller G, Birkhahn R, Taub P, Vilke G, Barnett O, McDonald K, Mahon N, Nu - nez J, Briguori C, Passino C, Maisel A, Murray Solek-Pastuszka San-Miguel T, Valles S, Aldasoro M, Vila J, Zarzoso M, Mauricio M. PPARgamma as an indicator of vascular function in an experimental model of metabolic syndrome in prognosis and in current treatment era. Results from the REHAP Registry. Internal Medici - ne Journal. J, Tarin J, Cano A. Positive association - cholesterol R. Pos - ancestral functions of the genetic and RNA operational precodes and the origin of the genetic system. Origins of life and G, Ghidini M, Nigro O, Gelsomino F, Zur - lo IV, Fulgenzi C, Lombardi P, Rosell\u00f3 Ker\u00e4nen S, Depetris I, Giampieri R, Morelli C, Di Marino P, Di Pietro FR, Zanaletti N, Vitale P, Garajova I, Spinelli GP, Zoratto F, Roberto M, Petrillo A, Aimar G, Pa - truno L, D'Orazio C, Ficorella C, Ferri C, Porzio G. - ve ctDNA monitoring: a canary Alabadi B, Martinez-Hervas S, Peiro M, Gonzalez-Navarro H, Piqueras L, Jesus Sanz M, Ascaso J, Real J. Post - prandial triglyceridemia is modulated by insulin re - sistance but not by grade of obesity in abdominal and morbid obese C, Sanz J, Gallardo-Morillo A, Garcia-Sola A, Torrent 333 333 INCLIVA SCIENTIFIC REPORT 2021publication list 9584. Capalbo A, A, Shukla V, Kudo Hoffding M, Krausz C, Hoffmann E, Simon Valles C. Preconception genome medicine: current sta - te and future infertility diagnosis and reproductive M. Predicting health-related quality of life in Spanish adolescents with aller - gic rhinoconjunctivitis and bronchial can - cer mortality in Europe in 2021: room for hope in the shadow of COVID-19?. Lopez-Garcia M, Martin-Salvago M, Ra - mirez-Tortosa C, Rezola R, Sancho M, Lopez-Vilaro L, Villardell F, Burgues O, Fernandez-Rodriguez B, Alfaro L, Peg V. Predictive and prognostic value of total 34830543 A, Rey-Ranal E, Moreno M, Escribano D, Moreno-Arribas J, Quintanilla M, Zuazola P, Nunez J, Bertomeu-Gonzalez V. Predictive value through segmentation gene mu D, Frana M, Bachmann R, Mazzucco J, Marti-Bonmati L. Precise whole liver automatic segmentation of S, Casadevall D, Galbardi B, Dugo M, Servitja S, Montero J, Soria-Jimenez L, Sabbaghi M, Pena R, Madoz-Gurpide J, Lloveras B, Lluch A, Eroles P, Arribas J, Pandiella A, Gianni L, Rojo F, Rovira A, Albanell J. Preclinical and J, Vilchez JJ, Lopez Munain Varela MA, Wood P, Leo B, Laux-Biehlmann A, Hoff - mann A, Zollner T, Saunders P, Simitsidellis I, Cha - rrua A, Cruz F, Gomez R, Tejada M, McMahon S, Lo Re L, Barthas F, Vincent K, Birch J, Meijlink J, Hum - melshoj L, Sweeney P, Armstrong J, Treede R, Nagel J. D, Blazquez-Estrada M, Calopa M, Escamilla-Sevilla F, Freire E, Garcia Ruiz P, Gran - das F, Kulisevsky J, Lopez-Manzanares L, Martinez Castrillo J, Mir P, Pagonabarraga J, Perez-Erraz - quin F, Salom J, Tijero B, Valldeoriola F, Yanez R, Avi - les A, Luquin M. Present and future of Parkinson's disease in Spain: PARKINSON-2030 Delphi F, van Tri - cht M, McGuire P, Morgan C, Gayer-Anderson C, Kempton M, Valmaggia L, Quattrone D, di Forti M, van der Gaag M, Kirkbride J, Jongsma H, Jones P, Parellada M, Arango C, Arrojo M, Bernardo M, Sanjuan Arias J, Santos J, Szoke A, Tortelli A, Llor - ca P, Tarricone I, Tripoli G, Ferraro L, La Cascia C, Lasalvia A, Tosato S, Menezes P, Del-Ben C, Nel - son B, Riecher-Rossler A, Bressan R, Barrantes- Vidal N, Krebs M, Nordentoft M, Ruhrmann S, Sachs G, Rutten B, van Os J, Velthorst E, de Haan L, EU-GEI High Risk Study. Pre-training inter-rater reliability of instruments in an Nadal E, Insa A, Garcia-Campelo R, Lazaro M, Domine M, Majem M, Rodriguez-Abreu D, Martinez-Marti A, de Cas - tro-Carpeno J, Cobo M, Lopez-Vivanco G, Del Bar - co E, Bernabe Caro R, Vinolas N, Barneto Aranda I, Viteri S, Massuti B, Barquin M, Laza-Briviesca R, Sierra-Rodero B, Parra E, Sanchez-Espiridion B, Rocha P, Kadara H, Wistuba I, Romero A, Calvo V, Provencio M. Pre-treatment tissue TCR repertoi - re evenness Arroyo-Es - pliguero R, Eid C, Romero R, Uribarri A, Fernan - dez-Rozas I, Aguado M, Becerra-Munoz V, Huang J, Pepe M, Cerrato E, Raposeiras S, Gonzalez A, Franco-Leon F, Wang L, Alfonso E, Ugo F, Garcia- Prieto J, Feltes G, Abumayyaleh M, Espejo-Paeres C, Arenal A, Ruiz Granell R, San - chez Gomez J, Perez L, Martinez-Ferrer J, Alzueta J, Perez-Lorente F, Vinolas X, Fidalgo Andres M, Fernandez de la Concha J. Predictors of adoption and impact Ruiz M, Ferreyro B, Angriman F, Arruti E, Torres A, Barbeta E, Villar J, Ferrando C, COVID-19 Spanish ICU Network. Pre - dictors of failure with high-flow nasal oxygen thera - py in COVID-19 respiratory - lure: a Becerra- Munoz VM, Alfonso-Rodriguez E, Huang J, Ortega- Armas ME, Pepe M, Gonzalez A, Bertolazzi M, Cerrato E, Quezada A, Raposeiras-Roubin O, Feltes-Guzman G, Pardo F, Sabater L, Lopez Ben S, Quijano MY, Villegas T, Blanco Fernandez G, Diez Valladares L, Lopez Rojo I, Martin Perez E, Pereira F, Gonzalez AJ, Herrera J, Garcia go Molina I, Martinez-Alday J, of a home-based primary care service in an urban area of Barce - lona (Spain): an observational study and cluster analysis. Bardaji A, Marin F, Ruiz-Nodar JM, Ibarra Alonso GL, E, Formiga F, E, Ariza-Sole A, Sanchis J. Prognosis impact of diabetes in elderly women and men with non-ST elevation acute coro - Fernandez-Vazquez F, Arzamendi D, Pan M, Pascual I, Nombela-Franco L, Amat-Santos I, Freixa X, Hernandez-Antolin R, Trillo-Nouche R, Ikazuriaga L, Lopez-Minguez J, Cervera D, Sanchis J, Diez-Gil J, Ruiz-Quevedo V, Urbano-Carrillo C, Becerra-Munoz V, Benito-Gonzalez T, Li C, Mesa D, Avanzas P, Armijo G, Serrador-Frutos A, Sanchis L, Loban C, Cid-Alvarez B, Hernandez-Garcia J, Garro - te-Coloma C, E, Romero M, Arguero V, Cruz-Gonzalez I. Prognostic role of TAP - SE to PASP ratio in patients undergoing mitraclip J, Estrada and 30-day mortality in hospitalized Tena I, Chirivella I, Richart-Az - nar P, Segura A, Sanchez-Heras A, Martinez-Due - nas E. Prevalence and clinicopathological La Calle G, Orun O, Chen W, Raman R, Simpson B, Wilson-Linville S, Hinojal Olmedillo B, Vallejo de la Cueva A, van der Jagt M, Navarro Casado R, Leal Sanz P, Orhun G, Ferrer Gomez C, Nunez Vazquez K, Pineiro Otero P, Tac - cone F, Gallego Curto E, Caricato A, Woien H, La - cave G, O'Neal H, Peterson S, Brummel N, Girard T, Ely E, Pandharipande P, COVID-19 Intensive Care International Study Group. Prevalence and risk factors for delirium in critically CO - (COVID-D): Dasi F, Saez G, Carrera E, Alvarez-Gallego F, Loeken M, Viana M. Prevention of teratogenesis in - J, Sanchez C, Pajares P. Primary care at home in the framework of the COVID-19 pandemic. Atencion Primaria. 2021 Mar;53(3):101963. - ginning in childhood and risk for Valles E, Barrera A, Toquero J, Ormaetxe J, Sanchez J, Ruiz-Granell R, Amador P, Rubio J, -336 REPORT novel parents adolescents: a cross-sectional and longitudinal analysis of the impact of the COVID pandemic. Journal Gea-Caballero V, Garcia-Molina Vinaspre-Hernandez R, Rodriguez-Velasco F, Juarez-Vela R. Psychological impact on the nur - sing professionals of the Rioja Health Service (Spain) due to the SARS-CoV-2 Virus. International Journal of Environmental Research and PMID: Queralt A, De Velasco J, Salvador-Sanz A, Jennings C, Wood D, Trapero I. Psycho-social factors in patients with cardiovascular I, Huntley D, Alcaraz M, Albert E, Colomina J, Ferrer J, Carratala A, Navarro D. Qualitative assessment R, Santas E, Zegri Reiriz I, Gorriz J, Cobo Marcos M, Nunez J. Quantification and treatment of congestion in heart failure: a cli - nical C, Palmer R, de Anda Moratal D. Quantitative analysis of real-time Montenegro A, Cardenal Alvarez A, Guerrero Jimenez F, Albiol Vi - nals P, Uso Blasco utility the qSOFA scale in patients Internal Medicine Benavent R, Pinto C, Ruiz A, San - chez MT, Noceda J, Redon BMC Emergen Kelm M, Sigal S, van Heerden P, Boumendil A, Artigas A, Cecconi M, Marsh B, Moreno R, Oeyen S, Bollen Pinto B, Szczeklik W, Leaver S, Walther S, Schefold J, Joannidis M, Fjolner J, Zafeiridis T, de Lange D, Guidet B, Flaatten H, Jung C, VIP2 study group. Provision of critical care for the elderly in Europe: a retrospective comparison of national healthca M, Klimczak P, Gramuntell Y, Couillard-Despres S, Na - J. PSA Depletion the differentiation of immature neurons in the of adult mice. International E, Esteba - nez A, Peredo A, Ruiz M, Monteagudo C, Quiles M. 337 337 INCLIVA SCIENTIFIC REPORT 2021publication list 9N, van den Heuvel M, Benkouar R, Findeisen H, Al - haddad I, Balbissi Barge-Caballero Ghazi Martens P, Mullens W. and design of the efficacy of a standardized diuretic protocol in acute heart failure study. Dec;8(6):4685-4692. - yonas A, de Castro E, Perez-Segura P, Canovas M, Gomez D, Moran L, de Tejada M, Segui E, Lopez G, Adrian S, Campos M, Olmos V, Portero B, Moyano M, Crespo J, Sanchez L, Rebollo M, Rivas P, Alto - zano J, Lescure A, Munoz-Martin A. Rationale, de - sign and methodology of TESEO study: a registry of thrombosis and neoplasia of SEOM (Spanish 32789772 628. Torres I, Qualai J, Albert E, Bueno F, Huntley D, Pou - jois S, Gil MT, Navarro D. Real-life evaluation of a ra - pid extraction-free SARS-CoV-2 (CO - VID-19 PCR Fast-L) MJ, Pa - yer A, Ortiz M, Perez I, Cuellar-Garcia C, Fernandez de la Mata M, Rodriguez A, Lario A, Delgado J, Go - doy A, Arguinano Perez JM, Berruezo MJ, Oliveira A, Hernandez-Rivas JA, Garcia Malo MD, Medina A, Garcia Martin P, Osorio S, Baltasar P, Fernandez- Zarzoso M, Marco F, Vidal Mancenido MJ, Smu Simonovich A, Lopez Rubio I, Suarez A, Fernandez Alvarez R, Lancharro Anchel A, Rios E, Losada Castillo MC, Perez Persona E, Garcia Munoz R, Ramos R, Yanez L, Bello JL, Loriente C, Acha D, Villanueva Villacampa G, Martinez-Cibrian N, Bai - len R, Lopez Corral L, Sanchez J, Guerreiro M, Ca - ballero A, Mussetti A, Sancho J, Hernani Morales R, Abrisqueta P, Solano Vercet C, Sureda A, Brio - nes J, Martin Garcia-Sancho A, Kwon M, I, San Miguel P, Martin-Gil J, Sam - pol-Bas Abreu-Sanchez of the different available techniques. Revista Espanola de Medicina Nu Cervantes Ruescas A, Ruiz V, Valero E, Bonanad C, Garcia-Blas S, Fernandez-Cisnal A, Gonzalez J, com parison exercise versus care in older with frailty after acute myo med.2020.09.019. Zara C, George V, Cobo-Marcos M, Knappe D, Shchekochikhin D, Lekhakul A, Klincheva M, Frea S, Miro O, Barker D, Borbely A, Nasr S, Doghmi N, de la Espriella R, Singh J, Bovolo V, Fialho I, Ross 338 338 INCLIVA SCIENTIFIC REPORT 2021publication list9resis (GEA). Recommendations for the Ada ge zo-Gonzalez N, Martinez-Navarro I, Hernando-Fus - ter B, Hernando-Domingo C. of inflam - mation, cardiac, and muscle damage biomarkers after running a marathon. Journal of Strength and Conditioning and meta-analy - of Oral Pathology & Medicine. 2021 doi: Gomez-Cabrera C, Carretero Correas AG, Olaso-Gonzalez G, Mom - peon A, Hermenegildo C, Novella S. Regulatory network analysis in estradiol-treated human en - dothelial cells. International Journal of ller C, Filippatos G, Nowak R, Hogan C, Kontos M, Cannon C, Mueller G, Birkhahn R, Taub P, Vilke G, Barnett O, McDonald K, Mahon N, Nunez J, Bri - guori C, Passino C, Maisel A, Murray P. Relation of and to diuretics to biomarker changes and outcomes in cute heart GETH Real-world of tisagenlecleucel for the treatment of relapsed or R, Borges M, Rascado P, Maseda E, Oliver A, Marco F, Adalia R, Aguilar G, Estella A, Lopez R, Marcos M, de Molina F, Garcia R, Salavert M, Gomez J, Poliakova Y, Pasquau J, Azan - za J, Arevalo G, P, P, del Barrio J, Pablo-Julvez L, Munoz-Negrete F, Zarranz-Ventura J, de la Colina J, Silva V, Jimenez- Alfaro I, Calonge-Cano M, Galindo-Ferreiro A, Casti - Duch-Mestres F, Elies-Amat D, Ortega-Usobiaga J, Saornil-Alvarez M, Cuadra - do A, Aramburu G, Carduch A, Coma J, Delpech S, Carceles J, Sanchez J, Sanchez P, Castano M, A, Ophthalmology Recommendations for ophthalmologic practi - ce during the res. Acta I, Iacoboni Alsina- Manrique L, de Heredia C, Fortuny-Guasch C, Gar - cia-Cadenas I, Garcia-Vidal C, Gonzalez-Vicent M, Hernani R, Kwon M, Machado M, Martinez-Gomez X, Maldonado V, Pla C, Pinana J, Pomar V, Reguera- Ortega J, Salavert M, Soler-Palacin P, Vazquez-Lo - pez L, Barba P, Ruiz-Camps I. Recommendations for screening, monitoring, prevention, Pascual Izquierdo C, Gonza - lez A, Viejo Llorente A, Valcarcel Ferreiras D, Se - bastian E, Garcia Candel F, Sarmiento Palao H, Go - mez Segui I, de la Rubia J, Cid J, Martinez Nieto J, Hernandez Mateo L, Goterris Viciedo R, Fidalgo T, Salinas R, Del Rio-Garma J, Grupo Espanol de Afe -339 339 INCLIVA SCIENTIFIC REPORT 2021publication list 9Carratala-Munuera C. Renal function and attribu - table risk of death and cardiovascular hospitali - zation in participants with diabetes from Lonn E, Mahfoud F, Emrich I, Mancia G, Redon J, Schmieder R, Sliwa K, Lehrke M, Marx N, Weber M, Williams B, Yusuf S, Mann J. Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular VM, Alfonso-Rodriguez Garcia-Prieto JF, Gonzalez A, F, Cerrato E, Bondia E, Raposeiras-Roubin S, Mendez JL, Espejo C, Lopez-Masjuan - yyaleh M, Corbi-Pascual M, Liebetrau C, Ramakris - hna H, V, Macaya C, A. Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for CO - V, Cervantes A, Fleitas T. Reply to the letter to the editor: adjuvant nivolu - mab for the management of - sidual disease in esophageal Schwartz G, Szarek M, Bittner V, Bhatt D, Diaz R, Goodman S, Jukema J, Loy M, Manvelian G, Pordy R, White P, Investigator. Relation of Lipoprotein(a) le - vels to incident type 2 diabetes and modification by O, Mezquida G, Moreno-Izco L, Merchan-Naranjo J, Amoretti S, Ruiz P, Gonzalez- Pinto A, Molina-Garcia M, Corripio I, Vieta E, Baeza I, Berge D, Penades R, Sanchez-Torres A, Cuesta M, Bernardo M, Castro-Fornieles J, PEPs Group. Relationship between cognition and age at on - set of first-episode psychosis: comparative study between M, Martin Hernandez-Navarro Huelamo - incertus the - L, Torous J, Arce D, Blanquer I, San - juan Arias J. ReMindCare, an app for daily clinical practice in patients with first episode psychosis: a pragmatic real-world study J, Menendez E, Perez-Navarro A, Fernandez-Gimenez A, Lopez-Pi - neda A, Quesada J, Pallares-Carratala V, Gil-Guillen V, Mart\u00edn Moreno J, Bleda-Cano J, Carrascosa S, 340 340 INCLIVA SCIENTIFIC REPORT 2021publication list9Genis A, De La Esprie - lla Juan R, Nunez E, Lorenzo Hern\u00e1ndez M, N\u00fa\u00f1ez Mar\u00edn G, Valero Picher E, Bod\u00ed Peris V, Chorro Gas - c\u00f3 Fores A, Bayes-Genis in heart failure. factors and management strategies associa - ted with non-response to aminosalicylates for maintenance treatment in ulcerative colitis. Revista de Arribas J, Vazquez A, Carne - ro M, Sarralde J, Cal-Purrinos N, Canovas S, Ma - roto L, Gutierrez F, Hornero F, Bautista-Hernan - dez V. Risk factors Manosa M, Ricart E, Nos P, Iglesias- Flores E, Vera I, Lopez-SanRoman A, Guardiola J, Taxonera C, Minguez M, Martin-Arranz MD, de Castro L, de Francisco R, Rivero M, Garcia- Planella E, Calvet X, Garcia-Lopez S, Marquez L, Gomollon F, Barrio J, Esteve M, Munoz F, Gis - bert JP, Gutierrez A, Hinojosa J, Arguelles-Arias F, Busquets D, Bujanda L, Perez-Calle JL, Sicilia B, Merino O, Martinez P, Bermejo F, Lorente R, Barreiro-de Acosta M, Rodriguez C, Garcia- Sepulcre MF, Monfort D, Canete F, Domenech disease. cohort study of the ENEIDA registry. Journal of Crohn's & Co -Martinez A, Salvador-Palmer R, Cibrian Ortiz de Anda R. Reproducibility of skin temperature response cold Game preli - minary study. International Journal of 31913869 Simon C, Ruiz M, Mol B, Valbuena D. Response to: comments on the V, Cervantes A, Rosell\u00f2 S, Fenocchio E, Milanesio M, Lombardi P, Ciardiello D, Martini G, Martinelli E, Ciardiello F, Troiani T, Napolitano S. Retrospec - tive study of regorafenib versus TAS-102 Cano A, Min - kin M, Rachon D, Ruan X, Beer A, Schnitker J, Henneicke-von iCR E, Minana G, Palau P, De La Espriella R, Lorenzo M, Nunez G, Sanchis J, Chorro FJ, Bayes-341 341 INCLIVA Bocigas I, Bures E, Mora H, Monclou E, Mulet A, Quezada A, Royo P, Signes- Costa J. ROX index as predictor of high flow nasal cannula therapy success Grinshpun A, Hamy AS, de Azambuja E, Carras - co Paluch-Shimon Poorvu C, Livraghi L, Ponzone R, De Marchis L, Po - goda K, Sonnenblick A, Villarreal-Garza C, Cordoba O, Teixeira L, Clatot R, Dieci FP, Puglisi F, Ferreira AR, Blondeaux E, Peretz-Yablonski T, Caron O, Saule C, Ameye L, Balmana J, Partridge AH, Azim HA, Demeestere I, Lambertini M. Safety of assisted variants in BRCA1/2 Ba - denes R, Taccone F, Helbok R, Thomas W, Pelosi P, C. profile of enhanced thrombo - strategies for critically ill COVID-19 pa - tients during the first wave of the pandemic: obser - vational report from Marrazzo N, Pecora D, Bottoni N, Solimene F, Schillaci M, S, Baiocchi C, Santoro A, Donzelli S, De Ruvo E, Lavalle C, Sanchez-Gomez J, Pas - tor J, Grandio P, Ferraris F, Castro A, Rebellato L, Marchese P, Adao L, Primo J, Barra S, Casu G. Safety, efficacy, and reproducibility of cavotricus - myasthenia - perience in clinical Alvarez F, Santos Rodriguez F, Martin Ramos S, Fernandez Novo G. Rituximab treatment in pediatric patients with J, Bravo Marques R, Chinchurreta Capote P, Lopez Tejero S, Gon - zalez Correa J, Mesa Prado F, Valle Alberca A, Ruiz Mateas F. Rivaroxaban PMID: 34514988 666. Rios Navarro C, Hueso Soler L, Diaz Cuevas A, Marcos Garc\u00e9s V, Bonanad Lozano C, Ruiz Sauri A, Vila Salinas J, Sanz Ferrando M, Chorro Gas - c\u00f3 F, Piqueras Ruiz L, Bod\u00ed Peris V. Role rro M, Lurbe I Ferrer E. Scientific mapping of the research output on hypertension in children and adolescents, 2010-2018. Journal Kozijn A, Polverelli N, Heras I, Perez A, Sanz J, Berghuis D, Vazquez L, Suarez-Lledo M, Itala-Remes M, Ozce - lik T, Iturrate Basaran I, Karakukcu M, Al Zahrani M, Choi G, Cuesta Casas M, Batlle Massana M, Viviana A, Blijlevens N, Ganser A, Kuskonmaz B, P, Yegin Gonza - lez-Vicent M, Rocha V, Ferster A, Knelange N, Na - varro D, Mikulska M, de la Camara R, Styczynski J, Infectious Diseases Working Party of the Euro - pean Society for Blood and, Marrow Transplanta M, Pereferrer F, Vilallonga R, Lopez O, Lo - pez A, Dejardin D, de Gordejuela A, Lopez-Barajas J, Carrasco M, Spanish Surg Assoc Collaborati - ve G. Seeking an a and sepsis: a narrative A, Jhaveri K, Varga A, Wong A, Schram AM, Ambrose H, Carr TH, safe an interna - tional prospective cohort 675. D'Marco MA, Gandia L, Ro - mero-Alcaide S, Gimenez-Civera E, Molina P, Pani - zo N, Reque J, Gorriz JL. SARS-CoV-2 vs. the population: what should we expect?. International Journal of Torres Fink I, Re - migia Pellicer M, Alcar\u00e1z Soriana M, Galindo Puerto M, Blasco Cortes M, Solano Vercet C, Forner Giner M, Red\u00f3n Mas J, Signes-Costa Mi\u00f1ana J, Navarro Ortega cells in patients B, Gimenez E, Laguna-Goya R, Trujillo H, Caravaca-Fontan F, Gutierrez E, Lopez- Medrano F, Remigia M, Almendro-Vazquez P, Polan - co N, Gonzalez E, Ruiz-Merlo T, Parra P, San Juan R, Andres A, Navarro D, Aguado J. SARS-CoV-2-spe - cific A, Clares-Villa L, Martin-Cortazar C, De Paz R, Marcos A, Vicario J, Balas A, Garcia- Sanchez F, Eguizabal C, Solano C, Mora-Rillo M, Soria B, Perez-Martinez A. SARS-CoV-2-specific 343 Perez A, Paro - dy R, Ferra C, Cadenas I, Herruzo B, Dorado N, Hernani R, Sanchez-Ortega I, Torrent A, Sierra J, Martino R, Spanish Grp Hematopoietic Stem. Severe infections and infection-related Sevoflurane well-handled in children is excellent, but in the wrong hands can be life-threatening. Monme - neu JV, Lopez-Lereu MP, Gavara J, Marcos-Garces V, Rios-Navarro C, Perez N, de Dios E, Nunez E, Sanchis J, Chorro FJ, Bayes-Genis A, Bodi V. Sex differences on Putter Kranenbarg R, L, T, Ten Tije A, Capdevila J, Hendriks M, Edhemovic I, Cervantes A, Nilsson P, Glimelius B, van de Velde C, Hospers G, Marcos H, Gutierrez G, Perez-Elias M, de Quiros J, Pulido F, Gorgolas M, Sanz J, Suarez-Garcia I, Fernandez M, Losa J, Perez J, Ladrero M, Prieto M, Gonzalez G, Izquier - do A, Viloria L, Lopez I, Martinez E, Castrillejo D, Aranguren R, Belmonte M, Aranda-Garcia I, Arrai - za A, Diaz A, Hospital Survey Study Group. Self- rated health among people living with HIV in study. Hernandorena M, Tajahuerce M, Rodriguez H, Bermejo B, Ramirez J, Burgues O, Diaz S, Alcala G, Ortega Guerra E, Manso L, Martin-Lorente C, Martinez-Garcia J, Perez-Fidalgo J, Varela M, Rubio Monllor P, Giraldo E, Badia M, de la Asuncion J, Alonso M, Lloret A, Vina J. Serum levels of cluste - Abreu-Gonzalez P, Ramos-Gomez L, Argueso M, severe trauma - tic brain injury. Anaesthesia Critical Care & Pain 344 344 list9700. Jongsma H, Gayer-Anderson C, Tarricone I, Velthorst E, van der Ven E, Quattrone D, di For - ti M, Menezes P, Del-Ben C, Arango C, Lasalvia A, Berardi D, La Cascia C, Bobes J, Bernardo M, Sanjuan Arias J, Santos J, Arrojo M, de Haan L, Tortelli A, Szoke A, Murray R, Rutten B, van Os J, Morgan C, Jones P, Kirkbride J, EU-GEI WP2 Group. Social disadvantage, M, Guillen-Climent S, Martinez-Casimiro L, Fabra M, Castro C. Soft nodule on the heel in an elderly male Martinez-Casimiro Fabra M, Castro C. Soft nodule on the heel in an elderly male patient: challenge. Machado I, Nieto Morales MG, Cruz J, Lavernia J, Giner F, Navarro S, Ferrandez may better predict patient outcome. Interna 30;22(17):9423. doi: 10.3390/ijms22179423. PMID: 34502329 704. Pascual T, Oliveira M, Ciruelos E, Ezquerra M, Saura C, Gavila J, Pernas S, Munoz M, Vidal M, Vila M, Ce - jalvo J, Gonzalez-Farre B, Espinosa-Bravo M, Cruz J, Salvador-Bofill F, Guerra J, Barrera A, de Dios M, Es - ker S, Fan P, Martinez-Saez O, Villacampa G, Pare L, Ferrero-Cafiero J, Villagrasa P, Prat A. SOLTI-1805 TOT-HER3 Meca-Lallana V, Gascon-Gimenez F, Martinez-Gines M, Ramio-Torrenta L, Costa-Fros - sard L, Fernandez O, Moreno-Garcia S, Medrano N, Maurino J, Casanova B. Short-term data on disease activity, cognition, stigma of patients with primary Tejada M, Perazzoli G, Nieto F, Cobos E. Sigma-1 receptor: a drug target for the mo Huang J, Liederer B, Meng R, Patel P, Deng Y, Cervantes A, Tabernero J, Musib L. and multiple-dose 97. Vilella F, Wang W, Moreno I, Roson B, Quake S, Si - mon C. Single-cell RNA sequencing of SARS-CoV-2 Cortes R, Redon J. Small Rab GTPases in intracellu - lar vesicle trafficking: the case of Rab3A/Raphillin- 3a complex in the kidney. International Journal A, Rungapiromnan W, Jiamsuchon P, Po - khagul P, Castro J, Saint-Gerons D, Ghukasyan G, Teferi M, Gupta M, Pal S. Smart Safety Surveillan - ce (3S): experience Cli Bayes-Genis A, Revuelta E, Mi\u00f1ana Escriva G, Santas Olmeda E, Llacer P, Gar - cia Blas S, Fern\u00e1ndez Cisnal A, Bonanad Lozano C, Ventura S, Sanchez R, Bod\u00ed Peris V, Cordero A, Fa - cila De La Esperanza R, Mollar Fernandez A, San - chis Fores J, heart international recommendations for - C, Mazon Ramos P, Garcia Sanz R, Virizuela J, Arenas M, Egocheaga Cabello I, Albert D, Anguita Sanchez M, Arrarte Esteban V, Ayala de la Pena F, Bonanand Lozano C, Castro A, Castro Fernandez A, Cordoba R, Cosin-Sales J, Chaparro-Munoz M, Dalmau R, Drak Hernandez Y, Deiros Bronte L, Diez-Villanueva P, Escobar Cer - vantes C, Fernandez Redondo C, Garcia Rodriguez E, Lozano T, Marco Vera P, Martinez Monzonis A, Mesa D, Oristrell G, Palma Gamiz J, Pedreira M, Reinoso-Barbero L, Rodriguez I, Serrano Antolin J, Toral B, Torres Royo L, Velasco Del Castillo S, Vicente-Herrero T, Zatarain-Nicolas E, Tamargo J, Lopez Fernandez T. Stratification and management of cardiovascular risk in cancer patients. A consen -705. Bhatt D, Szarek M, Pitt B, Cannon C, Leiter L, Mc - Guire D, Lewis J, Riddle M, Inzucchi S, Kosiborod M, Cherney D, Dwyer J, Scirica B, Bailey C, Diaz R, Ray K, Udell J, Lopes R, Lapuerta P, Steg P, SCO - RED Investigators. Sotagliflozin in patients with diabetes and chronic kidney Cannon C, Leiter L, McGuire D, Lewis J, Riddle M, Voors A, Metra M, Lund L, Komajda M, Testani J, Wilcox C, Po - nikowski P, Lopes R, Verma S, Lapuerta P, Pitt B, SOLOIST-WHF Trial Investigators. Sotagliflozin in patients with diabetes and recent worsening heart failure. New England Journal of Medicine. 17-128. Mira Caride-Miana in Spain: a cross-sectional study. Primary PMID: F, Sabater Orti L, Lo - pez-Ben S, Quijano Y, Villegas T, Blanco-Fernandez G, Diez-Valladares L, Lopez-Rojo I, Martin-Perez E, Pereira F, Gonzalez A, Herrera J, Garcia-Domingo M, Serradilla M. Spanish multicenter of pancreatic S, Lopez Castro R, Martinez Hernandez N, Mezquita Perez L, Moreno Casado P, Zabaleta Jimenez J. Long- term follow-up for operated patients with Garrido N, Cruz F, Egea R, Simon C, Sadler-Riggle - man I, Beck D, Nilsson E, Ben Maamar M, Skinner M. Sperm DNA Dolz A, Pellino G, Orbis F, Arroyo A, L, Martin-Gonzalez I. approaches G, A, doi: 10. 1097 M, Ballester Ferre M, Dorcaratto D, Villagrasa Manzano R, Mu\u00f1oz Forner E, G\u00f3mez Adri\u00e1n J, Sanchiz So - ler V, Sabater Orti L, Ortega Serrano J. Surgi - cal treatment of an intraductal papillary muci - nous neoplasm of the biliary Bodi Garcia A, Vila L, Marin P, Bernabeu A, Villarroel- Vicente C, Hennuyer N, Staels B, Franck X, Fi - gadere B, Cabedo N, Cortes D. Synthesis Almendro-Vazquez P, Gimenez E, Marcacuzco A, San Juan R, Justo I, sus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, A, Mosteiro F, Martinez D, Fernandez L, Soler JA, Parra L, So - lano R, Soro M, Del Campo R, Gonzalez-Luengo RI, Civantos B, Montiel R, Pita-Garcia C, satis - faction. International Journal of Environmental Re - doi: Latorre V, Frances-Gomez C, Ferrer J, Forque L, Costa R, de la Asuncion C, Huntley D, Gozalbo-Rovira R, Buesa J, Gimenez E, Rodriguez-Diaz J, Geller R, Navarro D. Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS-CoV-2 neutralizing ac Kola - revic R, Jamin Y, Yuan Y. SuperHistopath: a deep learning pipeline for mapping tumor heterogenei - on Rob - ba C, Zaid S, M, Badenes R. in with traumatic centesis guided by ultrasonography: an anatomi - cal study. Journal Orte - ga B, Moragon S, Rosello S, Insa A, Navarro J, Sanmartin A, Julve A, Buch E, Pena A, Franco J, Martinez-Jabaloyas J, Marco J, Forner MJ, Cano A, Silvestre A, Teruel A, Lluch A, Cervantes A, Chiri - vella Gonzalez I. Ten-year assessment of time since intervention, Martinez de Maranon A, Banuls C, Lopez-Domenech S, Rocha M, Hur - tado-Murillo F, M, Santos-Caballe - ro M, Gomez-Navas C, Tejada M, Nieto F. Tetrodo - toxin, Hedenstierna G, Jaber S, Hiesmayr M, Hollmann M, Mills G, Melo Calvo-Pulido J, Garcia-Sesma A, Manrique A, Caso O, Cambra F, Talayero P, Lopez-Medrano F, Remi - gia MJ, Ruiz-Merlo T, Parra P, Paz-Artal E, Jimenez C, Loinaz Navarro D, Laguna-Goya to SARS-CoV-2 in Luque M, Sanz-Alvarez M, Santamaria A, Zazo S, Cristobal I, de la Fuente L, Minguez P, Eroles P, Rovi - ra A, Albanell cardiology in the elderly. The Kotfis K, Jasch - inski U, Estella A, Leone M, Jakob S, Wittebole X, Fontes L, Gurgel M, Midega T, Vincent J, Ranieri V, SOAP ICON Investigators. Temporal changes in J, Alonso Salinas G, Vieitez Florez J, Ariza Sole A, Lopez de Sa E, Sanz Ruiz R, Burgos Palacios V, Raposeiras-Roubin S, Gomez Varela S, Sanchis Fores J, Silva Melchor L, Martinez-Seara X, Malagon Lopez L, Zamorano Gomez J, Sanmar - tin Fernandez M, CIVIAM Study Investigators. Tem M, Martinez-Manez R, Bagan-Debon L, Vina-Almunia A, Martinez-Santa - maria M, Ruiz-Luque M, Alonso-Fernandez J, Ba - nuls C, Saez G. The Effectiveness of glutathione redox status as a possible tumor marker in colo - rectal cancer. International C, Badenes Qui - les R. The effects of arterial CO2 on the injured brain: two faces of the same coin. Journal of 1016/j. jcrc.2020.10.028. Riera J, Fernandez-Barat L, Ceccato A, Perez-Arnal R, Garcia-Gasulla D, Pe - nuelas O, Lorente J, Rodriguez A, de Gonzalo-Cal - vol D, Almansa R, Gabarrus A, Menendez R, Ber - mejo-Martin J, Ferrer R, Villar R, Anon J, Barbera C, Barberan J, Ortiz A, Bustamante-Munguira E, Caballero J, Carbajales C, Carbonell N, Catalan- Gonzalez M, Galban C, Gumucio-Sanguino V, de la Torre M, Diaz E, Estella A, Gallego E, Garmendia J, Garnacho-Montero J, Gomez J, Huerta A, Gar - cia R, Loza-Vazquez A, Marin-Corral J, de la Gan - dara A, Varela I, Messa J, Albaiceta G, Novo M, Penasco Y, Pozo-Laderas J, Ricart P, Salvador-Ade I, Sanchez-Miralles A, chinesta S, Socias L, Sole- Violan J, Sipmann Lomas L, Trenado J, Barbe F, CIBERESUCICOVID Project Cov20 001 1, ISCIII. The evolution of the ventilatory ratio is a prognostic factor in mechanically ML, Pantoja L, Ler\u00edn-Lozano C, Garc\u00eda-D\u00edaz S, Galindo MJ, Ma - r\u00edn-Jim\u00e9nez I, Fern\u00e1ndez S, Mestre Y, Orozco-Bel - tr\u00e1n D. The experience with health care of patients with inflammatory arthritis: a cross-sectional sur - vey using instrument the experien - P, Wrigge H, Cambronero O, Ball L, de Abreu M, Pe - losi P, Schultz M, LAS VEGAS Study-Iinvestigators, PROtective VEntilation Network, European Soc Anaesthesiology. The Association - ve driving pressure with postoperative pulmonary complications in open versus posthoc propensity score- Richards A, Tripoli G, Ferraro L, Quattrone A, Marino P, Rodriguez V, Spi - nazzola E, Gayer-Anderson C, Jongsma H, Jones P, La Cascia C, La Barbera D, Tarricone I, Bonora E, Tosato S, Lasalvia A, Szoke A, Arango C, Bernardo M, Bobes J, Del Ben C, Menezes P, Llorca P, San - tos J, Sanjuan J, Arrojo M, Tortelli A, Velthorst E, Berendsen S, de Haan L, Rutten Lynskey Fre eman J, Sham P, O'Donovan M, Cardno A, Vassos E, van Os J, Morgan C, Murray R, Lewis C, Di Forti M, EU-GEI Collaborators. The continuity of effect of schizophrenia and patterns of cannabis be a setback for gender equality in Greenhalgh T, Gurdasani D, Kang G, Falade A, Busse R, E, Martinez-Cuadron D, Carreno-Tarragona G, Bergua J, Vives S, Alga - rra J, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lorenzo J, Vidriales M, Labrador J, Falantes J, Sayas M, Paiva B, Barragan E, Prosper F, Sanz M, Martinez-Lopez J, Montesinos P, PETHEMA Martinez-Useros J, Eroles P, Rovira A, Albanell J, Madoz-Gurpide J, novel oral 10.3390/can - c e r s13112778 754. Ortega R, Hueso L, Benito E, Ortega J, Civera M, Sanz M, Real J, Piqueras L. The nuclear retinoid-re - lated orphan receptor RORalpha controls adipose tissue inflammation in patients with morbid obesi - nadero R, Jimenez C, Rodriguez-Sodupe P, Boloix A, Toledano I, Guillen G, Navarro A, Llobet-Navas D, Villanueva A, Sanchez de Toledo J, Roma J, Nogue - ra R, Moreno L, Krauss R, Gallego S, Santamaria A, Segura M. The oral KIF1 1 inhibitor 4SC-205 Martinez-Ricos J, Teruel-Marti V, Blasco- Serra A, Lloret A, Celada P, Cervera-Ferri The oscillatory profile induced by deep brain stimula -746. Lopez M, Chiner-Oms A, Garcia de Viedma D, et al. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic key M, Del Rio M, J, Leira R, Trochet J, Pozo-Rosich P. Spanish. A, JR, G, Tosato S, Jongsma H, de Haan L, Tarricone I, Bernardo M, Velthorst E, Braca M, Arango C, Arrojo M, Bobes J, Del-Ben CM, Di Forti M, Gayer-Anderson J, A, Llorca PM, van Os J, Rutten BPF, Murray RM, Morgan C, Leboyer M, Szoke A, F. The independent Mart\u00edn-Moreno JM. The Influence of in - fection and colonization in with covid-19: are forgetting A, M, Lupon J, Husser O, Bayes-Genis A. The influence of sex and body mass index on the association between soluble neprilysin and risk of heart failu - re hospitalizations. Scientific Reports. 2021 M, Mezquida G, Gonzalez Pinto A, Berge D, Lobo A, Aguilar EJ, Usall J, Corripio I, Bobes J, Rodriguez Jimenez R, Sarro Contreras F, Ibanez A, Gutie - rrez M, Mico JA. The the background, rationale and study Revista Mental. 2021;14(3):164- 176. doi: 10. 1016/j.rpsmen.2021.08.001. M, Mezquida G, Gonzalez-Pinto A, Berge D, Lobo EJ, J, Corripio I, Bobes J, Rodriguez- Jimenez rrez M, Mico JA. The the background, rationale and study Revista Mental. 2021;14(3):164- 176. doi: 1016/j.rpsmen.2021.08.001. 763. Dabrowski D, C, Bade - nes R, Malbrain M. The prone position must ac - commodate changes in IAP in traumatic brain Smith- Ballester female reproductive tumors: over La Cascia C, La Barbera D, Sanchez- Gutierrez T, Tripoli G, Seminerio F, Sartorio C, Ma - rrazzo G, Sideli L, Arango C, Arrojo M, Bernardo M, Bobes J, Del-Ben C, Gayer-Anderson C, Jongs - ma H, Kirkbride J, Lasalvia A, Tosato S, Llorca P, Menezes P, Rutten B, Santos J, Sanjuan J, Sel - ten J, Szoke A, Tarricone I, Muratori R, Tortelli A, Velthorst E, Rodriguez V, Quattrone A, Jones P, Van Os J, Vassos E, Morgan C, de Haan L, Reininghaus U, Cardno A, Di Forti M, Murray The Ribelles A, Heredia A, Guerra-Garcia P, Verdu-Amoros J, Andres M, Ca - nete A, Rives S, Perez-Martinez A, Mora J, Patino- Garcia A, Lassaleta A, Llort A, Ramirez M, Mata C, Gallego S, Martin-Broto J, Cruz O, La Madrid A, Solano P, Romera I, Fernandez-Teijeiro A, Bautis - ta F, Moreno L. The paediatric cancer clinical re - search landscape in Spain: a 13-year multicentre experience of the new agents group of the Spanish Society of H, de Boer R, Emdin M, Gonzalez A, Jaarsma Jhund P, Mueller C, Nunez J, Rossignol P, Milinkovic I, Rosa - no G, Coats A, Seferovic P. The 'Peptide for Life' Ini - tiative: a call for action to provide equal access to the use of natriuretic peptides in the diagnosis of acute heart failure across Europe. European Jour - JE, Heitor M, Tabernero J, Schuz J, Baumann M, Henrique R, Aapro M, Basu P, Beets-Tan R, Besse B, Cardoso F, Carneiro F, van den Eede G, Eggermont A, Frohling S, Galbraith S, Garralda B, Kallioniemi O, Kasler M, D, Machado JC, Martin-Moreno JM, Me - unier Oliveiera K, Valentini V, Voest E, Weiderpass E, Wilking N, Wren A, Zitvogel L. The Porto European Can - cer - tential between of or he - REPORT list 9771. Carcamo-Calvo R, Munoz C, Buesa J, Rodriguez- Diaz J, Wolf D, Busque L, Hernandez-Boluda J, Swanink R, Regueira P, Lipton J. The safety and efficacy of dasatinib plus nivolumab in Pradera J, Bobes Gar - cia J, Moran-Barrios J, Ruiz De Gauna P, Saenz-He - rrero M, Aguilar Garcia Iturrospe E. summary Congress of Psychiatry. 2019. Revista de Psiquiatria Di S, Pienkowski T, Im YH, Valeria Bianchi G, Galbardi B, Dugo M, De Cecco L, Tseng LM, Liu MC, Bermejo B, Semiglazov V, Viale G, de la Haba-Rodriguez J, Oh DY, Poirier B, Valagussa P, Gianni L, Tagliabue E. classifier Dabrowski W, Bassetti M, Giacobbe D, Czosnyka M, Badenes R, Pelosi P, Matta B. The use of different compo - nents of brain oxygenation for the assessment of cerebral haemodynamics: a prospective ob - servational Amoretti S, Cuesta M, Fraguas D, Lobo A, Gonzalez-Pinto A, Diaz-Caneja M, Corripio I, Vieta E, Baeza I, Mane A, Garcia-Rizo C, Bioque M, Saiz J, Bernardo M, Mas S, Balanza Martinez V. The usefulness of premorbid adjustment and cognitive characteris - tics at first episode psychosis: findings from the EU-GEI study. Gomez-Casares Abuin Blanco A, Noya Pereira M, Raya J, Andra - de-Campos M, Alvarez A, Lewandowki K, Fox Golos A, Gasior Kabat M, Magro Mazo E, Czyz A, Martin Martin A, Bellosillo Paricio B, Quin - teiro Garcia C, Gonzalez Martin Stuckey R. The risk of thrombosis in essential thrombocythemia is associated with the type of R, Buesa J, Monedero V, Rodr\u00edguez-D\u00edaz J. The role of host glycobiology and gut microbiota in rotavi - rus and norovirus infection, an update. Interna - tional Journal role non- brain in Manzano A, Olivar LC, Nava M, Sa - lazar J, D'Marco L, Ortiz R, Chacin M, Guerrero- Wyss M, Cabrera de Bravo M, Cano C, Bermudez V, Angarita L. The role of the alpha Cell in the patho - genesis of diabetes: a world beyond the mirror. In - ternational Journal of Molecular Sciences. 2021 Jadraque-Rodriguez R, Moreno-Lopez P. The Is it time for a chan - ge?. Diabetes Research and Clinical Practi - A, Weisz N, Kleinjung T, Shekhawat G, Elgoyhen A, Song J, Andersson G, Adhia D, de Azevedo A, Ba - guley D, Biesinger E, Binetti A, Del Bo L, Cederroth C, Cima R, Eggermont J, Figueiredo R, Fuller T, Ga - llus S, Gilles A, Hall D, Van de Heyning P, Hoare D, Khedr E, Kikidis D, Kleinstaeuber M, Kreuzer P, Lai J, Lainez J, Landgrebe M, Li L, Lim H, Liu T, Lopez- Escamez J, Mazurek B, Moller A, Neff Park S, Piccirillo J, Poeppl T, Rauschecker J, Salvi R, Sanchez T, Schecklmann M, Schiller A, Sear - chfield G, Tyler R, Vielsmeier V, Vlaeyen J, Zhang J, Zheng Y, de Nora M, Langguth B. Tinnitus and tin - nitus disorder: theoretical defini - M, F, Rodriguez C, Barreiro-de Acosta M, Martinez-Cadilla J, Arroyo M, Mancenido N, Sierra-Ausin M, Vera-Mendoza I, Casanova M, Nos P, Gonzalez-Munoza C, Martinez T, Bosca Watts M, Calafat M, Busquets D, Girona E, Llao J, Martin-Arranz M, Piqueras M, Ramos L, Suris G, Bermejo F, Carbajo A, Casas-Deza D, Fer - nandez-Clotet A, Garcia M, Ginard D, Gutierrez- Casbas A, Hernandez Lucendo A, Marquez L, Merino-Ochoa O, Rancel F, Taxonera C, Lopez San - roman A, Rubio S, Domenech E, Gisbert J. Tofaci - tinib in ulcerative colitis: real-world evidence from the ENEIDA Registry. Journal of Crohn's & Colitis. olanzapine plasma concentrations in The USPSTF call to inaction on blood pressure screening in children and adoles - cents. Pediatric 778. Ampudia-Blasco F, Palanca A, Trillo J, Navarro J, Real J. Therapeutic inertia in patients with type 2 diabetes treated with A, Martinez-Hervas S, Gonzalez-Navarro H. Therapies for the treatment of cardiovascular disease associated with type 2 diabetes and dyslipidemia. International Journal of Molecular Sciences. 2021 Jan A, Guillen Cli - ment S, Porcar Saura S, Ramon multiorgan autoimmunity with prominent muco-cutaneous involvement: two ca - ses and review of the literature. International Jour - nal of Dermatology. 2021 Feb;60(2):e47-e49. Maldonado-Araque C, Lago A, Ocon P, Calle A, Castano L, Delgado E, Menendez E, Franch-Nadal J, Gaztambide S, Girbes J, Chaves F, S, P. Training, management, and quality of nursing care of vascular access in adult patients: the INCATIV Project. Journal of Vascu - Baena-Canada J, Lope V, Antolin S, Garcia-Saenz J, Bermejo B, Munoz M, Ramos M, de Juan A, San - chez C, Sanchez-Rovira P, Anton A, Brunet J, Gavila J, Salvador J, Arellano E, Bezares S, de Larrea-Baz N, Perez-Gomez B, Martin M, Pollan M. Trajecto - ries of alcohol consumption during life and the J, Suay-Garcia B, Climent J, Fal - co A, Valencia A, Puig-Butille J, Puig S, Tabares- Seisdedos R. Victor - diagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, depressive disorder, bipolar disorder, and schizophrenia: 34965401 798. Ballester M, Lluch P, Gomez C, Capilla M, Tosca J, Marti-Aguado D, Guijarro J, Minguez M. P, Durmusoglu F, Erkkola R, Goulis DG, Kiesel L, P, D, Tabares-Seisdedos Tor sade de pointes associated with chloroquine, hy - droxychloroquine, and azithromycin: a retrospec - of individual safety 33938974 Wong B, Green M, Reid J, Martin-Moreno J, Davi - dovitch N, Chambaud L, Leighton R, Middleton J. Toward 'Vac - cine Internationalism': the need for an equitable and coordinated global vaccination approach to effectively combat COVID-19. International Jour C, Posadas T, Bures E, Banuls P, Fernandez-Presa L, Royo P, Blasco M, in assistance a review of development assistance, government, out-of-pocket, and other private spending on health for countries and territories, Nacher J, Aguilar E. Training psychiatry residents in descriptive psycho - pathology: a DJ, Czerw Kroger N, Kos - ter L, Reinhardt HC, Angelucci E, Robin M, Born - hauser M, Passweg J, Clark A, Vydra J, Blau IE, Niittyvuopio P, a Ditschkowski M, Moonim M, Polverelli N, Robin P, Butler J, Desai A, Filippatos G, Gniot J, Fu M, Gu - llestad L, Howlett J, Nicholls S, Redon J, Schenken - berger I, Silva-Cardoso J, Stork S, Krzysztof Wra - nicz J, Savarese G, Brueckmann M, Jamal W, Nordaby M, Peil B, Ritter I, Ustyugova A, Zeller C, Salsali A, S. Underlying D, Spanic F, Vuksic M, Hof P. emotions: Wang W, Moreno I, Quake SR, Simon C. Understanding the human endometrium in the 21st century. American 15664. 800. Burkhardt B, Taj M, Garnier N, Minard-Colin V, Ha - zar V, Mellgren K, Osumi T, Fedorova A, Myakova N, Verdu-Amoros J, Andres M, Kabickova E, Attarbas - chi A, Chiang A, Bubanska E, Donska S, Hjalgrim L, Wachowiak J, Niggli F, Csoka M, Krivan G, Palma J, Burke G, Beishuizen A, Koeppen K, Mueller S, Herbrueggen H, Woessmann W, Zimmermann M, Balduzzi A, Pillon M. Treatment and outcome analysis of 639 relapsed non-hodgkin lympho - mas Sanfelix- Gimeno G. Treatment patterns and appropriate - ness of antipsychotic prescriptions al. Treatment with tocilizumab or for Trend in Spanish cardiology research and global comparative analysis of major topics. a retrospective analysis and critical as - sessment of a 10-year prospective national regis - Perez Hernandez J, Mart\u00ednez Arroyo O, Ortega Guti\u00e9rrez A, Galera Martos M, Solis Salguero M, Chaves Mart\u00ednez F, Red\u00f3n Mas J, Forner Giner M, Cort\u00e9s Vergaz R. Mielke S, Taskinen M, Blijlevens N, Rodriguez M, Solano C, Nikolousis E, Biffi A, Groll A, Junghanss F, Fagioli F, Knelange N, Wendel L, Gil L, de la Cama - ra R, Mikulska M, Ljungman P. Use of letermovir in Diseases Wor - king Party of Blood and Ma - Nichols E, Abd-Allah F, Abdoli et al. Use of mul and the Aging, Demographics, and Memory Study. BMC - cal Siwicka-Gieroba D, Robba C, Bielacz M, Badenes R. Usefulness of cerebral oximetry in TBI by NIRS. Journal of Lim E, Ro - senthal R, Martinez-Ruiz C, Hiley C, Al Bakir M, Salgado R, Moore D, Jamal-Hanjani M, Swanton C, McGranahan N, TRACERx Hernandez Mu - noz C, Calvo D, Fernandez-Armenta J, Garcia-Fer - nandez A, Zorio E, Arce-Leon J, Mosquera-Perez I, Arias M, Diaz-Infante E, Exposi - to V, Jimenez-Ramos V, Teijeira E, Canadas-Godoy M, Guerra-Ramos J, Oloriz T, Basterra N, Sousa 810. Alvarez-Larran A, Sant'Antonio E, Harrison C, Kilad - jian J, Griesshammer M, Mesa R, Ianotto J, Palan - dri F, Hernandez-Boluda J, Birgegard S, Rumi E, Barbui T. Unmet clinical - in the management of CALR-mutated essential thrombocythaemia: a consensus-based Rodriguez-Nogales C, Martin-Vano S, Vicente-Mu - nuera P, Canete A, S, R. Unraveling matrix- aid better COVID-19 and STEMI: an emerging need for knowledge sharing. American Journal of Physiology-Heart and 33716105 Costa R, Bueno F, Albert E, Torres I, Carbonell-Sahu - quillo S, Barres-Fernandez A, tract SARS-CoV-2 loads in symptomatic and A, Martinez-Arroyo O, Perez-Gil D, Olivares D, Solaz E, Martinez F, Martinez-Hervas S, Chaves F, Redon J, Ruiz-Gaitan A, Salavert M, Tormo M, Peman J. What do we know about candida auris? sta - te of the art, knowledge 34391694 829. Castro R. What ingredients are essential for the recipe of a M. When animals cry: the effect of adding tears to animal expressions on human jud - gment. Lorenzo-Salazar J, Corrales A, Prieto-Gonzalez M, Rodriguez-Perez A, Carriedo D, Blanco J, Ambros A, Gonzalez-Hi - gueras E, Casanova N, Gonzalez-Garay M, Espino - sa E, Muriel A, Dominguez D, de Lorenzo A, Anon J, Soro M, Belda J, Garcia J, Villar J, Flores C, Ge - netics Sepsis GEN-SEP Network. Whole-Blood mi - tochondrial Garcia-Bolao I, Gonzalez-Juanatey J, Brugada R, Gimeno J, Brugada J, Arbelo E. Va - lidation of multiparametric approaches for the of Aug 31:S1885-5857(21)00223-1. doi: 10. 1016/j. r e c . 2 0 21. 0 7. 0 0 7. P M I D : 3 4 479 8 4 5 822. Harrois A, Anstey J, van der Jagt M, Taccone F, A, G, Quiles R, Prowle Ercole A, Oddo M, Schneider A, Wolf S, Helbok R, Nelson D, Cooper D, Bellomo R, TBI Co - llaborative. reduced expression of the with increased carotid intima media thickness: a cross-sectional study in late women. Medici - ne. 2021 1 1;100(23):e26216. doi: 1097 P. Vitamin D receptor gene ApaI and FokI polymorphisms and its association with inflammation and Gonzalez- Jimenez Vitamin status in pediatric and young adult cystic fibrosis patients. Are the new recommendations effective?. Nutrients. 9trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representati - ve studies sive TLR7 deficiency in ~1% of men 60 years with life-threatening COVID-19. Hernandez M, Gea A, Arruti E, Aldecoa C, Martinez-Palli G, Martinez-Gonzalez M, Slutsky A, Villar Spanish Network. features, ventilatory management, and outcome are similar to of Intensive Care A, Burge Mone dero P, Tamayo E, Alvarez J, Murie M, Wijeysundera DN, Vives M, Vives M, Mendez E, Pasqualetto A, Mon T, Pita R, Varela MA, Esteva C, Pereira MA, Sanchez J, Rodriguez MA, Garcia A, Carmona P, Lopez M, Pajares A, Vicente R, Aparicio R, Gragera I, Calderon E, Cande - la A, Marcos JM, Gomez L, Rodriguez JM, Matilla A, Medina A, Morales L, Santana L, Garcia E, Monedero P, Montesinos S, Munoz P, Bravo B, Alvarez J, Blanco V. Corrigendum to X, Sobas M, Guerci-Bresler A, Garrido A, Pigneux A, Gil C, Raffoux E, Tormo M, Vey N, de la Serna J, Salamero O, Lengfelder E, Levis MJ, Fenaux P, Sanz APL patients frontline or without arsenic trio - M, Real F, Villamonte M, de Villarreal J, Perez M, Andaluz A, Moll X, Berjano E, Dorcaratto D, Sanchez-Velazquez P, Cl\u00ednico of Valencia INCLIVA Health Research Institute2021 SCIENTIFIC REPORT Avda. Men\u00e9ndez Pelayo, 4 accesorio \u00b7 46010 Valencia (Espa\u00f1a) Tel. 34 96 197 35 17 Fax 34 96 197 35 40 "}